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Summary 
The aims of this thesis were to characterise further lesion-induced impairments in 
unilateral rodent models of Parkinson’s disease (PD) on a more cognitive level and to 
investigate the effects of cell replacement therapies on these tests.  
 
Chapter 3.1 deals with the effects of dopamine depletion on a lateralised choice 
reaction time task in the Skinner box as this apparatus is more widely available than 
the 9-hole boxes on which initial studies have been based. Unilateral near complete 
lesions of the nigro-striatal pathway induced a stable side bias that was comparable 
to the lesion-induced deficits that have been reported in the 9-hole box apparatus. 
Chapter 3.2 reports on the effects of similar lesions on a more spatial reaction time 
task and the effects of engraftment of dopamine rich tissue in the denervated 
striatum. The lesions induced a spatial bias that was only marginally improved by the 
cell transplantation, clearly showing the limitations of ectopic graft placement. 
Nevertheless, small but significant improvements on that task could be shown as 
grafted animals performed with higher accuracy and had reduced movement times 
compared to the lesion only counterparts. Chapter 3.3 explores the lesion-induced 
deficit in more detail by implementing an error correction rule on the operant task to 
enforce a change in the animals’ response strategy. The results of this chapter 
confirmed earlier findings, that the dopamine depletion produced by the lesion gives 
rise to a strong near hole bias on the contralateral side which did not recover, even 
with extensive post lesion testing, i.e. the lesion-induced deficit is most likely to be 
caused by a misrepresentation of response space, rather than caused by a shift in 
response strategy. 
 
The second strand of this thesis focuses on the development of mouse models of 
similar dopamine-depleting lesions that are typically used in rat models of PD. In 
Chapter 3.4 the three most common lesion models are compared to each other on 
an extensive battery of simple motor tests. The aim was both to characterise the 
behavioural impact of dopamine depletion in different sites, as well as to identify 
appropriate hand tests, capable of distinguishing lesions greater than 70% depletion. 
The differences and similarities between lesions were evaluated and correlations 
between behavioural performance and nigral cell loss were observed. In Chapter 3.5 
I developed parameters which allowed application of the lateral choice reaction time 
task to mouse models of dopamine depletion. Here I demonstrate the effects of two 
lesions, either to the medial forebrain bundle or the substantia nigra, on the same 
task conducted in mice. Lesioned mice of the former group displayed a stronger 
deficit largely because of the larger dopamine depletion. Subsequently, in Chapter 
3.6 I characterise the effects of primary fetal tissue grafts on the previously 
established model and task. Primary fetal tissue was able to ameliorate some of the 
lesion-induced deficits on an operant choice reaction time task and a series of simple 
motor screens. 
 
The results of both strands of research in the present thesis have implications for the 
understanding of the cognitive and motor deficits that are induced by the most 
commonly used lesion model of PD and for the parameters that can be recovered by 
cell replacement therapies. The primary fetal tissue will serve as a baseline, against 
which future stem cell based therapies can be measured. 
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Foreword on the format of this thesis 
Following planning the submission of this thesis my supervisor Professor Stephen B. 
Dunnett suggested to submit the present work as a series of self-contained 
publications which have either been accepted for publication, are submitted and 
currently under review, or are in preparation for submission. This format of thesis 
submission has been adopted in agreement with the former head of graduate studies 
Professor Vic Duance, Head of Biosciences and the University of Cardiff.  
 
The submission by paper format has the advantages of (i) conducting and planning 
experiments that are suitable for submission to journals, (ii) all of the results of the 
work conducted can be cited and used for future work already at the time of thesis 
submission, (iii) publications prior to submission are highly advantageous for the 
candidate’s CV as they can be a proof of productivity, (iv) the process of peer-review 
and manuscript submission, an important component in the overall scientific process 
of bringing experimental results into the public domain and are, in my opinion, 
essential for the education of a young researcher, (v) peer-reviewed publications are 
essential in many European countries to obtain a PhD and therefore submitting in the 
paper format is important when applying for international jobs in countries that are 
not familiar with the U.K. system, and (vi) the critical process offered by peer-review 
has the potential to strengthen my writing of the submitted work and to aid my 
preparation for the thesis defence, as the ideas and results contained therein will 
already have been scrutinised - and where necessary challenged - by experts in the 
field. 
 
The general introduction and discussion as well as the methods sections are 
presented in the conventional thesis format, but they are reduced in length as the 
individual manuscripts will provide full information about the respective procedures. 
Some of the presented publications have multiple authors as conducting scientific 
research depends on collaboration, interaction and the exchange of ideas. In the 
introduction of each experimental chapter a brief statement provides the information 
about the input of each author in the presented experiment. Especially in 
experimental chapter 3.4 I fully acknowledge the close collaboration with Dr. Gaynor 
Ann Smith, a former fellow PhD student within the same research group in Cardiff. 
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Abbreviations 
The abbreviations listed below will be used throughout this thesis. Abbreviations 
other than these will be clearly labelled in the text/figure legend.  
 
5-HT   Serotonin 
6-OHDA  6-hydroxydopamine 
ACh   Acetylcholine 
AChE   Acetylcholinestherase 
ANOVA  Analysis of Variance 
AP   Anterior-Posterior 
BDNF   Brain Derived Neurotrophic Factor  
BBB   Blood brain barrier 
CV   Cresyl Violet 
DA   Dopamine 
DARPP-32   Dopamine and cyclic AMP-regulated phosphoprotein 
DAT   Dopamine transporter 
DMEM   Dulbecco’s modified eagle’s medium 
DV   Dorsal-Ventral 
E   Embryonic Day 
EpiSC   Epiblast derived stem cell 
ESC   Embryonic stem cells 
GABA   "-Aminobutyric acid  
GFP   Green flourecent protein 
GPi/e    Globus pallidus (internal/external) 
HD   Huntington’s disease 
iPSC   Induced pluripotent stem cells 
ITI   Inter trial interval 
LX   Post lesion 
ML   Medial-Lateral 
MFB   medial forebrain bundle 
MSNs   Medium spiny neurons 
NeuN   Neuronal nuceli 
PBS   Phosphate buffered saline 
PD   Parkinson’s disease 
PFA   Paraformaldehyde 
SN   Substantia nigra 
SNpc   Substantia nigra pars compacta 
STN   Subthalamic nucleus 
TH    Tyrosine-hydroxylase 
TBS   Tris-buffered saline 
TNS   Tris Non Saline 
TOI   Time out interval 
TX   Post graft 
TxTBS   Triton X-100 TBS 
UPDRS  Unified Parkinson’s disease rating scale 
VMAT   Vesicular monoamine transporter 
VTA   Ventral tegmental area 
wGE   whole ganglionic eminence
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Chapter 1 General Introduction 
1.1 What is Parkinson’s disease? 
Parkinson’s disease (PD) was firstly described by the surgeon James Parkinson who 
in 1817 published his classic monograph about six cases that all show similar 
symptoms, which he termed “shaking palsy” and now, two centuries later, the 
disease is named after its discoverer (Parkinson, 2002). He noted that all cases had 
in common: involuntary muscle movements, reduction of muscle tension, and 
postural instability whilst (he claimed) showing no signs of cognitive dysfunction 
(Parkinson, 2002). One of the key symptoms Parkinson recognised was tremor at 
rest. In later stages of the disease patients appeared to suffer from additional sleep 
disturbances, difficulties in walking and swallowing, and agitation (Forno, 1996; 
Parkinson, 2002). An important key factor that distinguished this form of palsy from 
others was the tremor that occurred at rest when the patient did not execute any 
voluntary movements. According to the international classifications of diseases (ICD-
10) published by the World Health Organisation, PD falls within the category of 
extrapyramidal and movement disorders (G20), which encompasses patients with 
hemiparkinsonism, idiopathic parkinsonism, paralysis agitans, Parkinson’s disease 
NOS (not otherwise specified), and primary Parkinson’s disease (WHO, 1992). PD 
affects 0.3% of the entire population and 1% of the over 60s. Although disease onset 
is seldom before the age of 50, there is a steep increase in prevalence after the age 
of 60 (Forno, 1996; de Lau & Breteler, 2006). 
 
1.2 Economic considerations 
In the United Kingdom each of the 109,806 patients which have been diagnosed with 
PD are estimated to produce annual costs of £13,804 and the cost for the 1.2 million 
patients across Europe is estimated to cost an average #13.933 billion (McCrone et 
al., 2007; Lees et al., 2008; Gustavsson et al., 2011). Demographic changes predict 
an increase in the number of elderly people, and hence the number of PD patients. 
As health care costs are constantly rising it is imperative to find remedies that cure, 
halt, or slow down the progression of the disease as well as improve the patients’ 
quality of live. The European Union has realised that investments have to be 
undertaken now and currently 339 programs are funded under the EU 7th framework 
programme (http://cordis.europa.eu). The Brain Repair Group at Cardiff University is 
involved in three of such multinational research networks: NeuroStemCell, TansEuro, 
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and REPLACES. These grant consortia aim to push forward on important issues to 
get cell replacement therapies into the clinic. 
 
1.3 Pathology  
PD is now defined as a progressive, neurodegenerative disorder, in which the 
underlying pathology consists, among others, of a prominent degeneration of the 
pigmented, dopaminergic neurons in the substantia nigra pars compacta (SNpc), a 
brain structure in the ventral tegmental region of the brain (Olanow & Tatton, 1999; 
Lees et al., 2008). Alongside to the overt loss of DAergic cells in the SN, histology of 
patients’ brains has revealed fibrilisation of the protein $-synuclein throughout the 
brain, which leads to the formation of intracellular inclusions called Lewy bodies and 
Lewy neurites (Spillantini et al., 1997; Spillantini et al., 1998; Spillantini, 1999). Lewy 
bodies are of globular shape and mainly found in the cell perikarya whereas the Lewy 
neurites are spindle-like filaments and granular material located in the cellular 
processes (Braak et al., 2003). 
 
The motor impairment in PD is attributed to a dysfunction and degeneration in the 
nigro-striatal DA pathway. In the healthy brain DAergic neurons from the SNpc send 
afferents to the caudate-putamen (striatum) which is important, within the basal 
ganglia, for controlling voluntary movement, action selection, and stimulus-action 
associations (Hauber, 1998; Hayes et al., 1998; Blandini et al., 2000; Packard & 
Knowlton, 2002; Nicola, 2007; Rang et al., 2007). Although other neurotransmitter 
systems, such as the serotonergic (5-HT), the acetylcholinergic (ACh), and the (nor-) 
adrenergic systems are affected as well, the primary neuropathology of PD is the 
degeneration of the neurons in the SNpc causing the depletion of striatal DA levels.  
 
The Russian Konstantin Tretiakoff was the first who described in his doctoral thesis 
(1919) the loss of pigmented cells (‘black stuff’) in the SN togther with swelling of the 
remaining cell bodies in 54 brains of PD patients (Lees et al., 2008). Carlsson and 
colleagues found that 3,4-dihydroxyphenylanine (a DA precursor) was able to 
reverse akinetic effects of reserpine-treated rabbits and mice (Carlsson et al., 1957). 
Ehringer and Hornykiewicz were the first to report in 1960 the relation between the 
loss of DA in the striatum in patients diagnosed with idiopathic PD and 
postencephalitic PD (Ehringer & Hornykiewicz, 1998). Although they proposed the 
location of the DAergic cell bodies to reside within the striatum (large multipolar 
neurons), their finding was of utmost importance for establishing the hypothesis that 
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DA is not just a precursor of noradrenaline but a neurotransmitter in its own right, 
and, furthermore, that it is the loss of DA in the striatum that causes the akinetic 
symptoms seen in PD (Ehringer & Hornykiewicz, 1998). It has been shown 
subsequently by the use of the new flourecent method that the DAergic cell bodies 
actually reside in the SN and that they are projecting and innervating the striatum 
(Dahlstrom & Fuxe, 1964). In addition to the loss of DA neurons, protein 
aggregations (Lewy bodies) can be found within the brain of patients (Rinne et al., 
1989; Rinne, 1991; 1993; Spillantini et al., 1997; Spillantini et al., 1998; Harding & 
Halliday, 2001). The cytoplasmic accumulation of the misfolded protein $-synuclein 
has been linked to cell death via apoptosis in PD, although the exact mechanism 
remains elusive. Transgenic animal models which overexpress $-synuclein have 
been developed and were useful for studying the effect of agents that prevent/inhibit 
the misfolding of the protein (Lotharius & Brundin, 2002a; b; Soto, 2003; Buchman & 
Ninkina, 2008; Chesselet, 2008). In the human brain, Lewy bodies have been located 
throughout the brain of PD patients and the spread of these protein aggregations in 
PD is suggested to follow a defined pattern (Braak et al., 2003; Braak et al., 2005; 
Braak et al., 2006).  The pathology is first observed in the olfactory tubercle and the 
dorsal motor nucleus and then is seen to spread to include the ventral medulla, raphe 
nucleus, locus coeruleus and the SNpc. From there the pathology spreads further to 
the nucleus basalis of Meynert and amygdala and subsequently affects the cerebral 
cortex (Braak et al., 2003; Braak et al., 2005; Braak et al., 2006). For a detailed 
description of pathology spread the reader is referred to Braak et al. (2003).  
 
1.4 Symptomatology 
PD is primarily considered a movement disorder with the following hallmark 
symptoms: akinesia (inability to initiate movement), bradykinesia (slowness in the 
execution of movement), hypokinesis (diminished or reduced movement), postural 
instability, muscular rigidity, and resting tremor (4-6 Hz) (Olanow & Tatton, 1999; 
Deumens et al., 2002; Parkinson, 2002; Dauer & Przedborski, 2003; Bove et al., 
2005; Rang et al., 2007). Common comorbidity with PD is depression, dementia 
(poor concentration, general slowness of cognitive speed, memory loss), 
hallucinations and psychosis (most related to high doses of levodopa), and sleep 
disturbances, as well as anxiety, impulsivity and fatigue have been reported 
(Shulman et al., 2001; Racette et al., 2002; McDonald et al., 2003; Leibson et al., 
2006; Bertram & Williams, 2012; Latoo et al., 2012). As the disease is progressive, 
symptoms usually worsen with time. Whilst at the onset of the disease many 
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symptoms can present themselves unilateral, at later stages of the disease the entire 
body is affected (Frank et al., 2006). Dementia, autonomic dysfunctions, postural 
instability and heightened mortality risk are common in advanced PD (Olanow & 
Tatton, 1999; de Lau et al., 2005). 
 
Diagnosis of PD is difficult for the physician as a defitive confirmation can only be 
established post-mortem. As the disease is progressive the symptoms are small in 
the beginning and can easily be missed if not searched for. Next to the classical 
tremor, rigidity, akinesia, and postural instability, clinicians can notice micrography, 
changes in gait, facial expression, and loss of olfactory function (Frank et al., 2006). 
Although brain imaging does not provide conclusive evidence, newly developed 
techniques as DAT-imaging can help diagnostics (Scherfler et al., 2007; Felicio et al., 
2009; Brooks, 2010) as well as a trial period on levodopa-carbidopa for several 
weeks might be considered (Frank et al., 2006).  
 
1.5 Etiology 
The etiology of PD is largely unknown but genetic and environmental factors do play 
a role. About 90% of the cases are idiopathic, while the remaining 10% are ascribed 
to inherited genetic mutation (‘familial PD’), in which the disorder is thought to be 
manifest due to underlying genetic predispositions and/or environmental factors. 
Specific risk factors for developing PD include exposure to pesticides, herbicides, 
industrial chemicals, farming, living in a rural environment, as well es exposure to 
exogeneous toxins as trace metals, cyanide, and organic solvents (Olanow & Tatton, 
1999). Several genes have been identified that are involved in the development or 
heightened risk of developing PD (dominant or recessive), which are $-synuclein, 
Parkin (PARK2), UCHL-1 (PARK5), DJ-1 (PARK7), PINK1 (PARK6), LRRK2 
(PARK8), NR4A2 (NURR1), PARK3, PARK4, PARK9, PARK10 and PARK11 (de Lau 
& Breteler, 2006). Importantly, certain genetic abnormalities do heighten the risk for 
PD (Olanow & Tatton, 1999; de Lau & Breteler, 2006) but disease development is 
less certain as in other degenerative disease as Huntington’s disease (HD). Most 
frequently herbicides and pesticides are associated with a higher risk of developing 
PD. Rotenone is one commonly used pesticide and exposure has been linked with 
the formation of Lewy bodies and some parkinsonian symptoms (Tanner et al., 2001; 
Tanner et al., 2009). In the more common idiopathic form of PD, the progression of 
the disease is relatively slow. The first overt motor abnormalities are usually detected 
after approximately 80% of the nigral neurons are lost and the striatal DA levels are 
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depleted to 60% - 80% of the original levels (Berhnheimer et al., 1973; Price et al., 
1978; Mardsen, 1983; Uhl et al., 1985; Uhl et al., 1994; Rang et al., 2007). 
 
1.6 Cognitive symptoms in PD 
Traditionally research has focused on the more overt motor symptoms of the 
disease. Recently research has shown that PD patients also exhibit cognitive and 
psychiatric impairments. These cognitive impairments may even precede the first 
overt motor symptoms. A considerable subset of patients report episodes of 
depression, which can be as disabling as the motor impairments because they can 
reduce the patients’ quality of life (Kuopio et al., 2000). Non-motor symptoms include 
neuropsychiatric symptoms (depression, apathy, anxiety, anhedonia, attention deficit, 
hallucinations, dementia, and panic attacks), sleep disorders (restless leg, REM 
sleep behaviour disorder, non-REM sleep-related movement disorder, daytime 
somnolence, vivid dreaming, insomnia, sleep-disordered breathing), autonomic 
symptoms (bladder disturbances, sweating, orthostatic hypotension, sexual 
dysfunction, dry eyes), gastrointestinal symptoms (dribbling of saliva, ageusia, 
dysphagia, reflux, nausea, constipation, faecal incontinence), sensory symptoms 
(pain, paraesthesia, olfactory disturbance), as well as fatigue, diplopia, blurred vision 
and weight loss (Chaudhuri et al., 2006). The most prominent cognitive impairments 
in patients, present as disturbances in memory, attention, executive function, and 
visuospatial function (Aarsland et al., 2010). Furthermore, PD patients in early stages 
of the disease have been shown to perform worse on several 
cognitive/neuropsychological tests when compared to age-matched healthy controls 
(Lees & Smith, 1983; van Spaendonck et al., 1998; Cools et al., 2010). Performance 
on the Wisconsin Card Sorting Task revealed that PD patients produce more 
perseverative errors and show difficulties in switching between response sets, 
although they do not show an impairment in their general intelligence score as 
determined by the Wechsler Adult Intelligence Scale (Lees & Smith, 1983). Taken 
together, although the predominant disabling nature of the disease is mainly linked to 
the motor component, the non-motor symptoms appear to impact more greatly on 
impairing the quality of patient life (Chaudhuri et al., 2006; Aarsland et al., 2010). 
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1.7 The basal ganglia and the striatum 
The human striatum consists of two nuclei, the caudate nucleus and the putamen, 
which are separated by the internal capsule. The striatum is considered to be part of 
a larger set of nuclei which together make up the basal ganglia: comprising the 
striatum, the internal and external segment of the globus pallidus (GPi and GPe), the 
subthalamic nucleus (STN), and the substantia nigra pars reticula (SNpr) and pars 
compacta (SNpc). The striatum is the main input structure of the basal ganglia 
whereas the GP and the SNpr are the output nuclei. The striatum has four major 
inputs, which are topographically organized from the cortex and the thalamus 
(glutamatergic) and more diffusely from highly branched brain stem regions (DAergic 
and serotonergic). The neurons in the GPe/GPi, STN and SN display autonomous 
pacemaker activity, i.e. always providing a tonic level of activation/suppression, 
depending on their respective neurotransmitter (Gerfen, 1984; 1985; Joel & Weiner, 
1994; 1997; Bolam et al., 2000; Joel & Weiner, 2000; Gerfen & Surmeier, 2011; 
Mathai & Smith, 2011). The output of striatal information processing terminates 
ultimately in the thalamus where activation leads to a facilitation of movement, 
whereas an inhibition has the opposite effect.  
 
The basal ganglia are a functionally heterogeneous group of nuclei through which 
pass several distinct but parallel interconnected pathways or loops of connections, 
named after the functional associations of the particular cortical areas from which 
each loop originates (Alexander et al., 1986; Alexander & Crutcher, 1990; Alexander 
et al., 1990; Wichmann & DeLong, 1996). Thus, each ’cortico-striatal’ loop arises 
from a different part of the cortical mantle and projects to topographically different 
areas within the striatum, the GP, and the thalamus, where information is processed 
and eventually fed back to the cortical areas of origin as well as exhibiting a degree 
of convergence on cortical and subcortical motor outputs. Although the loops are 
thought to run in parallel, there is considerable overlap as well as exchange of 
information between the individual loops. The motor loop (control of facial, limb and 
trunk muscles), for example runs from the cortex to the supplementary motor area, to 
the putamen, and further to the GPi/SNr and ends in the ventral-lateral thalamus from 
which information is fed back into the cortex (Alexander & Crutcher, 1990; Alexander 
et al., 1990). Other proposed loops are the oculomotor loop (controls saccadic eye 
movements), the dorsolateral-prefrontal loop (exectutive functions), the lateral 
orbitofrontal loop and the anterior-cingulate loop (emotions) (Alexander et al., 1986).  
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The output projections of the striatum have been divided into a direct and an indirect 
pathway. The direct pathway projects from the striatum to the GPi and SNpr and from 
there to the thalamus. The indirect pathway projects from the striatum to the GPe, 
which in turn projects to the GPi and the SNpr, which further terminates in the 
thalamus. A second projection from the GPe projects to the STN which then projects 
to the GPi and the SNpr (see Figure 1.1 and Figure 1.2). Although nowadays the 
clear cut distinction has been questioned as there is some overlap between the 
pathways, it still remains a good heuristic on a conceptual level (Mathai & Smith, 
2011).  
 
 
Figure 1.1. Schematic representation of the circuitry of the basal ganglia motor loop 
in the normal (left side panel) and parkinsonian (right side panel) brain. Adapted from 
Wichmann and DeLong (1996). Abbreviations: SNpc = substantia nigra pars 
compacta; SNpr = substantia nigra pars reticula; STN = subthalamic nucleus; GPi = 
globus pallidus internal segment; GPe = globus pallidus external segment. Red 
arrows represent excitatory connections; blue arrows represent inhibitory 
connections. Note that in the parkinsonian state the net output of the GPi/SNpr 
results in a suppression of the pacemaker activity of the thalamus. 
 
The basal ganglia circuitry mainly uses "-amino-butyric acid (GABA) as the inhibitory 
neurotransmitter and glutamate as the excitatory neurotransmitter. From the cortex 
excitatory glutamatergic connections terminate in the STN and in the striatum 
together with DAergic projections from the SNpc. The striatum uses GABA and 
substance P as inhibitory neurotransmitters along the direct pathway from the 
striatum to the GPi/SNpc in contrast to GABA and enkephalin in the indirect pathway 
to inhibit GPe. There are two main classes of DAergic receptors in the striatum (D1 
and D2 type) via which this structure can be excited (D1 receptors) or inhibited (D2 
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receptors), with a bias to D1 influence over direct pathway projections and D2 
influence over indirect pathway projections (Yung et al., 1995; Yung et al., 1996). 
From the STN excitatory glutamatergic projections target in the GPi/SNpr. The output 
from the latter structure to the thalamus is inhibitory and GABAergic (Alexander & 
Crutcher, 1990; Wichmann & DeLong, 1996; Hauber, 1998). The direct and indirect 
pathways can be distinguished by their neurotransmitter expression (direct pathway: 
Dynorpnin, Substance P; indirect pathway: Enkephaline) as well as by relative 
expression of D1 and D2 like receptors, respectively (Gerfen & Surmeier, 2011). The 
direct pathway sends its outputs to the GPi and the SNpr, which both forward the 
information to the thalamus, whereas projections from the indirect pathway mainly 
innervate the GPe (Crittenden & Graybiel, 2011). This striatal circuitry comprising 
direct and indirect pathway allows for different degrees of inhibitory effects on the 
thalamus. If the normal balance is disturbed as in PD or HD, the thalamus can 
receive too much inhibition due to an overactive indirect pathway (PD), resulting in 
inhibition of movement as seen in PD, or it can lead to the opposite, a facilitation of 
movement due to too little inhibition of the thalamus as in HD (Wichmann & DeLong, 
1996). Although the direct/indirect pathway model is an oversimplification of the 
actual anatomy of the human basal ganglia with its parallel and overlapping loops the 
model has great explanatory value (Mathai & Smith, 2011). 
 
The neurons of the striatum are principally classified by size and morphology and 90-
95% of striatal neurons are termed medium and spiny neurons (MSNs) which can be 
further classified into four subgroups, depending on their co-expression of GABA with 
other neurotransmitters. One type is associated with parvalbumin and D2 receptors, 
whereas another type coexpresses calretinin. Type three coexpresses somatostatin, 
neuropeptide Y, NOS, and D2 receptors, whereas type four coexpresses choline 
acetyltransferase (ChAT) and dopamine- and cAMP-regulated neuronal 
phosphoprotein) DARPP-32 (Hirsch et al., 1989; Holt et al., 1997; Crittenden & 
Graybiel, 2011). 
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Figure 1.2.  Schematic representation of the direct (A.) and the indirect (B.) pathways of the 
basal ganglia (adapted from Graybiel, 2001). 
 
Another distinction of striatal organisation can be made by their neurotransmitter 
staining for acetylcholinesterase (AChE) and opiate-receptors, which have revealed 
darker stained “patches” or “striosomes” and matrix regions with lighter or a lack of 
staining within the striatum. Patches are generally defined by their high opiate 
receptor binding whereas matrix cells are staining for AChE (Gerfen, 1984; 1985; 
Gerfen et al., 1985; Gerfen et al., 1987; Nastuk & Graybiel, 1988; Hirsch et al., 1989; 
Jimenez-Castellanos & Graybiel, 1989). Neurons within the matrix mainly project to 
associative and sensorimotor regions of the cortex, whereas those of the patch 
regions project to the limbic system and are the only region in the striatum that 
contains cells that possess direct synapses with DAergic cells in the SNc (Holt et al., 
1997; Crittenden & Graybiel, 2011). The patches are densely innervated by 
projections from orbitofrontal, anterior cingulated, insular cortex whereas matrix 
MSNs are mainly innervated by terminals that originate from somatosensory, motor 
and association cortices (Crittenden & Graybiel, 2011). Both, patches and matrix, 
receive DAergic input from the SNpc, although from different regions. The ventral tier 
of the A9 cell group predominantly projects to patches, whereas cells from the dorsal 
tier of the SNc, as well as cells from the retro-rubal area (A8) and VTA (A10) 
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innervate the matrix (Gerfen et al., 1985; Gerfen et al., 1987; Joel & Weiner, 2000). 
DA in the striatum is not only involved in the facilitation of movement, but also it has 
been implicated in decision-making processes. Although DAergic cells in the SNpc 
display pacemaker like activity patterns and provide tonic DA levels in the striatum, 
when an animal encounters a positive reward, DA release is temporarily increased 
whereas it is temporarily decreased in aversive events. These findings have linked 
the phasic DA signal to be attributed to the concepts of promoting long-term 
depression and long-term potentiation, the underlying mechanisms of learning 
(Gerfen & Surmeier, 2011).  
 
1.8 Pharmacological treatment of PD 
None of the pharmacological compounds tested so far have been able to halt, slow, 
or reverse the progression of the disease, as also with all other therapeutical 
approaches. The majority of compounds available are aimed at increasing the 
availability of DA in the brain, thereby restoring the neurotransmitter that is lost during 
disease progression. DA is synthesized from L-tyrosine via the rate limiting enzyme 
tyrosine-hydroxylase to L-Dihydroxyphenalaline (l-DOPA, Figure 1.3). Via DOPA 
decarboxylase and Aromatic L-amino acid decarboxylase, l-DOPA is then 
transformed to DA. DA can be further synthesised to noradrenaline via DA-%-
hydroxylase and from there via Phenylethanolamine N-methyltransferase to 
adrenaline. The most successful line of research has been in restoring the levels of 
DA in the brain by administration of levodopa (l-DOPA), a DA precursor that crosses 
the blood brain barrier and can be converted to DA by the remaining neurons. 
Metabolic products of DA degradation via monoamine oxidase (MAO) and catechol-
O-methyl transferase (COMT) are homovanillic acid (HVA) and 3,4-
Dihydroxyphenylacetic acid (DOPAC). DA that is not broken down is taken back into 
the synapse and stored in vesicles via the vesicular monoamine transporter (VMAT)-
2.  
 
Reserpine is a drug that inhibits the VMAT-mediated transport of DA (and others) into 
the DAergic cell for packaging into the vesicles, thereby causing DA deficiency. Initial 
studies showed that the behaviour of DA depleted mice and rabbits, via injection of 
reserpine, could almost completely be restored by injections of l-DOPA (Carlsson et 
al., 1957; Hornykiewicz, 2001; 2010). Since then much progress has been made and 
l-DOPA is currently the standard therapy for PD patients (Schapira, 2005; Hauser, 
2009; Schapira et al., 2009). Orally taken l-DOPA is broken down in the gut and liver 
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relatively fast if not taken in combination with an inhibitor of peripheral decarboxylase 
(i.e. carbidopa) to prevent breakdown and ensure availability in the brain (Schapira, 
2005; Hauser, 2009; Nagatsua & Sawadab, 2009; Schapira et al., 2009). Additional 
medications that provide some symptom relief include MAO and COMT inhibitors 
which slow the breakdown of DA, as well as DA agonists (Chen et al., 2007; Caslake 
et al., 2009; Schapira et al., 2009).  
 
Although l-DOPA provides great relief for several years its effectiveness is limited to 
the remaining DA cells and tolerisation of the receptors. The effective window is 
usually 5-10 years and, with progression of the disease higher doses of the drug 
have to be taken. Side effects of l-DOPA ingestion include gastro-intestinal 
abnormalities, orthostatic hypotension (‘head rush/dizziness’), hallucinations, 
sleepiness and behavioural problems (Schapira et al., 2009). The main motor side 
effects that are reported are severe motor disability and rigidity that occurs in the “off-
phase” of the drug and dyskinesias (jerky involuntary movements) that can occur at 
higher doses (Marsden & Parkes, 1976; Olanow et al., 2004; Santini et al., 2007; 
Lane & Dunnett, 2008; Santini et al., 2008; Hauser, 2009; Santini et al., 2009; Lane & 
Smith, 2010; Stocchi et al., 2010). Therefore, although l-DOPA therapy is highly 
effective, especially during early stages of PD, the effects are limited to a narrow 
therapeutic window and higher doses are less well tolerated (Bjorklund et al., 2003; 
Olanow et al., 2004; Schapira, 2005; Schapira et al., 2009). Alternative strategies, 
like cell replacement therapies offer promising alternatives to circumvent these 
shortcomings.  
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Figure 1.3. Synthesis of catecholamines.  
 
1.9 Deep brain stimulation 
Another promising approach to alleviate the motor symptoms is deep brain 
stimulation (DBS). In DBS, electrodes are implanted into the patient’s brain, usually 
targeting the subthalamic nucleus (STN) and the electrodes are connected to a 
pacemaker which is transplanted in the chest delivering an electric current through 
the electrodes (Benabid et al., 1991; Benabid et al., 1993; Phillips & Brown, 1999; 
Blandini et al., 2000; Temel et al., 2005; Temel et al., 2006a). DBS treatment is 
effective in controlling the motor symptoms and suited for advanced stages of PD 
when conventional therapies such as l-DOPA medication are no longer effective. 
Major drawbacks of DBS are the invasive surgery and the risk of behavioural side 
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reported to develop manic personality and changes in character (Leentjens et al., 
2004).  
 
1.10 Transplantation as a therapy for Parkinson’s disease 
As mentioned, l-DOPA relies on the remaining cells to convert this precursor to DA in 
the brain, and, therefore it has only a limited therapeutic window and higher doses 
produce disabling dyskinesias (Bjorklund et al., 2003; Olanow et al., 2004; Schapira, 
2005; Schapira et al., 2009). Transplantation of DAergic cells is therefore a promising 
alternative for patients who suffer from drug-induced dyskinesisas (Bjorklund et al., 
2003; Winkler et al., 2005). The underlying principle of transplantation is that DAergic 
precursors are harvested from embryos and then transplanted into the patient’s 
brain. Within the host brain, the precursors develop into DAergic neurons replacing 
the lost neurons and form connections with the remaining striatal cells.  
 
Transplantation of DAergic cells as a therapy for PD is based on two major 
assumptions: (i) the hallmark symptoms of the disease are based on degeneration of 
the DAergic cells in the nigro-striatal pathway, and (ii) engrafted cells will survive the 
transplantation procedure and develop into mature DA releasing cells that release 
DA into the depleted striatum, thereby alleviating (at least in part) the symptoms 
caused by the loss of DA (Bjorklund et al., 2003).  
 
Proof that cell replacement is a viable and highly promising therapy for PD comes 
from numerous experiments in lesioned rats, mice and non-human primates. Early 
studies have shown that engrafting unilateral 6-OHDA lesioned rats with DA rich 
tissue grafts resulted in a reduction in some tests of motor behaviour, specifically, 
drug-induced rotations in response to amphetamine and apomorphine which 
correlated highly with the amount of DA re-innervation of the depleted striatum 
(Perlow et al., 1979; Dunnett et al., 1981a; Dunnett et al., 1984; Torres & Dunnett, 
2007). Initial studies engrafted tissue pieces into cortical cavities that were above the 
striatum (Bjorklund & Stenevi, 1979; Dunnett et al., 1981a; b). Later studies looked at 
transplantation into the denervated tissue by employing enzymatic and mechanical 
dissociation of the cells into a quasi-single cell suspension which allowed delivery of 
the cell suspension via stereotaxic surgery into the lesioned striatum (Schmidt et al., 
1981; Bjorklund et al., 1983a; b; Dunnett et al., 1983b; a; Schmidt et al., 1983; 
Dunnett et al., 1984). Alongside transplanting cells as a suspension graft, rather than 
solid tissue pieces, there are three main factors that affect graft survival in the adult 
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brain, which are (i) age of donor, (ii) site of transplantation, and (iii) technical factors 
(Stenevi & Bjorklund, 1978). Survival of fetal tissue is better than tissue derived from 
the adult or post-natal brain (Stenevi & Bjorklund, 1978). However, even with 
prenatal ages, the right developmental time point for transplantation has to be found. 
It has been shown that engrafting cells just before their final division has been found 
to greatly enhance cell survival, leading to larger grafts (Fricker et al., 1997a; Fricker 
et al., 1997b; Gates et al., 2006; Torres et al., 2008a; Torres et al., 2008b; Bye et al., 
2012). Furthermore, the site of transplantation has a great influence on cell survival. 
Cells survive better when they become quickly re-vascularised (Stenevi et al., 1976; 
Stenevi & Bjorklund, 1978). Furthermore, sites which are thought to be (at least 
partly) immuno-privileged, such as the anterior eye-chamber or the brain, allow for 
better survival (Malmfors & Olson, 1967; Olson & Malmfors, 1970; Dunnett, 2010). 
Technical factors to increase graft survival range from the use of aseptic surgery, to 
how the tissue is transplanted into the brain. It has been shown that the use of 
smaller deposits placed using fine glass cannulae leads to better survival than metal 
cannulae (Stenevi et al., 1976; Nikkhah et al., 1993; Nikkhah et al., 1994a; Nikkhah 
et al., 1994b; Nikkhah et al., 1994c; Nikkhah et al., 1995; Nikkhah et al., 2009).  
 
Unilateral or bilateral lesioned/transplanted animals displayed recovery on some, but 
not all, tests of sensori-motor function (Dunnett et al., 1981b; a). Tests that require a 
higher degree of circuitry reconnection are more difficult to restore. The limited 
functional recovery that has been reported in animal studies of PD has been ascribed 
to incomplete reconstruction of the nigro-striatal circuit. In the majority of studies, 
including animal and human clinical trials, the engrafted cells are transplanted into 
the striatum, the target area of the DAergic nerve terminals, as opposed to the SN 
where the cell bodies originate. The main reason for this ectopic graft placement had 
been the better re-innervation found with this model (Bjorklund et al., 2003). 
Furthermore, several reports have questioned the ability of striatal grafts to grow the 
long distance from the SN to the lesioned striatum (Barker & Dunnett, 1999). It has 
been argued that one reason why reconnection from SN to the striatum is not 
achieved routinely is the glial scar/extent of neuronal degeneration that is achieved 
by the complete lesion models, which was necessary until recently to distinguish 
donor from host fibres (Aguayo et al., 1984; Doucet et al., 1990; Dunnett, 2010). It 
has been speculated that using lesions to the SN there would be enough fibres left to 
guide the axonal outgrowth into their target areas, and indeed, using Green 
Flourecent Protein (GFP), it has been reported that cells transplanted into the SN do 
grow projections that re-innervate the striatum, nucleus accumbens, and even the 
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frontal cortex in a mouse model of PD (Thompson et al., 2005; Thompson et al., 
2009). It has been speculated that ectopic graft placement does not achieve true 
“circuit reconstruction” because the DAergic cells are deprived of their natural 
input/environment and DA release might not be as regulated as it would have been if 
cells would reside in their normal habitat (Winkler et al., 2000; Bjorklund et al., 2003). 
Nevertheless, nigral fetal cells that are transplanted into the rat striatum do survive, 
form synaptic contacts and release DA into the surrounding tissue (Freund et al., 
1985; Doucet et al., 1989; Fisher et al., 1990; Wictorin et al., 1990b; Wictorin et al., 
1992). 
 
After the initial reports that nigral fetal rat tissue was able to survive, restore DA 
levels in the striatum and alleviate motor symptoms in the adult rat brain, the first 
clinical trials were planned. The first trials were conducted using autologous 
chromaffin cells of the adrenal medulla as these cells were known to produce 
catecholamines and reverse motor symptoms in the rat (Freed et al., 1980; Freed et 
al., 1981; Backlund et al., 1985; Freed et al., 1990; Date, 1996; Dunnett, 2010). 
Unfortunately, clinical effects were small although catecholaminergic metabolites 
were elevated after the graft surgery (Backlund et al., 1985). A follow-up trial in 
Mexico reported a dramatic improvement in patients rigidity and akinesia and a 
reduction of tremor (Madrazo et al., 1987). This sparked a series of studies, but the 
results could not replicate the dramatic improvement previously reported (Bakay et 
al., 1990; Goetz et al., 1991). In contrast, the publication of a multicentre study in 
North America revealed that 18% of these patients died, and 50% of the deaths were 
directly related to the surgical procedure. Although some beneficial effects were 
reported up to two years post surgery as determined via the UPDRS, other measures 
did not improve. Additional adverse effects reported were persistent psychiatric 
morbidity (Goetz et al., 1991). The results led investigators to move on from 
medullary grafts to the more promising alternative of fetal nigral tissue. Several small 
open label clinical trials have shown that embryonic fetal tissue that is transplanted 
directly into the brain of PD patients can survive and show significant and promising 
functional benefits on neurological assessment scales (Lindvall et al., 1988; Madrazo 
et al., 1988; Lindvall et al., 1989; Lindvall et al., 1990a; Lindvall et al., 1990b; Lindvall 
et al., 1994). Engrafted DAergic cells into the putamen have been shown, via use of 
the agent [11C]-raclopride (D2 receptor antagonist), to (i) release DA from the 
synapses, (ii) lower UPDRS scores two years post-transplantation, (iii) reduced time 
off medication from 1 year post engraftment onwards and (iv) to increase [18F]-dopa 
uptake in the treated hemisphere (Piccini et al., 1999). 
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It has been suggested that patient selection is essential for improved therapeutic 
outcome of DA cell replacement therapy. Younger patients showed greater benefit 
from the transplants than older patients (Freed et al., 2001; Bjorklund et al., 2003). 
Other factors considered before surgery were baseline responsiveness to l-DOPA, 
severity of PD symptoms at time of surgery, tailoring of graft location, age of donor 
tissue (5.5 – 9.0 weeks gestation), number of embryos used (2-9 per patient), 
hibernation of the tissue before use (up to 4 weeks), tissue preparation (cell 
suspensions vs. tissue pieces), and immunosupression method (Freed et al., 2001; 
Winkler et al., 2005).  
 
The first double-blind, sham surgery-controlled trial disclosed showed that the 
benefits obtained by the engraftment of embryonic DA rich tissue into the caudate-
putamen of patients with advanced PD showed little clinical benefit as assessed by 
the UPDRS, the Schwab and England scale, and the scale of the Core Assessment 
Program for Intracerebral Transplantations (Freed et al., 2001). Next to the marginal 
clinical improvements, there were severe side effects such as graft-induced 
dyskinesias reported in several patients (15%), even during off medication. Division 
into sub-groups showed that patients that were more likely to benefit from the cell 
replacement therapy were younger (<60 years) although individuals of the older 
group (>60 years) also showed some improvements (Freed et al., 2001). Subsequent 
inspection of the data has shown that this effect was most likely due to 
responsiveness to l-DOPA rather than age of the patient per se (Bjorklund et al., 
2003; Winkler et al., 2005). The improvements in the neurological rating scales were 
supported by increased [18F]-DOPA uptake and survival of TH-ir cells in 2 deceased 
patients (Freed et al., 2001).  
 
The report sparked a series of replies and discussions into (i) why the reported 
therapeutic effect was low overall, especially compared to some of the improvements 
seen in the earlier open-label clinical trials, and, (ii) why the side effects were so high 
(Dunnett et al., 2001; Bjorklund et al., 2003; Winkler et al., 2005; Brundin et al., 
2010). Freed et al. (2001) reported that cell survival was relatively low, compared to 
previous reports using open label clinical trials (Brundin et al., 2001). Furthermore, 
the Freed study was criticised for being variable and inconsistent with previous 
reports in terms of tissue preparation, implantation techniques and 
immunosupression (Brundin et al., 2001; Dunnett et al., 2001). Major differences to 
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previous reports were the relatively low number of TH-ir cells transplanted (Kordower 
et al., 1995; Bjorklund et al., 2003).  
 
There are several problems associated with the transplantation of cells derived from 
human fetal tissue. The largest constrains concern the ethics, availability, logistics 
and quality control that is associated with obtaining the optimal donor tissue 
(Bjorklund et al., 2003). Alternative cell sources such as stem cells and/or xenogeic 
cells are being investigated as potential alternatives (Barker et al., 1999; Barker et 
al., 2000; Barker, 2002; Bjorklund et al., 2003; Harrower et al., 2006; Kriks et al., 
2011). Although promising in providing a solution to some of the above mentioned 
problems, using stem cells or xenografts harbour their own problems such as 
extensive proliferation and/or zoonotic infection (Barker et al., 2000; Dunnett et al., 
2001; Bjorklund et al., 2003). 
 
A complementary experimental approach, which could be used in conjunction with 
cell replacement therapies, is to decrease the progression of the disease by 
delivering brain growth factors (Sinclair et al., 1996; Kirik et al., 2000a; Kirik et al., 
2000b; Kirik et al., 2001a; Kirik et al., 2004; Monville et al., 2004; Dowd et al., 2005b; 
Torres et al., 2005a; b). As PD is a progressive neurodegenerative disorder once it is 
diagnosed the ideal would be to halt or slow down disease progression. 
Neuroprotection has been demonstrated in research models using trophic factors like 
GDNF or BDNF which can protect cells from oxidative stress caused by 6-OHDA 
lesions. Other approaches have used lazaroids or anti-apoptotic agents to promote 
cell survival (Brundin et al., 2000b; Castilho et al., 2000). In a phase I clinical trial the 
direct delivery of GDNF into the putamen of 5 patients has shown an increase in [18F-
]dopa influx and a decrease in scores on the Unified Parkinson’s Disease Rating 
Scale (UPDRS) scores motor and daily living subscales (Gill et al., 2003). Although 
the use of GDNF showed promising results in the 6-OHDA lesioned rat model of PD 
and in the open-lable clinical trial mentioned above, the first placebo-controlled 
clinical trial failed to show any significant benefits and the trial had been stopped 
prematurely because of adverse effect in the American arm (Lang et al., 2006; 
Hutchinson et al., 2007). A recent publication has shown that indeed GDNF was not 
effective in protecting DAergic cells from $-synuclein pathology (Decressac et al., 
2011). 
 
In summary, cell replacement therapies have several advantages over current drug-
based therapeutic approaches. The main advantage of transplantation of cells is that 
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it has the potential to restore DA levels in the brain on a sustainable basis, at 
physiological levels, under local regulation, and delivered synaptically to the precise 
areas where DA is lost (Dunnett et al., 2001; Bjorklund & Dunnett, 2007b; Brundin et 
al., 2010). Furthermore, as cell survival has been shown long term, it is not affected 
by a small therapeutic window as, e.g. l-DOPA therapy, which is dependent on 
remaining DA turnover in the brain (Dunnett et al., 2001; Bjorklund & Dunnett, 
2007b). Cell replacement therapy can be a promising treatment when done correctly. 
Graft-induced dyskinesias have been associated with DA-Hotspots in the brain due 
to the grafting technique (Winkler et al., 2005; Brundin et al., 2010). However, one of 
the main issues raised in cell transplantation is the small percentage of cells, 
specifically DAergic cells that survive the transplantation process (Barker et al., 1996; 
Bjorklund et al., 2003). Some progress has been made to increase the survival of 
donor tissue in animal models of the disease and it has been shown that the use of 
younger donor tissue or trophic factors can increase cell survival (Annett et al., 1997; 
Torres et al., 2005a; Torres et al., 2007; Torres et al., 2008a; Kauhausen et al., 
2013). Taken together, although cell replacement therapy is currently hampered by 
several factors to become a mainstream therapy as an alternative to DBS and 
pharmacological approaches (Bjorklund et al., 2003), it still holds great promise. The 
problems of cell survival, storage, differentiation, etc. are currently addressed in 
European multi-centre trials and most importantly, via inspection of individual cases, 
clear proof-of-principle data shows that patients benefit long term from the approach. 
Selection of the right patient population will give us further insights as to whether cell 
replacement therapy is a viable alternative to the current therapeutic options. 
Therefore, although transplantation studies in humans have shown limited success, a 
subset of patients have shown to have benefited from the engrafting (Dunnett & 
Bjorklund, 1997; Brundin & Hagell, 2001; Fricker-Gates et al., 2001; Fricker-Gates & 
Dunnett, 2002; Bjorklund et al., 2003; Bjorklund & Dunnett, 2007b; Bjorklund et al., 
2009; Brundin et al., 2010). 
 
1.11 Dopaminergic cells  
Since the first description of catecholaminergic cell groups in the brain (Carlsson et 
al., 1962; Dahlstrom & Fuxe, 1964) and the advent of immunohistochemical 
techniques, nine major DA cell groups have been identified in the brain. Of 
importance for this work are the three DAergic cell groups A8 (retrorubal area), A9 
(SN), and A10 (VTA), which are located in the mesencephalic region of the brain. In 
the rodent there are about 20,000 to 30,000 DAergic cells in mice, depending on 
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strain (Nelson et al., 1996) and 1,300 (A8), 10,500 (A9) and 10,200 (A10) DAergic 
cells in rats (German & Manaye, 1993) distributed over all three cell groups. In 
humans, there are 400,000 to 600,000 DAergic cells in these three areas, with about 
70% of cells being located in the SN (Bjorklund & Dunnett, 2007a). However, an 
absolute characterisation based on immunohistochemical methods is difficult as SN 
cells do co-express different markers complimentary to TH and their projections do 
not always innervate specific targets (about 5% of cells do send projections to both, 
patch and matrix striatal cells). Although there is a low level of overlap, the two major 
cell populations in the SN and VTA can be identified by their coexpression of either 
TH and the potassium channel subunit G protein activated inward rectifier potassium 
channel (GIRK)-2 for DA cells in the SN and TH and calbindin for DA cells in the VTA 
(Thompson et al., 2005; Bye et al., 2012). However, this distinction is not absolute as 
a large proportion of the DA cells in the respective nucleus does co-express the 
respective protein and can therefore be identified in combination with their cell 
morphology. SN cell morphology has been described as larger and more angular in 
shape, whereas VTA cells are smaller and rounder by comparison to the former cell 
type (Thompson et al., 2005; Thompson et al., 2009). The third factor by which they 
can be identified are their projection patterns. Whereas SN DA cells largely send out 
their efferents to the dorsal striatum, VTA cells largely project to the ventral striatum 
including the nucleus accumbens, parts of the limbic system, and further to the 
prefrontal cortex (Bjorklund & Dunnett, 2007a; Thompson et al., 2009). 
 
Other methods of distinguishing these cell types from other ventral mesencephalic 
cells include characterisation of their electrophysiology, since both sub-groups of DA 
cells can be characterised by their pacemaker activity and slow action potentials. SN 
and VTA cells share many electrophysiological properties and can only be 
distinguished on a cell population level (Karschin et al., 1996; Neuhoff et al., 2002). 
In recent reports it has been shown that when transplanting primary fetal ventral 
mesencephalon (VM), consisting of developing neurons from both SN and VTA, into 
6-hydroxydopamine (6-OHDA)-lesioned rats, the transplanted cells show a different 
pattern of distribution within the graft and connection to the host brain (Thompson et 
al., 2005). Cells in the centre of the graft are on average smaller in diameter (12.9 &m 
vs. 19.1 &m), and a larger proportion stained positive for calbindin whereas cells in 
the periphery of the graft were larger and a larger proportion was positive for GIRK-2 
(Thompson et al., 2005). It has been suggested that next to being DAergic, cells 
used for transplantation might need to be of the A9 phenotype (Lindvall & Bjorklund, 
2004). Indeed, from retrograde tracing and behavioural assessment previous studies 
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report that (i) prelabeled cholera toxin subunit % injected into the dorsal striatum 
stained cells that were located in the periphery of the graft and many of the cells also 
co-labelled for TH and GIRK-2 and were larger and angular in shape, therefore 
suggesting that A9 type cells predominately re-innervate the surrounding striatal 
structure (Thompson et al., 2005; Thompson et al., 2009). In contrast, frontal cortical 
injections largely labelled cells in the centre of the graft which were round and 
calbindin positive (Thompson et al., 2005; Thompson et al., 2009). There is, 
however, no clear distinction between the two cell types as cells of either phenotype 
have been found throughout the graft, and therefore rather represent the majority of 
cells (Thompson et al., 2005; Thompson et al., 2009) (ii) only cells of the A9 
phenotype were able to normalise cFos expression in the striatum after 6-OHDA 
lesions and were able to completely restore the behavioural deficits induced by the 
lesion twelve weeks post transplantation as assessed via amphetamine-induced 
rotation and the cylinder test. In contrast, grafts that were composed of A10 type cells 
did not improve behavioural deficits (Grealish et al., 2010a). 
 
1.12 6-Hydroxydopamine 
Animal models that mimic all or certain aspects of the human disease are essential in 
understanding disease mechanisms and possible treatment options. The most 
commonly used agent to induce a unilateral rat model of PD is 6-OHDA (Ungerstedt, 
1968; 1971; Beal, 2001; Dawson et al., 2002). When injected directly into the brain 6-
OHDA is neurotoxic and selectively kills catecholaminergic neurons (DA, adrenaline, 
and noradrenalin). 6-OHDA does not cross the BBB and therefore must directly be 
injected into the brain via stereotaxic surgery (Bove et al., 2005; Rang et al., 2007). It 
is theorised that 6-OHDA is brought into the cell via the DAT and then oxidation leads 
to the production of reactive oxygen species and para-quinone (Dauer & Przedborski, 
2003; Bove et al., 2005).  
 
It was discovered that direct lesions to the SN did not only lead to degeneration of 
DAergic neurons in this structure but furthermore a depletion of tyrosine-hydroxylase 
(TH) in the neuron terminals within the striatum (Ungerstedt, 1968). The depletion in 
the striatal region occurred in a time-delayed manner relative to the injection to the 
SN. Furthermore it was discovered that unilateral lesioned animals displayed 
lateralised motor impairments (Ungerstedt, 1968; Ungerstedt & Arbuthnott, 1970; 
Ungerstedt et al., 1974; Ljungberg & Ungerstedt, 1976). 6-OHDA lesioned rats that 
were injected with a DA agonist displayed a rotational behaviour (Ungerstedt & 
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Arbuthnott, 1970; Ljungberg & Ungerstedt, 1978; Ungerstedt et al., 1978). Depending 
on the percentage of neuronal loss, animals that are challenged with the indirectly-
acting DA agonist methamphetamine (stimulates DA realase and blocks reuptake), 
circle towards the side of the lesion. In near-complete unilateral lesions there is an 
imbalance in DA innervations between the intact and the lesioned striatum. 
Methamphetamine acts only on the un-lesioned side causing the animal to rotate 
towards the lesion, as the release of the neurotransmitter is restricted to the intact 
side only. Conversely, animals that are injected with the true agonist apomorphine at 
(very) low doses rotate away from the side of the lesion, as the DA-receptors up-
regulate after dopamine depletion and therefore the lesioned side is rendered 
supersensitive to (post-synaptic) DA activation (Ungerstedt & Arbuthnott, 1970; 
Zigmond & Stricker, 1972; Ungerstedt et al., 1975; Kelly & Moore, 1976; 1977; 
Truong et al., 2006; Torres & Dunnett, 2007; Grealish et al., 2008). Lesions to either 
the ascending axonal bundle of the ventral mesencephalic DAergic neurons or to the 
neuronal terminals within the striatum produce contralateral motor impairments (Kirik 
et al., 1998; Grealish et al., 2008). Whereas lesions to the medial forebrain bundle 
lead to near complete depletion of TH-positive cells, terminal lesions, when aimed at 
the dorsal striatum, do not lead to extensive depletion of TH-ir neurons in the VTA 
(Zigmond & Stricker, 1972; Truong et al., 2006; Grealish et al., 2008). As a model of 
PD, 6-OHDA is usually injected unilaterally into SN, the medial forebrain bundle or 
into the striatum. The unilateral model has been used extensively and has been 
shown to produce deficits on the side of the body contralateral to the hemisphere in 
which the injection was administered in various motor tests, such as the cylinder test, 
adjusting steps test, drug induced rotations, corridor test and operant tests of 
behaviour (see section below) (Ungerstedt & Arbuthnott, 1970; Ungerstedt, 1971; 
Zigmond & Stricker, 1972; Schallert et al., 1978; Carli et al., 1985; Carli et al., 1989; 
Montoya et al., 1990; Schallert et al., 2000; Dowd & Dunnett, 2004; Dowd et al., 
2005a; Iancu et al., 2005). Bilateral injections are less common as, dependent on the 
extent of DAergic depletion, lesioned animals usually drop in weight and/or have an 
inability to feed themselves (Zigmond & Stricker, 1972; Dunnett et al., 1983b; Bove et 
al., 2005). Due to this, extensive post-operative care with tube feeding and daily 
injections with glucose-saline to stabilize the animals’ weight might be necessary. 
 
The major drawbacks of the 6-OHDA lesion model of PD are that the lesion only 
produces a subset of the impairments seen in PD. However, none of the other animal 
models produce the characteristic tremor either, at least in rats. Furthermore, as with 
all toxin based models, the onset of the “disease” is acute and not progressive as 
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seen in the human condition and the 6-OHDA lesion model does not produce Lewy-
bodies that are found in the brains of human PD patients. Therefore, it is important to 
keep in mind that it is a model of DA depletion, the major hallmark of PD, and not a 
model of PD itself.  
 
1.13 Modelling PD though $-synuclein overexpression 
Linking $-synuclein to genetic causes of PD pathology has sparked research into 
modelling the overexpression of the gene in animals as a research tool (Kirik et al., 
2008). The first three genetic mutations of the protein $-synuclein that were 
discovered in familial PD were A53T (Polymeropoulos et al., 1997), A30P (Kruger et 
al., 1998), and E46K (Zarranz et al., 2004). 
 
Overexpression of these human forms of $-synuclein via viral vectors has been 
shown to be toxic to SN DA cells and have several advantages above transgenic 
mice in that (i) the transgene can be introduced at any time point in the animal’s life, 
(ii) higher transgene expression is achieved, (iii) slower progression of the disease as 
compared to the acute insult by catecholaminergic neurotoxins (iv) the 
overexpression can be induced in other models than mice, (v) vector injections can 
be aimed at specific brain structures via stereotaxic surgery, (vi) unilateral disease 
models can be created so that each animal can serve at its own within-subject 
control, (vii) bilateral models can be created which more closely resemble the human 
condition and are required for testing of higher cognitive functions and (viii) due to 
manipulations of the vector more than one gene can be mutated, i.e. generating 
models of A53P or A30P (Kirik et al., 2002; Kirik et al., 2003; Kirik & Bjorklund, 2003; 
Maingay et al., 2005).  
 
Although transgenic $-synuclein mouse models exist, they only show a limited 
reduction in tyrosine-hydroxylase immunoreactive (TH-ir) density in the striatum and 
no detectable cell loss of TH-ir cells in the SN (Blandini & Armentero, 2012). We 
therefore focus here on the overexpression of $-synuclein via viral vectors. For a 
review on transgenic mouse models of PD please see (Fleming et al., 2005; Harvey 
et al., 2008). 
 
After vector injection into the SN the first $-synuclein-ir deposits can be found as 
early as 3 weeks post injection and 10 weeks after injections PD like pathology in the 
form of $-synuclein-ir inclusions as well as swollen axons and dendrites have been 
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reported (Kirik & Bjorklund, 2003; Chu et al., 2012). Cell bodies in the SN appear 
shrunken with $-synuclein-ir deposits, which resemble the Lewy bodies found in the 
brains of PD patients (Kirik et al., 2002; Kirik et al., 2003; Kirik & Bjorklund, 2003). 
The $-synuclein vector model has been used successfully in rodents and non-human 
primates, in that it can induce nigral cell loss, striatal DA depletion and the formation 
of inclusions (Lo Bianco et al., 2002; Eslamboli et al., 2003; Kirik et al., 2003; Kirik & 
Bjorklund, 2003; Eslamboli et al., 2007; Koprich et al., 2011). The loss of TH-ir cells 
in the SN is highly variable and depletion ranges between 30% and 80% have been 
reported (Kirik et al., 2002; Klein et al., 2002; Lo Bianco et al., 2002; Lo Bianco et al., 
2004; Chung et al., 2009; Koprich et al., 2010; Koprich et al., 2011; Chu et al., 2012; 
Decressac et al., 2012a; Decressac et al., 2012b; Lundblad et al., 2012). 
 
Despite a lack of long term behavioural studies (>6 month), the tests that were 
conducted show that the cell loss and striatal TH depletion occurs over a time frame 
of 3 to 16 weeks, after which expression of $-synuclein, striatal TH depletion and TH-
ir SN cell degeneration is maximum. Although $-synuclein can still be detected in 
cells up to 6 month post injection, clear signs of recovery were found in the form of 
missing $-synuclein-ir inclusions, and recovery of striatal density (from 50% to 80%) 
(Kirik et al., 2002; Koprich et al., 2010; Koprich et al., 2011). However, this recovery 
was not complete, i.e. striatal DA content was still at 50% of control and the deficits 
could be partially reinstated by alpha-methyl-para-tyrosine (Kirik et al., 2002), 
suggesting that remaining cells compensate for the loss by sprouting, more DA 
release and up-regulation of synaptic transport. Long term assessment for 12 months 
after overexpression of the A30P variant in the SN revealed a 53% loss of SN DA 
neurons and $-synuclein-ir deposits in the SN and striatum but failed to show any 
behavioural deficits (Klein et al., 2002). The assessment method in the reported 
study was unusual as they activated rats on a low dose (2mg/kg) d-Amphetamine 
injected intra-muscularly, instead of the usual method using 2.5mg/kg 
methamphetamine or 2.5-5.0mg/kg d-amphetamine injected i.p., therefore the 
threshold of depletion for assessment of motor deficits may not have been reached. 
This posed problems for the use of this model for behavioural testing as (i) a 
depletion of striatal TH of >50%-70% is needed to show robust behavioural deficits 
and (ii) the lesion should be stable and not be prone to spontaneous behavioural 
recovery as any effects by intervention cannot be assigned to the intervention with 
confidence (Kirik et al., 1998; Kirik et al., 2002; Dowd & Dunnett, 2004; 2005b). 
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A first attempt to increase the transfection rate by using a woodchuck hepatitis virus 
posttranscriptional regulatory element did increase expression by 4-5 fold and led to 
degeneration of TH-ir cells in the SN by 70% of control (Decressac et al., 2012a; 
Decressac et al., 2012b). The degeneration reported was progressive and occurred 
over a period of 8-16 weeks with the first behavioural effects being detectable after 3 
weeks post transfection (Klein et al., 2002). Animals displayed a bias on both, the 
cylinder test and amphetamine-induced rotations (Decressac et al., 2012a). 
However, unfortunately the motor deficits were small compared to neurotoxic lesions 
(Kirik et al., 2002; Decressac et al., 2012a) and although analysis was carried out up 
to 16 weeks post injection it is still possible that the animals would undergo the same 
recovery as the ones in the Kirik et al. (2002) study. Interestingly the accumulated 
data suggests that the levels of $-synuclein between cells might vary and that some 
cells, although expressing the protein, will recover because the critical threshold for 
neurodegeneration to occur has not been reached (Kirik et al., 2002). Furthermore 
some cells do survive for 5 months post injection whilst expressing the mutant $-
synuclein (Lo Bianco et al., 2002). Other problems with the use of the $-synuclein 
model for PD, is that the area affected as well as the lesion extent is difficult to 
define. Whereas 6-OHDA can be used to selectively lesion the dorsal striatum and 
cause reliable deficits in motor and cognitive functions, the viral vector model has not 
been shown to produce well defined depletion in one area only (Kirik et al., 1998; 
Koprich et al., 2010; Koprich et al., 2011; Decressac et al., 2012a). For the purpose 
of brain repair a lesion in the dorsal striatum is necessary to obtain stable deficits, 
which can then be used for testing therapies such as DBS or cell replacement. The 
$-synuclein model, at the present time, does not allow to pursuit those strategies as 
(i) the lesion is not well defined, (ii) the deficit induced is prone to spontaneous 
recovery, (iii.) the behavioural deficits are small (i.e. rotations: 3rpm compared to 
>6rpm after 6-OHDA insult), (iv) the ‘success rate’ is relatively small as on average 
25% of animals display a depletion of sufficient size to display motor problems 
whereas in the 6-OHDA lesion model a near complete depletion can be achieved 
relatively easily (>90%) (Torres et al., 2011), and (v) adequate control groups are 
lacking for comparison as protein overload can be toxic to cells whereas empty 
vectors are not sufficient (Kirik et al., 2002; Klein et al., 2006; Decressac et al., 
2012a; Decressac et al., 2012b).  
 
Although the $-synuclein model is a beneficial addition to the scientific toolbox 
available and will be especially valuable in investigating neuroprotective agents, at 
present the degree of depletion is not high enough to produce reliable and robust 
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behavioural deficits which are needed for the assessment of cell replacement therapy 
(i.e. only 25% of the animals injected with the virus display behavioural deficits). At 
the moment the $-synuclein model is rather useful for investigations into the 
underlying neuropathology of PD until a higher level of DA depletion is achieved. 
 
1.14 MPTP 
In California, in 1982 four patients were discovered who developed parkinsonism 
within a week after use of a synthetic heroin substitute. The patients were reported to 
have developed all of the hallmark symptoms of PD such as immobility, postural 
instability, impairments in speech, eye movement and blinking, as well as shuffling 
gait and bradykinesia (Langston et al., 1983). This was striking as usually juvenile 
cases are rare and the progression of the disease is typically slow, taking years. All 
patients were responsive to l-DOPA treatment and symptoms returned completely 
upon withdrawal of the medication. One of the patients died within two years after a 
drug-overdose and examination of his brain revealed a loss of pigmented cells in the 
SN (caudal region most affected). Although, in contrast to idiopathic PD patients, 
other nuclei, such as the locus coeruleus and dorsal motor vagus nucleus, were not 
affected, the behavioural symptoms, the responsiveness to l-DOPA and the loss of 
cells in the SN led to the conclusion that the synthetic drug intoxication can lead to a 
form of PD (Langston et al., 1983). The compound injected was subsequently 
identified to consist of 1-methyl-4-phenyl-1,2,5,6-tetrahyropyridine (MPTP) with 
traces of 1-methyl-4-phenyl-4-propionoxy-piperidine (MPPP) (Langston et al., 1983). 
After injection, MPTP readily crosses the BBB and is taken up by glial cells. In those 
glial cells MPTP is converted via Monoamine Oxidase-B (MAO-B) to MPDP+ and 
then to MPP+, which is the toxic agent. Although it is unknown how MPP+ leaves the 
glial cell, it is taken up by the DA neurons via the DAT (Schapira, 1999a; b). Inside 
the DA neuron it can be clustered inside synaptic vesicles via the VMAT-2, where it 
can interact with cytosolic enzymes and build up in the mitochondria (Dauer & 
Przedborski, 2003). Inside the mitochondria it can inhibit enzyme complex I of the 
electron transport chain and subsequently lead to a reduction in ATP levels and an 
increase in reactive oxygen species (Schapira, 1999a; b). The relative selective 
neurotoxicity to DAergic cells of the SN does make MPTP an excellent research tool 
to model DA loss in animal models of PD. Since its discovery it has been applied to 
model PD in mice, rats, and non-human primates (Lange, 1989; 1990; Sundstrom et 
al., 1990; Sedelis et al., 2000a; b; Jenner, 2003; 2009). Although the MPTP monkey 
has been valuable in modelling the disease, the application in mice has shown that 
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toxicity of the compound varies with age, gender, and strain (Ricaurte et al., 1987; 
Sundstrom et al., 1990; Irwin et al., 1992; Sedelis et al., 2000a; b; Hofele et al., 
2001). Younger mice are relatively resistant to MPTP lesions and display a high 
degree of behavioural recovery whereas in older animals the compound is often 
lethal (Langston et al., 1983; Langston et al., 1987; Irwin et al., 1992; Sedelis et al., 
2000a). MPTP has also shown higher toxicity in male mice compared to females 
(Ookubo et al., 2009), and certain strains are more resistant to MPTP induced DA 
cell degeneration than others (Sedelis et al., 2000a; b; Hofele et al., 2001). Most of 
the effects of toxin resistance have been attributed to reduced levels of MAO-B, 
which is responsible for converting MPTP into the toxic agent MPP+. Furthermore, 
systemic injection in the rat does not lead to SN DA cell degeneration and stereotaxic 
injection is required. Other concerns with the use of MPTP as a research model are 
the mode of administration as the standard acute lesions are achieved via systemic 
injections and therefore lead to a bilateral depletion model. As the aim of the present 
work is to assess unilateral deficits and using the intact hemisphere as within-subject 
control, the unilateral stereotaxic injection is more appropriate. Furthermore, although 
MPTP can be handled if the right precautions are met, it still is highly toxic to man, 
and suitable precautionary measures must be taken. 
 
1.15 Other models 
Other toxins that are used to model PD in animals were discovered, after structural 
similarities were seen between MPTP and certain herbicides/pesticides. The two 
most common are rotenone and paraquat (Blandini & Armentero, 2012). The focus 
here is these and the reader is referred to the review by Caudle et al. (2012) for an 
overview about industrial toxins (Caudle et al., 2012).  
 
Chronic injection into the rat of rotenone leads to relative selective degeneration of 
DAergic SN cells and to the formation of $-synuclein positive inclusions (Blandini & 
Armentero, 2012). The disadvantages with the rotenone model are mainly its high 
variability and the high mortality as the compound also attacks cells in the liver, gut, 
heart and kidneys (Blandini & Armentero, 2012). Recent advances have been made 
by characterisation of direct injection of rotenone into the brain of laboratory rats. 
Injection at any level of the nigro-striatal pathway resulted in loss of TH from the 
striatum and a loss of TH-ir DA cells in the SN (Saravanan et al., 2005; Sindhu et al., 
2005; Mulcahy et al., 2011) without the adverse effects of increased weight loss and 
increased levels of mortality. Recently a combination of the AAV-$-synuclein model 
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and subsequent (13 weeks) intra-nigral infusion of rotenone has shown to increase 
the depletion of striatal DA depletion, SN TH-ir cell loss and contralateral motor 
deficits (Mulcahy et al., 2012). Despite this, the specific neurotoxicity has been 
questioned and lesions beyond the boundaries of the injection site have been 
reported (Klein et al., 2011). Paraquat does selectively destroy SN cells but its toxic 
effect is relatively weak and the resulting cell loss in range of 20-30% (Blandini & 
Armentero, 2012). The two most common pharmacological models are reserpine and 
Haloperidol. Although they do mimic some aspects of the disease they are limited in 
that they are transient, and do not show any pathology. Reserpine injection results in 
a temporary loss of striatal and nigral DA (monoamines) for 2-3 days via inhibition of 
the VMAT-2. Reserpine injected rats do display some PD like features, such as 
rigidity and akinesia, which could be reversed via l-DOPA administration (Carlsson et 
al., 1957; Carlsson et al., 1968; Duty & Jenner, 2011). Haloperidol on the other hand 
does not mimic any of the parkinsonian features seen in patients, but nevertheless, 
injection of haloperidol has an antagonistic effect on D2 and D1 receptors on striatal 
MSNs (Duty & Jenner, 2011).  
 
1.16 Rationale for using 6-hydroxydopamine 
Although all of the above mentioned models have major advantages and drawbacks 
in their use as tools to model PD, here I chose to use the 6-OHDA lesion model in 
the following experiments for a combination of reasons. Firstly, practically working 
with 6-OHDA is much less dangerous as it only affects humans when administered 
into the brain whereas the other toxins can cross the BBB, e.g. MPTP has induced 
Parkinsonism in a chemist working with the substance (Langston & Ballard, 1983). 
Furthermore, this model has been widely used for over 40 years of research and 
therefore results obtained are more easily comparable with the existing literature. 
Various studies have assessed the effects of DAergic depletion on animals’ 
behaviour and the effect of neuroprotective agents, DA replacement and neuronal 
grafting in this lesion model. Thirdly, the aim of this work is to investigate the 
behavioural effects of DAergic depletion therefore the lack of protein inclusions is 
acknowledged but regarded as a minor drawback concerning this research. 
Additionally, the 6-OHDA model allows, via selective lesions, depletion of DA 
dissociation of nigro-striatal degeneration from other aspects of PD. As the main aim 
of the present thesis is the characterisation of the lesion induced deficit for 
subsequent transplantation, a large DA depletion model is thought to be more 
relevant to the clinical case where patients with a more ‘pure’ parkinsonism, that is 
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highly responsive to l-DOPA therapy, display greater therapeutic benefits by the cell 
replacement. 
 
Importantly, Kirik et al. (1998) showed that 6-OHDA can be used to produce lesions 
of various extents, depending on the site of injection and the concentration used. As 
the main goal is to develop and characterize models that are sensitive 
measurements of graft induced recovery a stable lesion that does not show signs of 
spontaneous recovery is warranted. Since DA depletion generally has to be greater 
than 60%-70% before the first behavioural abnormalities can be detected, we aimed 
for lesions that lead to a high depletion (Kirik et al., 1998; Truong et al., 2006). 
 
Therefore, although 6-OHDA does not mimick the pathogenic process as done by 
MPTP or $-synuclein, which would be important in studying neuroprotection, it does 
provide a reliable lesion model that is reproducible and stable over time, which are 
important factions for studying DAergic cell replacement approaches and functional 
recovery.  
 
1.17 Operant analysis of behaviour 
Operant analysis of animals’ behaviour has several advantages to simple tests of 
motor and sensory-motor tasks. Although training animals to perform on operant 
tasks at a high level can be time consuming, many animals can be trained at the 
same time in an objective manner, largely eliminating the effects of experimenter 
bias. Whereas simple motor tasks are dependent on the expertise of the 
experimenter, in operant tasks the animals are placed in a computer controlled 
environment and tested independently from the experimenter. Furthermore high 
numbers of trials can be conducted leading to more sensitive testing. The large 
number of trials gathered within a 30 minute session facilitates tight variance and 
power/sensitivity to detect small effects. This does not only make behavioural testing 
more efficient, but it also reduces the number of animals required to detect medium 
or small sized effects, which provides an additional advantages in the 3Rs 
(Replacement, Refinement, Reduction) and animal welfare. A large number of 
parameters, including reaction and movement time latencies accurate to the 
millisecond, can be recorded at the same time, allowing for a detailed functional 
analysis of the determinants of behavioural responses, rather than simple empirical 
assays of behavioural deficits.  
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In operant analysis of behaviour the animal can be trained to learn arbitrary ‘stimulus-
response’ or ‘action-outcome’ associations. Often a stimulus light signals that a 
certain action is required by the animal in order to obtain a reward in the form of an 
incentive reward, such as sucrose pellets. Lesions to sub-regions of the lateral and 
medial striatum have shown that the striatum is heterogeneous in function. Whereas 
lesions to the dorsal/lateral part prevent the formation of habits, lesions to the medial 
part of the striatum disrupt action-outcome related behaviours (Yin & Knowlton, 2002; 
2004; Yin et al., 2004; 2005a; Yin et al., 2005b; Yin & Knowlton, 2006; Yin et al., 
2006). During initial task performance animals do not respond out of habit to the 
stimulus light that is presented but they rather focus on the reward to be obtained. 
This type of behaviour is goal-directed and it has been shown that devaluation of the 
reward does influence the behaviour of the animal (Yin & Knowlton, 2002). 
Overtrained animals start to develop a habit, which is association of the stimulus 
when the association with the outcome is lost, i.e. not influenced by outcome 
devaluation. 
 
All of the above mentioned studies utilise cell body lesions in the striatum by means 
of infusion of an excitotoxic as quinolinic or ibotenic acid, and/or temporarily 
inactivation, to produce stable and defined lesions. DA depletion via 6-OHDA infusion 
has been shown to produce variable lesions, which can undergo compensation and 
spontaneous behavioural recovery can occur. Remaining cells up-regulate their DA 
release and sprouting of terminals has been reported (Acheson & Zigmond, 1981; 
Robinson & Whishaw, 1988). Furthermore, striatal cells that are depleted of their 
DAergic input will up-regulate their DA receptors. Remaining tonic striatal DA by 
neighbouring innervations make it difficult to produce defined lesions as can be done 
by aforementioned neurotoxins. Although the literature on habit formation using DA 
lesions is sparse, the accumulated evidence suggests (lateral) DA depleted rats will 
continue displaying goal-directed behaviour when control animals are habitual (Faure 
et al., 2005; Faure et al., 2010).  
 
The first studies that investigated unilateral striatal DA depletion by injecting the 
selective neurotoxin 6-OHDA into the striatum of laboratory rats on operant tasks 
showed that animals developed a deficit when responses had to be made to the side 
of the body contralateral to the lesioned hemisphere (Carli et al., 1985; Carli et al., 
1989). Animals that were trained in the 9-hole box apparatus on a lateralised choice 
reaction time task had to perform a sustained nose-poke into an illuminated centre 
hole. After a delay, a stimulus light to either the left or the right side of the animals’ 
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head indicated the response hole to which a nose poke would result in the delivery of 
a food reward. Animals that were lesioned showed a deficit in their accuracy when a 
response was required contralateral to the lesion (Carli et al., 1985; Carli et al., 
1989). Using a slightly different version of this task, in which lower stimulus-response 
associalibility is achieved by requiring rats to respond to the hole on the opposite side 
of the light stimulus, it was revealed that the observed motor deficit was not sensory 
in nature. Here, animals continue to demonstrate a motor deficit on the side of the 
body contralateral to the side of the lesion, similar to animals that have to respond to 
the same side where the stimulus is presented, while demonstrating an intact ability 
to perceive the visual stimulus on the contralateral side (Carli et al., 1985; Carli et al., 
1989; Dowd & Dunnett, 2005a; b). Brown and Robbins (1989) modified the paradigm 
of Carli et al. (1985) and instead of using a bilateral hole configuration they trained 
the animals to report the occurrence of a stimulus light to either a near or a far hole 
on the same side of the animal’s head. After training, they subsequently lesioned the 
right striatum in one group of animals and the left striatum in the other cohort, via 
intracerebral injection of 6-OHDA. Animals that were lesioned ipsilateral to the side of 
response did not show a deficit on the operant task whereas animals that were 
lesioned on the side contralateral to the response location showed an interesting 
deficit. Contralateral lesioned animals were still able to register the occurrence of the 
stimulus and execute a response but they were biasing their responses almost 
completely too the nearer of the two response locations. Interestingly, when given a 
bilateral choice, lesioned animals developed a bias towards the side ipsilateral to the 
lesion, but when given no choice they respond to the relative ipsilateral location 
(Brown & Robbins, 1989a). In subsequent experiments it has been shown that near 
complete unilateral DA depletion from the striatum via injection of the neurotoxin into 
the ascending DAergic bundle can produce a stable deficit whereas terminal lesions 
can show spontaneous recovery over the weeks of post lesion testing (Carli et al., 
1985; Dowd & Dunnett, 2005a; b). Therefore, only severe DA depletion leads to a 
stable lesion model that is suitable for long term behavioural analysis and 
subsequent evaluation of cell replacement strategies. Although spontaneous 
recovery occurs in partially lesioned animals, the deficit can usually be re-instated by 
further DAergic depletion by injection of $-methyl-p-tyrosine, an inhibitor of DA 
synthesis (Carli et al., 1989; Dowd & Dunnett, 2004). Other studies have shown 
reaction time impairments after unilateral lesions that are suspected to be the result 
of a movement initiation deficit, similar to that seen in humans with PD (Amalric & 
Koob, 1987; Jahanshahi et al., 1993; Blokland, 1998). The measurement of reaction 
time deficits mainly depends on the sensitivity of the apparatus and nature of the 
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required response. Reaction time impairments have been shown in the 9-hole box 
but not in the Skinner box in striatal lesioned animals that received quinolinic acid 
lesions (Brasted et al., 1998). In order to test the efficacy of treatment options for PD 
such as neural restoration or cell replacement it is important that the tests that are 
employed are sensitive enough to detect changes in the animals’ behaviour. 
Whereas subtle improvement may be missed when the crude and simple tests of 
motor asymmetry are applied, operant analysis of behaviour can detect more subtle 
changes (Dowd & Dunnett, 2004; 2005b). 
 
1.18 Reaction time testing in rodents 
The time to react to external stimuli can be assessed using one of three possible 
paradigms, (i.) simple reaction times, (ii.) choice reaction times, and (iii.) cued 
reaction times (Hauber, 1998). Whereas during voluntary movement the stimulus to 
execute the movement is internal, in simple and choice reaction time tasks there is 
an external imperative stimulus that signals the animal to initiate the movement. 
From this external stimulus the animal then has to select the appropriate response 
profile (motor programs) and subsequently initiate the movement. Importantly, in 
simple reaction time tasks all the information about ‘where’ the to-be-executed 
response has to be directed is available to the animal at all times. The only 
parameter of uncertainty is ‘when’ the response has to be executed. This advanced 
information allows selecting and assembling the movement plan already before the 
imperative signal is perceived. In contrast, in choice reaction times there is a high 
level of uncertainty of ‘where’ and ‘when’ the response has to be made. Information is 
only available with the onset of the stimulus and therefore motor preparation cannot 
start before this information is available to the animal (Hauber, 1998). Exeptions to 
this rule are cued choice reaction time tasks. In general, a pre-cue is given to the 
animal with information regarding where the response is located in space, therefore 
some of the information can be given to the animal in advance. Usually, the cue is 
given at different times before or together with the imperative stimulus, thereby 
assessing the ability of the animal to make use of this advanced information.  
 
Reaction time testing in rats has a long history in analysing the deficits induced by 
unilateral DA depletion and allows for the dissociation of multiple task parameters as 
the time to initiate an execute (lateralised) responses. Whereas reaction time testing 
in humans and non-human primates is often accompanied by recording 
electromyographic activity, this is generally neglected in the rat (Hauber, 1998). 
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Therefore it is difficult to further separate the time of stimulus detection, preparing of 
a motor plan and the signal sending to the muscle. A great deal of research has shed 
light on the lesion-induced deficit and especially on the role of the DAergic system 
therein. Early studies have investigated whether the deficit in reaction time 
responding is more likely to resemble bradykinesia (slowness of movement 
execution) and/or akinesia (initiation of movement), both symptoms are known to be 
caused by dysfunction of the basal ganglia, or if they are caused by deficits in 
sensory perception (Hauber, 1998). Using a conditioned-turning test in rats, Dunnett 
and Bjorklund (1983) have shown that unilateral 6-OHDA lesions do disrupt the 
acquisition and the maintenance of the conditioned response when they had to turn 
contralateral to the lesion, but not ipsilateral. The authors concluded that the deficit 
caused by the lesion was a disruption of movement initiation rather than movement 
execution, per se (Dunnett & Bjorklund, 1983). Furthermore, when animals are 
required to make a sustained hold before the imerative stimulus signals the execution 
of the (lateralised) response, longer ‘fore-periods’ led to shorter reaction times than 
shorter ‘fore-periods’ (Brown et al., 1991; Courtiere et al., 2011). Another observation 
was that animals do respond faster when a congruent cue is given rather than an 
incongruent (Courtiere et al., 2011). Partial 6-OHDA lesions into the dorsal striatum 
do not impair the congruency-effect but does impair the effect of fore-period, 
although during the first post-operative week of testing (Courtiere et al., 2011). Using 
the choice reaction time task Carli and colleagues elegantly showed that lesioned 
rats indeed displayed deficits in movement initiation, rather than a deficit due to 
primary sensory perception and/or primary movement execution (Carli et al., 1985). 
When comparing two groups of rats that, after a responding to a centre hole, had to 
report the occurrence of a lateralised stimulus light either with a nose poke into, or 
away, from the location of the stimulus, they found that both groups of rats could 
accurately detect the stimulus, therefore excluding a deficit in sensory perception 
(Carli et al., 1985). In a further study they demonstrated that the deficits was caused 
by depletion in the striatum whilst additional depletion of DA from the nucleus 
accumbens did not have additive effects (Carli et al., 1989). On a simple reaction 
time task bilateral terminal 6-OHDA lesions impaired reaction time performance 
whereas bilateral lesions to the nucleus accumbens did not have a significant effect 
(Amalric & Koob, 1987). This is in accordance with the view that the nucleus 
accumbens is rather involved in reward signalling and motivational aspects of an 
operant task than reaction time performance, per se (Cousins et al., 1993; Salamone 
et al., 1994). Both operant studies showed that next to the accuracy deficit, lesioned 
rats displayed an increase in reaction time latencies (Carli et al., 1985; Carli et al., 
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1989). Furthermore, rats that are trained to release a lever upon an imperative signal 
and receive the DA antagonist (receptor blocker) haloperidol into the striatum display 
an increase in reaction time latencies, a reduction in the number of usable trials, and 
an increase in anticipatory trials (Amalric & Koob, 1989) to a similar extent to bilateral 
6-OHDA lesions (Amalric & Koob, 1987). Interestingly, the increase in reaction time 
latencies, which was accompanied by an increase in the number of delayed 
responses in a simple lever release task, could be reduced by subsequent bilateral 
lesions of the STN (Baunez et al., 1995b). Similar, intra-striatal administration of d-
amphetamine led to a speeding-up of reaction time latencies (Baunez et al., 1995a). 
 
In an interesting study by Brown and Robbins (1991), rats were tested in choice and 
cued conditions within the same session; the brightness of the bilateral presented 
stimuli indicated an ipsilateral or contralateral response and rats were presented 
either simultaneously with an auditory signal as imperative signal or the imperative 
auditory cue was delayed after the presentation of the visual stimuli, thereby, 
according to the authors, turning the task into a simple reaction time task (Brown & 
Robbins, 1991). Unilateral DA depleted rats were still able to make use of the 
advanced information as shown by superior performance in the simple reaction time 
setting compared to the choice setting. Although an elegantly designed study, the 
effects of pre-cueing are addressed as the authors state themselves that ‘[!], fully 
cued reaction time tasks are equivalent to simple reaction time tasks on neither 
theoretical nor empirical grounds’ (p.866; Gauntett-Gilbert & Brown, 1989). There is 
still a level of uncertainty until the cue is presented and it is not clear that lesioned 
animal’s have enough time to incorporate the information to prepare the motor-plan 
(Gauntlett-Gilbert & Brown, 1998). Nevertheless, simple reaction time was faster than 
choice reaction time, an effect that was not disturbed by the 6-OHDA lesion, and it 
was therefore concluded that DA depleted rats are capable of integrating advanced 
information (Brown & Robbins, 1991). Systemic administration of amphetamine 
furthermore enhances motor readiness on a simple reaction time task (Brown et al., 
1996). 
 
Taken together, the above studies demonstrate the effect of striatal DA loss on 
reaction time, whereas loss in the nucleus accumbens was not effective in inducing 
similar deficits. Dopamine depletion in the striatum leads to an impairment in 
movement initiation, whereas primary sensory and/or motor deficits can be excluded 
(Carli et al., 1985). The reintroduction of DA to the depleted striatum via direct 
infusion of the neurotransmitter (Baunez et al., 1995a) or by means of engrafting DA-
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rich fetal cells (Lelos et al., 2012) did reduce reaction time after the lesion. 
Importantly, the right amount of DA is critical, as too much or little can have negative 
or no effects, respectively. The engraftment of cells that can regulate the DA release 
will therefore be more likely to show therapeutic benefits, if appropriate re-
inneravation is achieved, than infusion via, i.e. a minipump, into the brain. Choice 
reaction time testing is able to dissociate impairments in stimulus perception, 
movement initiation and movement execution. 
 
1.19 Simple tests of motor asymmetry 
The 6-OHDA unilateral lesion model has been a valuable research tool for almost 4 
decades since its introduction. Rats that received unilateral lesions along the nigro-
striatal pathway have been shown to develop contralateral motor impairments and 
show a form of contralateral sensori-motor neglect. Simple tests of DA imbalance, 
such as the drug-induced rotation test, or tests of motor function such as the cylinder 
test, the adjusting steps test, the staircase test, single pellet reaching test, and the 
corridor test have been shown to be sensitive to unilateral DA depletion (Ungerstedt 
& Arbuthnott, 1970; Schallert et al., 1978; Montoya et al., 1990; Montoya et al., 1991; 
Olsson et al., 1995; Kirik et al., 1998; Nikkhah et al., 1998; Schallert et al., 2000; 
Dowd et al., 2005a; Marin et al., 2006; Torres & Dunnett, 2007; Grealish et al., 2008) 
 Although all of these tests have been valuable both in investigating the function of 
DA in producing motor behaviour and in the ability of DA rich transplants to restore 
the lesion-induced deficits, they have some limitations.  
 
1.20 The 6-OHDA mouse lesion model of PD 
The 6-OHDA lesion model has been the gold standard as a PD model for 
researchers with the vast majority of studies conducted using the rat as the model 
organism. Despite 6-OHDA mouse lesion models being used over the years there is 
little standardisation about the parameters used. Across the literature (see Table 1.1) 
there is a huge variation in background strain, injection volumes, toxin concentration, 
and even lesion coordinates that target the same structure (Smith & Heuer, 2011). 
Furthermore, there has been little systematic characterisation in the mouse with 
regards to behavioural assessment and their correlations with lesion extent. In the 
rat, several studies have established thresholds and indicators that allow researchers 
to identify if an animal is well lesioned or not (Kirik et al., 1998; Torres & Dunnett, 
2007; Grealish et al., 2008).  
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With the advent of genetic mouse models and the relative ease with which these can 
be generated compared to the rat there is a need for a thorough characterisation of 
the mouse lesion model. The rat bundle lesion model provides the most reliable 
lesion with a near complete depletion of TH-ir DA cells on the side of injection. A 
direct transfer to the mouse has been proven difficult for several reasons: (i) the 
lesion success rate has been more variable than in the rat, (ii) bundle lesions in 
particular are associated with a very high mortality rate, although the same procedure 
in rats generally does not cause mortality; (iii) parameters for the lesion procedure 
have not been systematically investigated, and (iv) there are not standardised 
behavioural tests characterised that can distinguish lesioned from partially lesioned 
mice. 
 
All these factors are very important for studies that require a full lesion, i.e. for the 
development of dyskinesias, and for the investigation of long term treatment effects, 
e.g. cell replacement therapy. Partially lesioned animals can display spontaneous 
recovery and the effects of any therapeutic intervention can therefore be masked. 
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Table 1.1. Parameters of mouse unilateral 6-OHDA lesion model. Adapted from (Smith & 
Heuer, 2011) 
 
Concentration Dose Volume Target Coordinates Strain Sex Reference 
4 µg/µl 16 µg 4 µl Striatum 
AP= +5 (to occipital structure) 
ML= -2.2 
DV= -3.5 
Swiss-Webster M (Torello et al., 1983) 
4 µg/µl 16µg 4 µl Striatum 
AP= +0.5 
ML= -2.4 
DV= -3.1 
C57Bl/6 M/F (Randall, 1984) 
3.32 µg/µl 13.3 µg 4 µl Striatum 
AP= +4.8 (from Lambda) 
ML= -1.7 
DV= -3.0 and -2.7 
MNRI M (Brundin et al., 1986) 
 
3 µg/µl 
 
3.9 µg or 5.4 µg 1.3 µl or 1.8 µl Striatum 
AP=-1.2 
ML=±1.1 
DV=-5.0 
CBA F (Iancu et al., 2005) 
1.6 µg/µl 2.4 µg 1.5 µl SN 
AP=-3.0 
ML=-1.2 
DV=-4.5 
NMRI F (Grealish et al., 2010b) 
4 µg/µl 16 µg 4 µl Striatum 
AP= +0.5 
ML= -2.4 
DV= -3.1 
C57Bl/6 M (Mandel & Randall, 1990  
2 µg/µl 4 µg 2 µl Striatum 
AP= +0.4 
ML= -1.8 
DV= -3.5 
C57/Bl6 M (Bensadoun et al., 2000) 
3 µg/µl 3 µg 1 µl MFB 
AP= -1.2 
ML= -1.2 
DV= -4.75 
C57Bl/6 M (Lundblad et al., 2004) 
3 µg/µl 6 µg 
 
 
2x2 µl 
Striatum 
AP1 = +1.0 and +0.3 
ML= -2.1 and -2.3 
DV = -2.9 and -2.9 
C57Bl/6 M (Lundblad et al., 2004; Lundbl   al., 2005) 
2.5 µg/µl 10 µg 2x 2 µl Striatum 
AP= +0.5 
ML= +2.4 
DV -4.0 and -3.0 
C57BL/6J/ 
OlaHsd M (Pavon et al., 2006) 
3 µg/µl 12 µg 2x 2 µl Striatum 
AP1 = +1.0 and 0.3 
ML= - 2.1 and -2.3 
DV= -3.2 and -3.2 
C57Bl/7 M (Santini et al., 2007) 
4 µg/µl 8 µg 2 µl Striatum 
AP= + 0.4 
ML= - 1.8 
DV= - 3.5 
C57Bl/6 M (Alvarez-Fischer et al., 200  Alvarez-Fischer et al., 2008) 
8 µg/µl 16 µg 2 µl Striatum 
AP= + 0.8 
ML= -1.9 
DV= - 2.6 
C57Bl/6 M (Richter et al., 2008) 
8 µg/µl 16 µg 4 µl Striatum 
 
N/A 
 
Not specified M (Von Voigtlander & Moore, 19  
1 µg/µl 2 µg 2 µl Striatum 
AP= +0.9 
ML=1.9 
DV= -3.1 
BALB/cyJ M (Filipov et al., 2002) 
2 µg/µl 4 µg 2 µl Striatum 
AP= +0.4 
ML=1.8 
DV= 3.5 
C57Bl/6J M (Bensadoun et al., 2000) 
3 µg/µl 12 µg 4 µl Striatum 
AP=0.0 
ML=2.0, 
DV=-2.0 
ddY M (Iwata et al., 2004) 
2 µg/µl or 4 µg/µl 4 µg or 8 µg 2 µl Striatum 
AP=0.8, 
ML=2.0 
DV=3.6 
Mixed B6; 
129S4 M (Perez et al., 2005) 
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1.21 Effects of nigral grafts in the 6-OHDA lesion model  
 
As discussed above due to the ectopic graft placement nigral grafts to not provide a 
circuit reconstruction as is theoretically possible in the striatal graft model. After a 
unilateral infusion of 6-OHDA along the nigro-striatal pathway there is a degeneration 
of DA neurons in the SN and subsequent depletion of DA in the striatum. This is 
accompanied by up-regulation of post-synaptic receptors. This asymmetry in DA 
release and post-synaptic receptor up-regulation leads to circling behaviour in the 
animal shortly after the lesion (Ungerstedt, 1968; Ungerstedt & Arbuthnott, 1970). 
Although there is some compensation of behaviour in animals the circling behaviour 
can be re-introduced via injection of drugs that act on the DA system. Amphetamine 
and apomorphine are the two most used compounds to study the effects of unilateral 
DA depletion and the effects of subsequent DA replacement via engrafting of 
DAergic tissue (Torres et al., 2007). Interestingly, the amount of circling is related to 
the level of depletion in both the SN and the VTA, with circling behaviour being 
introduced after SN DA lesions but the amplitude of rotations depending on relative 
sparing of DA neurons in the VTA (Kelly, 1975; Kelly et al., 1975; Kelly & Moore, 
1976; Brundin et al., 1987; Torres et al., 2007). Next to the reduction in drug-induced 
rotation DAergic grafts are able to partly ameliorate the deficits on a number of tests 
that do not require drug administration. Small, but highly significant benefits as 
compared to lesioned rats were found on the stepping test, the cylinder test, and the 
corridor test, whilst skilled paw reaching, as assessed via the staircase test, could not 
be improved (Dowd et al., 2005a; Torres et al., 2008a). The failure to ameliorate the 
deficit in the staircase test is partly due to lesioned animals not attempting to retrieve 
pellets, rather than an inability to reach for the pellet, per se. A reduction in 
motivation has been reported in other tasks where lesioned rats do attempt fewer 
trials and make fewer responses in general, a phenomenon that has been linked to 
DA depletion in the nucleus accumbens (Cousins & Salamone, 1996; Dowd & 
Dunnett, 2004; Dowd et al., 2005a; Torres et al., 2008a). Also on other tests of 
sensory neglect DA grafts fail to improve the lesion-induced deficits in paw use, 
whilst improving whole body motor asymmetry in spontaneous rotation and sensori-
motor function (Dunnett et al., 1987). Grafts are able to improve sensori-motor and 
akinetic impairments, but fail to improve eating and drinking behaviour in severely, 
bilaterally lesioned rats (Dunnett et al., 1983b). Effects of grafts are furthermore 
dependent on their placement within the striatum, the method of grafting, age of the 
donor, and depending on the function assessed (Dunnett et al., 1981b; c; a; Dunnett 
et al., 1983b; Nikkhah et al., 1995), as ventro-lateral grafts can ameliorate sensori-
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motor deficits whereas central grafts ameliorate drug-induced circling (Mandel et al., 
1990). On operant tests, 6-OHDA lesioned rats that were engrafted with VM did 
sustain mean lever press rates on an intracranial self stimulation task compared to 
rats that received cortical grafts, when the electrode was placed adjacent to the 
DAergic cell bodies (Fray et al., 1983) and improves performance on the lateralised 
choice reaction time task in that engrafted rats attempt more trials, commit fewer 
procedural errors, improve in their contralateral response accuracy and display a 
reduction in their movement time latencies to execute the lateralised response, 
compared to lesion only controls (Dowd & Dunnett, 2004). Although a great deal of 
functions of DAergic grafts have been assessed and advances have been made in 
improving many parameters including graft survival and outgrowth, there is a lack of 
studies looking at recovery on more complex functions.  
 
1.22 The Dowd extinction effect – “Movement without 
dopamine” 
 
Recently, Dowd and Dunnett  (2004, 2007) showed that animals that received near 
complete unilateral DA depletion showed a contralateral deficit on the Carli task that 
was not present when the animals were first re-introduced into the operant 
chambers, but instead the deficit appeared over a few days of testing (Dowd & 
Dunnett, 2004; 2007). Although there was near complete DA depletion, the animals’ 
performed similarly to control animals on the first days of testing. It has been 
suggested that the animals initially perform on the task ‘out-of-habit’ (Dowd and 
Dunnett, 2007, p. 429) which can temporally overcome the DA depletion. The 
authors argue that the observed deficit was not attributable to an impairment in motor 
initiation but to an impairment in reward-signalling (Dowd & Dunnett, 2004; 2007). 
The “extinction effect” has been linked to theories of reward signalling of neurons in 
the tegmental area, such as those suggested by Schultz and colleagues (Dowd & 
Dunnett, 2007). In a series of experiments Schultz has shown that neurons in the 
VTA and the SN signal the prediction of a reward in response to an external stimulus. 
Recordings of neurons in the VTA/SNpc in non-human primates and rats revealed 
that the phasic firing pattern of these neurons are able to form the neuronal basis of 
the ‘reward prediction error’ (Schultz et al., 1997; Schultz, 2000; 2006). Schultz 
argued that the neuronal firing is not due to the presence of the rewarding stimulus 
itself (Schultz, 1997; 1998). The reward prediction error describes the relationship 
between the likelihood that a reward is obtained and the presence of the reward in a 
given situation. With every experience the reward prediction error is updated to 
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enable the animal with a prediction of a given outcome dependent on the situation 
and the behaviour of the animal. If the actual reward is similar to the expected reward 
the reward prediction error is near zero whereas if the animal anticipates a big 
reward and no reward is present the reward prediction error will be large. Neurons 
fire homogeneously when an unexpected reward is present but they inhibit firing 
when an expected reward is not present (Schultz et al., 1992; Mirenowicz & Schultz, 
1996; Hollerman & Schultz, 1998; Hollerman et al., 1998; Schultz, 2001; Cromwell & 
Schultz, 2003). The reward prediction error forms the neuronal basis of “extinction” in 
the Dowd & Dunnett (2007) paradigm. Bayer and Glimcher (2005) have shown that 
phasic firing continues although behaviour is not adapted once the stimulus response 
association has been learned. Over the time course of learning the phasic response 
shifts from reward delivery to the onset of the first predictor or cue (Schultz et al., 
1997; Schultz, 2000). Interestingly, the two DAergic cell groups in the VTA and SNpc 
show similar firing patterns (Hollerman & Schultz, 1998; Bayer & Glimcher, 2005). It 
is assumed that the phasic firing of tegmental DAergic neurons towards reward 
predicting stimuli is needed to maintain a previously learned stimulus-response 
association. The lack of the phasic signal (via the lesion) leads to a reduction in 
responses contralateral to the lesion that resembles extinction. When animals are 
trained on a lateralized choice reaction time task and after training on one side is not 
rewarded anymore, the animal will cease responding towards that side (Dowd & 
Dunnett, 2007). Although the response pattern shares similarities, the pattern of 
decline in accuracy is less steep than the one after the lesion. After initial learning the 
response association is assumed to be stored at the level of plasticity at the cortico-
striatal synapse (Centonze et al., 2003a; Centonze et al., 2003b; Calabresi et al., 
2006; Calabresi et al., 2007). Whereas quinolinic acid lesions destroy the striatal 
synaptic targets of the cortico-striatal inputs, in the 6-OHDA lesion model only the 
supply of the phasic reward signal is broken, and not the response association itself. 
Neuronal replacement in the QA lesion model and in the 6-OHDA lesion model will 
have different effects on improving the animals’ behaviour. Whereas in the QA lesion 
model the neural circuit that was destroyed can be reconstructed by striatal 
transplants because the cells are placed homotopically back into the striatum from 
where they are lost, in the 6-OHDA lesion model nigral cell transplants are placed 
ectopically, and provide local re-innervation (and DAergic activation) but do not allow 
for nigro-striatal reconstruction, as would be required (at least in principle) to restore 
reward signalling. The graft in the QA lesion model does not show a behavioural 
improvement after the first days of testing, but after extensive post-operative training 
the animals are able to “re-learn” the task (Mayer et al., 1992; Brasted et al., 1999b). 
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Because of intact reward signalling a new S-R association can be formed with the 
newly integrated donor tissue. Conversely, in the 6-OHDA lesion model, where the 
ectopic graft placement only allows tonic DA levels to be elevated, it does not allow 
for the reward signal to be re-constructed. Therefore, even with graft-induced 
improvements seen in the 6-OHDA lesion model, full recovery is unlikely to be 
achieved.  
 
1.23 Aims of this thesis 
The introduction has given a brief overview of the current state of models and 
research in the field of PD. Furthermore it has shown the respective level of 
understanding of rat and mouse models that utilise 6-OHDA to create animal models 
of PD. What is clear from the literature is that more work has been conducted using 
rat models, compared to mouse, and that not many complex behavioural tasks have 
been employed to investigate the effects of cell replacement therapies. With new 
transplantation trials fast approaching it is only a matter of time before stem cells 
derived from other sources will become available. It is important to know how these 
cells, and any cell for that matter, will function once transplanted into the brain. 
Whereas cell biologists are concerned with the expression of certain biomarkers, 
most transplantation laboratories apply rather simple (and occasionally simplistic) 
behavioural analyses, such as overcompensation of the rotational response to 
amphetamine. Although both approaches are important research tools, it is 
imperative to characterise the lesion model they are tested on fully, and, furthermore, 
to investigate whether, and to what extent, cell replacement therapies can and/or 
cannot ameliorate the deficits. The ultimate question will then be how do other cell 
sources compare to the ‘gold standard’ of primary fetal tissue.  
 
The main goals of this thesis were to characterise the lesion-induced deficits 
following the 6-OHDA lesion focussing on more complex behavioural tasks of motor 
and cognitive function for the purpose of the assessment of cell replacement 
therapies. More complex analysis and exploration of what functions can be recovered 
and which cannot is important in the pre-clinical analysis of cell replacement 
therapies. Therefore, first, I aimed to utilise versions of the lateralised choice reaction 
time task to investigate the lesion-induced deficits and the potential of cell 
replacement therapies to alleviate the deficit. Second, as interest in mouse models 
(which are currently less well characterised) has increased over recent years, I aimed 
to characterise basic and more complex lesion-induced deficits in mice, followed by 
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an initial grafting experiment to assess the validity of the model to serve for future 
therapies.  
 
Thus, my experimental programme reported in this thesis falls into a series of 
discrete experiments: 
 
1.) Assessment of lesion induced deficits on choice reaction time tasks in rat 
models of Parkinson’s disease (Experiments 1 & 3; assessed in rats) 
2.) Assessment of primary fetal tissue to ameliorate lesion induced deficits on a 
complex behavioural task (Experiment 2; assessed in rats) 
3.) Development and behavioural characterisation of mouse 6-OHDA lesion 
models (Experiment 4; assessed in mice) 
4.) Characterisation of lesion induced deficits on complex behavioural tests 
(Experiment 5; assessed in mice) 
5.) Assessment of primary fetal tissue to alleviate lesion induced deficits on 
complex behavioural tests (Experiment 6; assessed in mice) 
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Chapter 2 Materials and methods 
Chapter 2.1 - Subjects 
 
All testing was done in accordance to the UK, Scientific Procedures Animals Act of 
1986 and local ethical review. All experiments were conducted under the Project 
Licence PPL 30/2498 and Personal Licence PIL30/8115.  
 
2.1.1 Rats 
In all experiments regarding rats, female animals of the Lister Hooded strain (Charles 
River, UK) were used. All rats were housed in standard laboratory cages in groups of 
3-4. When not on food restriction the animals had free access to standard laboratory 
chow and water at all times. The home-cages were equipped with one cardboard 
tube and wood-sticks for environmental enrichment. The holding room was regulated 
at a temperature of 21 ± 1°C and 50% relative humidity. The light cycle was set to 
12:12 hours with lights on at 07:00 am.  
Rats were food restricted to 90% of their free-feeding body weights one week prior to 
operant training, by providing them with weighed amounts of food at the completion 
of each day’s testing. They were allowed ad libitum access to water in the home 
cages throughout all stages of the experiment. 
2.1.2 Mice 
In experiments conducted on mice, animals of the C57/Bl6 (Harlan, UK) strain were 
used. Animals were held in standard laboratory cages in groups of 5-6 (Experiment 
4) or 1-2 (Experiments 5 & 6). Each cage was fitted with a cardboard tube and wood-
sticks for environmental enrichment. The holding room was held at a constant 
temperature of 23 ± 2°C and 50% relative humidity.  The dark-light cycle was set to 
12:12 hours with lights on at 06:00 am. Except during periods of behavioural testing 
in which food restriction was required all mice had access to food and water ad 
libitum at all times. During periods of testing which required motivation animals were 
food restricted to 85-90% of their free feeding weight by providing the animals with 
weighted amounts of food that was made available ad libitum after testing sessions. 
The weight of all animals was recorded three times per week and the amount of food 
was adjusted accordingly. 
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Chapter 2.2 Apparatus 
2.2.1 Skinner box rat 
Testing in the Skinner box operant chamber (Paul Fray Ltd., Cambridge, UK) was 
conducted in a bank of 12 equally designed boxes (see Figure 2.1). The dimensions 
of the boxes were 26cm x 27cm x 23cm. On the front wall of the chamber two 
retractable levers were fitted to each side of a food magazine with a Plexiglas panel. 
45mg precision sucrose pellets (Sandon, USA) could be delivered into the magazine 
via the attached pellet disperser. The two response levers that are located to either 
side of the magazine were positioned 1.5cm from the respective side wall and 6cm 
from the grid floor. Three stimulus lights were located 4cm above each lever and the 
magazine.  
 
 
 
Figure 2.1 Schematic illustration of the Rat Skinner box.  
 
stimulus lights (3)  
pellet hopper 
retractable levers 
 
food panel 
panel 
 
house light 
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2.2.2 9-Hole box rat 
The rat 9-hole box (Figure 2.2) is fitted with an array of 9 response holes mounted to 
the rear wall of the operant chamber which has been described previously (Carli et 
al., 1983; Dowd & Dunnett, 2005b). Briefly, the operant chamber is fitted with a 
curved array of 9 response holes which can be illuminated by a green LED and 
detect a hole entrance via the break of a infrared beam that runs vertically across the 
entrance of the response hole. On the opposite side of the chamber a food magazine 
is fitted to which a pellet dispenser is connected. The whole apparatus is enclosed in 
a wooden sound attenuating cubicle with an extractor fan to dampen background 
noise. Holes that are not in use in a given task paradigm are typically covered with 
metal well blanks. The 9-hole boxes were controlled by the Cambridge Cognition 
Control software (Campden Instruments LTD., version 1.23) running on a standard 
desktop PC using the Windows XP operating system.  
 
2.2.3 9-Hole box mouse 
The 9-hole box used for the operant testing of mice is in principle a scaled down 
version of the rat 9-hole box with some changes to adapt for the smaller size of the 
animal. The most important changes made to the rat version is that instead of sugar 
pellets, strawberry milk (Yazoo®, Campina) at a volume of 5!l is provided as reward. 
Furthermore, the Perspex® panel door that covers the entrance of the magazine was 
removed and substituted by fitting infrared sensors which could detect a magazine 
entry (Bensadoun et al., 2004).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Schematic illustration of the 9-Hole box. 
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Chapter 2.3 - Operant tasks 
 
Task parameters 
Operant tasks will be described in general and the actual parameters such as 
session length of stimulus duration may vary between experiments and/or between 
tasks that are run in rats and mice. Details of the specific task parameters can be 
found in the respective experimental chapter and an overview is presented in Table 
2.1. Here we will focus on the general task outline only.  
 
Experiment #1 Carli #2 Brown/Brasted #3 Error correction #5/#6 Carli 
Apparatus Skinner Box 9-Hole box 9-Hole box 9-Hole box 
Species Rat Rat Rat Mouse 
SD 1000 200 300 300 
Holds 100, 300, 600, 900 50, 100, 150, 200 50, 100, 150, 200 25, 50, 75, 100 
ITI 2000 2000 2000 2000 
TOI 5000 5000 5000 5000 
 
Table 2.1. Overview of task parameters used. All times are given in ms. SD = 
Stimulus duration, ITI = Inter-trial interval, TOI = Time-out interval.  
 
2.3.1 Carli-task in the Skinner box 
In experiment 1 (Chapter 3.1) all configurations of the Skinner box version of the 
Carli task were adapted from Dobrossy and Dunnett (1997, 1998). The outline of the 
task is shown in Figure 2.3. In brief, each trial starts with the illumination of the 
central magazine light to which the animal has to respond with a sustained nose-pole 
for one of four randomly chosen delays. Upon completion of the sustained nose-
poke, one of the two stimulus lights located above the response lever was illuminated 
(randomly determined by the computer) and signalling the correct response option. 
The stimulus light remains illuminated until the animal makes a response on either 
lever; when a lever response is made both levers are retracted. A correct response is 
further rewarded by the delivery of a 45mg precision sucrose pellet into the 
illuminated magazine. An incorrect response is ‘punished’ by a time out period in 
darkness. After the animal retracts its nose from the magazine after retrieving the 
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food reward or after the time out period a two second inter trial interval with only the 
house light illuminated is conducted before initiation of the next trial. The main 
adaptation from previous versions of the task was that the lateralised stimulus was 
only briefly illuminated, whereas in previous versions the light stayed on until the 
animal had made a response (Dobrossy & Dunnett, 1997; 1998).  
 
 
Figure 2.3 Schematic outline of the Skinner box version of the lateralised choice 
reaction time task. A. Each trial starts with an illumination of the central stimulus light 
inside the food hopper. B. The animal is required to make a sustained nose poke for 
various delays (50ms, 300ms, 600ms, 900ms). C. If the animal does not retract its 
nose before the required interval, the centre light extinguishes and one of the 
stimulus lights located above the lateralized levers is illuminated, thereby indicating 
the side of required response. D. The animal is required to press the lever, beneath 
the illuminated stimulus light. A correct response (left in this example) will result in 
illumination of the central stimulus light and delivery of a sugar pellet into the food 
hopper. In case of an incorrect response (right in this example), the animal will be 
punished by a time out period of 5 seconds in darkness.  
 
2.3.2 Brown/Brasted task in the 9-hole box 
In experiments 2 and 3 we tested rats on an adaption of the classic lateralised choice 
reaction time task (Carli et al., 1985). The current version of the choice reaction time 
task is adapted from Brown and Robbins (1989) and Brasted et al. (1997) and is 
shown in Figure 2.4. At the beginning of each trial the house lights were switched off 
and the centre hole was illuminated. When a nose-poke was made into the 
illuminated hole the centre hole light was extinguished. The animal then had to 
A 
B 
C 
D 
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sustain its nose-poke for a variable delay (50, 100, 150, 200ms). When the animal 
sustained its nose poke for the required interval one of the two lights on the left or the 
right (dependent on the day of testing) was randomly illuminated. Upon detection of 
the stimulus the rat had to retract its nose form the centre hole and perform a nose-
poke in the hole indicated by the illumination. A correct response resulted in the 
delivery of a food pellet into the food hopper whereas an incorrect response or a 
premature withdrawal resulted in a ‘punishment’ of a time out period where all lights 
were extinguished (Brown & Robbins, 1989b; Brasted et al., 1997).  
 
 
 
 
 
Figure 2.4. A. The animal is set in the operant chamber with only the centre hole and 
the two adjacent holes being exposed (right side in this example; the side is 
dependent on the day of testing). B. The stimulus light in the centre hole is 
illuminated. C. The animal has to perform a sustained nose-poke in the illuminated 
centre hole. D. One of the two stimulus lights in the adjacent holes is illuminated. E. 
A nose-poke in the illuminated hole results in reward delivery whereas an incorrect 
response or omission results in a time-out period. 
 
2.3.3 Carli task in the mouse 9-hole box 
In experiments 5 and 6 we tested mice on an adaption of the classic lateralised 
choice reaction time introduced by Carli et al. (Carli et al., 1985; Carli et al., 1989; 
Dowd & Dunnett, 2004). Testing was conducted in mice 9-hole boxes as described in 
section 2.2.3.  
In brief, each trial was started with all lights extinguished, followed by constant 
illumination of the light in the central hole (Figure 2.5). The mouse then had to 
respond to the illuminated hole via a sustained nose poke into the hole for a variable 
A 
B 
C 
D 
E 
Correct Incorrect 
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delay. Upon completion of the hold period one of the lateralised stimulus holes was 
briefly illuminated (randomly chosen by the computer). The mouse then had to 
withdraw the nose from the centre hole and respond to the hole that had been 
illuminated via a nose poke within a limited response time. A correct response 
resulted in the delivery of 5!l strawberry milk into the illuminated magazine. Upon 
collection of the reinforcer a brief inter trial interval was started before the next trial 
commenced. 
 
 
Figure 2.5. Outline of the lateralised choice reaction time task. After initiating a trial 
via a sustained nose poke into the illuminated centre hole (A.) the animal had to 
report the occurrence of a brief lateralised stimulus light (B.) via withdrawal of the 
nose from the centre hole (C.) and a nose poke response into the indicated response 
location (D.). 
 
2.4 Simple behavioural screens 
Several tests of simple motor asymmetry have been applied in the experimental 
chapters. A detailed description of each of the tests will be given in the respective 
chapter and tests will only be mentioned briefly here. 
 
2.4.1 Drug-induced rotations 
Drug induced rotations were induced via i.p. injection of 2.5mg/kg of 
methamphetamine or 0.05mg/kg apomorphine. All assessments were conducted in 
automated rotometer bowels which were modelled after the design of Ungersted 
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(Ungerstedt & Arbuthnott, 1970), with the exception of experiment 4 (Chapter 3.4), in 
which mice were video-recorded and rotations in either direction were scored post-
hoc. 
 
2.4.2 Locomotor activity 
The general locomotor activity was measured in mice using Med Associate 
automated locomotor boxes. The animals were placed individually in plastic cages 
that were fitted with three infrared sensors. All beam breaks in a 2 hour period were 
recorded. 
 
2.4.3 Cylinder test 
The cylinder test measures paw use preference and utilised the exploratory 
behaviour of mice. Each mouse is placed in a glass cylinder and video recorded for 3 
minutes from the front, with two mirrors positioned at a 60 °angle to allow for a 360° 
view. Post-hoc freeze-frame analysis was used to count the number of respective 
ipsilateral and contralateral touches of the cylinder wall. 
 
2.4.4 Elevated beam 
The elevated beam test measures balance and motor coordination. In brief, the 
mouse was placed on the lower end of an inclining beam that was wide at the base 
and narrowing towards the top end where a home box was located. The animal had 
to traverse the inclining beam to reach the home box. The number of foot slips as 
well as the latency to traverse the beam were scored live from one side whereas the 
opposite side was video-recorded and analysed post-hoc. 
 
2.4.5 Corridor test 
The corridor test measures sensory-motor neglect. In brief, 10 pairs of small plastic 
containers are placed in regular intervals along a Perspex corridor and filled with 
reward pellets. The mouse is placed in the corridor and allowed to retrieve pellets for 
5 minutes or until 20 explorations have been made, whichever occurres first.  
 
2.4.6 Staircase test 
The staircase test assesses paw use and dexterity of the animal. Each staircase 
apparatus consists of a double staircase, which is fitted with food wells on each 
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individual step. Each of the steps is baited with reward pellets. Between the double 
staircases a platform with a plinth is located to which the mouse has to climb onto 
from its home box in order to reach down to the steps to retrieve the reward pellets.  
 
2.4.7 Rotarod 
The rotarod apparatus was used to assess general motor coordination and balance. 
The apparatus consists of a rotating rod whose rotation speed was increased for 4 
rpm to 44 rpm over a period of 5 minutes.  
 
2.4.8 Stepping test 
The stepping test adapted for mice was conducted via pulling the animals backwards 
on a flat surface over a distance of 50 cm over 5 seconds. The mice were video-
recorded from the front and the number of adjusting steps of the respective forepaw 
was scored post-hoc.  
 
2.4.9 Gait analysis 
For analysing the animals gait pattern as stride length, base width, etc., we coloured 
the animals’ fore and hind paws with different colours and let them run over 
absorbent paper on a flat surface. The gait pattern of 3 consecutive strides was 
scored. 
 
2.4.10 Grip strength 
Grip strength was assessed in mice via the inverted cage lid method. In brief, mice 
were placed on a metal grid with a rectangle taped off. The grid was then slowly 
inverted and the latency to fall was recorded.  
 
2.5. Surgery 
General surgical protocols were identical for rats and mice. Individual differences, i.e. 
in lesion coordinates and toxin concentrations, are given in Table 2.1. 
 
2.5.1 Lesion surgery 
Anaesthesia was induced in an induction chamber with 5% isoflurane using oxygen 
as the carrier gas and maintained by a nose mask delivering 1-2% isoflurane in 2:1 
O2/NO. The surgical area was shaved and the animal was placed in a stereotaxic 
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frame (Kopf model 900). A 30-gauge cannula connected to a 10µl Hamilton syringe 
driven by a microdrive pump was used to deliver the toxin at a flow rate of 1µl/min. 
The required volume of 6-OHDA (see table 2.2) was calculated from freebase weight 
(5.14!g hydrobromide salt, Sigma Chemicals, UK) and dissolved in a solution of 0.2 
mg/ml ascorbic acid in 0.9% sterile saline. After injections were made the needle was 
left in place for an additional 3 minutes to allow for diffusion before the injection 
needle was carefully retracted (Torres & Dunnett, 2007). After surgery the wound 
was cleaned and sutured and the animal was placed on a heated blanket for 
recovery. Post-operative analgesia was given by addition of paracetamol to the 
drinking water for three days post surgery (Experiment 1) or via s.c. injection of 
Metacam (Meloxicam, Boehringer, Ingelsheim, Germany). 
 
Species Concentration Dose Volume Target Coordinates 
Rat 4 µg/µl 12 µg 3 µl MFB 
AP= -4.0 
ML= -1.3 
DV –7.0 
Mouse 6 µg/µl 9 µg 1.5 µl SN 
AP= -3.0 
ML= -1.2 
DV= -4.5 
Mouse 6 µg/µl 6 µg 1 µl MFB 
AP= -1.2 
ML= -1.2 
DV= -4.75 
Mouse 6 µg/µl 18 µg 2 x 1.5 µl Striatum 
AP= +1.0 and +0.3 
ML= -2.1 and -2.3 
DV= - 2.9 and -2.9 
Table 2.2. Lesion coordinates by species and target structure in mm. 
 
2.5.2 Graft surgery 
2.5.2.1 Dissection and cell preparation 
Pregnant dams were deeply anaesthetized by intra peritoneal injection of sodium-
pentobarbital (Euthatal) and killed by dislocation of the neck. After cleaning the 
abdominal area with 70% ethanol an incision was made so that the uterine horns 
containing the embryos could be accessed. The embryos were collected in Hank’s 
Balanced Salt Solution (HBSS) (Gibco), and the brains were removed. The VM was 
dissected out as described in Dunnett and Bjorklund (1992, 1997). The dissected 
VMs from all embryos were pooled in one eppendorf tube and washed with HBSS. 
The tissue pieces were then transferred into a solution of 0.1% trypsin (Worthington, 
NJ, USA) and incubated for 20 minutes at 37°C. The trypsin was removed and 
replaced by trypsin inhibitor (Sigma Chemicals, UK) and DNAse (Sigma Chemicals, 
UK) and then incubated for a further 5 minutes at 37°C. The tissue was then washed 
in DMEM/F-12 (Gibco) and centrifuged at 1000rpm for 3 minutes to form a pellet from 
the tissue pieces. This pellet was re-suspended in 200!l DMEM/F-12 and 
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mechanically triturated with a 200!l pipette (Gilson) to produce a single cell 
suspension. Cell counts were conducted via the trypan blue (0.4%, Sigma 
Chemicals, UK) technique using a haemocytometer (Dunnett & Bjorklund, 1992; 
1997).  
2.5.2.2 Graft surgery 
Graft surgery was carried out using the same principles as lesion surgery, described 
in section 2.3.4.1. The main difference was that a cannula with a wider inner 
diameter was used to inject the cells into the denervated striatum. Detailed 
descriptions are given in the respective experimental chapters (Chapter 3.2 and 
Chapter 3.6).  
 
2.6 Perfusion and histology 
 
2.6.1 Perfusion 
Following completion of the experiment the animals were deeply anesthetized with 
200 mg/kg sodium pentobarbitone and transcardialy perfused through the heart with 
phosphate buffered saline (PBS) pH=7.4, followed by paraformaldehyde in PBS 
(Experiment 1 & 2: 4%; Experiments 3-6: 1.5%) for a duration of 5 minutes. The 
brains were then carefully removed from the skull and post-fixed for 24 hours in the 
paraformaldehyde in PBS before they were put in a 25% sucrose solution in PBS, 
where they were kept until they sunk (Torres & Dunnett, 2007). For visualizing lesion 
extent brains were sliced coronally using a freezing sledge microtome, at a thickness 
of 40µm. Sections were cut into 0.1 M TRIS buffered saline pH 7.4 (TBS) and stored 
at +4°C prior to staining. All staining was done using standard histological techniques 
on a 1 in 12 series of coronal sections.  
 
2.6.2 Immunohistochemistry 
All Immunohistochemical stains were done following the protocol of Dr. Eduardo 
Torres (Torres & Dunnett, 2007). A detailed list of the respective antibodies used can 
be found in the respective experimental chapters. 
For all immunohistochemical stains coronal brain sections (40!m) were washed in 
TBS before quenching endogenous peroxidise activity to reduce non-specific 
background staining (80% distilled water; 10% H2O2; 10% Methanol) for 10 minutes. 
This was followed by three washes in TBS (pH 7.4) before blocking in normal serum 
(horse 3% in TXTBS) for 1 hour to prevent non-specific binding of the antibodies 
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used. After this the sections were transferred, without washing, into the primary 
antibody at the required concentration in TXTBS with 1% serum and incubated at 
room temperature overnight. After three washes in TBS the sections were then 
transferred into the biotinylated secondary antibody in TBS with 1% serum for 3 
hours. Following this step the sections were washed again 3 times in PBS before 
incubation in a dako streptavidin ABC kit (Dako, Glostrupp, Denmark) in 1% serum 
for 2 hours. After washing three times in PBS and two washes in TNS the antibodies 
were visualized by staining with diaminobenzidine (DAB: Sigma, Poole, Dorset) at a 
concentration of 0.5mg/ml in TNS with 3% H2O2. When the colour reaction was 
sufficient for visualization the sections were washed 3 times in TNS and 2 times in 
TBS before mounting them on gelatine-covered glass slides. The slides were left to 
dry overnight before dehydrating in an ascending series of alcohol (70%, 95%, and 
100%; 5 min each) and removal of lipids in xylene. All slides were then coverslipped. 
 
2.6.3 Cell counts 
After staining the sections for TH positive cells, cells of the SN were counted at the 
level of the medial terminal nucleus of the accessory optic tract (Dowd & Dunnett, 
2004). Cell counts were done under a bright light Leica microscope with a 40x 
magnifying lens.  
 
For an estimation of cell numbers in the transplants all TH-ir cells on every 6th 40!m, 
thick coronal section was counted at x40 magnification (oil lens). The diameter of 
each cell was estimated from an average of at least 100 randomly sampled cells over 
all grafts of a given cell suspension group. The total number of cells per graft was 
estimated using the Abercrombie correction formula (Abercrombie, 1946): 
 
T = F x A x M / (D/M) 
 
T = Total number of cells 
F = Frequency of sections 
A = Total counts for one animal 
M = Section thickness 
D = Average cell diameter 
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2.7 Statistical analysis 
For all experiments statistical analysis used are described in detail in the respective 
manuscripts. In general for all experiments !-levels of 0.05 were used to determine 
significant F-ratios for rejection of the null-Hypothesis. 
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Chapter 3.1 
Experiment 1: Unilateral 6-OHDA lesions induce 
lateralised deficits in a ‘Skinner box’ operant choice 
reaction time task in rats. 
 
PD is most commonly modelled via depletion of DA by unilateral infusion of 6-OHDA 
along the nirgo-striatal pathway. The injection of 6-OHDA into the MFB leads to a 
near-complete unilateral DA depletion, which is regarded as stable and does not 
undergo spontaneous recovery. Previous work conducted in the 9-hole box has 
shown that the lateralised choice reaction time task is sensitive enough to detect 
lesion-induced impairments and graft induced recovery in 6-OHDA lesioned rats. The 
lateralised choice reaction time task is therefore a valuable research tool to 
investigate the effects of unilateral manipulation of the striatum. Although a few 
studies have described a translation of this task to the Skinner box, no studies, to our 
knowledge, have used the near complete bundle lesion model. 
 
Due to availability of operant equipment and to learn the associated procedures 
(surgery, programming, data analysis, histology) Professor Dunnett had me conduct 
the first experiment in the Skinner box apparatus.  
 
Initial studies have shown that partially lesioned rats do recover to pre-lesion 
performance over two weeks of post lesion testing. In order to assess the effects of 
potential therapies we need to characterise the lesion-induced behavioural response 
profile on the Skinner box version of this task. The main questions for the present 
study were: (i) is the Skinner box version of the lateralised choice reaction time task 
sensitive to lesion induced changes? and (ii) is the deficit stable over acute and long 
term testing? 
 
The experiment conducted in the present paper as well as analysis of the data, 
histology and preparation of the manuscript was done by the author of this thesis. 
Professor S.B. Dunnett was involved in planning of the experiment and gave help 
and advice throughout as well as in the writing of the manuscript.  
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Unilateral 6-OHDA Lesions Induce
Lateralised Deficits in a ‘Skinner box’
Operant Choice Reaction Time Task in Rats
Andreas Heuer∗ and Stephen B. Dunnett
Brain Repair Group, School of Bioscience, Cardiff University, Cardiff, Wales, UK
Abstract.
Background: Parkinson’s disease (PD) is most commonly modelled in rats via injection of the neurotoxin 6-hydroxydopamine
(6-OHDA) into the medial forebrain bundle. Assessment of lateralised choice reaction time is usually conducted in the 9 hole
box, a highly specialized apparatus that is not widely available in many behavioural laboratories. The retractable lever Skinner
box on the other hand is more readily available and may have the additional advantage of faster training of animals.
Objective: The present study assesses the performance of lesioned rats on a lateralised choice reaction time task that allows for
quantitative assessment of the behavioural profile of models of neurodegenerative diseases in the retractable lever Skinner box.
Methods: Here we compared the post lesion performance of pretrained female Lister hooded rats that received unilateral 6-
OHDA lesions to the medial forebrain bundle and untreated controls on the choice reaction time task conducted in the Skinner
box.
Results: Lesioned animals displayed impairments in contralateral accuracy, a reduced number of usable trials, as well as a
slowing down of contralateral reaction and bilateral movement time latencies.
Conclusions: The findings presented allow greater comparison between laboratories, and may be useful for the investigation of
treatment strategies and remedies on this model of PD.
Keywords: Parkinson’s disease, 6-OHDA, operant behaviour, Skinner box, choice reaction time, dopamine, rat
INTRODUCTION
The unilateral 6-hydroxydopamine (6-OHDA)
lesion model is the most widely used model to study
the dopamine loss of Parkinson’s disease (PD) and
to assess the ability of treatments to alleviate the
symptoms [1–4]. Unilateral 6-OHDA lesions to the
nigro-striatal pathway cause a degeneration of neurons
in the substantia nigra (SN) and therefore a depletion
of dopamine in the ipsilateral striatum on the side of the
lesion. These lesions produce a sensory-motor impair-
∗Correspondence to: Andreas Heuer, Brain Repair Group, School
of Bioscience, Cardiff University, Museum Avenue, Cardiff CF10
3AX, Wales, UK. Tel.: +44 2920 874684; Fax: +44 2920 876749;
E-mail: HeuerA@cf.ac.uk.
ment on the side contralateral to the lesion that has
been well characterised on a broad range of tests of
simple and more complex motor behaviours [2, 5–11].
Operant testing allows for a more in-depth analysis
of the animals’ behavioural change after a lesion than
is allowed by simple tests of rotation, neglect or bal-
ance [7, 12]. In particular, operant reaction time tasks
have been valuable in investigating the behavioural
profile of models of neurodegenerative diseases [5–7,
13–31] and the effects of treatment options such as
cell replacement therapy or deep brain stimulation [7,
32–39].
The lateralised choice reaction time task, first intro-
duced by Carli et al. [5], is sensitive to dopaminergic
depletion, and allows for quantitative assessment of
ISSN 1877-7171/12/$27.50 © 2012 – IOS Press and the authors. All rights reserved
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associated impairments in multiple aspects of the
animals’ simple and choice reaction and movement
times [5, 6]. Usually conducted in the rat 9-hole
box, rats have to report the occurrence of a brief
light stimulus to either side of the animals head by
responding with a nose poke into the illuminated
hole. This task allows for the assessment of response
accuracy as well as reaction time and movement time
latencies for each side of responding [5], which is a
key advantage over other reaction time measures [28]
where response profiles are not separated by laterality
of the stimuli and responses. The multi-level analysis
of the animals’ behaviour is extremely important in
unilateral lesion studies where performance is not
only compared between-subjects but each animal can
also serve as its own ‘within-subject’ control. The
Carli task has been shown to be a valuable tool to
assess the effects of 6-OHDA terminal and bundle
lesions and graft induced recovery [5–7, 22, 40].
Although the choice reaction time task has been suc-
cessfully applied in the 9-hole box, this apparatus is
not widely available. Therefore, in order to allow for
greater comparison between laboratories, a number of
studies have sought to transfer the Carli tasks to the
more readily available Skinner box apparatus. In par-
ticular, the response profile of striatal lesions using
quinolinic acid and ibotenic acid have been charac-
terised in Skinner box versions of the choice reaction
time task [14, 34, 37, 41], but the effects of 6-OHDA
dopamine lesions has not hitherto been examined.
Therefore, in the present experiment we characterise
and validate the behavioural response profile of near-
complete unilateral lesions of the ascending forebrain
dopamine pathway on the choice reaction time task in
the Skinner box, using unilateral infusion of 6-OHDA
into the medial forebrain bundle (MFB), as necessary
to obtain stable behavioural deficits [22].
MATERIALS AND METHODS
All procedures carried out were in accordance
with the United Kingdom Animals (Scientific Proce-
dures) Act, 1986 and local ethical review at Cardiff
University.
Subjects
In the present experiment 24 female rats of the
Hooded Lister strain were used (Charles River, UK),
weighing 200–225 g at the time of arrival into the labo-
ratory. They were housed in standard laboratory cages
in groups of 4 with free access to water at all times.
Holding rooms were maintained at an 21◦C ambient
temperature and 50% humidity under a 12 h:12 h dark-
light cycle with lights being switched on at 7 : 00 h.
Commencing 7 days after arrival and during all periods
of behavioural testing, the animals were food restricted
to feeding with weighed amounts of standard lab chow
at the end of each daily testing session so as to maintain
90% of their free feeding weight.
Procedure
A timeline of the experimental plan is presented in
Fig. 1. After initial training to the boxes (see below)
animals were trained on the lateralised choice reaction
time task (see below). Once all rats were performing at
a high level of Accuracy on the task (>90% correct tri-
als) they were divided into two matched groups, one to
receive unilateral 6-OHDA lesions (n = 12), the other
served as sham controls (n = 12). The completeness of
the lesions was initially assessed behaviourally, using
drug-induced rotations 2 and 4 weeks after the surgery.
The effect of the lesion on task performance was then
assessed 5 weeks post lesion for a block of 5 con-
secutive days. A second assessment took place from
week 17 to week 19 post lesion with two weeks under
the standard configuration (week 17 & week 18; 2 × 5
day blocks) and one week under probe trial configu-
ration (week 19; 1 × 5 day block). After completion
of behavioural testing, all rats were sacrificed and the
brains removed for histological analysis.
Apparatus
Operant testing was conducted in a bank of
12 identical Skinner boxes (Campden Instruments,
Loughborough, UK) as described previously [14]. In
brief, each box was fitted with a house light, a maga-
zine light and two stimulus lights which were located
above two retractable levers, on one side of the wall.
The levers were located 4 cm either side of a magazine
to which 45 mg sucrose reward pellets could be deliv-
ered. The magazine entrance was covered by a hinged
Perspex panel. The whole system was controlled by the
Cambridge Cognition Control BNC software (Cam-
pden Instruments, Version 1.23) run on a standard
desktop computer.
Training
After 7 days of food restriction rats were habituated
to the Skinner boxes for 30 min with 30 reward pel-
lets placed in the lit food magazine at the beginning
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Fig. 1. Outline of the experimental plan by week of testing. Dark shaded areas indicate weeks of food restriction whereas light shaded areas
indicate weeks of operant testing.
of the session. On the second day only one reward
pellet was delivered in the illuminated magazine. Upon
retrieval by the rat the magazine light was extinguished
and the house light switched on. After a 2 s intertrial
interval the magazine light was illuminated again and
the house light switched off. An entry into the illumi-
nated magazine resulted in delivery of a reward pellet.
All rats earned >80 reward pellets per session over
three days of training. On day 5 of training one of the
retractable levers was introduced to the boxes with the
stimulus light above the lever illuminated and a lever
press would result in the delivery of a reward pellet.
Only one lever was introduced during a given trial to
prevent the animals from developing a side bias. In
the next training phase, each trial was started by illu-
mination of the magazine light and insertion of the
levers into the operant chamber. A poke into the illu-
minated magazine would extinguish the magazine light
and illuminate at random one of the two stimulus lights
above the levers. A correct response (press of the illu-
minated lever) would result in retraction of the lever
and the delivery of a reward pellet into the illuminated
magazine whereas an incorrect response (press of the
non-illuminated lever) resulted in a 5 s time out period
with all lights extinguished. The task parameters were
gradually adapted over 3 wk of testing to the settings
outlined below.
Task parameters of the lateralised choice reaction
time task
The final task parameters of the lateralised choice
reaction time (Fig. 2) task were as follows: Rats were
required to respond to the illumination of the mag-
azine light by making a sustained nose poke for a
variable interval (delay), randomly chosen by the com-
puter. The four delay periods were set to 100, 300, 600,
and 900 ms. Withdrawal from the magazine before the
delay period elapsed resulted in a 5 s time out. Upon
completion of the sustained nose poke the stimulus
light above the lever was briefly illuminated for 1 s and
the rat was then required to respond to the stimulus by
making a lever press within 5 s.
After assessing post-lesion performance a probe trial
was conducted to assess the effect of changing the stim-
ulus duration by randomly presenting the stimulus light
for 500, 1500, 2500, or 3500 ms, with all other task
parameters as described above, with the delay period
set to 300 ms for all trials. The main outcome mea-
sures that were collected were the number of trials
usable (i.e. trials initiated and the nose poke sustained
for the required delay period); task accuracy (the per-
centage of correct responses divided by the number
of usable trials); reaction time (the mean latency from
onset of the lateralised stimulus light to the withdrawal
from the magazine); and movement time (the mean
latency from magazine withdrawal to execution of the
lateralised response).
Drug induced rotations
The rotational response to 2.5 mg/kg metham-
phetamine. HBr (Sigma, Poole, Dorset) i.p. was
assessed in automated rotometer bowels modelled after
the design of Ungersted [2]. Ipsilateral and contralat-
eral rotations were recorded over 90 min commencing
immediately after injection, and expressed as total
average (ipsilateral – contralateral) rotation/min.
Lesion surgery
Inhalation anaesthesia was induced by 5% isoflu-
rane in O2 carrier gas, and maintained after mounting
the animal in a Kopf model 900 stereotaxic frame by
1.5–2% isoflurane in a 2 : 1 O2 : NO mixture. Lesion
injections into the MFB were made by stereotaxic
infusion of 3l of 6-OHDA HBr at a concentra-
tion of 4g/l (calculated from freebase weight) in
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Fig. 2. Schematic outline of the operant task in the retractable-lever
Skinner box used in the present experiment. (A.) Each trial starts with
an inter-trial interval. After illumination of the magazine light (B.)
the rat had to respond with a sustained nose poke into the magazine
(C.) for the required delay. If the hold period expired, a brief stimulus
above one of the levers (C.) indicated the required response. In order
to obtain a food reward, the rat now had to withdraw its nose from
the magazine (reaction time); (D.) and respond via a lever press
(movement time); E. to the lateralised stimulus light.
a solution of 0.2 mg/ml ascorbic acid in 0.9% sterile
saline via a 30-gauge stainless steel cannula targeted
at: AP = −4.0 mm anterior to bregma, ML = −1.3 mm
(lateral to midline), and DV = −7.0 mm (below dura).
Sham lesions were conducted with the vehicle only.
To control delivery, the cannula was connected via
fine polyethylene tubing to a 10l Hamilton syringe
mounted on a Harvard microdrive pump set at a flow
rate of 1l/min and delivered over 3 min with a fur-
ther 3 min allowed for diffusion of the toxin before
slow retraction of the cannula. Post-lesion analgesia
was given in the form of 0.3 ml injection of Metacam®
(Meloxicam, Boehringer, Ingelheim, Germany) s.c.
immediately after surgery.
Histology
Upon completion of behavioural testing, all rats
were deeply anaesthetised by 200 mg/kg sodium pen-
tobarbitone i.p. and perfused through the heart with
100 ml of 0.1 M phosphate buffered saline (PBS,
pH = 7.4) followed by 250 ml of 4% paraformaldehyde
in PBS. The brains were then removed from the skull
and post-fixed for 24 h before being transferred into a
25% sucrose solution until they sank. The brains were
cut in coronal sections (40m) on a freezing sledge
microtome and stored in 0.1 M Tris buffered saline
(TBS, pH = 7.4) at + 4◦C before staining. Immunohis-
tological staining for tyrosine hydroxylase (TH; raised
in rabbit, polyclonal, Chemicon, 1 : 1000) was con-
ducted on a 1 : 12 series of sections after a standard
histological protocol [42]. The colour reaction was
evoked by the stretavindin-biotin reaction with 3,3′-
diaminobenzedine as chromogen [42]. After staining
all sections were mounted on gelatine-coated glass
slides and air dried overnight, before being cover
slipped using a DPX mountant medium.
Cell counts
Cell numbers of TH-ir neurons were counted on
a Leica DM/RBE light microscope at 10 × magnifi-
cation on the side ipsilateral and contralateral to the
lesion, respectively. Cell counts were conducted in one
section at the level of the medial terminal nucleus of the
accessory nucleus of the optic tract as an anatomical
landmark to distinguish cells in the ventral tegmental
area (VTA) and the SN [7]. Since the purpose was to
assess relative depletion on the lesion side in compar-
ison to the intact side (rather than to estimate actual
cell numbers), no additional correction factors were
applied to adjust for cell size and section thickness.
Statistical analysis
All data were analysed using the GENSTAT
v13.1 software package (VSN International, Oxford,
UK) with a significance level of = 0.05 chosen
for all analysis. Post-hoc comparisons (Newman-
Keuls) for significant interactions are indicated in the
respective figures. Operant behavioural data were anal-
ysed by split plot analysis of variance with Group
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(Control, Lesion) as between-subject factor and Side
(Ipsilateral, Contralateral) and/or Week (Baseline,
Lesion weeks 1–3) as within-subject factors. All
latency data were analysed using geometric, rather
than arithmetic, means so as to reduce the influence
of infrequent very slow responses.
RESULTS
Rotations
Lesioned rats rotated at high rates towards the
side of the lesion when challenged with 2.5 mg/kg
methaphetamine (Group, F1,44 = 81.17, p < 0.001),
whereas rats of the control group did not display a
rotational bias. As expected, rotations were higher
for lesioned animals in the second rotation test
(Group × Week, F1,44 = 8.63, p < 0.01), with the lesion
group increasing their average net rotation scores from
11.50 ± 1.14 to 21.37 ± 1.87 turns/min and the con-
trol group exhibiting only low levels of rotation at
1.05 ± 1.31 and 0.81 ± 2.32 turns/min, respectively.
TH-immunohistochemistry
At the level of the striatum, the lesions induced an
extensive loss of TH-ir terminals in the striatum on the
injected side in all animals (Fig. 3A, B). At the level
of the brainstem, the lesions caused almost complete
(∼97%) loss of TH-ir cells in the ipsilateral SN and a
partial (∼52%) depletion of cells in the adjacent ipsilat-
eral VTA, whereas the cells contralateral to the lesion
remain unaffected (Fig. 3C, D). Cell counts of the SN
and VTA confirmed that the percentage cell depletions
induced by the lesion in the SN (Fig. 3E) and VTA
(Fig. 3F) were both highly significant (F1,22 = 179.57
and 83.77, respectively, both p < 0.001). There was no
difference in cell counts between the groups in the
contralateral SN or VTA (F1,22 = 1.18 and 0.16, respec-
tively, both n.s.), confirming that the lesion effects were
restricted to the hemisphere, as expected.
Operant task
Total trials usable
During baseline testing all rats produced a high
number of usable trials (>160) and there was no dif-
ference between the two groups (Fig. 4A, Baseline;
Group, F1,22 = 0.07, n.s.). After the lesion, rats that
received unilateral infusions of the neurotoxin did
produce significantly less usable trials compared to
their unlesioned counterparts (Control: 156.27 ± 5.27,
Lesion: 44.22 ± 3.67; Week × Group, F3,66 = 43.83,
p < 0.001). Although animals of the control group pro-
duced fewer usable trials during the last two weeks of
testing, the effect of the lesion was stable over the three
time points of post-lesion assessment (Week × Group,
F2,44 = 2.68, n.s.).
Accuracy
During baseline testing there was no difference
between rats of the control and rats of the lesion
group as they were matched according to this outcome
measure (Fig. 4B; Control: 97.01% ± 0.23, Lesion:
95.99% ± 0.36; Group, F1,22 = 1.30, n.s.). All animals
performed with a high accuracy to stimuli on each
side (Sides, F1,22 = 0.26, n.s.). After receiving unilat-
eral infusion of 6-OHDA lesions to the MFB, the lesion
groups’ accuracy was significantly reduced compared
to rats of the control group (Control: 95.63% ± 0.27,
Lesion: 46.21% ± 1.94; Week × Group, F3,66 = 44.05,
p < 0.001). Whereas control rats continued to perform
with high accuracy to stimuli presented to either side
of the animals’ head, lesioned rats performed with a
decreased accuracy to ipsilateral and contralateral pre-
sented stimuli, with the contralateral side affected more
(Sides × Groups, F1,22 = 28.18, p < 0.001). The deficit
at the 17 wk post-lesion time point was similar to the
5 wk post-lesion testing period (Week, F1,22 = 1.68,
n.s.), with a significantly reduced response accuracy
in the lesion group which was more pronounced on
the side contralateral to the lesion (Side × Group,
F1,22 = 19.75, p < 0.001). Previous reports have shown
an ‘extinction’ like effect during the first days of testing
when rats are re-introduced into the operant chambers.
Although rats of the lesion group responded with a
higher overall response accuracy on the first day of
testing after the lesion (Day 1: 35.01% ± 4.39) com-
pared to last day of testing in the post lesion block
(Day 5: 18.05% ± 4.57), this difference failed to reach
statistical significance (Days × Group, F4,88 = 2.28,
p = 0.067). After re-introducing the rats into the boxes
at week 17 post lesion showed the same effect with
none of the days of testing being significantly different
from each other (Day × Group, F4,88 = 2.11, n.s.).
Reaction time
At time of baseline testing there was no difference
between the groups on the time taken to detect the
lateralised stimulus (Fig. 4C; Control: 0.31 s ± 0.01,
Lesion: 0.31 s ± 0.01; Group, F1,22 = 0.00, n.s.). After
the lesion animals of the lesion group responded slower
when the stimulus was presented on the side contralat-
eral to the lesion (Contralateral: Control: 0.31 s ± 0.01,
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Fig. 3. Histological confirmation of the lesion. Representative samples of coronal sections stained for TH for Control (A, C) and Lesion (B, D)
groups. Note the lack of TH-ir staining in the ipsilateral striatum and the loss of TH-ir cell bodies in the ipsilateral SN. Scale bar represents
1000m. Cell counts of TH-ir cells in the midbrain at the level of the accessory optical nerve for neurons in the SN (E) and VTA (F), respectively.
Cell counts are expressed as percentage remaining cells ipsilateral from total per experimental group.
Lesion: 0.49 s ± 0.04; Group × Sides, F1,22 = 13.34
p < 0.001). The difference between the groups did
not undergo spontaneous behavioural recovery even
after testing the animals 12 weeks later (wk 5 vs. wk
17; Weeks × Groups, F1,22 = 0.61, n.s.) and lesioned
animals continued to respond with prolonged reac-
tion times to contralateral stimuli (wk 5 vs. wk 17;
Sides × Group, F1,22 = 34.85, p < 0.001). Furthermore,
even with additional continuous testing there was no
recovery on reaction time between the second chronic
week of testing and the other two post-lesion assess-
ments (Weeks × Groups, F1,44 = 1.26, n.s.).
Movement time
During baseline data acquisition, there was no dif-
ference in the time to execute the lateralised response
between the groups (Fig. 4D; Control: 0.72 s ± 0.01,
Lesion: 0.75 ± 0.01; Groups, F1,22 = 0.10, n.s.) nor
was there a difference in response speed between the
sides of stimulus presentation (Sides, F1,22 = 0.00,
n.s.). After the lesion, movement times were prolonged
in the lesion group compared to animals of the control
group (Contralateral: Control: 0.70 s ± 0.02, Lesion:
1.94 s ± 0.10; Ipsilateral: Control: 0.73 s ± 0.02,
Lesion: 1.56 s ± 0.06; Weeks × Group, F3,66 = 29.71,
p < 0.001). Although lesioned animals displayed
prolonged movement latencies towards both sides
compared to control animals, they took significantly
longer to respond towards the side contralateral to
the lesion (Weeks × Sides × Group, F3,66 = 11.65,
p < 0.001). The prolonged movement time latencies
were stable in the lesion group over the three time
points of assessment with contralateral response
times even increasing over the course of testing
(Weeks × Sides × Group, F3,44 = 6.78, p < 0.01).
Errors
Procedural errors, in the form of premature with-
drawals from the magazine, were the most common
type of errors made (Table 1). These accounted for
25% of all aborted trials that were initiated. Although
the error rate increased over the course of testing from
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Fig. 4. Main Parameters of the lateral choice reaction time task presented by week of testing and side. Lesioned rats produced fewer usable
trials A. and displayed a lower response accuracy B., especially when the required response had to be directed to the side contralateral to the
lesion. The time to react to the contralateral stimulus light via withdrawal of the nose from the magazine was increased in lesioned animals
for contralateral stimulus presentations C. and the latencies to execute the lateralised response was increased in lesioned animals D., with
latencies to the contralateral side to the lesion being slower than ipsilateral responses. Asterisks denote significant different at the p < 0.01 level
of significance.
22% at baseline to 28% during the last week of operant
testing (Week, F3,66 = 3.41, p < 0.05), the lesion did
not affect premature withdrawals (Week × Group,
F3,66 = 0.94, n.s.). In contrast, lesioned animals made
significantly more errors in the form of lever responses
instead of initiating the trial by a nose poke into the
magazine (Week × Groups, F3,66 = 7.65 and 7.38 for
the ipsilateral and contralateral levers, respectively,
both p < 0.001). Lesioned animals missed more lat-
eralised responses after completion of the sustained
nose poke. Approximately 10% of trials started were
not completed by a lateralised response in lesioned ani-
mals within the 5 s of limited response time, compared
to 1% of trials in the control group (Week × Group,
F3,66 = 12.63, p < 0.001).
Probe trial
After assessing chronic post-lesion performance, we
manipulated the stimulus duration to assess the effects
of reduced task difficulty. In the present paradigm
the stimulus duration was randomly selected by the
controlling computer to be either 500 ms, 1500 ms,
2500 ms, or 3500 ms. Note that the 500 ms duration
was shorter than the duration used in the standard
setup of the task (1000 ms) whereas the longest stim-
ulus duration was longer than rats of the lesion group
required to execute the lateralised response on the most
impaired side (2300 ms). The longer stimulus dura-
tion was thought to reduce the cognitive workload as
rats to not have to remember the location of the later-
alised stimulus until the response is executed; rather
they could have used the stimulus light as guidance
towards the response location.
All rats responded on the manipulated version of
the choice reaction time task as during the standard
configuration. Similar to the standard configuration,
lesioned rats produced a lower number of usable trials
compared to their unlesioned counterparts (Fig. 5A;
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Table 1
Procedural errors on the choice reaction time task
Week Control Lesion Post-hoc
Premature withdrawal (% of TTS) Baseline 21.95 ±1.29 22.87 ±0.95 n.s.
L × 5 24.02 ±1.42 30.05 ±1.42 p < 0.05
L × 17 25.93 ±1.52 25.50 ±1.42 n.s.
L × 18 28.51 ±1.28 28.67 ±1.62 n.s.
Lever press instead of centre poke (% of TTS) Baseline 1.08 ±0.15 1.27 ±0.23 n.s.
L × 5 1.00 ±0.11 25.38 ±2.11 p < 0.01
L × 17 3.66 ±0.44 32.88 ±2.48 p < 0.01
L × 18 1.34 ±0.18 30.18 ±3.03 p < 0.01
Omission of lateralised response (% of TTU) Baseline 2.46 ±0.30 2.88 ±0.35 n.s.
L × 5 3.10 ±0.28 20.25 ±1.61 p < 0.01
L × 17 4.16 ±0.67 24.40 ±2.29 p < 0.01
L × 18 3.16 ±0.44 27.91 ±2.16 p < 0.01
Fig. 5. Main Parameters of the lateral choice reaction time task for the probe trial, presented by stimulus duration and side. Lesioned rats
produced fewer usable trials A. and displayed a lower response accuracy B., especially when the required response had to be directed to the
side contralateral to the lesion. On ipsilateral days of testing increasing the stimulus had a positive effect on response accuracy in lesioned
animals. The time to react to the contralateral stimulus light via withdrawal of the nose from the magazine was increased in lesioned animals
for contralateral stimulus presentations C. but was not affected by the stimulus duration. Latencies to execute the lateralised response were
increased in lesioned animals D., with latencies to the contralateral side to the lesion being slower than ipsilateral responses. The number of
asterisks denote significant differences at the p < 0.05 and p < 0.01 level of significance, respectively.
Group, F1,22 = 34.35, p < 0.001). As previously,
response accuracy was significantly different between
the two groups whereby the lesioned rats respond
with a reduced response accuracy on both sides,
whereby accuracy is reduced much more when a
response was required on the side contralateral to
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the lesion (Fig. 5B; Sides × Groups, F1,22 = 18.34,
p < 0.001). Stimulus length was significantly affected
accuracy with longer stimulus durations resulting in
a higher accuracy (Duration, F3,66 = 15.31, p < 0.001).
Note that the shortest stimulus duration was shorter
that during the standard setting. Manipulating the
stimulus duration had a different effect depending
on the side to which the response required was made
(Duration × Sides, F3,66 = 5.39, p < 0.001), with the
ipsilateral side responses displaying a larger increase
in response accuracy with increasing stimulus length
(Ipsilateral; Duration, F3,66 = 7.43, p < 0.05), which
was not different between the groups (Ipsilateral;
Duration × Group, F3,66 = 1.27, n.s.), when compared
to the side contralateral to the lesion. Here only
the control group benefitted from the increased
stimulus duration whereas the lesion group did
respond with equal accuracy to either of the four
stimulus lengths (Contralateral; Duration × Group,
F3,66 = 5.35, p < 0.01). As during the other post-lesion
time points reaction times were increased for lesioned
rats on the contralateral side (Fig. 5C; Sides × Group,
F1,22 = 13.70, p < 0.01) but reaction times were not
affected by the duration of stimulus presentation
(Duration × Group, F3,66 = 1.24, n.s.). The time to
execute the lateralised response was similar for all four
stimulus durations (Fig. 5D, Duration, F1,22 = 0.26,
n.s.) and, as previously, lesioned rats responded slower
to both sides with a more pronounced deficit when
responses were made to the side contralateral to the
lesion (Sides × Groups, F1,22 = 7.78, p < 0.05).
DISCUSSION
In the present experiment we confirm that the
Skinner box apparatus offers the same experimental
utility for assessing lateralised reaction time impair-
ments in experimental hemiparkinsonian rats, and does
not require use of a specialist 9-hole box facility.
Specifically, we have assessed the effects of unilateral
near-complete dopamine depletion on the lateralised
choice reaction time task in the Skinner box in rats, and
shown that the lesion caused impairments in response
accuracy that were more pronounced when responses
had to be made on the side contralateral to the lesion,
accompanied by increases in contralateral reaction
time latencies and bilateral movement time latencies,
with response execution towards the contralateral lever
being more impaired. The lesion induced deficits were
relatively stable, being similar in sub-acute (5 wk post-
lesion) and chronic (17–18 wk post-lesion) testing.
Near-complete unilateral lesions on the lateralised
choice reaction time task produce similar deficits as
have been reported when testing was conducted in the
9-hole box apparatus [22, 23]. The major differences
were that in the 9-hole box the deficit was more lat-
eralised, with response accuracy not being affected
on the ipsilateral side of the lesion [7, 23], whereas
in the present experiment there was a 20% reduction
in accuracy on the ipsilateral side also. However the
contralateral deficit was large, stable over the course
of testing, and could not be alleviated by the reduc-
ing task demands. Furthermore, the lesions caused
a marked reduction in the number of usable trials
which we consider most likely to be attributable to
reduced motivational state, since these lesions caused
a significant depletion in the VTA and the ventral
striatum/nucleus accumbens [43] in addition to the
destruction of TH-ir cells in the SN. The differences in
response profile are likely to be due to differences in the
configuration of the different forms of operant appa-
ratus. Although the tasks are conceptually the same,
in the 9-hole box the lateralised response is made via
a nose poke by the rat into the previous illuminated
response hole, whereas in the Skinner box a lever press
is required. Depending on the distance from the cen-
tre hole, the lateralised response is one continuous
event in the 9-hole box, whereas a series of move-
ments are required for the execution of the lever press
in the Skinner box [44]. These differences are repre-
sented in the prolonged movement times in the Skinner
box (here: 1.5–2 s), whereas the response in the 9-hole
box is shorter than 1 s [7, 22]. Indeed, even in the
9-hole box initial studies did not find an increase in con-
tralateral movement time when the response hole was
immediately adjacent to the centre hole [5], whereas
when the response hole was moved further away from
the centre location stable movement time deficits were
found [22, 23]. Rats need to use all parts of their body to
execute the ipsilateral response in the Skinner box set-
ting, including the side that is controlled by the lesioned
hemisphere. We therefore speculate that the apparatus
revealed ipsilateral deficits because of the nature of the
response required, whereas the ipsilateral response in
the immediate adjacent hole in the 9 hole box does
require relatively little movement [5].
During post-lesion assessment we observed the ani-
mals during the task and discovered that the increased
movement time latencies were not only due to a gen-
eral slowing of movements but rather due to a change
in response strategy. As has been reported previously
in the Skinner box version of the task [14], lesioned
rats respond to the contralateral lever by making a full
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360◦ body turn, a strategy that has not been described
when testing was conducted in the 9-hole box [5, 22,
23, 29, 44].
Interestingly, increasing the stimulus duration for
longer than the contralateral response took to execute
(∼1500–2000 ms) did not increase response accuracy
in lesioned rats. This suggests that they are not simply
attending to the ipsilateral stimulus after they exit the
magazine and responding towards the ipsilateral lever
if the stimulus light is illuminated, whereas they con-
tinue to turn and press the contralateral lever if the
stimulus light is not illuminated. If this were the case,
we would have expected more incorrect ipsilateral
responses at the shortest stimulus duration (500 ms)
than at the longest stimulus durations (3500 ms), which
was not the case. Whereas ipsilateral response accu-
racy increased for both groups with increased stimulus
length, contralateral response accuracy was equally
unaffected in lesioned rats for short and long stimulus
durations.
In earlier Skinner box studies, assessing striatal
lesions [14], it was speculated that the response could
be broken down into three separate events: (i) later-
alised attention, (ii) withdrawal from the magazine
after stimulus detection, and (iii) execution of the later-
alised response [14]. Furthermore, we postulated that
lateralised attention was not necessary in the Skinner
box version during the sustained magazine press as
the stimulus was illuminated until the rat made a lat-
eralised response (or had been timed out), where as it
was imperative in the 9-hole box as the stimulus was
only presented briefly (200 ms). Here we show that the
response deficit, in unilateral 6-OHDA near-complete
lesioned rats, is similar for both conditions, i.e. (i) when
the stimulus duration is short and lateralised attention
is necessary, and (ii) when the stimulus duration is long
and it is not necessary.
When lateralised reaction time was assessed in the
9-hole box with similar lesion an interesting effect was
observed. When lesioned rats were first re-introduced
to the operant boxes the deficit in response accuracy
was not apparent on the first day of testing but gradually
emerged over the following days. This effect was sim-
ilar when rats were re-introduced 2 weeks post lesion
as well as 12 weeks post lesion [7, 45]. This extinc-
tion profile was similar to when one of the sides is
not rewarded [45]. The authors argue that dopamine is
not necessary to complete the contralateral movement,
but rather that it is necessary to learn and main-
tain stimulus-response associations [45]. Although
response accuracy was declining over the first 5 days
of re-testing animals at the first time-point after the
lesion, this decline failed to reach statistical signifi-
cance. Furthermore, even on the first day of re-testing
lesioned rats displayed a deficit in response accuracy
in the Skinner box apparatus, whereas lesioned rats
did not display a deficit on day 1 when testing was
conducted in the 9-hole box [7, 45]. This difference
is likely to be the result of differences in the appara-
tus and the nature the lateralised response as executed.
As described above, the response in the Skinner box
requires a greater movement pattern, and can be bro-
ken down into more steps, whereas the response in the
9-hole box is relatively simple, i.e. it does not require
additional use of the paw to respond to the manipu-
landum. It would be interesting to test animals in the
9-hole box with the response options moved further
away from the centre location to see if this is the case.
A difference in lesion extent/remaining dopamine is
unlikely as in both types of studies lesions are almost
complete (present manuscript: SN: 97% depletetion;
Dowd & Dunnett 2005, 2007 : 98% and 96% depletion,
respectively).
Although the first testing session in the present
experiment was conducted 5 weeks after the lesion
whereas in previous reports testing commenced
already two weeks after the lesion, the time difference
is unlikely to have and effect as the same pattern of
‘extinction’ was seen during acute (2 week post lesion)
and chronic (12 weeks post lesion).
The validation of the lateralised choice reaction time
task in the unilateral 6-OHDA lesion model will enable
a more widespread comparison of behavioural data,
as the Skinner box is more widely available across
behavioural laboratories. Although the 9-hole box has
many advantages, the retractable levers in the Skinner
box allow a response option to be withheld from the
animals, thereby focussing them on the task, whereas
intrusive response options cannot be withheld in the 9-
hole box. This might lead to a faster training and fewer
errors committed [14]. Operant analysis of behaviour
is particularly valuable for the screening of therapeu-
tics and for investigation in the underlying deficits
of any disorder, not least because of the objective
collection of automated data, the large numbers of tri-
als that can be run under standardised conditions to
reduce variability and enhance the power to estimate
small effects, and the ability to collate a comprehensive
profile of behavioural function from multiple simulta-
neously collected parameters of performance. Future
work can now be addressed to investigate the effects
of cell replacement therapies or other therapeutics on
this lesion model, as had been done in the 9-hole box
[7, 34, 39, 40].
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CONCLUSION
We here reported the effects of near-complete unilat-
eral lesion model of PD on a lateralised choice reaction
time task in the Skinner box. 6-OHDA lesions induced
deficits comparable with previous reports which have
been conducted in the 9-hole box in a conceptually
similar task. The lesion induced a stable deficit that
involved a reduction of usable trials, a reduction of
response accuracy when the conditioned response had
to be directed in contralateral space as well as increased
contralateral reaction and bilateral movement time
latencies. The present design is therefore useful for the
investigation of lesion-induced deficits and long term
testing of therapies, without the risk of spontaneous
recovery. The validation of the near complete unilat-
eral 6-OHDA lesion model on the Skinner box version
of this task allows for a wider comparison of results
between behavioural laboratories.
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Chapter 3.2 
Experiment 2: Dopamine-rich grafts alleviate deficits 
in contralateral response space induced by extensive 
dopamine depletion in rats 
 
The present study was inspired by two strands of research: (i) studies have shown 
that 6-OHDA lesioned rats only display a severe contralateral neglect when tested in 
a bilateral hole configuration but when tested only on the side contralateral to the 
lesion, in a choice reaction time setting with a proximal and a distal response 
location, they are perfectly able to respond in contralateral space, but rather bias 
their responses towards the proximal response location on the contralateral side; and 
(ii) a conceptually similar task has been used to investigate the effects of cell 
replacement therapy in a quinolinic acid lesion model of HD. This and other studies 
have shown that the transplant is not effective in ameliorating the lesion induced 
response bias, but rather a period of specific training is required.  
 
The effects of primary VM transplants in the rat model of PD using the choice 
reaction time task has been reported previously as has the spatial version of the task 
using terminal lesions. The novel adaptation of the Carli task allows for the 
assessment of more parameters as well as a more complex analysis of the spatial 
neglect that is induced by the lesion. Although the Carli task has been shown to 
provide valuable information on the restorative capabilities of primary fetal tissue we 
here wanted to explore the capabilities and limitations of the same tissue on the 
novel adaptation of this task. For this we firstly need to demonstrate that bundle 
lesions produce a stable and lasting deficit that does not undergo spontaneous 
recovery, i.e. mask the potential therapeutic effect, and show the long term effect of 
repeated testing.  
 
The experiment conducted in the present paper as well as analysis of the data, 
histology and preparation of the manuscript was done by the author of this thesis. 
Professor S.B. Dunnett was involved in planning of the experiment and gave help 
and advice throughout as well as in the writing of the manuscript. Dr. Torres 
dissected the embryos and prepared the cell suspensions and Dr. Kelly helped with 
the transplantation of the tissue. Dr. Lelos, Dr. Kelly and Dr. Torres provided advice 
throughout and gave input into the final version of the manuscript.  
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Primary fetal tissueUnilateral infusion of 6-hydroxydopamine into the nigro-striatal pathway in the rat is the most common do-
pamine lesion model of Parkinson's disease. In the present study, we explore the impact of near complete
unilateral loss of dopamine along the nigro-striatal pathway and subsequent cell replacement therapy in a
choice reaction time task in rats, with assessment of spatial responding towards either side of the body
(ipsilateral or contralateral to the lesion) on alternate days. Results indicated a stable contralateral deﬁcit
in response accuracy, reaction times and motor function for 50 consecutive days of testing, with no signs
of recovery or compensation. All lesioned rats developed a near-hole bias and displayed prolonged move-
ment and reaction times when responses had to be directed towards a distal response location on the side
of the body contralateral to the lesion, as well as a smaller ipsilateral impairment in response accuracy and
movement times. Grafts of dopamine-rich tissue into the denervated striatum improved some, but not all,
of the deﬁcits induced by the lesion. Speciﬁcally, grafted rats performed at a similar level to control animals
when assessed on the ipsilateral side, they demonstrated a partial restitution of their ability to respond to far
contralateral stimuli, and they exhibited a marked reduction in the time to complete all lateralised responses
on both sides. The present characterisation of the task and the effects of cell replacement via primary fetal
mesencephalic tissue demonstrate restorative properties in alleviating the marked spatial response bias
induced by unilateral loss of dopamine.
© 2013 Elsevier Inc. All rights reserved.Introduction
To model Parkinson's disease (PD) in the laboratory, loss of dopa-
mine cell projections from the SN to the striatum is typically induced
in the rat using the unilateral 6-hydroxydopamine (6-OHDA) lesion
(Bove et al., 2005; Deumens et al., 2002; Grealish et al., 2008; Kirik
et al., 1998; Ungerstedt and Arbuthnott, 1970). This results in a
‘hemiparkinsonian’ syndrome with degeneration of dopaminergic
cells on the ipsilateral side of the toxin injection. Behaviourally these
unilateral lesioned rats will display impairments on the side opposite
(contralateral) to the side of toxin injection. Speciﬁcally, lesioned rats
display marked impairments in detecting and responding to visual
stimuli (e.g. lights) on the contralateral side of the body (Brown and
Robbins, 1989a, 1989b; Carli et al., 1985, 1989; Dowd and Dunnett,
2004, 2005a, 2005b; Ljungberg and Ungerstedt, 1976). A characteristic
behavioural response proﬁle of such a lesion can be found when unilat-
eral lesioned rats are tested in a choice reaction time task conducted in
the 9-hole operant chamber, inwhich rats have to report the occurrence
of a lateralised stimulus light presented to either side of the animals'
head. This paradigm reveals a characteristic response bias, whichff University, Museum Avenue,
rights reserved.
pamine-rich grafts alleviate d
/dx.doi.org/10.1016/j.expneurmanifests as impaired accuracy, reaction andmovement timeswhen re-
sponses are directed to the side contralateral to the lesion, irrespective
of the side of stimulus delivery (Carli et al., 1985, 1989; Dowd and
Dunnett, 2004, 2005a, 2005b). This bias to respond preferably to the ip-
silateral side of the lesion was characterised further by Brown and
Robbins (1989a) who have shown that lesioned animals were able to
respond accurately in contralateral space, but developed a response
bias to a proximal response location when offered a choice between
two response options (Brown and Robbins, 1989a, 1989b). The authors
argue that dopamine depletion results in a distortion of spatial coding
when responses have to be directed into a spatial location on the
contralateral side of the lesion while remaining unimpaired when
responding towards a spatial location on the ipsilateral side (Brown
and Robbins, 1989a, 1989b).
To replace dopamine innervation in denervated target areas, cell
replacement therapies have been developed involving transplanta-
tion of dopamine rich tissue harvested from the developing fetal ven-
tral mesencephalon (VM) to provide a long-term restitution of
synaptic DA release in the denervated striatum (Björklund et al.,
1980, 2003; Perlow et al., 1979). Ectopic engraftment into the dener-
vated striatum has shown to be a promising intervention to alleviate
certain aspect of the impairment induced by 6-OHDA lesions in rats
(Björklund and Stenevi, 1979; Dowd and Dunnett, 2004; Dowd et
al., 2005; Dunnett and Bjorklund, 1999; Fray et al., 1983; Torres eteﬁcits in contralateral response space induced by extensive dopamine
ol.2013.01.020
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tive for the development and assessment of therapeutics for PD.
Whereas on the lateralised version of the choice reaction time task
the effects of the lesion were assessed long term, on the novel version
introduced by Brown and Robbins (1989a, 1989b) the stability of the
deﬁcit is unknown and spontaneous recovery might impede the use-
fulness of the task to assess therapeutic interventions (Dowd and
Dunnett, 2004, 2005a, 2005b). With an increase in the development
of alternative cell sources to primary fetal tissue (Kriks et al., 2011),
it is imperative not only to provide a detailed analysis of behavioural
deﬁcits induced in animal models of the disease, but also to fully char-
acterise the parameters that can be improved by a given intervention.
Choice reaction time tasks have been valuable in characterising re-
sponse proﬁles induced by lesions (Baunez et al., 1995a, 1995b;
Brasted et al., 1997; Brown and Robbins, 1989a, 1989b; Carli et al.,
1985, 1989; Courtiere et al., 2005; Döbrössy and Dunnett, 1997;
Dowd and Dunnett, 2005a, 2005b; Ward and Brown, 1996), to
probe pharmacological challenges (Baunez et al., 1995a, 1995b;
Blokland, 1998; Blokland et al., 2005; Scholtissen et al., 2006), assess
transgenic animals (Fielding et al., 2012; Temel et al., 2006), test cell
replacement therapies (Brasted et al., 1999a, 1999b, 2000; Dowd and
Dunnett, 2004) and evaluate deep brain stimulation (Darbaky et al.,
2003; Temel et al., 2005, 2006).
Although the acute effects of dopamine depletion have been tested
after terminal lesions 5 days and 4 weeks post-lesion, no long-term as-
sessment of the stability of the lesion has been reported. Stable lesions
are imperative for the assessment of cell replacement therapies as
there is a risk of spontaneous recovery with incomplete lesions due to
compensatory mechanisms affecting the lesion stability and the risk
that re-learning might overshadow the effects of the transplant
(Dowd and Dunnett, 2004, 2005a, 2005b).
Here we use a novel variant of the lateralised choice reaction time
task to provide a more in-depth analysis of both motor and non-
motor deﬁcits and recovery in dopamine-depleted and dopamine
cell-rich grafted rats, as well as extending our understanding of the
role of dopamine in responding in contralateral space. Speciﬁcally, we
explore (i) the effects of near complete lesions aimed at the medial
forebrain bundle (MFB) on a near/far version of the lateralised choice
reaction time task, (ii) whether the lesion-induced deﬁcit is stable
over time, and (iii) the effects of restoring striatal dopamine levels by
means of grafting dopamine rich neural precursors derived from E14
embryonic VM, on both motor and non-motor parameters.
Materials and methods
All procedures were performed according to the United Kingdom
Animals (Scientiﬁc Procedures) Act, 1986 and approved by local eth-
ical review at Cardiff University.
Subjects
A cohort of 32 female Lister Hooded rats (Charles River, UK)
started operant training at 12 weeks of age (mean weight: 200–
225 g). Rats were housed in standard laboratory cages with 3–4 rats
per cage, at a constant temperature of 21±1 °C and 50% humidity.
The day–night cycle was set to 12:12 h, with the light turned on at
07:00 am. Rats were food restricted to 90% of their free-feeding
body weights starting one week prior to operant training, by provid-
ing them with weighed amounts of food at the completion of each
day's testing. They were allowed ad libitum access to water in the
home cages throughout all stages of the experiment.
Apparatus
Operant testing was conducted in standard 9-hole operant cham-
bers (Campden Instruments, Loughborough, UK), which have beenPlease cite this article as: Heuer, A., et al., Dopamine-rich grafts alleviate d
depletion in rats, Exp. Neurol. (2013), http://dx.doi.org/10.1016/j.expneurdescribed in detail previously (Carli et al., 1983; Dowd and Dunnett,
2004). Brieﬂy, the operant chamber is ﬁtted with a horizontal curved
array of 9 response holes which can be illuminated by a green LED
and into which a nose poke is detected by break of an infrared
beam. A food magazine is ﬁtted in the opposite side of the chamber,
to which a pellet dispenser is connected. During operant training
and testing, only the centre hole in the array and the two adjacent
holes on either the left or the right of the centre hole (depending on
the day of testing, see below) were left open, whereas all other
holes were covered with well blanks. The 9-hole boxes were con-
trolled by the Cambridge Cognition Control software (Campden In-
struments, version 1.23) running on a standard desktop PC using
the Windows XP operating system.
Training
Rats were habituated to the operant boxes during a 30 min ses-
sion in which 30 precision food pellets (45 mg, Sandown Scientiﬁc,
Hampton, Middlesex, UK) were delivered via the pellet dispenser to
the food magazine at the beginning of the session. During the second
magazine training session, rats were put into the operant chambers
with the house light illuminated. After a short interval the house
light was extinguished and the light behind the panel of the magazine
was illuminated. Each nose poke into the illuminated magazine
resulted in a pellet reward.
Upon conclusion of magazine training, nose poke training com-
menced. Initially, the centre hole (hole 5) in the array was uncovered
and illuminated at the beginning of each trial while all other lights
were turned off. A nose poke into the illuminated centre hole resulted
in the delivery of a food pellet in the magazine. At the same time, the
centre hole light was extinguished and the light in the magazine was
illuminated until the food pellet was collected, at which point a new
trial commenced.
Once all rats learned to nose poke, the two holes on just one side
of the centre hole were uncovered (holes 3 and 4 to the left, or
holes 6 and 7 to the right) alternating between the two sides on suc-
cessive days. Rats were required to respond in the illuminated centre
hole (hole 5), which resulted in illumination of one of the lateral
holes (holes 3 and 4 on odd days, holes 6 and 7 on even days; see
Fig. 1). The lateralised stimulus light remained lit until the rat
responded with a nose poke, at which point a food pellet was deliv-
ered into the magazine. After achieving >80% correct trials on the
basic task, the stimulus duration was gradually reduced from contin-
uous to 200 ms and the required duration of the centre nose poke
(hole 5) hold was gradually increased. Once all the rats performed
at an asymptotic level on the task, at the longest centre poke duration
(400 ms), the rats were trained on the ﬁnal conﬁguration for a period
of three weeks. This consisted of sessions in which the centre hold du-
ration was pseudo-randomly chosen between 4 different hold dura-
tions (50 ms, 100 ms, 150 ms, and 200 ms), and the duration of
stimulus illumination was always 200 ms. The variable centre holds
served to reduce the incidence of anticipated nose withdrawals
from the centre hole, thereby enhancing the accuracy of the reaction
time measure. The last two weeks of pre-lesion training was recorded
as baseline data. A correct response resulted in the delivery of a food
pellet into the food magazine, whereas an incorrect response or a pre-
mature withdrawal resulted in a “punishment” of a time out period of
5 s where all lights were extinguished (schematic outline in Fig. 1).
The main outcome measures recorded for each session are:
• Trials usable, the number of usable trials was deﬁned as those in
which the rat responded to the illuminated centre hole for the re-
quired delay, initiating the presentation of the stimulus light.
• Accuracy, the percentage of correct responses made on each side, for
the near and the far hole respectively, divided by the total number
of usable trials with the matching stimulus.eﬁcits in contralateral response space induced by extensive dopamine
ol.2013.01.020
Fig. 1. Schematic outline of the choice reaction time task used in the present study (the side is dependent on the day of testing, and on the right side in this example): (A) the animal
is set in the operant chamber with only the centre hole and the two adjacent holes being exposed. (B) At the start of each trial, the stimulus light in the centre hole is illuminated.
(C) The animal has to perform a sustained nose-poke (50 ms, 100 ms, 150 ms, 200 ms) in the illuminated centre hole. (D) The centre light is switched off and the stimulus light in
one of the adjacent holes is simultaneously illuminated. (E) A nose-poke in the illuminated hole (E Correct) marks a correct response which is rewarded with a precision sugar
pellet, whereas a nose poke into the non-illuminated hole (E Incorrect) results in a 5 s time-out “punishment” for the animal, during which all lights are switched off.
3A. Heuer et al. / Experimental Neurology xxx (2013) xxx–xxx• Reaction time, the mean latency to initiate a response, calculated
separately for correct responses and incorrect responses to near
and far holes on the left and right sides, from onset of the lateral
stimulus light to withdrawal of the nose from the centre hole.
• Movement time, the mean latency to execute the choice response,
calculated separately for correct responses and incorrect responses
to near and far holes on the left and right sides, from the withdrawal
of its nose from the centre hole to nose-poking the correct (lit) or in-
correct (unlit) hole.Procedure
After pre-lesion training, ratswere rank-ordered on the basis of their
accuracy in the task and divided into three matched groups. Rats were
given oneweek of ad libitumaccess to foodprior to surgery. Two groups
(each n=11) received unilateral 6-OHDA injections into the MFB, the
remaining rats (n=10) were left as untreated controls. Three weeks
post-surgery, rats were food restricted again and tested for 6 days
(3 days per side, alternating) to assess the inﬂuence of the lesion on
performance in the task. The lesioned rats were rank ordered again to
ensure the two groups displayed comparable levels of post-lesion per-
formance. Half of the lesioned rats (Graft; n=11) received E14 VM
grafts, as described below, whereas the remaining rats remained lesion
only (Lesion; n=11). Three months post-transplantation, all rats were
food restricted and tested for 50 consecutive days on the operant choice
reaction time task (alternating sides each day, starting ipsilateral). After
50 days of testing, several probe trials were conducted to investigate
the effects of altering the stimulus duration and changing the conﬁgura-
tion of the response locations.
Lesion surgery
Anaesthesia was induced using 5% isoﬂurane with oxygen as carrier
gas. Thereafter, anaesthesia was maintained during surgery by 1–2%
isoﬂurane in a 2:1 O2/NO gaseous mix. The skin over the surgical area
was shaved, and the rat was placed in a Kopf model 900 stereotaxic
frame with the nose bar set to−4.5 mm. To produce unilateral lesions
of the MFB (Torres and Dunnett, 2007), the neurotoxin 6-OHDA
(hydrobromide salt, Sigma Chemicals, UK) was injected at stereotaxicPlease cite this article as: Heuer, A., et al., Dopamine-rich grafts alleviate d
depletion in rats, Exp. Neurol. (2013), http://dx.doi.org/10.1016/j.expneurcoordinates (from bregma): AP −4.0 mm (behind bregma), ML
−1.3 mm (right hemisphere) and DV −7.0 mm (below dura). The
toxin was infused via a 30-gauge stainless steel cannula connected by
ﬁne polyethylene tubing to a 10 μl Hamilton syringe in a micro-pump
set to a ﬂow rate of 1 μl/min. In total 3 μl of 6-OHDA was delivered at
a concentration of 4 μg/μl (calculated from freebase weight), dissolved
in a solution of 0.2 mg/ml ascorbic acid in 0.9% sterile saline. Injections
were made over a period of 3 min after which the injection needle was
left in place for an additional 3 min to allow for diffusion of the toxin
before the injection needle was carefully retracted. After surgery, the
wound was cleaned and sutured and the rat was placed in a heated re-
covery box. Post-operative analgesia was provided by the addition of
paracetamol (500 mg dissolved in 0.5 l) to the drinking water for
three days post-surgery.
Graft surgery
For transplantation of the primary fetal VM, one pregnant Lister
Hooded dam was sacriﬁced when embryos were of gestational age
E14.5 (CRL=11–12 mm). Cell suspensions were prepared according
to a standardprotocol (Mayer et al., 1992). In total 15 embryoswere dis-
sected and the tissue was pooled in 60 μl of medium resulting in a total
yield of 6.5×106 cells with 99.7% viability as assessed by trypan blue
exclusion. Cells were re-suspended to a density of 100,000 cells/μl and
injected into the denervated striatum at the following coordinates in
mm from bregma: (i) AP +1.2, ML −2.2; (ii) AP +0.5, ML −2.9;
(iii) AP −0.3, ML −3.6, and (iv) AP −1.1, ML −4.2, at three depth
below dura for each of the burr holes (DV −5.5, −5.0, −4.5). A total
volume of 4 μl was injected over the four injection sites with the injec-
tion needle slowly raised over the three depths over the injection period
of 3 min (1 min at each depth). The grafting cannulawas left in place for
an additional 3 min to allow for diffusion of the suspension before slow
retraction. Post-op care was as described above (see Lesion surgery
section).
Simple behavioural screens
The success of the lesion surgery and the functional efﬁcacy of the
grafts were assessed using the drug-induced rotation test at multipleeﬁcits in contralateral response space induced by extensive dopamine
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Fig. 2. Drug-induced rotations recorded over 90 min in response to 2.5 mg/kg
methamphetamine. LX=post-lesion; TX=post-transplantation. Here only animals that
had viable grafts were included in the analysis.
4 A. Heuer et al. / Experimental Neurology xxx (2013) xxx–xxxtime points (2 and 4 weeks post-lesion; 3, 6, and 20 weeks post-
transplantation). Rotation was assessed in automated rotometer
bowls which were built after the design of Ungerstedt and Arbuthnott
(1970). Amphetamine-induced rotation was induced by intra-
peritoneal injection of 2.5 mg/kg methamphetamine hydrochloride
(Sigma Chemicals, UK) dissolved in sterile saline and behaviour was
recorded over a period of 90 min. All rotation scores were expressed
as an average of ipsilateral rotations minus contralateral rotations
(Torres and Dunnett, 2007).
Histology
Following the completion of testing (week 20 post-transplant),
rats were deeply anaesthetised with 200 mg/ml sodium pentobarbi-
tone and transcardially perfused with 100 ml of phosphate buffered
saline (PBS) pH=7.4, followed by 250 ml of 4% paraformaldehyde
in PBS. The brains were carefully removed from the skull and post-
ﬁxed in 4% paraformaldehyde in PBS for 24 h, after which they were
placed in 25% sucrose solution in PBS until they sunk. To visualise
the extent of the lesion, coronal brain sections were cut on a freezing
sledge microtome at a thickness of 40 μm into 0.1 M TRIS buffered sa-
line (pH=7.4, TBS) and stored at +4 °C prior to staining. Immuno-
histochemical analysis of tyrosine hydroxlase (TH) was conducted
on a 1 in 6 series of free-ﬂoating sections, by the streptavidin–biotin
reaction using a DAKO kit and with 3,3′-diaminobenzedine as chro-
mogen, as described previously (Torres and Dunnett, 2007).
TH-ir cell counts
For the assessment of lesion extent all TH-immunoreactive (TH-ir)
cells in the ipsilateral and contralateral SN and VTA were counted in
one section of the ventralmidbrain for all rats on a Leica DM/RBEmicro-
scope. Themedial terminal nucleus of the accessory nucleus of the optic
tract was used to deﬁne the boundary between the SN and the VTA and
to select the respectivemidbrain section. All cell counts were expressed
as percentage of the contralateral side. For the assessment of surviving
grafts every TH-ir cell was counted across a 1:6 series of sections on
an Olympic C.A.S.T. grid system. 100 TH-ir cells across all grafts were
randomly selected and their average diameter was measured. The
total number of surviving cells was estimated using Abercrombie's cor-
rection procedure (Abercrombie, 1946): T=F×A×M/(D/M), where
T=total number of cells, F=frequency of sections, A=total cell counts,
M=section thickness, and D=average cell diameter.
Statistics
Statistical analysis of the behavioural data was carried out using the
GENSTAT v13.1 statistical software package (VSN International Ltd.;
Hemel Hempstead, UK). For all analyses a signiﬁcance level of α=0.05
was used. For post-hoc comparisons, Newman–Keuls' tests were used,
as appropriate. The operant behavioural data were analysed using
repeated-measures analyses of variance with Group (Control, Lesion,
Graft) as the between-subjects factor, and Side (Ipsilateral, Contralateral),
Week (Baseline, Lesion, Transplant 1 to 5) and Distance (Near, Far) as
within-subject factors. The comparison of mean latencies uses geometric,
rather than arithmeticmeans, for each rat's daily reaction andmovement
times, to reduce the inﬂuence of outlier data points.
Results
One rat in the control group died over the course of the experi-
ment, unrelated to any treatments. Furthermore, after analysis of ro-
tational behaviour in response to 2.5 mg/kg methamphetamine and
after examining the brain sections for the presence of TH-ir cell bod-
ies (see below; Immunohistochemistry for tyrosine-hydroxylase sec-
tion) we excluded animals that did not have visible surviving graftsPlease cite this article as: Heuer, A., et al., Dopamine-rich grafts alleviate d
depletion in rats, Exp. Neurol. (2013), http://dx.doi.org/10.1016/j.expneurand therefore the ﬁnal group sizes available for analysis were: Control,
n=9; Lesion, n=11; Graft, n=5.
Amphetamine-induced rotation
Drug induced rotations per experimental time-point are presented
in Fig. 2. There was a signiﬁcant difference in the number of rotations
per group (Group, F2,22=63.65, pb0.001) and this effect was different
for the groups between the weeks of testing (Week×Group, F8,88=
15.71, pb0.001). The lesion group rotated at a rate thatwas signiﬁcantly
higher than the control group when challenged with amphetamine in
all test sessions (pb0.001). The graft group had rotation scores as high
as the lesion group (n.s.) during the ﬁrst two weeks of assessment
(i.e., during the two post-lesion sessions). Rotationwas reduced follow-
ing transplantation, such that by 6 weeks post-grafting the perfor-
mance of the grafted group was similar to the control group (n.s.) and
signiﬁcantly lower than rotations of the lesion group (pb0.001). There
was no difference in rotation scores for any of the groups between the
last two rotation sessions.
Immunohistochemistry for tyrosine-hydroxylase
Representative examples of coronal sections stained for TH-ir for each
of the three groups are presented in Fig. 3. Injection of 6-OHDA into
the MFB caused degeneration of TH-ir terminals in the ipsilateral stria-
tum (Fig. 3B) and degeneration of the dopaminergic cells in the SNc
andpart of the VTAon the ipsilateral side of injection (Fig. 3E). The extent
of the lesion was assessed by visual conﬁrmation of denervation of TH-ir
ﬁbres and terminals in the striatum and quantiﬁed by TH-ir cell counts in
the host VM. Cell counts at the level of the accessory optic nerve for
the SNc and the VTA (Table 1) were signiﬁcantly reduced in rats
that underwent the lesion surgery, relative to controls (Group, F2,27=
533.70, pb0.001) and no difference between the Lesion only and Graft
group was evident (n.s.). The number of TH-ir cells in the other ventral
midbrain dopaminergic nucleus, the VTA, was also affected by the lesion
(Table 1) but to a lesser extent than the SN (Table 1, Group, F2,27=9.94,
pb0.001). No differences in VTA cell countswere found between the two
lesion groups (both, n.s.), which in turn both differed signiﬁcantly in
their cell numbers from control (Lesion, pb0.01; Graft, pb0.05).
Dopamine-rich grafts re-innervated the denervated striatum
(Fig. 3C) and contained cells staining positive for TH (TH-ir cell
count: 2805±356), mostly in the periphery of the graft (Fig. 3F).
However, analysis of the tissue revealed viable grafts in only ﬁve of
the grafted rats, whereas six animals had no viable grafts and only
needle tracts were visible. These latter cases were excluded fromeﬁcits in contralateral response space induced by extensive dopamine
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Fig. 3. Photomicrographs of representative brain sections of animals of the control group (A, D), the lesion group (B, E) and the graft group (C, F) stained for TH. The hash symbol
marks the location of the VTA whereas the asterisk marks the location of the SN. Note the lack of TH-positive ﬁbres in the lesioned striatum (B) and degeneration of TH-positive
neurons in the SN (E) of the lesion group. The graft is clearly visibly in the dorsolateral striatum, with graft-derived ﬁbre reinnervation throughout the lateral half to two thirds
of the striatum (C) and high-power magniﬁcation shows donor derived dopaminergic neurons in the periphery of the graft (F). Scale bar=1000 μm for A, B, D, and E; 1000 μm
for C and 100 μm for F.
5A. Heuer et al. / Experimental Neurology xxx (2013) xxx–xxxthe behavioural analysis. As all of the non-surviving grafts were im-
planted by one experimenter we assume technical factors with the
grafting syringe as reason for the low viability of the transplants.
Results of operant analysis of behaviour
Trials usable
A trial was considered ‘usable’ when the required hold duration in
the centre hole was completed successfully, regardless of whether the
subsequent response was correct or not. The mean number of usable
trials is shown in Fig. 4A for each group. Data are collated into blocks
of 5 days, with the exception of the post-lesion assessment, which
consisted of 3 days on each side. There were signiﬁcant differences
in the numbers of usable trials between the three groups per week
of testing (Week×Group, F12,132=18.92, pb0.001) but not between
the sides of testing (Sides, F1,22=1.29, n.s.). All rats produced a high
number of usable trials during pre-lesion training. After the lesion,
control rats still produced a high number of usable trials (69.94±Table 1
Dopaminergic cell counts in the ventral mesencephalon for each experimental group.
Test Control Lesion Graft
SN (%) 99.62±4.22 6.00±1.58 2.78±0.94
VTA (%) 98.12±4.46 69.18±8.45 57.22±4.52
Data represent mean and standard error of measurement.
Please cite this article as: Heuer, A., et al., Dopamine-rich grafts alleviate d
depletion in rats, Exp. Neurol. (2013), http://dx.doi.org/10.1016/j.expneur1.92), whereas rats in the two lesion groups produced on average less
than half the number of usable trials (Lesion: 29.28±1.22; Graft:
32.4±2.58). Interestingly, after transplantation, grafted rats produced
more usable trials than lesioned rats, although this did not reach the
level seen in the control rats (t22=4.88, pb0.01).Accuracy
Accuracy was deﬁned as the number of correct trials divided by
the number of usable trials, expressed as a percentage (Figs. 4B, C).
During pre-lesion acquisition, all rats performed with high accuracy
and there was no difference between the groups (Group, F2,22=
1.39, n.s.) nor the side of testing (Side, F1,22=0.33, n.s.). Accuracy
was higher when responses were directed towards the nearer of the
two response locations (Distance, F2,22=34.51, pb0.001) and this
difference in response accuracy was not different between the groups
(Distance×Group, F2,22=2.11, n.s.).
After receiving unilateral nigrostriatal lesions, the lesioned rats
displayed a marked reduction in accuracy which was most affected
when responses had to be directed to the far contralateral response
location (Distance×Side×Group, F2,22=9.73, pb0.001). Restricting
the analysis to the side contralateral to the lesion revealed a reduction
in accuracy in the two lesion groups (Group, F2,22=42.54, pb0.001)
relative to the control group. Although ipsilateral accuracy was slightly
reduced in the lesion group, this effect failed to reach statistical signiﬁ-
cance (Fig. 4C; F2,22=2.81, n.s.).eﬁcits in contralateral response space induced by extensive dopamine
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6 A. Heuer et al. / Experimental Neurology xxx (2013) xxx–xxxAfter engrafting one of the lesion groups, testing continued for
25 days per side and data were collated into 5 day blocks. Analysis
of the test sessions post-transplantation revealed an interaction
between the groups, the side of testing and the response location
for the accuracy measure (Distance×Sides×Group, F2,22=17.77,
pb0.001). Comparing rats' responses on the contralateral side only
demonstrated a signiﬁcant interaction between the week of testing,
group and response location (Week×Distance×Group, F8,88=3.15,
pb0.01). Whereas the control group responded highly accurately to
the far contralateral response location during all days of post-graft
testing, the lesion group was signiﬁcantly impaired in responding ac-
curately to this far hole location, and the graft group improved mar-
ginally over the 5 weeks of testing. There was no signiﬁcant group
difference in accuracy on the contralateral near hole (Group, F2,22=
2.04, n.s.) and response accuracy on the contralateral near hole did
not change over the course of testing (Week X Group, F8,88=1.15,
n.s.; analysis restricted to the near response location). When ratsPlease cite this article as: Heuer, A., et al., Dopamine-rich grafts alleviate d
depletion in rats, Exp. Neurol. (2013), http://dx.doi.org/10.1016/j.expneurwere tested on the side ipsilateral to the lesion there was a signiﬁcant
difference between the three groups over the 25 days of post-
transplantation testing (Group, F2,22=14.41, pb0.001). This effect did
not change as function of week (Week×Group, F8,88=1.93, n.s.). The
effect of response location was also not different between the three
groups on the ipsilateral side (Distance×Group, F2,22=2.13, n.s.). Inter-
estingly, the post-graft ipsilateral accuracy was highest in the control
group and lowest in the lesion only group, with both the Control and
Graft groups performing signiﬁcantly better than the rats with lesion
alone (Newman–Keuls, pb0.001 and pb0.05, respectively).
Reaction time
Reaction time on correct trials was deﬁned as the latency to with-
draw from the sustained centre nose poke upon illumination of a
lateralised stimulus light (see Figs. 4D, E). During pre-lesion acquisition,
there was no interaction between the groups, side of testing and
response location for the reaction times (Distance×Sides×Group,eﬁcits in contralateral response space induced by extensive dopamine
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7A. Heuer et al. / Experimental Neurology xxx (2013) xxx–xxxF2,22=0.64, n.s.). Post-lesion, the reaction times increased for rats of the
lesion groups (Group, F2,22=12.94, pb0.001) and differed according to
response location and side of testing (Distance×Side×Group, F2,22=
4.51, pb0.05).Whereas reaction times of the control groupwere similar
for near and far hole responses, they were increased in the two lesion
groups with longer reaction times for near hole responses. The increase
in reaction time was more prominent when lesioned rats were tested
on the side contralateral to the lesion. During the 5 weeks of post-
graft testing, reaction times did not change for each of the three groups
(Week×Distance×Group, F8,88=0.47, n.s.). Restricted analysis of reac-
tion time performance on the contralateral side alone revealed a group
difference (Group, F2,22=9.25, pb0.01) and that demonstrated that re-
action time was longer when the stimulus was presented in the near
hole (Distance, F1,22=11.36, pb0.001).
Movement time
Movement time was deﬁned as the time taken to respond to the
stimulus and was measured starting from the withdrawal of the
nose from the centre hole to the entrance of the nose into the correct
response location. As can be seen in Figs. 4F and G, movement times
were similar for the three groups during pre-lesion training (Group,
F2,22=1.24, n.s.) and no differences were evident between the sides
of testing (Sides, F1,22=0.28, n.s.). As expected, response latencies
were longer when executed to the far response hole than to the
near response hole (Distance, F1,22=244.95, pb0.001), and this effect
was similar for all three groups (Distance×Group, F2,22=0.89, n.s.).
Post-lesion, an effect of group was revealed when rats were tested
on the side ipsilateral to the lesion (Group, F2,22=8.45, pb0.01) with
the two lesion groups responding slower on average than the control
group. Movement times remained slower for responses to the far re-
sponse location (Distance, F1,22=26.51, pb0.001) but this effect was
similar for all three groups (Distance×Group, F2,22=1.44, n.s.). As
can be seen in Fig. 4 movement times for far contralateral responses
were much slower for the lesion only groups. Response execution
on the side contralateral to the lesion was affected similarly to ipsilat-
eral movement times, although the effect was larger. There was also a
difference in movement times between the three groups (Group,
F2,22=9.61, pb0.001), with the lesion group respondingmuch slower
compared to the other two groups. Movement times were faster for
responses made to the near contralateral location (Distance, F1,22=
6.12, pb0.05) and for all three groups responses to the farther re-
sponse location took longer to execute (Distance×Group, F2,22=
1.68, n.s.).
After transplantation, the graft group differed in movement times
executed to the ipsilateral and contralateral sides (Side, F1,22=16.50,
pb0.001). On the ipsilateral side, the post-graft performance was
similar to the post-lesion performance, with a difference evident be-
tween the three groups (Group, F2,22=16.47, pb0.001) and an in-
creased time to respond to the far ipsilateral location (Distance,
F1,22=17.77, pb0.001), an effect that did not differ between the
groups (Distance×Group, F2,22=1.97, n.s.). Across both sides and re-
sponse locations, movement times did not change as a function of
week of post-graft testing (Week, F4,88=1.99, n.s.). This effect was
not different between the groups (Week×Group, F8,88=0.92, n.s.).
On contralateral days of post-graft testing, rats displayed a similar
pattern of movement times towards near and far response holes as
on ipsilateral testing days, although the differences were more pro-
nounced on the contralateral side. There were differences in move-
ment times between the groups (Group, F2,22=16.88, pb0.001)
with the control group responding faster than the lesion and graft
groups. Whereas the lesion only group had signiﬁcantly slower move-
ment times than the control group (t22=8.26, pb0.01) and the graft
group (t22=6.33, pb0.01) there was no signiﬁcant difference be-
tween the graft and the control groups (t22=1.93, n.s.). There was
no change in movement times over the 5 blocks of post-graft testing
(Week, F4,88=1.27, n.s.). Interestingly only the lesion group respondedPlease cite this article as: Heuer, A., et al., Dopamine-rich grafts alleviate d
depletion in rats, Exp. Neurol. (2013), http://dx.doi.org/10.1016/j.expneurwith increased movement time latencies towards both the near and
the far contralateral and ipsilateral response locations, whereas the
graft group responded with speeds similar to those of the controls.
Probe trials
After completion of the 50 consecutive days of post-transplantation
testing, two probe trials were conducted to assess the performance
deﬁcit in further detail, by manipulating task demand and altering the
response requirements. Firstly, the effect of manipulating the duration
of the stimulus light was investigated and, secondly, the response loca-
tions were shifted to new, more distal, locations. Testing of each probe
manipulation occurred over 10 consecutive days (5 days per side) and
always started with testing on the side ipsilateral to the lesion. One
rat of the lesion group died in the course of probe testing (under cir-
cumstance unrelated to any procedure) and was therefore excluded
from further analyses. When analysing probe trials response accuracy
was expressed as near hole bias (Bias=Accuracynear/(Accuracynear+
Accuracyfar)×100).
Manipulation of the stimulus duration
In order to assess the impact of stimulus duration on performance,
the duration of the required sustained nose-poke in the centre hole
was reduced such that rats were only required to sustain the hold
for 50 or 100 ms. The stimulus light, which indicated the correct re-
sponse location, was then pseudo-randomly selected to be either
400, 200, 100, or 50 ms in length. All other parameters were kept
constant. Interestingly, all groups performed similarly with regard
to the number of usable trials executed, and the reaction and move-
ment time latencies, in spite of the manipulation of the stimulus
duration (data not shown). The manipulation had a small effect on
the near hole bias, which was different between the three groups
(Fig. 5A, Stimulus Length×Group, F6,61=6.81, pb0.001). The lesion
group displayed almost exclusive responding towards the near re-
sponse location, irrespective of the stimulus length, compared to con-
trols (all t22>7.59, pb0.01) and the grafted group (all t22>4.24,
pb0.05). Only at the very shortest stimulus duration failed the differ-
ence in response accuracy between animals of the control group and
the engrafted group to reach signiﬁcance (t22=3.35, n.s.). As can be
seen in Fig. 5A, only the control group was affected by the stimulus
duration, with shorter stimulus lengths leading to bias responses to-
wards the nearer response location.
The effects of shifting the response location
Next, the effect of manipulating the response location was assessed,
such that the previous far hole became the nearest and a new hole
was unblocked to become the new far location. The unused response
hole next to the centre hole was, as all other non-utilised holes, cov-
ered and not accessible to the rat. Similar to the post-transplantation
test period, rats that underwent lesion surgery displayed a greater near
hole bias than the control group (Group, F2,21=26.40, pb0.001, Fig. 5B).
The graft group again demonstrated a moderate, but signiﬁcant, im-
provement in performance when compared to the lesion group
(Lesion, Graft; both, pb0.001), but still directed signiﬁcantly more
responses to the near response location than control rats did (Lesion,
Graft; both, pb0.001). Interestingly, despite demonstrating severe
impairments in responding to the far hole during the initial post-
lesion and post-graft testing, rats in the lesion only and graft groups
were unimpaired in responding to that same response location
when, relatively-speaking, it was shifted to being the ‘nearer’ re-
sponse hole.
Discussion
The present experiment assessed the effects of near-complete uni-
lateral striatal DA depletion on an operant choice reaction time task ineﬁcits in contralateral response space induced by extensive dopamine
ol.2013.01.020
Fig. 5. Probe trials that were conducted after post-graft data had been collected. (A) Probe trial 1 (near hole bias %): the effect of stimulus manipulation on the deﬁcit/recovery for
responses to the contralateral side. Use of only two hold durations (very short i.e. 50 and 100 ms) and randomly presenting the stimulus light for 50, 100, 200 or 400 ms. (B) Probe
trail 2 (near hole bias %): the effect of moving the response hole (i.e. previously far hole becomes the nearer hole of the two-hole choice) for contralateral days of testing. Animals
tested for 5 days/side, starting ipsilateral to the lesion (data not shown).
8 A. Heuer et al. / Experimental Neurology xxx (2013) xxx–xxxrats and the effects of dopamine replacement therapy on multiple as-
pects of behaviour. The aim of the present experiment was threefold.
Firstly, we assessed and characterised the response proﬁle of near-
complete DA depletion on the present version of this task as only
partial lesion models have been utilised previously. Secondly, we
assessed the lesion-induced deﬁcit at two time points, (i) acute test,
shortly (3 days/side) after the lesion and (ii) chronic test, over 50
consecutive days (25/side) beginning 4 months after the lesion.
Thirdly, we assessed the ability of transplanting DA-rich tissue into
the denervated striatum to alleviate lesion-induced deﬁcits.
The main ﬁndings of the present study were that, ﬁrstly, the lesion
caused a marked reduction in response accuracy when the stimulus
light was presented in the far contralateral location, which was ac-
companied by increases in reaction and movement times on contra-
lateral days of testing. Secondly, the lesion-induced deﬁcit was
stable over the weeks of testing, and thirdly, the effects of the graft
were small, but highly signiﬁcant, with an increase in usable trials
and an improvement in far contralateral response accuracy, which
was accompanied by a marked reduction in contralateral movement
time. All effects observed were stable over the 50 days of consecutive
testing. All three main ﬁndings of the present study are novel and will
contribute to the progression of cell based therapies to the clinic. This
is the ﬁrst time that the more complete bundle lesion model has been
applied in combination with dopamine-rich grafts on the variant of
the lateralised choice reaction time task introduced by Brown and
Robbins (1989a). Furthermore, the task utilised here provides a
more in-depth analysis of behaviour than did previous versions of
the lateralised choice reaction time task. Next to reporting ipsilateral
deﬁcits that have not been reported in the literature after dopamine
depletion in rats in choice reaction time tasks, the present experiment
showed that grafts not only improve the animals deﬁcit on the con-
tralateral side but also on the ipsilateral side as well when each is
probed independently.
Lesion-induced deﬁcits
The impact of the near-complete unilateral lesions on performance
further supports previous ﬁndings, that unilateral lesioned rats display
longer reaction times towards contralateral stimuli and increases in
movement times, when a response is required towards the side contra-
lateral to the lesion (Brasted et al., 1998; Carli et al., 1985; Döbrössy and
Dunnett, 1997; Dowd andDunnett, 2005a, 2005b). The impact of termi-
nal striatal lesions, which result in a more modest depletion of DA,
has been reported on a conceptually similar experiment and here the
authors demonstrated an impairment only on responses directed in
space contralateral to the lesion (Brown and Robbins, 1989a, 1989b).Please cite this article as: Heuer, A., et al., Dopamine-rich grafts alleviate d
depletion in rats, Exp. Neurol. (2013), http://dx.doi.org/10.1016/j.expneurThe present experiment revealed a similar pattern of impairment in
rats with MFB lesions, in which signiﬁcantly more DA depletion is evi-
dent in both the dorsal and ventral striatal regions. The fact that shifting
the response locations further away from the centre hole enabled le-
sioned rats to execute responses to a high degree of accuracy in a loca-
tion that had previously been the most distal, and consequently the
most impaired, suggests that the ability to execute responses in contra-
lateral space remains intact, while spatial coding of the response or the
representation of egocentric space is impaired (Brown and Robbins,
1989a, 1989b). Indeed, in the present study, lesioned rats are able to ex-
ecute responses to one of the contralateral stimuli with a high degree of
accuracy and reasonable movement times, indicating a sparing of sen-
sory processing facilities and no primary motor impairment since the
animals are still capable of responding to the neglected contralateral lo-
cation when the response hole was shifted. Furthermore, the deﬁcits in
accuracy andmotor functionwere stable over the time course of testing
and did not show signs of spontaneous behavioural recovery. This is im-
portant for long-term testing of therapeutic interventions in animal
models of disease, since spontaneous recovery and compensatory
mechanisms can limit the use of the intra-striatal method of DA deple-
tion (Dowd and Dunnett, 2004). Interestingly ipsilateral effects of MFB
6-OHDA lesion have not been reported previously on response accuracy
whereas an increase in movement time was shown before (Dowd and
Dunnett, 2004, 2005a, 2005b). During the long term post-graft assess-
ment both experimental groups and the lesion group especially
displayed ipsilateral deﬁcits on near hole accuracy and movement
time latencies towards both ipsilateral response locations. Themain dif-
ference to the work of Dowd and Dunnett (2004) is the task utilised.
Whereas in previous studies the response optionswere located to either
side of the animals' head, i.e. responses had to bemade either ipsilateral
or contralateral within a session, in the present study these were
assessed on alternating days. Ipsilateral deﬁcits might not have been
detected in this setting because animals bias their responses towards
the ipsilateral hole. In a follow-up study, we have shown a small ipsi-
lateral deﬁcit in a conceptually similar task with the presence of an ip-
silateral deﬁcit depending partly on hole conﬁgurations and partly on
task demands (Heuer and Dunnett, 2013). The study of Brown and
Robbins only tested animals on the same side and placed the lesion ei-
ther ipsilateral or contralateral to the side of testing (Brown and
Robbins, 1989a, 1989b). There are two explanations for the differences
between the two studies, ﬁrstly the lesion was less pronounced as par-
tial lesions largely spare cells in the VTA and therefore dopamine in-
nervation of the ventral striatum/nucleus accumbens, and secondly
continuous testing on one side might have masked ipsilateral effects
as the ipsilateral response is the default response by the lesioned
animal.eﬁcits in contralateral response space induced by extensive dopamine
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coded in absolute contralateral space and it was shown that blocking
the nearer of two contralaterally located holes allowed improved di-
rection of responses into the previously more distal location (Brown
and Robbins, 1989b). Increasing the duration of the stimulus light
during the probe trials was intended to decrease task demand by
eliminating the reliance on working memory function and negating
the need to code spatially the response location from the centralised
position, but, interestingly, manipulation of the stimulus duration
(Probe 2) had no effect on the performance of the lesion group. More-
over, the lesioned animals always directed their responses to the
nearer of the two contralateral response options, irrespective of the
absolute spatial location of these (compare standard conﬁguration
to Probe 1), which provides further support for the theory that re-
sponses are misdirected in contralateral space, rather than an inabil-
ity to detect (primary sensory impairment) or make responses to
(primary motor impairment) the contralateral stimulus. When the
stimulus duration is extremely short (i.e. 50 ms) even animals of the
untreated control group bias more of their responses towards the near
contralateral hole compared to long stimulus duration (i.e. 400 ms).
Response bias as a failure of space representation
It has been proposed that the accuracy deﬁcit is due to a distortion in
space representation. Response space and representational neglect can
be ascribed to either of three possible frames of reference, (i) egocentric
or viewer centred neglect, (ii) allocentric or environmentally centred
neglect, or (iii) object centred neglect, irrespective of the objects loca-
tion in space (Kerkhoff, 2001). In the absence of an ipsilateral impair-
ment, responses in far contralateral space were changed after the
lesion, supporting the view of en egocentric deﬁcit in absolute contra-
lateral space (Brasted et al., 1997, 1999a, 1999b, 2000; Brown and
Robbins, 1989a, 1989b). When faced with only one response option
on the side contralateral to the lesion, i.e. in a simple reaction time
task setting, lesioned rats were able to respond correctly to both, near
and far, spatial locations, supporting the argument that responses are
misdirected rather than an inability to locate the stimulus in space
(Brown and Robbins, 1989a, 1989b). The pattern of responding in the
present study further supports theories of failure to direct responses
in the presence of competing response locations in absolute egocentric
space where sensorimotor deﬁcits are secondary (Brasted et al., 1997;
Brown and Robbins, 1989a, 1989b). Interestingly grafting rats with
DAergic cells restored the animals' ability to respond towards the far
contralateral stimulus location. Although this ability to direct responses
into far contralateral space is not recovered in the true sense that
grafted animals display equal performance to those of the control
group, but given that animals of the lesion group did bias their re-
sponses almost completely towards the contralateral near hole, a re-
sponse accuracy of >25% of far hole is a remarkable achievement with
the type of graft used.
Effects of grafts
The grafts alleviated many of the deﬁcits induced by the lesion, in-
cluding increasing the number of trials attempted, improving the re-
sponse accuracy on contralateral trials and reducing movement
times. Indeed, a previous study (Dowd and Dunnett, 2004) demon-
strated the efﬁcacy of cell replacement strategies using dopaminergic
donor tissue in the unilateral 6-OHDA lesion model. There, the graft
group displayed a modest but signiﬁcant increase in contralateral re-
sponse accuracy and a substantial increase in the number of trials
attempted (Dowd and Dunnett, 2004), which is in accordance with
the improvements produced by cell replacement therapy in the
present paradigm. In both studies the grafts failed to provide com-
plete recovery of function but improved the rats' performance
compared to those of the lesion groups. Furthermore, in the presentPlease cite this article as: Heuer, A., et al., Dopamine-rich grafts alleviate d
depletion in rats, Exp. Neurol. (2013), http://dx.doi.org/10.1016/j.expneurstudy, the graft effect was stable over time and grafted rats performed
signiﬁcantly better than those of the lesion group. In previous reports
the effect of the graft on response accuracy could only be seen for two
weeks and was not different from the lesion only group from day 14
onwards on this parameter (Dowd and Dunnett, 2004). In the present
experiment, using more extensive lesions, we can report that the
effect of the graft is stable even after 50 days of consecutive testing
(25 days/side). Interestingly, the graft had an effect on ipsilateral
days of testing when performance is compared to the lesion only
group. Whereas response accuracy was also reduced in lesioned ani-
mals on the ipsilateral side, and movement times were increased,
the grafted animals performed similar to unlesioned controls on
both parameters. Although ipsilateral effects of grafts have not, to
our knowledge, been assessed in the 6-OHDA lesion model in choice
reaction time tasks, it has been shown that unilateral grafts in pa-
tients can alleviate ipsilateral symptoms, such as reducing bilateral
arm rigidity and improving movement speed, especially in ﬂexion
movements (Lindvall et al., 1990). Although recovery was higher on
contralateral parameters, the ipsilateral facilitation of movement
after engraftment of dopamine rich mesencephalic tissue is remark-
able (Lindvall et al., 1990). Whereas small ipsilateral improvements
in movement time latencies have been reported after transplantation
into Parkinson's disease and Huntington's disease models (Brasted et
al., 1999a, 1999b; Dowd and Dunnett, 2004), we believe this to be the
ﬁrst study to report an improvement of ipsilateral response accuracy
in the 6-OHDA lesion model in rats using primary fetal mesencephalic
donor tissue.
Here we show that the largest effect the graft had on contralateral
performance was in the reduction in contralateral movement times;
on this parameter, lesioned rats eventually resembled control ani-
mals. Indeed, it has been shown previously that re-introduction of
tonic striatal dopamine facilitates movement into contralateral
space (Dowd and Dunnett, 2004). Importantly, whereas tonic dopa-
mine is sufﬁcient for movement initiation, the phasic reward signal-
ling is necessary for reward prediction and learning (Montague et
al., 1996; Schultz, 2000; Schultz et al., 1997). Whereas Dowd and
Dunnett (2007) speculate that the maintenance of the contralateral
response is dependent on phasic reward signalling (Dowd and
Dunnett, 2007), we demonstrate that the grafts can restore, at least
partly, the conditioned contralateral response, as manifested by in-
creased number of trials usable and increased choice response accu-
racy. Dopamine depletion in the entire striatum – and especially the
large depletion of the ventral striatum and nucleus accumbens – has
been shown previously to reduce the number of trials attempted
(Cousins and Salamone, 1996; Cousins et al., 1993; Darbaky et al.,
2003; Dowd and Dunnett, 2005a, 2005b), whereas striatal dopamine
depletion does lead to impairments in reaction and movement times,
with accumbens lesions having no (additional) effect (Amalric and
Koob, 1987; Carli et al., 1989).
The behavioural paradigm utilised in the present study has allowed
us to characterise further the role of striatal dopamine in motor and
non-motor functions. The efﬁcacy of the cell replacement therapy
leads us to hypothesise that this dopaminergic intervention not only
improves global motor function, but also speciﬁcally reinstates the abil-
ities to encode spatially and to direct attempted responses in egocentric
space.
Limitations of dopaminergic grafts
The functional efﬁcacy of cell transplantation to combat neuro-
degeneration is dependent on several factors and not every tissue/cell
type allows complete restoration back to control levels. Whereas
engraftment of the developing striatum may result in recovery to
almost control levels in rat models of Huntington's disease (Brasted
et al., 1999a, 1999b, 2000; Döbrössy and Dunnett, 1998; Dunnett,
1995), such a recovery has often not been achieved after replacementeﬁcits in contralateral response space induced by extensive dopamine
ol.2013.01.020
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may be several reasons for the limitations of dopaminergic cell replace-
ment therapies. Firstly, the site of tissue transplantation is sub-optimal
as by transplantation into an ectopic location the cells are deprived of
their natural input signalling from the SN. Behavioural effects may
therefore be due to a tonic elevation of striatal dopamine, though the
phasic dopamine input necessary for reward signalling, normal learning
and performance has not been reconstructed (Montague et al., 1996;
Schultz, 2000; Schultz et al., 1997). Secondly, the graft only partially re-
stores DA in the transplantation site whereas the depletion caused by
the lesion encompasses the striatum, nucleus accumbens, the prefrontal
cortex and the olfactory tubercle (Dowd and Dunnett, 2004). Olfaction
is the primary sense for rodents and this is one of the main reasons
while exploration of the response holes as in the present study leads
to faster training than to press a lever as amanipulandum in the Skinner
box. Other affected structures such as the nucleus accumbens and the
prefrontal cortex have been implicated in general reward signalling, ad-
diction, impulsivity, and motivation/activity levels (Alderson et al.,
2001; Bowman and Brown, 1998; Cousins et al., 1993; Nicola, 2007;
Salamone et al., 1994; Sesia et al., 2010) and attention and decision
making (Birrell and Brown, 2000; Chudasama et al., 2003; Dunnett et
al., 2005; Eagle et al., 2008; Joel et al., 1997), respectively.
The extensiveness of the MFB lesion is a major confounding factor
that is important to consider when interpreting the results of both
post lesion and post graft performance. The main reason for utilizing
the near complete lesion model is practical insofar as terminal le-
sioned rats are prone to spontaneous recovery which renders them
useless for the assessment of long term testing that is necessary
when investigating the behavioural effects of cell replacement thera-
pies as presented in the present manuscript (Dowd and Dunnett,
2004).
As stated above, the reintroductionof dopamine in the striatumdoes
not directly affect all of these depleted areas. Although, graft location,
number of surviving TH-ir cells, reinnervation of TH-ir ﬁbres, does
allow for a greater recovery than with suboptimal parameters, some
functions have never been ameliorated by dopaminergic grafts whereas
striatal (whole ganglionic eminence) graftswere able to produce such a
(complete) recovery in excitotoxic lesion models of Huntington's
disease (Brasted et al., 1999a, 1999b; Mayer et al., 1992; Montoya et
al., 1990).
Although the graft had only small effects in the present study, the
improvement compared to lesion only animals is still remarkable.
Rats that received grafts not only attempted more trials during the
testing session but also markedly decreased the time it took to
move towards a stimulus and increased the accuracy of the response.
This improvement was stable for 50 days of testing and therefore
provides further evidence that cell replacement therapy can provide
long lasting effects.
Conclusion
The choice reaction time task in the near-far hole conﬁguration
has been shown to be sensitive to near complete depletion of striatal
dopamine. Impairments in contralateral performance were highly
stable over time and therefore provided an excellent model to inves-
tigate the effects of potential interventions, such as cell replacement
therapy. Dopamine depletion impaired the number of trials initiated,
increased the movement times bilaterally and reduced the response
accuracy to contralateral far stimuli, as well as increasing contralater-
al reaction times. The grafts were able to ameliorate the deﬁcit on
many task parameters. Importantly, this demonstrates that replace-
ment of tonic dopamine can facilitate both motor and non-motor per-
formance long-term, and there is a speciﬁc impact of tonic dopamine
release on the spatial coding of responses in egocentrically-deﬁned
space. Furthermore, the results presented here will form the baseline
to which alternative cell sources have to be measured. WhereasPlease cite this article as: Heuer, A., et al., Dopamine-rich grafts alleviate d
depletion in rats, Exp. Neurol. (2013), http://dx.doi.org/10.1016/j.expneurassessment of simple motor asymmetries such as drug induced rota-
tions provides good indications of lesion extent or cell survival, they
are further away from modelling graft-induced improvements than
the effects reported here, namely graft-induced amelioration on a
task that assesses goal directed behaviour, motivation, and attention.
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Chapter 3.3 
Experiment 3: Characterisation of spatial neglect 
induced by 6-OHDA lesions on a choice reaction time 
task in rats 
 
The rationale for this experiment resulted out of the findings of experiment number 2 
(Chapter 3.2). In the previous study we investigated the effects of near-complete 
unilateral 6-OHDA-induced DA depletion on a version of the lateralised choice 
reaction time task in rats. In the adaptation of the task rats were tested on alternating 
days (contralateral or ipsilateral to the lesion) to respond towards either a proximal or 
a distal response location. One of the most striking results was the long term stability 
of the lesion, i.e. even with extensive post lesion training of 50 days (25 days/side, 
alternating), lesioned rats biased all their responses towards the proximal response 
location when tested on the contralateral side to the lesion. 
 
Hence, we aimed to further explore the nature of this deficit. We speculated that this 
could be due either to a true misrepresentation of response space as argued by 
previous authors or to a change in the animals’ response strategy. Indeed in the 
current task animals that bias all of their responses towards one of the response 
locations would give a correct response in 50% of all trials. We therefore thought that 
this might be a cost-benefit decision of the rat so as to put in the effort for attention 
and memory to get every response correct or to transform the task into a simple 
reaction time task which is rewarded 50% of all times.  
 
Our primary aim was to ‘encourage’ rats to respond towards the distal response 
location and to prevent them from being rewarded for biasing their responses 
towards the most proximal response location. Therefore we included an error-
correction procedure into the task where in case of an erroneous response the same 
trial is offered again to the rat until a correct response has been made.  
 
The experiment conducted in the present paper as well as analysis of the data, 
histology and preparation of the manuscript was done by the author of this thesis. 
Professor S.B. Dunnett was involved in planning of the experiment and gave help 
and advice throughout as well as in the writing of the manuscript.  
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Unilateral  dopamine  depletion  and  excitotoxic  lesions  of the  striatum  have  been  shown  to  induce  a con-
tralateral  neglect  when  rats  have  to respond  in  a  choice  reaction  time  setting.  Whereas,  in a lateralised
setting  when  response  options  are  to  either  side  of the  animal’s  head  all  contralateral  responding  is
impaired,  testing  animals  only  on one  side  of  the  head  per  day  but  with  a near  and  far  response  option,
rats  are  able  to  correctly  respond  to contralateral  stimuli,  but  rather  bias  their  responses  towards  the  near
hole. Here,  we further  investigated  the  nature  of the  contralateral  neglect  in egocentric  space  coding  in
more  detail.  Firstly,  we  tested  the  effects  of near-complete  unilateral  dopamine  depletion  on  this  type  of
task. Secondly,  previous  observations  suggested  that  lesioned  rats  shifted  their  response  strategy  which
resulted  in a response  bias  towards  the  most  proximal  location  in  contralateral  space.  In  order  to  “encour-
age”  dopamine  depleted  rats  to  respond  to the neglected  response  location  we  implemented  an  error
correction procedure  to  the  task.  Near-complete  unilateral  dopamine  depletion,  via  6-hydroxydopamine
infusions  into  the  medial  forebrain  bundle  of  female  Lister  Hood  rats,  resulted  in a reduction  of  usable  tri-triatum als,  a near  hole  bias  when  animals  were  tested  on  the  side  contralateral  to the  lesion,  as  well  as  increased
reaction  and  movement  time  latencies.  The  introduction  of an  error-correction  procedure  had  no effect
on the  animals’  response  bias  towards  the  near  contralateral  location.  Probe  trials  showed  that  the  bias
is most  likely  the  result  of  responses  being  misdirected  when  in  a  choice  situation.  The  ﬁndings  further
highlight  the  role  of  dopamine  and  an  intact  striatum  to  code  responses  into  egocentrically  deﬁned  space.. Introduction
Parkinson’s disease (PD) is most commonly modelled in exper-
mental animals via infusion of the catecholaminergic neurotoxin
-hydroxydopamine (6-OHDA) along the nigro-striatal pathway,
hereby retrogradely destroying the dopaminergic cells in the ven-
ral mesencephalon, most prominently cells in the substantia nigra
SN) [1–3]. The unilateral lesion is characterised by a profound
eﬁcit when animals are tested on the side contralateral to the
esion [1,3–5].  Detailed characterisation of the lateralised deﬁcit
∗ Corresponding author at: School of Bioscience, Cardiff University, Museum
venue, Cardiff, CF10 3AX, Wales, UK. Tel.: +44 2920 874684; fax: +44 2920 876749.
E-mail address: HeuerA@cf.ac.uk (A. Heuer).
166-4328/$ – see front matter ©  2012 Elsevier B.V. All rights reserved.
ttp://dx.doi.org/10.1016/j.bbr.2012.09.038© 2012 Elsevier B.V. All rights reserved.
by means of operant testing in an operant choice reaction time
procedure showed that the deﬁcit is not due to a primary motor
or sensory impairment [4,6,7].  Furthermore, when testing was
restricted to the side contralateral to the lesion only, via provid-
ing lesioned rats a near and a far response location, the lesion
caused animals to direct nearly all their responses towards the
contralateral near hole, whilst ignoring the contralateral far loca-
tion. Ipsilateral testing did not reveal the same pattern of deﬁcit
[8].  We recently described the phenomenon of unilateral neglect
in near complete lesioned animals on a lateralised choice reac-
tion time task that assesses the animals’ responses in space on
the side ipsilateral and contralateral to the lesion on alternate days
[9]. In this study, animals received 6-OHDA lesions to the medial
forebrain bundle (MFB) after being trained on this version of the lat-
eralised choice reaction time task. The lesion deﬁcit was stable over
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ore than 50 consecutive days of testing and could only be partly
meliorated by dopamine rich grafts [9].  The lesioned animals
aintained a near-hole bias when tested on the side contralateral
o the lesion even after the extensive post operative training. The
nderlying deﬁcit has been proposed to be caused by a distortion in
bsolute egocentric space representation when tested on the side
ontralateral to the lesion [8,10,11], i.e. far contralateral responses
re misdirected although lesioned rats are capable of detecting and
esponding to stimuli in the neglected spatial location. Here, we
xplore the effects of implementing a learning rule that forces ani-
als to respond to the neglected location if they want to obtain
 reward. The implementation of this error-correction procedure
as thought to be less demanding on working memory and atten-
ion mechanisms as animals can perseverate on one hole, until an
ncorrect response had been made, in which case they could switch
he response location in order to obtain a reward.
We have two main hypotheses. Firstly, near complete unilateral
esions via infusion of 6-OHDA into the MFB  leads to an impairment
n response accuracy in far contralateral space and secondly, the
mplementation of an error correction procedure does allow for
ncreased accuracy in far contralateral space.
. Materials and methods
All procedures were conducted in accordance with the United Kingdom Animals
Scientiﬁc Procedures) Act, 1986 and local ethical review at Cardiff University.
.1.  Subjects
24 female rats of the Hooded Lister strain (Charles River, UK) were used in the
resent experiment. All animals weighed 200–225 g on arrival and were housed in
roups of 3–4 in standard laboratory cages. The holding room was  held at a constant
emperature of 21 ◦C and 50% humidity and a 12:12 h dark–light cycle, with the
ights turned on at 7:00 h. Seven days after arrival all rats were placed on a food
estriction regime whereby they were presented with weighed amounts of food
hich was available ad libitum after testing sessions to reduce their body weights
o  90% of their free feeding weight. The rats had free access to drinking water during
ll  stages of the experiment.
.2. Procedure
All animals were trained on the lateralised choice reaction time task outlined
elow (Section 2.5) to asymptotic levels of performance. Rats were then matched
nto 2 groups based on their overall response accuracy (Control, n = 10; Lesion, n = 14)
efore one group received unilateral 6-OHDA lesions to the right medial forebrain
undle. All rats were tested on amphetamine induced rotations 2 and 4 weeks post
urgery and at the end of the experiment, before sacriﬁcing for histology. Two  days
fter the last amphetamine session, animals were food restricted again for 7 days
efore being re-tested on the operant task. After post-lesion data was  gathered we
onducted a series of probe trials (Section 2.6) before all rats were sacriﬁced and
heir brains removed for further histological analysis.
.3. Apparatus
Behavioural testing was  conducted in a bank of 12 identical 9 hole operant cham-
ers (Campden Instruments, Loughborough, UK), as described previously [12,13]. In
rief, the operant chamber was  ﬁtted with a curved array of 9 response holes on
ne side of the chamber and a magazine on the opposite wall. In the curved array 9
djacent holes were ﬁtted which could be illuminated and which could record hole
ntries via breaking of an infrared beam that was vertically monitoring the entrance
f  the hole. The operant chambers were controlled by the Cambridge Cognition Con-
rol BNC (Campden Instruments, Version 1.23) software run on a standard windows
esktop personal computer.
.4. Training
7  days after food-restricting the animals to 90% of their free feeding weight (see
ection 2.1) animals were gradually trained to perform on the lateral choice reaction
ime task outlined below (see Section 2.5). All sessions in the operant chambers were
onducted over a 30 min  session. On the ﬁrst training day the animals were placed
nto  the box and 20 sucrose reward pellets (45 mg,  Sandon Scientiﬁc, Hampton,
iddlesex, UK) were placed into the magazine. On the second day of training the
agazine light was  illuminated and a reward pellet was delivered into the magazine.
fter the rat retrieved the reward, the magazine light was  extinguished and the
ouse-light illuminated. After an inter-trial interval (ITI) of 5 s the next pellet was
elivered with simultaneous presentation of the magazine light. On the third dayin Research 237 (2013) 215– 222
of testing a nose-poke into the illuminated centre hole (Hole 5) was rewarded by
delivery of a sucrose pellet into the illuminated magazine. After reward collection
the magazine light was  extinguished and the centre hole light was illuminated again.
After 5 days of training all rats were responding highly on this FR1 procedure and
were then placed on the choice reaction time task outlined below.
2.5.  Lateralised choice reaction time task
The lateralised choice reaction time task used has been described in detail
elsewhere [8,10].  In brief, animals were trained on different conﬁgurations on alter-
nating days, starting always on the side ipsilateral to the lesion. During the respective
side of testing, all unused holes were covered by metal well blanks and only three
response options were presented: Hole 5 hereafter referred to as centre hole, Hole
4  or 6 (contralateral or ipsilateral), hereafter referred to as near hole, and Hole 3
or  7, hereafter referred to as far hole. At the beginning of each trial the house light
was  extinguished and the centre light was illuminated. The rat was then required
to  respond to the centre light by making a sustained nose poke into the hole for
a  variable delay (50 ms,  100 ms, 150 ms,  200 ms). Upon completion of the delay, a
brief stimulus light (300 ms) was randomly presented at either the near or the far
response location. When the animal subsequently responded by a nose-poke into
the  previously illuminated hole it was  rewarded by a sucrose pellet into the illumi-
nated magazine. Incorrect responses were “punished” by a time out interval of 5 s
during which all lights were extinguished. During initial training all delays were set
to  50 ms  and the stimulus duration was set to 5000 ms. During subsequent train-
ing  sessions the delay was gradually increased and the stimulus duration gradually
decreased to the standard conﬁguration settings described above.
Importantly, the difference between the present task and previous applications
was the implementation of an error-correction procedure. If the animal made an
incorrect response the same trial was offered to the animal again after the time out
period.
2.6.  Probe trials
After collecting post lesion data we  conducted a series of probe trials to further
explore the lesion induced deﬁcit. All probe trials were conducted over 10 days with
5  days testing per side alternating and always starting with the side ipsilateral to
the  lesion.
2.6.1. Probe 1: Response location shift
The response location was  shifted further away from the centre location so that
response locations on contralateral days of testing were Far: Hole 2 and Near: Hole
3  and on ipsilateral days of testing Far: Hole 8 and Near: Hole 7.
2.6.2. Probe 2: Stimulus duration
In the second probe trial we kept the conﬁguration of the stimulus-response
array as during the probe trial 1 but increased the duration of the stimulus light to
5000 ms.
2.6.3. Probe 3: Simple reaction time near
We  tested the animals with only one response option one each side on alternate
days. The response locations were Hole 4 on contralateral and Hole 6 on ipsilateral
days of testing.
2.6.4. Probe 4: Simple reaction time far
We  tested the animals on a simple choice reaction time as described in Probe 3
with the exception that the response locations were furthest away from the centre
hole in the stimulus-response array. Therefore, on contralateral days of testing the
response location was  Hole 1 and on ipsilateral days of testing the response location
was  Hole 9.
2.7. Lesion surgery
Rats of the lesion group received unilateral infusions of the catecholaminer-
gic neurotoxin 6-OHDA (5.41 g/l  calculated from freebase weight, in 0.2 mg/ml
ascorbic acid in 0.9% sterile saline) at a volume of 3 l into the medial forebrain
bundle at stereotaxic coordinates AP: −4.0 mm,  ML: −1.3 mm,  DV: −7.0 mm,  with
the incisor bar set at −4.5 (assumed ﬂat head). Infusions were made via a 30-gauge
metal cannula which was  connected via polyethylene tubing to a 10 l Hamilton
syringe which was driven by a micro drive-pump [14]. The toxin was delivered at a
ﬂow rate of 1 l per minute (=3 min) and 3 min were allowed for the toxin to diffuse
in  the brain before the needle was carefully retracted. All animals received injec-
tions of Metacam® (Meloxicam, Boehringer, Ingelheim, Germany) as analgesic and
were placed in heated recovery boxes after surgery.
2.8. RotationsDrug-induced rotations were assessed via i.p. injections of 2.5 mg/kg metham-
phetamine hydrochloride (Sigma, UK) before animals were placed into rotometer
bowls modelled after the design of Ungerstedt [3].  The apparatus recorded net ipsi-
lateral and net contralateral rotations over a period of 90 min  distributed into 90
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-min  bins. All data were expressed as ipsilateral rotations minus contralateral
otations and averaged over the 90 min  session. Therefore a positive rotation score
epresents rotations towards the side of the lesion.
.9. Histology
Following collection of all behavioural data the rats were deeply anaesthetised
ith 200 mg/kg sodium pentobarbitone and perfused through the heart with 100 ml
hosphate buffered saline (PBS, pH 7.4), followed by 250 ml  of 1.5% paraformalde-
yde in PBS. Brains were then carefully removed from the skull and placed in the
xative for an additional 24 h after which they were placed in a 25% sucrose solution
ntil sunk.
For visualisation of lesion extent the brains were cut into coronal sections at a
hickness of 40 m on a freezing-sledge microtome into 0.1 M TRIS buffered saline
pH 7.4, TBS). Staining for tyrosin-hydroxylase immunoreactive (TH-ir) cells was
one  using standard immunohistochemical techniques on a 1 in 6 series of sections:
Coronal sections were ﬁrst washed in TBS before 5 min  quenching endogenous
eroxidase enzyme activity in a solution of 3% hydrogen peroxide and 10% methanol
n  distilled water. After thoroughly washing in TBS (3 × 10 min) they were placed in
 blocking solution (3% horse serum in TXTBS) for 3 h after which they were trans-
erred into primary antibody (TH raised in rabbit, polyclonal, Chemicon, 1:1000)
vernight. Then sections were washed again in TBS (3 ×10 min) and then incubated
or 3 h in biotinylated secondary antibody (anti-rabbit 1:200). After washing in TBS
3  × 10 min) staining was  visualised by 2 h incubation in ABC-kit followed by equib-
ilating the tissue in TNS (2 × 5 min) and evoking the colour reaction by incubation in
 3-3′-diaminobenzadine (DAB, Vector laboratories) solution with 0.3 l/ml hydro-
en peroxide. Stained sections were mounted on gelatine coated slides, airdryed
vernight and then coverslipped using a DXP mountant [15].
.10. Statistics
All data were analysed using the GENSTAT v 13.1 software package with
ewman-Keuls post hoc testing for multiple comparisons. A signiﬁcance level of
 = 0.05 was  chosen for all analysis. Operant data was analysed using repeated
easures analysis of variance with the factors Group (Control, Lesion), Side (Con-
ralateral, Ipsilateral), Response location (Near, Far), and Week. All data are collated
ver a 5-day block of testing and response latencies (reaction and movement times)
re expressed using geometric means, rather than the arithmetic mean, to reduce
he inﬂuence of extreme data points.
Main outcome measures are: Trials usable: the number of usable trials where
he  animal initiated a trial by responding to the illumination of the centre hole by
aking a nose-poke and sustain that nose-poke for the required duration (delay).
ccuracy: the number of correct responses divided by the number of usable trials
nd expressed as percentage for responses to the near and far response location,
espectively. Latencies: reaction (RT) and movement times (MT) for correct and
ncorrect responses were taken as the latencies from presentation of the lateralised
timulus to withdrawal of the rats’ nose from the centre hole (=RT) and from the
ithdrawal of the nose to executing the response in the response location (=MT).
epeated trials: the number of trials that were repeatedly offered to the animal as
 consequence of a previous incorrect response and expressed as percentage of the
otal number of usable trials. Note that premature withdrawals and omissions do
ot  count towards the number of repeated trials, although the same trial is offered
o  the rat until a correct response has been made.
. Results
One rat in the lesion group died unrelated to any treatments and
herefore the ﬁnal group sizes were: Control, n = 10; Lesion, n = 13.
o rats were excluded from the lesion group due to lesion size.
.1. Amphetamine induced rotation
There was a signiﬁcant difference in the average number of ipsi-
ateral rotations between the two groups (Group, F1,21 = 125.29,
 < 0.001), with the control group not rotating signiﬁcantly in any
irection (−0.26 ± 0.88 turns/min) and the lesion group exhibiting
trong contralateral turning (12.87 ± 0.77 turns/min). The ani-
als’ rotational response to methamphetamine increased slightly
rom 11.8 ± 0.86 turns/min to 13.65 ± 1.03 turns/min for the lesion
roup over the three testing sessions, but this marginal increase
ailed to reach conventional levels of signiﬁcance (Week × Group,
1,21 = 4.02, p = 0.058). However, whereas controls did not display a
otational bias during any session, lesioned animals rotated highly
owards the side of the lesion, therefore indicating a successful
esion.in Research 237 (2013) 215– 222 217
3.2. Immunohistology for tyrosine-hydroxylase
Representative samples of brain sections stained for TH are
shown in Fig. 1 for animals of both, the control group (Fig. 1A)
and the lesion group (Fig. 1B), respectively. The lesion successfully
destroyed the dopaminergic cell bodies in the substantia nigra and
largely affected cells located in the VTA as well. Furthermore, this
caused a marked depletion in TH-ir staining in the striatum as can
be seen in Fig. 1B.
TH-ir cell counts at the level of the medial terminal nucleus of
the accessory optical nerve have been used as anatomical borders
to separate VTA from SNc cells (Fig. 1C and D). Cell counts in the
respective areas ipsilateral and contralateral to the lesion revealed
that rats that received lesions displayed a near total (>95%) deple-
tion of TH-ir cells in the ipsilateral SNc (Fig. 1C, Group, F1,21 = 57.44,
p < 0.001) and a marked reduction in the number of TH-ir cells in the
VTA (60% of contralateral), which was  signiﬁcantly different from
control (Fig. 1D, Group, F1,21 = 71.06, p < 0.001).
3.3. Operant analysis of behaviour
3.3.1. Trials usable
Before the lesion all animals produced a high number of usable
trials (Fig. 2A; mean: 77.2 ± 1.7). Rats that received lesions to the
MFB  produced fewer usable trials than untreated controls in the
5-day block of post lesion testing (Week ×Group, F1,21 = 72.12,
p < 0.001). All rats produced more usable trials when tested on the
contralateral side to the lesion (Side, F1,21 = 86.03, p < 0.001) but
this effect was not different between the two experimental groups
(Side × Group, F1,21 = 0.09, p = n.s.).
3.3.2. Accuracy
During baseline performance all animals responded with a high
accuracy to the stimulus lights (Fig. 2B and C; Near: 93.35% and
Far: 74.13%). The lesion did affect response accuracy differently
between the groups, the distance of the response location and
the side of testing (Week × Distance × Group, F1,21 = 7.66, p < 0.05).
Whereas animals of the control group responded with a similar
accuracy to the respective near and far response location dur-
ing baseline and post lesion, irrespective of the side of testing,
animals of the lesion group did show a signiﬁcant reduction in
contralateral far response accuracy (analysis restricted to contralat-
eral: Week × Distance × Group, F1,21 = 61.07, p < 0.001). Whereas on
contralateral days of testing response accuracy to the near hole
is only reduced to 61.81%, far hole accuracy is reduced to 9.36%
correct trials. On ipsilateral days of testing responses to the far
hole were less accurate than responses directed towards the near
hole (Distance, F1,21 = 26.54, p < 0.001). This difference was  not
different between the groups (Analysis restricted to ipsilateral; Dis-
tance × Group, F1,21 = 3.02, p = n.s.). Overall ipsilateral accuracy was
slightly reduced (−10%) in animals of the lesion group compared to
their baseline performance (Week × Group, F1,21 = 11.46, p < 0.01).
3.3.3. Trials repeated
The error correction procedure led to the presentation of the
same trial until a correct response had been made. The pattern of
the number of trials that had to be repeated on the contralateral
side clearly demonstrated the pattern of responding induced by
the lesion. Animals of the lesion group had to repeat nearly twice as
many trials when the required response had to be made into the far
response location, and simultaneous lesioned animals had almost
never to repeat a trial that required responding into the near con-
tralateral location (Fig. 2D and E; Weeks × Side × Distance × Group,
F1,21 = 4.57, p < 0.05).
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Fig. 1. Histological analysis of lesion extent. (A/B) Representative coronal sections stained for TH for both experimental groups. In comparison to animals of the control
group  (A), rats that received unilateral MFB  lesions (B) displayed an absence of TH-ir staining in the contralateral hemisphere throughout the brain. Clearly visible is the TH
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.3.4. Reaction time
The time to react to the occurrence of the lateralised stimulus
ight was increased in lesioned animals after the surgery (Fig. 2F and
; Week × Group, F1,21 = 26.18, p < 0.001). Reaction time was only
ncreased when testing was conducted on the side contralateral
o the lesion (Side × Group, F1,21 = 30.41, p < 0.001). There was no
ifference in time to react to stimuli in either the near or the far
esponse location (Distance, F1,21 = 1.06, p = n.s.).
.3.5. Movement time
The time to respond to the lateralised stimulus was  longer
or far hole responses than for near hole responses (Fig. 2H and
; Distance, F1,21 = 17.34, p < 0.001). This effect was not different
etween the groups (Distance × Group, F1,21 = 1.31, p = n.s.) and
ot between the weeks of testing (Week × Distance, F1,21 = 1.34,
 = n.s.). Instead, similar to reaction time responding, the time to
xecute the response was increased on contralateral days of test-
ng in animals that received lesion surgery (Week × Side × Group,
1,21 = 24.11, p < 0.001). Although movement times were increased
n the lesion group on ipsilateral days of testing (Ipsilateral:
eek × Group, F1,21 = 15.95, p < 0.001), the increase in movement
ime was much more pronounced on contralateral days of test-
ng (Contralateral: Week × Group, F1,21 = 43.94, p < 0.001; Overall:
ide × Group, F1,21 = 25.36, p < 0.001).
.4. Probe trials
All probe trials were conducted over 10 consecutive days of test-
ng. During probe trials 1 and 2 testing was conducted on alternate
ays whereas during probe 3 and 4 testing was conducted over 5
onsecutive days/side, always starting ipsilateral.
.4.1. Shift of response location
During the ﬁrst probe trial we shifted the response options forne location further away from the centre hole, thereby making
he former far hole the near hole. The animals’ performance on this
onﬁguration was similar to testing under the standard conﬁgura-
ion used during baseline and post lesion testing (Fig. 3A). Althoughin the VTA of the lesion group are largely depleted as well. (C/D) TH-ir cell counts
ercentage of total cells for the C. SN and D. for the VTA, respectively. Dotted line
le bar represents 1000 m.
near hole accuracy was reduced for the lesion group (48.54% during
Probe compared to 61.81% during Standard, post lesion conﬁg-
uration), lesioned rats displayed a similar accuracy pattern with
higher response accuracy towards the near response location with
a response accuracy score of 2.28% towards the far contralateral
location (Distance × Side × Group, F1,21 = 8.83, p < 0.01). Important
to note is that lesioned rats now respond to exact same spatial
location that was neglected previously.
3.4.2. Shift of response location and increase in stimulus duration
The conﬁguration of the response holes was  as described above
(Section 3.4.1) but in an attempt to facilitate responding the stim-
ulus duration was  set to 5000 ms.  As can be seen in Fig. 3B lesioned
rats did increase response accuracy to the contralateral near hole
when compared to the conﬁguration used in Probe 1. This increase
in accuracy only affected the near contralateral response loca-
tion; when responses had to be directed towards the contralateral
far hole, animals still chose to ignore this spatial location (Dis-
tance × Side × Group, F1,21 = 174.62, p < 0.001).
3.4.3. Simple reaction time – near conﬁguration
After assessing the effects of the lesion on the 2-choice version
we tested all animals on a simple reaction time task with only one
response location. During this assessment only the centre hole and
the hole immediately adjacent was available to the rat (i.e. Hole 4
and Hole 6, respectively).
Here, the difference in contralateral accuracy was  too small to
cause a signiﬁcant difference between the two  experimental groups
(Fig. 3C; Sides × Groups, F1,21 = 4.05, p = 0.057), whilst, overall, the
lesion group did perform slightly under the control group (Group,
F1,21 = 6.81, p < 0.05).
3.4.4. Simple reaction time – far conﬁguration
After assessing the effects of removing one response option on
the simple near conﬁguration we  assessed the same effect when the
single response option was  located furthest away from the centre
hole.
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Fig. 2. Main effects of the choice reaction time task. Data are presented for the number of usable trials per side of testing (A) and split for responses ipsilateral (B, D, F, H) and
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ole  depicted in the schematic above the graphs for contralateral and ipsilateral res
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All lesioned animals displayed a contralateral deﬁcit in response
ccuracy with performance similar to control when tested on
he ipsilateral side (Fig. 3D; Side × Group, F1,21 = 19.64, p < 0.001).
lthough the animals had to respond to the furthest possible loca-
ion in our stimulus array, contralateral accuracy was  still 42.38%.
. Discussion
The version of the choice reaction time task used in the present
xperiment revealed differences in response patterns between
esioned and untreated control animals and further elucidates the
ole of dopamine depletion in the striatum. Rats that received uni-
ateral lesions to the MFB  displayed reduced responding to the
ontralateral far hole whilst leaving ipsilateral responding largely
ntact. Probe trials showed that the lesioned animals did not havees are shown for the near and far response location, respectively. The illuminated
s (B-I) indicate the correct response required. Asterisks denote signiﬁcant different
 or three asterisks, respectively.
an allocentric response deﬁcit as (i) lesioned rats did respond with
high accuracy towards ipsilateral near and far stimuli and con-
tralateral responding was  largely biased towards the nearer of two
response locations; (ii) lesioned rats were able to respond to the
previously neglected spatial location when the response options
were shifted, i.e. the default response proﬁle was to respond to
the most proximal location in contralateral space, irrespective of
the absolute spatial position, when faced with a response choice.
Reducing task demands increased overall accuracy but did not alle-
viate the response bias in lesioned rats. Interestingly, the described
deﬁcit was only apparent when the rats were faced with a choice
discrimination. When we conducted probe trials where rats had to
respond to only one stimulus on one side of the rats’ head (simple
reaction time task), there was  no difference between lesioned rats
and those of the control group. Furthermore, even when tested in
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Fig. 3. Percentage of correct responses when rats were tested on the different probe trials presented per side of testing. (A) Probe 1: the location of the response hole was
shifted  further away form the centre hole. (B) Probe 2: the conﬁguration of the response location was  kept as under Probe 1 and the presentation of the stimulus light was
increased from 300 ms  to 5 s. (C) Probe 3: the conﬁguration was  changed to a simple reaction time task with the only lateralised response option being the hole immediately
adjacent to the centre hole. The data shows the percentage of correct responses when rats were tested Probe 2. Data are presented for ipsilateral and contralateral responses
to  the near and far response location, respectively. (C) The data shows the percentage of correct responses when rats were tested on Probe 3. Data are presented for ipsilateral
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he most extreme/distal conﬁguration (Probe 4), lesioned rats dis-
layed lower response accuracy than control group animals when
ested on the contralateral side, but importantly, they responded
uch higher than during any of the far holes in all other tests, which
ere spatially closer to the rats starting position. Based on this, and
ndings from previous studies utilising partial lesion models, we
an conclude that the contralateral neglect that is caused by striatal
opamine depletion is not due to a primary impairment in sensory
r motor processing [4,6–8,16,17].
The deﬁcit seen in rats on this version of the choice reaction
ime task introduced by Brown and Robbins (1989) conﬁrmed the
eﬁcit of unilateral egocentric based neglect in contralateral space
hat has been reported after partial dopaminergic depletion [8]
s well as after excitotoxic lesions of the striatum [10,18]. Here
e report for the ﬁrst time that near complete lesions produce
imilar deﬁcits. The near complete lesion model via unilateral 6-
HDA infusions to the MFB  is the most commonly used model
o study the effects of cell replacement therapies. Whereas par-
ial lesions, via infusions of the neurotoxin to the terminals in theesponses when rats were tested on Probe 4. Data are presented for ipsilateral and
 the respective time point/response location at p < 0.01 or p < 0.001 for two  or three
striatum, are more variable and prone to spontaneous recovery, the
current model produced stable behavioural deﬁcits [1,6,7,13,19].
The assessment of behaviour by means of operant testing has been
shown to be more sensitive to the effects of therapies than tests of
simple motor asymmetry [13]. The novel description of the version
of the choice reaction time task that is employed in the present
study allows for a more in-depth analysis of the effects of cell
replacement therapies in the future.
Indeed because of previous ﬁndings that performance is only
impaired in a choice discrimination setting, the introduction of an
error correction procedure was implemented to encourage animals
to respond into far contralateral space in order to obtain a reward.
We speculated that the development of a near hole bias could be
due to a reduction in motivational drive and/or the development
of a alternate response strategy induced by the lesion. In a Skin-
ner box version of the choice reaction time task it became clear
that lesioned animals would respond to all stimuli by turning in
the same direction after the hold period had elapsed. They would
respond directly by turning towards the ipsilateral side to make the
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esponse or conduct a full body turn to execute the response to the
ever located contralateral to the lesion. Therefore, we  speculated if
he contralateral near hole bias was a result of a changed response
trategy. An alternative explanation would be that lesioned animals
isplay a lowered motivational state [20] as we  and others have
hown that the dopamine depletion causes a marked reduction in
he number of trials attempted [7,13,21]. Indeed, if animals would
nly respond towards the near hole, the task demand on working
emory and attention would be lower than when making choices.
lthough they would not get rewarded when the required response
ad to be made towards the far contralateral response location,
hey still received a reward on 50% of all trials as the chance of a
orrect near hole response was randomly determined by the com-
uter. The implementation of an error correction procedure was
hought to prevent this strategy as perseveration towards the near
ole would not lead to any rewards.
In contrast to our initial hypothesis, the error correction pro-
edure was not effective in forcing the animals to respond to the
ar response location on contralateral days of testing. As shown
y the number of trials repeated, lesioned rats persevered respon-
ing to the contralateral near hole. Shifting the response location
n this version of the task revealed, as previously [8,9], that rats
re capable of responding to this speciﬁc spatial location and that
he deﬁcit shifts to the new “far” hole, whilst responding with high
ccuracy to the, now “near”, response location that formerly had
een neglected. Increasing the stimulus length to 5000 ms,  longer
han the time needed by the animals to execute the lateralised
esponse, had only an effect on contralateral near hole accuracy.
lthough rats could have used the stimulus light as a beacon to
uide their responses they continued to direct almost all response
owards the near contralateral location.
Of interest are the results of the simple reaction time trials
hich show that, although accuracy was lower on contralateral tri-
ls in the far condition, lesioned animals still responded with high
esponse accuracy. Furthermore, a contralateral accuracy deﬁcit
as not found when the response locations were most proximal
o the animals’ head in a simple reaction time setting (Probe 3),
hereas a more lateralised deﬁcit was found when the response
ocation was set most distal (Probe 4).
The contralateral far hole neglect was only present when
nimals were presented with a response choice, but not when res-
onding was limited to one location only in near space. Previous
ork has shown that accuracy on a simple reaction time was not
ifferently affected by striatal lesions than accuracy on a choice
eaction time task [17]. This is in contrast to the ﬁndings pre-
ented above. The main difference between the two  studies is that
hereas we present the animals with a true simple reaction time
ask, with only one response option within session, the latter study
sed pre-cueing as a means to provide all information necessary to
he animal [17]. It has been argued that fully cued tasks are different
rom simple reaction time tasks [22], and only when enough time
s given pre-execution of the response similarities can be consid-
red [22]. Still, demands on working memory would be higher to
emember the cue compared to a situation when only one response
s possible.
Our results support previous ﬁndings of striatal dopamine
epletion and cell body lesions of the striatum on this type of
hoice reaction time task. The accumulating data show, that after
 lesion, responding in far contralateral space is impaired and that
his impairment is due to a failure in directing responses towards
he correct location [8,10].  Previous research has shown that when
he two striata are put in competition, by means of presenting
oth or neither stimulus simultaneously, lesioned animals display
 near hole bias when tested on the contralateral side of the lesion,
hereas no bias was recorded when no stimulus lights were pre-
ented [8].  Striatal cell body lesions caused the same egocentric
[in Research 237 (2013) 215– 222 221
contralateral neglect as discussed above [10] but the rats’ behaviour
on a series of probe trials revealed interesting functions of the stri-
atum. By means of shifting the response locations around the centre
hole whilst leaving the absolute distance between both locations
constant they showed that the deﬁcit is greater when contralateral
location is furthest away when compared to the mirrored conﬁgu-
ration (Near contra vs. far ipsi) [10].
In conclusion, we have shown that the response bias induced
by unilateral near-complete dopamine depletion in rats does not
recover by implementation of an error correction procedure that
“encourages” the animals to respond towards the far stimulus
conﬁguration in a choice reaction time setting. These ﬁndings fur-
ther highlight the role of dopamine in the facilitation of directing
responses into egocentrically coded response space.
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Chapter 3.4 
Experiment 4: Unilateral nigro-striatal 6-
hydroxydopamine lesions in mice I: Motor 
impairments identify extent of dopamine depletion at 
three different lesion sites 
 
The majority of studies applying the 6-OHDA lesion to model PD have been 
conducted in rats. Although initial studies utilised mice, only recently the mouse 
model has become more popular. Major challenges in injecting mice with the DA 
depleting toxin have been the high mortality rate in complete lesioned animals and 
the high variability in lesion success.  
 
Recent work from Sweden in Angela Cenci-Nilsson’s group and others have shown 
that by implementing an extensive caring protocol, mortality rates can be reduced to 
acceptable levels. Furthermore with the advent of mouse-derived stem cells and 
genetic manipulations the lesion mouse model is of interest for many neuroscientists. 
Although some of the lesion models have been investigated individually, i.e. MFB, or 
SN lesions, no study, to our knowledge, has attempted a direct comparison of lesion 
procedures on pathological changes in the brain or behavioural measures. Moreover, 
to date the behaviour conducted in mice is limited and mainly focuses on translations 
from the rat. Only the recent study by Grealish et al. (2011) – which was published 
after the present study had been completed - has attempted to characterise the 
behavioural sequalae of unilateral SN lesions, where the behavioural deficit was 
correlated with the extent of the lesion and provided first guidelines for a distinction 
between well lesioned from partially lesioned animals. The aim of the present 
experiment was to conduct a direct comparison of all three unilateral lesion models 
via infusion of 6-OHDA along either, the SN, the MFB, or the striatum and assess the 
lesion induced behavioural changes on a wide panel of behavioural tests.  
 
The experiment conducted in the present paper as well as analysis of the data, 
histology and preparation of the manuscript was undertaken by myself in close 
collaboration with a fellow PhD student, Gaynor Ann Smith, who is joint first author of 
the resulting publication presented below and the complementary paper (Smith et al. 
2012). Professor S.B. Dunnett, Dr. Lane and Dr. Lelos were involved in planning of 
the experiment and gave help and advice throughout as well as in the writing of the 
manuscript.  
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The  unilateral  6-hydroxydopamine  mouse  lesion  models  of  Parkinson’s  disease  have  received  increas-
ing attention  in recent  years,  but comparison  of  the  different  lesion  models  was  largely  focused  at  a
histological  level.  An  extensive  behavioural  comparison  between  different  mouse  models  on  tests  of
motor  function  has yet  to be carried  out,  to pin  point  tests  that  accurately  discriminate  between  different
extents  of  dopaminergic  depletion.  In  the  present  study  we examine  the consequences  of injection  of  the
toxin at  three  sites  along  the  nigrostriatal  tract  (substantia  nigra,  medial  forebrain  bundle,  and  striatum)
on a broad  range  of  simple  motor  tasks,  and  on  the dopaminergic  pathology.  All lesion  groups  demon-
strated  marked  behavioural  deﬁcits  and  displayed  distinct  proﬁles  of  degeneration  along  the  nigrostriatal
dopamine  pathway.  Tests  that  correlated  closely  with  the  level  of  substantia  nigra  cell  loss  included  the
corridor,  cylinder  and  balance  beam  tests,  the rotarod,  inverted  cage  lid  and  three  types  of  rotational
assessment  (spontaneous,  amphetamine-induced  and  apomorphine-induced).  Speciﬁc  tasks  are  identi-opamine
triatum
ﬁed which  are  capable  of  distinguishing  a near-complete  lesion,  with  amphetamine  rotation,  corridor
and cylinder  tests  showing  the  highest  correlations  with  levels  of  nigral  cell  loss.  Performance  in the  dif-
ferent  behavioural  tests  was  associated  with  distinct  proﬁles  of cell  loss  in  the  SN and  VTA.  We  provide  a
comprehensive  behavioural  assessment  of  lesion-induced  deﬁcits  in mouse  models  of PD, which  should
facilitate  selection  of  the  most  appropriate  lesion  model  and  most  sensitive  behavioural  tests  for  use  in
future  studies  investigating  therapeutic  interventions.. Introduction
Parkinson’s disease (PD) is a progressive neurodegenerative dis-
rder characterised by resting tremor, bradykinesia and postural
nstability [1].  Post mortem analyses of Parkinsonian brains have
evealed that substantial degeneration of the pigmented dopamin-
rgic cells in the ventral midbrain is the likely cause of many of the
otor features [2,3] and extensive degeneration of nigral dopamin-
rgic neurons is needed before the ﬁrst overt motor symptoms
ccur [4].
Since the ﬁrst description of the 6-hydroxydopamine (6-OHDA)
esion rat in 1968, injection of this catecholaminergic neurotoxin
as been widely used to model the nigrostriatal dopamine deple-
ion in PD [5,6]. Intraventricular injection of 6-OHDA in the rat
roduces a bilateral catecholaminergic depletion with consequen-
ial motor impairments and profound impairments in feeding,
∗ Corresponding author at: School of Bioscience, Cardiff University, Museum
venue, Cardiff, CF10 3AX, Wales, UK. Tel.: +44 2920 874684; fax: +44 2920 876749.
E-mail address: HeuerA@cf.ac.uk (A. Heuer).
1 These authors contributed equally.
166-4328/$ – see front matter ©  2011 Elsevier B.V. All rights reserved.
oi:10.1016/j.bbr.2011.11.027© 2011 Elsevier B.V. All rights reserved.
drinking and ability of the animal to maintain full health [7].
Unilateral administration avoids these health problems and cre-
ates a unilateral motor impairment, the extent of which can be
determined using a variety of behavioural tests. In the rat, the
most complete unilateral lesions are achieved via injection of the
toxin into the medial forebrain bundle (MFB) where the ascending
nigrostriatal ﬁbre pathway is at its most compact. Alternative sites
can be used along the nigrostriatal trajectory, directing the toxin to
either the cell bodies in the substantia nigra (SNc), or the terminal
region of the ﬁbres in the striatum, where the dopaminergic ter-
minals of the nigrostriatal pathway undergo massive ramiﬁcation
and make synaptic contact with their primary targets, the medium
spiny neurons. These approaches have the advantage of permitting
more selective nigrostriatal lesions, avoiding the ventral tegmen-
tal area projections involved in the limbic circuitry. From studies
in the rat we know that these different lesion proﬁles can pro-
duce distinct behavioural deﬁcits, reviewed in Refs. [8,9]. Now, with
the increasing use of transgenic mice in experimental therapeutics,
a comparable understanding of the deﬁcits and their dissociation
after different lesions in mice is needed to enable selection of effec-
tive lesions, assessment of pharmacotherapeutics and evaluation of
non-drug mediated treatment strategies such as cell replacement.
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Given that all the original lesion work and characterisation of
otor tests was carried out in the rat, developing and optimising
 similar lesion model and translating the now well-established
ehavioural tests into mice has faced signiﬁcant challenges
10–14].  A comparison of the available literature shows variable
esults across studies, particularly in the use of drug-induced
otation (e.g., following peripheral injections of apomorphine or
mphetamine) as a screening procedure for the extent of dopamine
epletion [13,15,16].  Many of the standard tests, which are reli-
bly used in the rat appear to be less discriminative in the mouse.
ractical problems in lesioning mice include very high mortality
ates when the toxin is aimed at the MFB, reaching >80% in some
tudies [10,13], which has led some groups to prefer nigral or stri-
tal lesions. A direct comparison between the three different lesion
odels has been described recently with regards to lesion effects on
istopathology and in vivo assessment of locomotor activity, rota-
ional response and paw preference [17], but there has yet to be a
omparison between the three lesion models on a wider array of
ehavioural tests and an explicit attempt to identify behavioural
hanges indicative of the extent of the lesion. The aim of the
resent study was to directly compare the relationship between the
xtent or pattern of unilateral dopamine depletion and behavioural
mpairment, to identify robust behavioural assays for selecting
ice with the most complete lesion. Criteria for behavioural tests
hould be that they allow for high throughput screening, simple
est administration and lesion-induced impairments that corre-
ate with nigral cell loss. We  therefore employed a comprehensive
ange of the most popular motor tasks after each lesion type, in
rder to determine the most reliable tests for identifying distinct
esion proﬁles. After analysis of the behavioural deﬁcits induced
y each lesion on simple motor tests, the relationship between the
agnitude and pattern of dopamine depletion and behavioural per-
ormance was evaluated allowing identiﬁcation of the tests that are
ost sensitive to the presence and extent of dopamine depletion.
. Materials and Methods
.1. Subjects
A  cohort of 105 male C57/Bl6 mice (Charles River, UK) aged 10–12 weeks on
rrival were housed in groups of 5–6 in standard laboratory cages with food and
ater ad libitum, at 21 ± 1 ◦C room temperature, 60 ± 1% relative humidity, and a
2:12 h dark–light cycle with lights on at 06:30 h. All testing was conducted between
8:00 h and 17:00 h. For the tests that utilised sucrose reward pellets, mice were
ood  restricted for 7 days prior to testing, maintaining them at 90% of their free
eeding weight, and with free access to drinking water at all times. All mice received
eighed quantities of food, which was then placed into the home cages for consump-
ion. All experiments were conducted in compliance with the UK Animals (Scientiﬁc
rocedures) Act 1986 and approved by local ethical review.
.2. Experimental design
After pre-lesion training on the staircase test (see Section 2.4.1), mice were
llocated into four matched groups based on the number of pellets eaten and the
resence of a side bias. One group (n = 15) served as untreated experimental controls
hat  did not undergo any surgical procedure, whilst the other three groups (n = 30 in
ach) underwent surgery. Unilateral lesions to the dopaminergic system were aimed
t the SNc, MFB, or striatum. Six weeks post-lesion, mice were food-restricted and
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Fig. 1. Experimental plan by week of testing. Area Research 228 (2012) 30– 43 31
tested on the staircase test and corridor test. Mice were allowed ad libitum access to
food for the remainder of the experiment. The following behavioural tests were then
conducted consecutively: balance beam, spontaneous rotation, cylinder, rotarod,
stepping, gait, inverted cage lid, locomotor activity and separate amphetamine- and
apomorphine-induced rotation sessions (Fig. 1).
2.3. Lesion surgery
Mice were anaesthetised in an induction chamber with 1.5–2.0% isoﬂurane using
oxygen as the carrier gas. The top of the head was shaved and the mouse was placed
into a Kopf stereotaxic apparatus providing 1.5–2.0% isoﬂurane anaesthetic in 2:1
oxygen/nitrous oxide carrier gas. For all three lesion types the incisor bar was  set
at  the level of the interaural line. Unilateral lesions were achieved by injection of 6-
OHDA (Sigma, Poole, UK) via a 30-gauge stainless steel cannula connected to a 10 l
Hamilton syringe mounted on a microdrive pump via polyethylene tubing. The neu-
rotoxin was used at a concentration of 6 g/l  (hydrobromide salt, calculated from
free  base weight) dissolved in a solution of 0.9% sterile saline in 0.2 mg/ml ascor-
bic acid. The cannula was  targeted at the right SNc (1.5 l), MFB  (1 l), or striatum
(2  × 1.5 l), at the following stereotaxic coordinates (relative to bregma, in mm):
SNc: AP = −3.0, ML = −1.2, DV = −4.5; MFB: AP = −1.2, L = −1.2, DV = −4.75; and stria-
tum: (i) AP = +1.0, L = −2.1, DV = −2.9; (ii) AP = +0.3, L = −2.3, DV = −2.9. The required
volume was injected at a rate of 1 l/min into each target, following which, the
cannula was  left in place for 3 min to allow for diffusion before retraction of the
cannula, cleaning and suturing the wound. At the end of each surgical session mice
were given a subcutaneous injection of 0.5 ml  of 0.9% sterile saline containing 4%
glucose daily (14 days), along with soluble paracetamol analgesia in the home cage
water bottle (1 g/l for 3 days) and provision of wet granulated food. Body weights
were monitored for 14 days post lesion. If the weight dropped below 85%, the health
of  the animal was  evaluated and the mouse was sacriﬁced if considered appropri-
ate. All mice were given access to free food and time for recovery for a total of 5
weeks post lesion before food was withdrawn 7 days prior to the commencement
of  post-lesion testing (Fig. 1).
2.4. Behavioural tests
Prior to each behavioural test, mice were habituated to the testing room for at
least 20 min. For the staircase test and the corridor test mice were food restricted for
1  week prior to testing. Assessments on all other behavioural tests were conducted
after mice had been allowed ad libitum access to food for at least 7 days. Behavioural
tests were conducted in the order outlined in Fig. 1 and as described below.
2.4.1. Staircase
The staircase test for mice has been adapted from the rat procedure as an objec-
tive test of skilled forelimb use [14,18]. A detailed description of the mouse staircase
apparatus (Campden Instruments, Loughborough, UK) can be found in Ref. [14] and
illustrated in Ref. [19]. In brief, a short corridor off the start box is ﬁtted with a cen-
tral  plinth onto which the mouse can climb and a narrow gap is present on either
side. On either side of the plinth there is a staircase with eight equal steps. Each step
is  baited with 2 precision sugar pellets (20 mg, Sandown Scientiﬁc). The apparatus
is  conﬁgured such that the mouse can only reach and retrieve pellets from each
staircase with the corresponding forepaw on that side, so that the total number of
pellets removed provides a measure of reaching success independently on each side
of  the body.
On the ﬁrst day of training, both staircases were baited with excess pellets and
additional pellets were scattered on the plinth of the platform, and food-restricted
mice (see Section 2.1) were placed in the staircase apparatus for 20 min to explore.
After this initial day of habituation, all mice were tested for 30 min over seven
consecutive days during which mice’ performance reached asymptote. The last 3
days of asymptotic performance were then collated as baseline (pre-lesion) per-
formance. Post-lesion data is similarly collated over a 3-day block. For statistical
analysis, reaching deﬁcits are expressed in terms of the number of pellets retrieved
on  the left (impaired, contralateral to lesion) side as a percentage of the number
retrieved on the right (control, ipsilateral to lesion) side.
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.4.2. Corridor
The corridor task assesses lateralised sensorimotor proprioception and neglect,
nd was adapted for use in the mouse based on previous studies in the rat [13,20].
he apparatus was custom built to have two adjacent corridors 60 cm long, 4 cm
ide and 15 cm high. Ten pairs of adjacent pots, each with a diameter of 1 cm and
ontaining six 20 mg  sugar pellets (Sandown, USA), were placed in one corridor,
qually spaced at 5 cm intervals. The adjacent corridor was used to acclimatise
ice to the equipment before the testing session. Food restricted mice (see Sec-
ion 2.1)  were tested on the corridor apparatus for three consecutive days, pre- and
ost-lesion. Mice were habituated to the apparatus for 20 min  on two consecutive
ays prior to testing. On the third day (test day) the number of right and left suc-
essful retrievals made by each mouse was counted until a total of 20 retrievals
ere recorded, or until 5 min elapsed. A % side bias score was calculated (100 × (left
etrievals)/(total retrievals)) and used for the statistical analysis.
.4.3. Balance beam
The beam test analyses the motor coordination of hindlimbs and forelimbs
uring precise locomotion and balance, and has been shown to be sensitive to uni-
ateral 6-OHDA lesions in the rat [21]. Here, the beam has been adapted such that
he height, 17◦ incline and converging width of the beam encourage the mouse to
scend from the start point to an enclosed box located at the uppermost and nar-
owest part of the beam (illustrated in Smith and Heuer [19]). Beam dimensions are:
80 cm,  W0.5–1.5 cm, H34–54 cm.  House dimensions are: L11 cm,  W11 cm,  H10 cm.
he  training protocol for the balance beam has recently been described in Ref. [22].
rieﬂy, all mice were tested on the balance beam apparatus for three consecutive
ays. During the ﬁrst 2 days the mice were trained to traverse the beam by ﬁrstly
abituating them to the goal box and secondly, moving them to the starting point on
uccessive trials further away from the entrance of the goal box until the mouse was
ble to traverse the entire distance of the apparatus. On the third (test) day, each
ouse was  video-taped on three consecutive trials and the time taken to ascend
he beam and the total number of hindlimb and forelimb foot slips were counted on
ach trial. The two quickest times and foot slip counts were averaged. Contralateral
oot slips were scored during the trials and ipsilateral foot slips were scored post
oc from video footage. A foot-slip side bias score was  calculated (as above, Section
.4.2) for each mouse.
.4.4. Cylinder
The cylinder test assesses the laterality of forelimb use in a novel environment
23,24].  Mice were tested for paw preference in a spherical glass beaker with a
iameter of 11.5 cm,  illustrated in Ref. [19]. Two mirrors were positioned at 60◦ and
laced directly behind the cylinder, which ensured a 360◦ view was available to the
bserver. Each mouse was allowed to make 20 rears with weight-bearing contact
gainst the side of the cylinder and the left/right forelimb bias was  recorded. The
ession was videotaped and scored by detailed freeze frame analysis. Simultaneous
psilateral and contralateral forelimb touches were excluded and mice that failed to
each 20 touches were removed from the cylinder after 10 min. Data are expressed
s  side bias of paw preference (calculated as above, Section 2.4.2). All mice were
ested only once on the cylinder test to prevent habituation to the apparatus.
.4.5. Rotarod
The rotarod apparatus (Ugo Basile, Varese, Italy) was  used to provide an overall
ssessment of balance, motor coordination and strength [23–26]. Mice were tested
ver three consecutive days with two training days of 3 trials at 12 rpm and 22 rpm,
espectively. Trials lasted 300 s and were separated by at least 1 h to prevent fatigue.
uring training, mice that fell off the beam were placed back on until the 300 s had
lapsed. On the test day mice were tested three times on an accelerating protocol
n  which the rotation speed was  increased from 4 to 44 rpm over 300 s. The time to
all  off the beam was recorded as the outcome measure and an average of the two
est trials was  used for statistical analysis.
.4.6. Stepping test
The stepping test [27] was conducted on one testing day using a modiﬁed proto-
ol  for mice [28]. In short, mice were placed on a ﬂat table and left there to settle for
 s. Subsequently the hind legs were elevated from the surface by lifting the mouse
y the base of its tail and gently pulling it backwards over a distance of 50 cm over
 s. Video recordings and frame-by-frame playback were used to count the number
f adjusting steps the mouse made. All mice were tested three times and the average
umber of adjusting steps for each side was  expressed as bias score (Section 2.4.2).
.4.7. Gait analysis
The animals’ gait was analysed using the footprint method by which the fore-
nd hind-paws were differently coloured using non-toxic water-based paint [29,30].
esting was conducted on one day in the corridor apparatus, which encouraged the
ice to run in a straight line (see above for dimensions) and white absorbent paper
as  laid down to record the footprints. The distance covered by three consecutive
trides was taken as the outcome measure.
.4.8. Inversed grid test
Mice were placed onto the centre of a metal home cage lid that was  taped off
round the edges, allowing access to a rectangle of approximately 20 cm × 21 cm Research 228 (2012) 30– 43
[31–33]. The cage lid was  then carefully inverted and secured in a stable position at
a  height of 30 cm.  To dampen any falls, the area under the cage lid was covered in
towels. Testing of all mice was  conducted on one day across three sessions, which
were separated by at least 1 h to prevent fatigue. The duration of time the mouse
spent grasping the grid without falling off was recorded, with a maximum of 300 s.
The average of the two  best times was used for the statistical analysis.
2.4.9. Activity cages
Locomotor activity was monitored over a 2 h period during the light phase using
an  automated system (Med Associates, St Albans VT, USA, with MED-PC IV software).
Mice were placed in individual Perspex cages with three infrared beams crossing
the  base of each box (dimensions: L42 cm,  W26 cm,  D19 cm). The total number of
non-perseverative beam-breaks was automatically recorded.
2.4.10. Rotation
Spontaneous rotation in a novel spherical environment was assessed using
video footage from the cylinder test. Net rotation during the ﬁrst 5 min  habitu-
ation phase was scored. This test was  based on open ﬁeld observations showing
that mice turn towards the side of the lesion when placed into a novel environ-
ment [10,12,34].  Amphetamine- and apomorphine-induced rotations were tested
on  two  separate occasions with the apomorphine test being conducted 1 week after
the amphetamine-induced rotation. During testing, mice were video-recorded from
above and rotational scores were scored post hoc [15,35,36]. Drug-induced rotation
has previously been validated in the lesion mouse model [15]. Each mouse was
placed in a glass cylinder and was videotaped using an overhead camera. Full turns
were counted in the ipsilateral and contralateral directions during a 20 min window
of  peak rotational response and data are expressed as net rotations (20–40 min  after
injection of d-amphetamine sulphate (2.5 mg/kg in 0.9% saline i.p.); 5–25 min  after
injection of apomorphine hydrochloride (0.05 mg/kg in 0.9% s.c.).
2.5.  Immunohistochemistry
After completion of behavioural testing the mice were terminally anaes-
thetised with sodium pentobarbital and transcardially perfused with approx. 25 ml
phosphate-buffered saline (PBS), followed by approx 100 ml 1.5% paraformaldehyde
(PFA, pH 7.4 in PBS). Brains were dissected from the skull and post-ﬁxed in 1.5% PFA
for 24 h before being cryoprotected in a 25% sucrose solution. Coronal sections were
then  cut at 40 m thickness using a freezing microtome and stored at 4 ◦C in PBS
with 0.01% azide. Standard immunohistochemical techniques were used to visualise
dopaminergic innervation of the striatum as well as cell bodies within the substan-
tial  nigra. In brief, sections were washed thoroughly in PBS before quenching of
endogenous peroxidases using 10% methanol and 3% hydrogen peroxide for 10 min.
After washing with Tris-buffered saline (TBS), the sections were incubated in 5%
normal horse serum (NHS) with 0.25% Triton X-100 dissolved in TBS (Tx-TBS). Tis-
sue  sections were then incubated in primary antibody for 16 h at room temperature
at  concentrations of 1:1000 tyrosine hydroxylase (TH, polyclonal raised in rabbit,
Chemicon International, CA, USA) in Tx-TBS with 1% NHS. Following rinsing in TBS,
sections were incubated in biotinylated horse anti-rabbit antibody secondary, 1:200,
for 3 h. The antibody was  visualised using a standard ABC kit (Vectastain Elite, Vec-
tor  Laboratories, Burlingame CA, USA) and the chromogen, 3-3′-diaminobenzadine
(DAB kit, Vector Laboratories). Tissue sections were mounted onto gelatine-coated
slides, dehydrated in successive concentrations of alcohol and coverslipped with
DPX.
Cell bodies were counted under a Leica DM/RBE light microscope under x10
optical magniﬁcation in the ventral tegmental area (VTA) and the substantia nigra
pars compacta (SNc) in one section at the level of the medial terminal nucleus of
the  accessory nucleus of the optic tract [37]. The density of TH-immunoreactive
(TH-ir) terminals in the dorsal and ventral striatum was measured using ImageJ
software (Version 1.42, National Institutes of Health, USA) from images of every
4th  section taken with Leica DFC420 camera and Leica application V3.6 software.
The camera was mounted on a free standing microscope (Wild-Heerburgg M420, so
that the whole section could be visualised in the photograph. Optical density was
measurement at 3 levels throughout the striatum, before their division into dorsal
and ventral regions. The levels analysed relative to bregma were +0.12 mm,  +0.5 mm,
and +1.34 mm.  Anatomical landmarks used to divide the striatum into dorsal and
ventral parts were made by drawing a horizontal line across the striatum using the
most dorsal point of the lateral ventricle for the ﬁrst two sections and the anterior
commissure for the latter.
2.6. Statistical analysis
All data are expressed as mean ± standard error of the mean (s.e.m.) and
were analysed using the Statistical Software Package for the Social Science
(SPSS v16). A signiﬁcance level of  ˛ = 0.05 was chosen for all comparisons.
All behavioural data were analysed using univariate analysis of variance and
Dunnett’s post hoc test using the control group as reference. When appropri-
ate, a bias score was calculated as (100× (ipsilateral paw or side)/contralateral
paw or side). Behavioural results were used for bivariate correlation anal-
ysis  with the histological measures of cell loss using Pearson correlation
coefﬁcients (one-tailed). Because of the presence of co-correlation between
A. Heuer et al. / Behavioural Brain
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3.3. Behaviourperative care was  implemented for the 14 days post lesion. Free access to high
aloric food (wet mash) was  provided to all cages.
H-ir cell loss in the SNc, in the VTA, and behavioural performance, we
sed partial correlation analysis to explore individual associations between
ehavioural performance and the respective areas of cell loss. Partial correlation
nalysis allows for controlling for the variance that is shared between two vari-
bles, allowing the contribution of variance associated with each variable to the
verall variation to be assessed. Accordingly, co-correlation between SNc and VTA
epletion was  taken into account using partial correlation analysis for each of the
ehavioural assessments.
. Results
.1. Mortality rates and survival
The majority of mice (88%) recovered from the three lesion surg-
ries after 14 days of post-operative care (Fig. 2A). The mortality
ates were low, with 83.3% of our MFB  lesion mice surviving the
urgery compared to up to 82% mortality that has been reported
lsewhere [10,13].  The recovery rates observed in the present study
ere comparable with Francardo et al. [17] who report a survival
ate of 80–100% over three experiments. In the present study, mice
ied or had to be sacriﬁced within the ﬁrst 10 days post lesion
nly (Fig. 1A). However, in the majority of mice, weight loss and
ehydration could be prevented by the feeding regime in combi-
ation with glucose-saline injections (Fig. 2B). The low mortality
ate in the present study may  have been the result of less severe
opaminergic depletion as compared to previous work. However,
e have found that by implementing an intensive care protocol
17,38] mortality rates remained low. As recently described in Ref.
17] the intensive care protocol led to 100% survival in one exper-
ment with bigger lesion effects than in the present study. Final
roup numbers for behavioural and histological assessment were
ontrol mice: n = 15, striatum lesion mice: n = 29, MFB  lesion mice: Research 228 (2012) 30– 43 33
n = 25, and SN lesion mice: n = 27 (from an original group number
of 30 per lesion group).
3.2. Histology
Representative examples of successful lesions are shown in
Fig. 3 for each of the three lesion types respectively. All three groups
exhibited clear loss of TH-ir cells in the substantia nigra on the side
of the lesion and clear loss of TH terminal staining in the forebrain,
most noticeably in the neostriatum. Extensive depletion was also
seen in ventral striatal areas of the nucleus accumbens and olfactory
tubercle in the MFB  lesion group (Fig. 3C), which was also present
but to a less marked degree in the SN and striatal lesion groups
(Fig. 3B and D).
3.2.1. Tyrosine hydroxylase immunoreactive cell counts
Overall, 6-OHDA administration caused a reduction of the
numbers of TH-immunoreactive cell bodies in the SNc (Group,
F3,90 = 13.33, p < 0.001) on the lesion side. The lesions caused a sig-
niﬁcant depletion of TH positive cells in the SNc of each of the three
lesion groups, differing signiﬁcantly from control (Fig. 4; striatum,
p < 0.001; MFB, p < 0.001; SN, p < 0.01). The striatal and MFB  lesion
groups also had signiﬁcant reductions in the number of TH-ir cells in
the VTA (striatum, p < 0.01 and MFB, p < 0.001). However, there was
no signiﬁcant reduction in the percentage of TH-ir cells in the VTA
in the SN lesion group, suggesting that lesions of the SN were more
focal to the more laterally located cells of the ventral midbrain.
Within each group the extent of lesions varied between relatively
small to almost complete (remaining cells of contralateral: MFB:
1.33% to 109%; SN: 1.56% to 117.65%; striatum: 1.43% to 110.20%).
As can be seen in Fig. 4 A, 20–50% of the mice in all groups exhibited
relatively complete lesions (>90% depletion), whilst a number of
mice in both the MFB  and SN lesion groups had very small lesions
(<25% depletion). The lesion success was  highest in the striatum
lesion group where the majority of mice exhibited at least par-
tial lesions. The variability of the lesions is considered further as a
covariate against behavioural deﬁcits (Section 3.4, below).
3.2.2. TH-ir cells correlate with TH-denervation of the striatum
The 6-OHDA lesion caused a reduction in TH-ﬁbre density in the
striatum on the side of the lesion (Group, F3,89 = 17.57, p < 0.001).
All three lesion groups exhibited a reduced density in TH-ir ﬁbres
in the whole striatum that signiﬁcantly differed from the control
group (all, p < 0.001). The MFB  lesion produced the largest reduc-
tion of overall striatal TH-ir ﬁbres, resulting in a 37% reduction
in the density of the contralateral side, followed by the striatal
lesion group which had 41% of the contralateral density remain-
ing and lastly the SN lesion resulted in 46% of contralateral density
remaining. Individual analyses of dorsal striatal and ventral striatal
density (Fig. 4C and D) revealed a signiﬁcant effect of Group for the
dorsal and ventral striatum (Group, F3,89 = 18.72 and 12.80, respec-
tively, both p < 0.001). The density in the dorsal striatum differed
signiﬁcantly from control for all three lesion groups (all, p < 0.001).
The ventral striatal density was also signiﬁcantly reduced (Group,
F3,89 = 12.80, p < 0.001), although to a lesser extent than dorsal stri-
atal density. Post hoc analysis showed that all three types of lesions
also signiﬁcantly reduced ventral striatal density compared to the
contralateral side (all, p < 0.001).Data from the behavioural tasks are plotted in Fig. 5A–L and the
results of the statistical analyses are presented in Table 1.
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Fig. 3. Bright ﬁeld photomicrographs of representative sections for successful lesions in coronal brain sections stained for TH-ir cells for each experimental group (A–D).
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.3.1. Staircase test
Control mice retrieved the same number of pellets from
oth sides of the staircase test and no impairments were
bserved in any of the lesion groups (Fig. 5A; Group, F3,91 = 0.58,
.s.).
.3.2. Corridor test
Control mice spent similar amounts of time retrieving pel-
ets from the left and right side of the corridor. However, mice
ith MFB  or striatum lesions demonstrated a signiﬁcant ipsi-ateral preference in collecting pellets compared to the control
roup (Fig. 5B; Group, F3,91 = 4.62, p < 0.01, post hoc: both, p < 0.01)
hilst the SN lesion group did not display a signiﬁcant side
reference.
able 1
orrelations between each behavioural test and SNc cell counts (% of contralateral).
Test Total Control 
Staircase (%) −0.076 0.213 
Corridor (%) 0.557** 0.030 
Balance beam (%) −0.399** −0.097 
Cylinder (%) −0.581** −0.416 
Rotarod (s) 0.304** 0.198 
Stepping bias (%) −0.254** 0.358 
Gait  (stride length left) 0.184* −0.049 
Cage  lid (s) 0.171 0.124 
Activity (beam breaks) 0.136 0.003 
Apomorphine rotation (%) 0.548** −0.259 
Amphetamine rotation (%) −0.698** −0.193 
Spontaneous rotation (%) −0.485** 0.003 
earson correlation coefﬁcients (r).
* p < 0.05.
** p < 0.01.) −5.2 mm from Bregma. Scale bar represents 1 mm.  Note the lack of TH-ir staining
d in the VTA region of the striatal (B) and the SN (D) lesion group companied with
3.3.3. Balance beam
Although the group effect on the balance beam failed to reach
conventional levels of signiﬁcance (Fig. 5C; Group, F3,90 = 2.65,
p = 0.054), the MFB  and striatum lesion groups show a clear trend
for increased foot slips on the side contralateral to the lesion, when
each of the lesion groups is compared to the control group individ-
ually (both, p < 0.05).
3.3.4. Cylinder test
The cylinder test revealed signiﬁcant group differences in paw
use preference for eliciting weight-bearing touches (Fig. 5D; Group,
F3,91 = 4.25, p < 0.01). The striatum and MFB  lesion groups predom-
inantly use the paw ipsilateral to the lesion in exploration of the
cylinder walls, compared to control mice which use both paws
equally (p < 0.01 and p < 0.05, respectively).
Striatum MFB  SN
−0.202 −0.009 −0.015
0.317 0.529** 0.734**
−0.104 −0.283 −0.778**
−0.336* −0.751** −0.442*
0.036 0.215 0.309
0.223 −0.205 −0.269
0.087 −0.009 0.248
0.027 −0.132 0.052
−0.009 0.258 0.110
0.359* 0.665* 0.476**
−0.623** −0.810** −0.619**
−0.153 −0.671** −0.630**
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.3.5. Rotarod
The latency to fall from the rotating rod was  signiﬁcantly
ffected by the lesion (Fig. 5E; Group, F3,91 = 3.76, p < 0.05). All three
esion groups showed a shorter latency to stay on the accelerating
ersion of the rotarod compared to control (striatum, p < 0.05; MFB,
 < 0.01; SN, p < 0.05).
.3.6. Stepping test
The stepping test revealed a difference in the number of steps
he mice made (Group, F3,88 = 4.50, p < 0.01), with control mice mak-
ng 8.12 ± 0.51 adjusting steps compared to the striatum lesion
roup 6.46 ± 0.36 adjusting steps, the MFB  lesion group 6.51 ± 0.37
djusting steps and the SN lesion group with 7.77 ± 0.36 adjust-
ng steps. Dunnett’s post hoc test showed that both the striatum
nd the MFB  lesion group made signiﬁcantly fewer adjusting steps
ompared to mice of the control group (both, p < 0.05). However, the
eﬁcit in the MFB  and striatal lesions groups was bilateral, rather
han affecting primarily the contralateral side, so that there was no
igniﬁcant group difference in the side bias index of adjusting steps
ade on the stepping test (Fig. 5F; Group, F3,85 = 1.63, n.s.).
.3.7. Gait analysis
There was no difference between the groups in stride length as
easured using the paw print method (Fig. 5G; Group, F3,81 = 0.71,
.s.).
.3.8. Inverted cage lid
There was a signiﬁcant reduction in the time lesion mice were
ble to cling onto the inverted cage lid (Fig. 5H; Group, F3,91 = 3.59,
 < 0.05). Post hoc analysis revealed a difference between the stria-
um lesion group and the control group on this measure of gripd per group. Ventral mesencephalic cell counts expressed as percent of contralateral
t of contralateral for the dorsal (C) and ventral (D) striatum, respectively. Number
.01, and the <0.001 level of signiﬁcance.
strength (p < 0.05), with the striatum lesion group spending less
time on the inverted grid.
3.3.9. Locomotor activity
No difference between the experimental groups could be
detected using the locomotor activity test (Fig. 5I; Group,
63,91 = 1.51, n.s.)
3.3.10. Rotation
Assessment of spontaneous rotation in a cylinder revealed
signiﬁcant differences between the groups (Fig. 5J; Group,
F3,90 = 10.597, p < 0.001). Post hoc tests demonstrated that only
the MFB  lesion group displayed a signiﬁcant spontaneous rota-
tional bias towards the side of the lesion (p < 0.01) compared to
control. Methamphetamine-induced rotation revealed differences
in the directional bias of rotation between the groups (Fig. 5K;
Group, F3,91 = 4.33, p < 0.01). The striatum and the MFB lesion groups
rotated signiﬁcantly towards the side of the lesion when compared
to mice of the control group (both, p < 0.01; MFB, p < 0.01). There
was a signiﬁcant group difference when mice were challenged with
apomorphine (Fig. 5L; Group, F3,89 = 6.09, p < 0.01). Post hoc test-
ing showed that mice of the striatum lesion group (p < 0.05) and
mice of the MFB  lesion group (p < 0.01) displayed signiﬁcantly more
contralateral rotations when compared to the control group.
3.3.11. Summary of behavioural tests
Of all the tests administered, eight tests were found to be sen-sitive to dopamine-depleting lesions of the nigrostriatal pathway:
the corridor test, the cylinder test, the rotarod test, the balance
beam test, the inverted cage lid test and all three types of rotational
assessments. However, because of the large variation in lesion size,
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ome of the behavioural effects of the lesions on group performance
ight be overshadowed by the mice with undetectable, small or
neffective lesions. A subset of well-lesioned mice, as deﬁned by
hree criteria (amphetamine-induced rotation >5 turns/min, >65%
orelimb preference on the cylinder test and less than 75 s latency
o fall on the rotarod), was taken for further investigation in Ref.
39]. It can be seen that analysis restricted to a subset of mice with
obust lesions yields a similar proﬁle of behavioural change and
ifferences between the three lesion conditions, albeit with lower
ithin-group variance to that provided in the present analyses in
he full (unselected) groups.
.4. Correlational associations between behaviour and histology
.4.1. Dopaminergic cell count in the SNc correlates with
ehavioural impairment
The proportion of dopaminergic cell bodies remaining in the
psilateral SNc (Table 1; Fig. 6) correlated well with contralat-
ral performance on the amphetamine-induced rotation test, theural tests administered. All percentages are expressed as percent of contralateral.
0.05, <0.01, and <0.001 level of signiﬁcance, respectively. Number of hashes denote
ugh ANOVA did not return signiﬁcant at the 0.05 level.
cylinder test, and the corridor test (r > 0.50, all p < 0.01). Signiﬁcant
correlations were also evident for the spontaneous rotation test,
the balance beam, the apomorphine-induced rotation test and the
rotarod test (all 0.50 > r > 0.30, p < 0.01). Although correlations for
the stepping test (p < 0.01) and the gait analysis (p < 0.05) were also
signiﬁcant, the effect sizes on these two  tests were relatively small
(all r < 0.30). The remaining three tests (staircase, inverted cage lid,
and locomotor activity) did not correlate well with the percentage
of TH-ir cells in the SNc.
When exploring the correlations between the proportion of
remaining SNc cells and performance on the behavioural tests for
each of the three lesion groups individually, the amphetamine-
induced rotation test was  found to produce the most robust
correlation effects with all three lesion groups (all, p < 0.01).
The other test that correlated signiﬁcantly with all three lesion
groups was the cylinder test (all, p < 0.05). Furthermore, these
two tests along with apomorphine-induced rotations provided the
only measures that correlated with the percentage of remaining
dopaminergic nigral cells in the striatal lesion group. SNc cell counts
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Fig. 6. Correlations between selected behavioural tests and SNc cell counts in respective lesion groups, where striatal (A–F), MFB  (Ai–Fi) and SN groups (Aii–Fii). All percentages
are  expressed as % of contralateral.
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Table 2
Correlations between each behavioural test and VTA cell counts (% of contralateral).
Test Total Control Striatum MFB  SN
Staircase (%) 0.016 −0.201 −0.234 0.213 0.317
Corridor (%) 0.383** −0.252 −0.035 0.568** 0.532**
Balance beam (%) −0.425** −0.331 −0.322 −0.408* −0.653**
Cylinder (%) −0.516** −0.599** −0.340* −0.797** −0.180
Rotarod (s) 0.275** 0.233 0.018 0.296 0.171
Stepping bias (%) 0.400** 0.054 0.374* 0.333 0.209
Gait  (stride length left) 0.081 −0.189 −0.063 0.297 0.151
Cage  lid (s) 0.080 0.343 −0.325* −0.254 0.368*
Activity (beam breaks) 0.156 −0.222 −0.019 0.185 0.252
Apomorphine rotation (%) 0.450** −0.286 0.355* 0.313 0.422*
Amphetamine rotation (%) −0.497** 0.232 −0.460** −0.483** −0.416*
Spontaneous rotation (%) −0.497** −0.040 −0.270 −0.530** −0.239
Pearson correlation coefﬁcients (r).
* p < 0.05.
** p < 0.01.
Table 3
Correlations and partial correlations between each behavioural test and cell counts (% of contralateral), calculated for the animals of the 3 lesioned groups only.
Test Total SNc Total VTA Partial SNc (controlling for VTA) Partial VTA (controlling for SNc)
Staircase (%) −0.095 0.036 −0.139 0.108
Corridor (%) 0.570* 0.372** 0.471** 0.078
Balance beam (%) −0.388** −0.422** −0.202* −0.268*
Cylinder (%) −0.554** −0.473** −0.396** −0.237*
Rotarod (s) 0.182 0.181 0.099 0.097
Stepping bias (%) −0.219* −0.214* −0.122 −0.113
Gait  (stride length left) 0.138 0.034 0.144 −0.053
Cage  lid (s) 0.056 −0.037 0.092 −0.083
Activity (beam breaks) 0.170 0.188 0.080 0.113
Apomorphine rotation (%) −0.322** −0.302** −0.193 −0.156
Amphetamine rotation (%) −0.681** −0.455** −0.577** −0.123
Spontaneous rotation (%) −0.441** −0.456** −0.252* −0.280**
Bold numbers highlight the larger of the two  signiﬁcant correlations of each test against the SNc or VTA cell counts for the overall correlation pair and the partial correlation
pair,  respectively.
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Pearson correlation coefﬁcients (r).
* p < 0.05.
** p < 0.01.
n the MFB  and the SN lesion groups also correlated signiﬁcantly
ith performances on the spontaneous rotation test and the corri-
or test (both, p < 0.01). The balance beam test only correlated with
he proportion of remaining cells in the SN lesion group (p < 0.01).
o other test correlated signiﬁcantly with cell loss in the lesion
roups.
.4.2. Dopaminergic cell counts in the VTA correlate with
ehavioural performance
The proportion of remaining cells in the VTA for all groups cor-
elated with performance on the cylinder, balance beam, stepping
nd corridor tests, the amphetamine-induced, spontaneous and
able 4
orrelations between each behavioural test and dorsal striatal TH-ir density (% of contral
Test Total Control 
Staircase (%) −.129 −.231 
Corridor (%) .291** −.480*
Balance beam (%) −.272** .157 
Cylinder (%) −.301** −.008 
Rotarod (s) .386** .553*
Stepping bias (%) −.179 .205 
Gait  (stride length left) .294** −.048 
Cage lid (s) .167 .197 
Activity (beam breaks) .012 .003 
Apomorphine rotation (%) −.211* .100 
Amphetamine rotation (%) −.380** .327 
Spontaneous rotation (%) −.371** −.483*
earson correlation coefﬁcients (r).
* p < 0.05.
** p < 0.01.apomorphine-induced rotation and performance on the rotarod
apparatus (all, p < 0.01, Table 2). When assessing each groups’
performance individually, the proportion of remaining VTA cells
correlated signiﬁcantly with amphetamine-induced rotation in all
three lesion groups (striatum and MFB, both p < 0.01; SN, p < 0.05).
Correlations between VTA cells and performance on the corridor
test and balance beam were evident for the MFB and SN lesion
groups (both p < 0.05), whilst the inverted cage lid test and the
apomorphine-induced rotations correlated with the striatum and
SN lesion groups (all, p < 0.05). The cylinder test correlated sig-
niﬁcantly with the striatum and the MFB  lesion group (striatum,
p < 0.05; MFB, p < 0.01). The stepping test only correlated with the
ateral).
Striatum MFB  SN
−.278 .159 −.219
−.033 .634** .178
−.172 −.217 −.278
−.039 −.587** .038
−.126 .594** .283
.183 −.213 −.251
.200 .415* .400*
.299 −.457* .116
.029 .175 −.065
.180 −.366 .071
−.324* −.513** −.083
.040 −.526** −.509**
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Table  5
Correlations between each behavioural test and ventral striatal TH-ir density (% of contralateral).
Test Total Control Striatum MFB SN
Staircase (%) −.125 −.007 −.408* .141 −.093
Corridor (%) .218* −.203 −.308 .590** .034
Balance beam (%) −.247* .472 −.221 −.182 −.153
Cylinder (%) −.221* .134 .126 −.498** .088
Rotarod (s) .289* .428 −.267 .571** .001
Stepping bias (%) −.180 .135 .086 −.266 .060
Gait  (stride length left) .324** −.035 .192 .320 .575**
Cage lid (s) .181* .204 .098 −.363* .399*
Activity (beam breaks) .032 −.584* −.119 .129 .101
Apomorphine rotation (%) −.291** −.096 −.092 −.417* .022
Amphetamine rotation (%) −.293** .250 −.062 −.441* .007
Spontaneous rotation (%) −.355** −.467* .102 −.409* −.109
P
s
o
t
3
a
d
u
p
m
o
c
l
l
(
l
r
A
t
S
t
d
a
d
T
B
A
A
cearson correlation coefﬁcients (r).
* p < 0.05.
** p < 0.01.
triatum lesion group (p < 0.05) and the spontaneous rotation test
nly correlated with the MFB  lesion group (p < 0.01) and the respec-
ive VTA cell counts.
.4.3. Partial correlations suggest distinct contributions of SNc
nd VTA to the different behaviours deﬁcits
We  explored which of the tests are particularly sensitive to
epletion in either of the two ventral midbrain dopaminergic nuclei
sing a partial correlations analysis, by correlating behavioural
erformance over all lesioned groups (excluding control group
ice) with nigral cell counts taking into account the inﬂuence
f VTA cell counts with partial correlations, and vice versa. As
an be seen in Table 3, seven of the behavioural tests corre-
ated well with cell loss in both the SNC and VTA. However, cell
oss in the VTA itself correlates highly with cell loss in the nigra
r = 0.630, p < 0.001). Of the 7 tests, which correlate with VM cell
oss, only the balance beam test and spontaneous rotation cor-
elated higher with VTA cell counts than with SNc cell counts.
fter accounting for the inﬂuence of the two dopaminergic nuclei,
hree interesting results emerged. Firstly, removing the inﬂuence of
Nc cell counts eliminated the signiﬁcance of several behavioural
ests correlating with the VTA, including the corridor and cylin-
er tests and both tests of drug-induced rotation, leading to the
ssumption that behavioural performance of the tests is mainly
riven by SNc cell counts. Secondly, we found that the two  tests
able 6
ehavioural outcome measures in a subset of mice that were selected on the basis of < 20
Test F3,45 Control 
SNc (%) 276.473*** 7.37 ± 1.25 
VTA (%) 21.381*** 57.65 ± 7.28 
Dorsal density 48.017*** 20.47 ± 6.98 
Ventral density 18.759*** 48.43 ± 9.64 
Staircase (%) 0.501 54.30 ± 2.07 
Corridor  (%) 7.117** 23.10 ± 4.79 
Balance beam (%) 5.323** 69.27 ± 3.91 
Cylinder (%) 6.204** 73.75 ± 4.59 
Rotarod  (s) 7.35*** 76.96 ± 10.47 
Stepping bias (%) 1.304 57.81 ± 1.88 
Gait  (stride length left) 0.878 128.81 ± 3.66 
Cage  lid (s) 1.923 109.86 ± 19.07 
Activity  (beam breaks) 0.959 1288.79 ± 127.16 
Apomorphine rotation 10.855*** −32.07 ± 8.02 
Amphetamine rotation 20.660*** 78.36 ± 9.46 
Spontaneous rotation 16.351*** 4.21 ± 2.39 
ll data represent mean ± s.e.m.
sterisks in the ﬁrst column (F-ratio) indicate a signiﬁcant main effect whereas asterisk
ontrol.
* Signiﬁcance for p < 0.05.
** Signiﬁcance for p < 0.01.
*** Signiﬁcance for p < 0.001.– balance beam and spontaneous rotations – that had higher
overall correlations between VTA cell counts and behavioural
performance did remain correlated higher, even after perform-
ing co-correlation with SNc cell counts. Interestingly this points
towards a speciﬁc inﬂuence of the VTA on those behavioural tests.
Thirdly, the results demonstrated that apomorphine-induced rota-
tion and the stepping bias were no longer correlated with cell loss in
either the SNc or VTA in isolation, and therefore it can be concluded
that both structures need to be depleted to produce a signiﬁcant
deﬁcit under the present circumstances.
3.4.4. Behavioural performance correlates with striatal density
measures
Correlations between striatal density measures and behavioural
tests are shown in Tables 4 and 5, for dorsal striatum and ven-
tral striatum, respectively. Dorsal striatal density correlated highest
with the MFB  lesion group on the corridor test, the cylinder test, the
rotarod test, the amphetamine and the spontaneous rotation (all
r > 0.500; p < 0.01), with gait analysis (r = 0.415; p < 0.05) and the
cagelid test (r = −0.457; p < 0.05). Dorsal striatal TH-ir density also
correlated with the SN lesion group on the gait analysis (r = 0.400;
p < 0.05) and the spontaneous rotation test (r = −0.509; p < 0.01).
The striatal lesion group only correlated with dorsal striatal TH-
ir density on the amphetamine induced rotation test (r = −0.324;
p < 0.05). TH-ir density in the ventral striatum also correlated
% SNc cells remaining and the animals of the untreated control group.
Striatum MFB  SN
7.37 ± 1.25*** 6.51 ± 1.24*** 5.73 ± 1.58***
57.65 ± 7.28*** 42.61 ± 6.19*** 69.40 ± 6.17**
20.47 ± 6.98*** 20.49 ± 6.17*** 17.25 ± 8.06***
48.43 ± 9.64*** 28.73 ± 7.86*** 40.70 ± 7.99***
54.30 ± 2.07 52.07 ± 2.04 50.34 ± 3.62
23.10 ± 4.79** 18.21 ± 3.34** 16.42 ± 4.55**
69.27 ± 3.91 80.63 ± 3.67** 89.74 ± 2.95**
73.75 ± 4.59** 77.77 ± 3.68*** 69.12 ± 7.18
76.96 ± 10.47** 58.83 ± 7.74*** 71.44 ± 13.59**
57.81 ± 1.88 61.76 ± 6.95 58.28 ± 6.34
128.81 ± 3.66 122.58 ± 3.65 124.06 ± 6.09
109.86 ± 19.07** 151.53 ± 30.71 124.21 ± 42.73
1288.79 ± 127.16 1133.83 ± 112.52 1479.38 ± 348.19
−32.07 ± 8.02* −66.25 ± 12.10*** −40.63 ± 9.86**
78.36 ± 9.46*** 101.75 ± 10.70*** 87.62 ± 15.17***
4.21 ± 2.39 20.33 ± 3.37*** 6.12 ± 1.67
s for the group columns (striatum, MFB, SN) denote signiﬁcant differences from
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ighest with behavioural tests in the MFB  lesion group on the
orridor test and the rotarod test (all r > 0.500; p < 0.01). Strong
orrelations were also found in the cylinder test, the cagelid test,
nd all three types of rotation tests (all 0.50 > r < 0.30; p < 0.05). In
he SN lesion group, ventral striatal TH-ir density correlated with
he gait analysis (r = .575; p < 0.01) and the cagelid test (r = 0.399;
 < 0.05) and in the striatal lesion group only the performance on the
taircase test correlated signiﬁcantly with ventral striatal density
r = −.408, p < 0.05).
.5. Behavioural performance of a subset of well-lesioned mice
Lesions in mice have shown to be highly variable in terms of
esion extent and behavioural performance. Because of this vari-
bility we have chosen to select a subset of mice with <20% SNc
ells left on the lesioned side and compared these new re-grouped
nimals with all 15 mice of the control group. As can be seen in
able 6 in these subsets of mice, there were signiﬁcant behavioural
ifferences in all three lesion groups in performance on the corridor
est, the rotarod test, amphetamine-induced and apomorphine-
nduced rotation test. The balance beam teased out a signiﬁcant
ifference between the control group and two of the lesion groups
MFB and SN), whereas the cylinder test showed signiﬁcant dif-
erences between the striatal lesion group and the MFB lesion
roup with the control group. When comparing the new, restricted
ataset, with the original analysis (which included all mice), all the
-ratios increased leading to smaller p-values in all tests that were
igniﬁcant in the previous, unrestricted analysis. Furthermore, per-
ormance on the balance beam was now signiﬁcant at conventional
evels of signiﬁcance (previously p = 0.052) and two  of the lesion
roups differed from control (MFB and SN). The SN lesion group as
 whole did not perform differently from the control group in the
riginal analyses of drug-induced rotations, but after restricting the
nalysis of mice to those with severe TH-ir cell depletion, the SN
roup performance was signiﬁcantly different to control mice on
he amphetamine- (p < 0.001) and apomorphine-induced (p < 0.01)
otation tests. All other behavioural measures were similar to the
riginal analysis.
. Discussion
Our study sought to provide a detailed comparison of unilateral
esions to the nigrostriatal dopamine pathway at three different
ites in mice, including behavioural assessment and correlation
etween motor function and pathological changes in the striatum
nd ventral mesencephalon. A primary aim was to identify tests,
hich are appropriate in each model for the identiﬁcation of an
ffective lesion, allowing the selection of well-lesioned mice to be
arried forwards into other studies.
.1. Lesion efﬁciency and survival/mortality
All lesions produced a marked degeneration of the dopaminer-
ic neurons in the SNc and a subsequent denervation of TH-ir ﬁbres
n the striatum. As expected, due to the compactness of the bun-
le, the lesions aimed at the MFB  were more complete, extending
heir degeneration to parts of the VTA and, therefore, to a large
roportion of the ventral striatum. The degree of degeneration and
enervation in the VTA and ventral striatum was more variable
n the other two lesion groups, with dopamine depletion primar-
ly restricted to the SNc and the dorsal striatum in the majority
f cases. As can be seen in Fig. 4, lesion success has been highly
ariable in the present study with only a subset of mice displaying
ubstantial cell depletion in the SNc and VTA and reduction in stri-
tal TH-ir density. This variability explains why not all tests that Research 228 (2012) 30– 43
correlate with SNc depletion show signiﬁcant group differences as
well.
Previous studies have advocated use of the SN and striatum
lesion models mainly because of the high mortality rate that has
been reported with lesions aimed at the MFB  [10,13,38].  Recently it
has been reported that implementing intensive post-operative care
can reduce mortality to ethically acceptable levels [10,12,38,39].
In support of this, despite initial reports of >80% mortality rates,
a recent study reports survival rates of 100% with extensive DA
depletion [17]. Although we  report the highest mortality rate in the
MFB  lesion group, which produced the most extensive lesions, the
percentage of mice lost was  relatively very low, at 17.7%, in compar-
ison with previous studies. Mortality rate and weight loss appears
to be directly linked to the extent and time-course of dopaminer-
gic depletion [24,40]. The more extensive MFB  lesion mice were
the most vulnerable. Moreover, the critical time window reﬂected
the location of the lesion, with lesions of the striatum having a
slower degeneration and thus longer post-surgical period during
which survival might be compromised [12,13,41].  Severe sponta-
neous rotations were exhibited by those mice suffering signiﬁcant
weight loss, a behaviour which likely impacted on their ability to
eat and drink.
4.2. Lesion-induced deﬁcits on behavioural tasks
The tests that were most sensitive to distinguish mice of the
respective lesion groups from untreated controls were the corri-
dor test (MFB, striatum), the cylinder test (striatum), the balance
beam (MFB, SN), the rotarod (all three groups), the inverted cage lid
test (striatum), and the rotational assessments (Spontaneous, MFB;
Amphetamine, all three groups; SN, striatum, MFB). Of all of these,
the amphetamine rotation test was  consistently the most reliable
(see below).
The cylinder test, which is a standard tool used for identifying
unilateral lesions in the rat model of PD, has also been seen to be
sensitive to 6-OHDA lesions in mice – of the striatum in the present
study, and of the SN in others [10,13,16].  The corridor test [20],
which has been shown to be sensitive to unilateral 6-OHDA lesions
aimed at the mouse SN [13], was sensitive to lesion-induced deﬁcits
in the present study. Interestingly, lesions aimed at the striatum
and the MFB  produced group effects different from control mice on
this task, whereas lesions aimed at the SNc did not [13]. The dif-
ferences between Grealish et al. [13] and the present study most
likely results from selection of the experimental cohort and their
respective overall degree of cell loss. Grealish et al. pre-selected
mice after the lesion on the basis of a series of behavioural tests.
Out of 122 lesion mice, which were tested behaviourally, 40 mice
were selected based on their behavioural performance to represent
subjects of a mild, intermediate and severe lesion type [13], where
even mice with a ‘mild’ lesion had a mean reduction of TH-ir SNc
cells of 71.4%. In our initial analysis we did not remove any mice
from the lesion cohorts and hence incorporated a wider range of
dopamine depletions and lesion deﬁcits (See Figs. 4 and 2 in Ref.
[16]). In that study, motor impairments on the rotational and cor-
ridor assessment are seen only in mice with >60% dopaminergic
depletion. When we  selected only severely lesioned mice post hoc
we also found that group effects became stronger. In keeping with
this, the largest effect of the lesion, in the unrestricted dataset, was
seen when the site of injection was  aimed at the neuronal terminals
in the striatum, which was the group with the largest percentage of
lesion mice with the smallest within-group variability, compared
to the other two lesion groups.Of particular interest are the results of the drug-induced rota-
tions, as these tests have been the most commonly used in assessing
success rate of unilateral lesions and cell replacement in the uni-
lateral rat model [42]. In the reviewed mouse literature, a wide
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ange of doses of amphetamine and apomorphine are reported
or the assessment of unilateral dopamine depletion in mice, e.g.
mphetamine, from 0.25 to 8.0 mg/kg [13,15,16,43,44]. The doses
f 2.5 mg/kg methamphetamine and 0.05 mg/kg for apomorphine
sed here were both found to induce circling behaviour without
he development of signiﬁcant stereotyped behaviour, which can
ose a signiﬁcant risk at the highest doses. The use of apomor-
hine as a measure of lesion success is slightly contentious; Grealish
t al. [13] report a robust and reliable response at 0.1 mg/kg, whilst
ancu et al. [16] found apomorphine-induced rotation (0.5 mg/kg)
nd percentage of SNc cell loss poorly correlated. Critically apo-
orphine produces signiﬁcant sensitisation of motor responding
hen administered repeatedly, and Grealish et al. report a reliable
esponse following 3 administrations. Furthermore, in the present
tudy apomorphine did not discriminate between SN lesion and
ontrol groups, most likely because this group had the highest per-
entage of cells remaining in the ventral mesencephalon, whereas,
t least in rats, a denervation beyond 90% appears necessary to
nduce consistent supersensitivity and apomorphine rotation [45].
t is important to note that higher doses of apomorphine may
nduce stereotyped behaviour, which in turn diminishes the rota-
ional response of the mice (which has been reported in Ref. [16]).
lso the negative results on some of the behavioural tests con-
rm ﬁndings of others. For example, the stepping test in mice has
ot been found to be sensitive to unilateral 6-OHDA lesions of the
Nc [13], although this test is sensitive to unilateral dopaminergic
epletion in the rat [13,27,41].  Furthermore, the gait analysis/paw
rint test has been shown to be sensitive to abnormalities in gait of
ransgenic and lesioned rats and mice [32,46,47],  but has not been
ensitive enough to detect differences between lesion and control
ice in the present study. The locomotor activity test, which did
ot show signiﬁcant differences between any of the groups, was
imilarly uninformative in the Lundblad et al. [10] study, where a
mall effect was reported which was subject to spontaneous recov-
ry after the ﬁrst testing session. These results indicate that some of
he behavioural screens used are not sensitive to small to medium
ized lesion effects.
.3. Behavioural performance correlates with ventral
esencephalic cell loss
6-OHDA injections aimed at the striatum produced a lesion in
ll cases over a smaller range of depletions (0–70% of contralat-
ral), whereas the other two lesion groups produced more variable
esions over a wider range of depletions (e.g. 0–110% of contralat-
ral, but see Fig. 5). It is worth noting that this difference in range of
triatal TH depletion, as well as the variable destruction of VTA cells,
ay  impact upon subsequent correlation analyses. Despite this,
he statistical analyses clearly demonstrated that the three lesion
roups differed in their relationship between TH cell loss and per-
ormance on many of the behavioural tests. Whilst performance on
ll tests of rotational behaviour (drug-induced and spontaneous-
otation and the cylinder test) correlated well with individual
esions, the corridor and balance beams tests also provided inter-
sting means of discriminating lesion types. Interestingly, when
orrelating only the lesioned animals’ cell counts with behavioural
erformance, it emerged that the majority of tests correlated higher
ith SNc rather than VTA cell counts.
Depletion of dopamine levels in the nucleus accumbens (NAcc),
ne of the main targets of the VTA, and dopamine levels in the
triatum have differential effects on drug-induced rotation in the
at model of PD. After almost complete destruction of mesen-
ephalic dopaminergic neurons by means of injection of 6-OHDA
nto the bundle, amphetamine-induced rotation could be observed
n all rats [48]. Subsequent grafting of TH rich tissue into either
he striatum only, or the striatum plus the NAcc, resulted in the Research 228 (2012) 30– 43 41
expected decrease in rotational behaviour, but rats that received
grafts in the NAcc only did not demonstrate a decrease in rotations,
suggesting that dorsal striatal dopamine is critically involved in the
rotational behaviour [48]. Furthermore, it has been demonstrated
that destruction of the NAcc or the VTA alone is not sufﬁcient to
induce rotational behaviour in the rat, and indeed rats that receive
both unilateral striatal and bilateral NAcc lesions rotate less than
those with an intact NAcc [49,50]. Additionally, bilateral lesions to
the NAcc, but not the striatum reduced locomotor activity, rela-
tive to sham rats, after treatment with low doses of amphetamine
[51]. Thus, these studies suggest that during the amphetamine-
induced rotation task, DA levels in the striatum determine the
direction and magnitude of rotation, whereas DA levels in the
NAcc impact upon the rate of locomotor activity, as the NAcc
mainly drives behavioural activation, as discussed in Ref. [42]. Rats
that received unilateral four-site intrastriatal 6-OHDA lesions, in
which the NAcc and VTA were largely spared, rotated more at 6
weeks post lesion than MFB  lesion rats [41]. Taken together, the
involvement of the mesencephalic sub-regions in the rotational
response to amphetamine can be summarised such that striatal
dopamine levels mediate the direction of the response and those
with spared mesocorticolimbic dopamine rotate higher. Therefore
the VTA mainly drives locomotor activity. In the present study
we have encountered the same case as in Ref. [52] in that striatal
dopamine was  not equally depleted across the groups and therefore
the bundle lesion group produced the highest number of rotations.
Once the inﬂuence of the SNc/VTA cell counts were accounted for
in each of the respective correlations, it became clear that the cor-
ridor test and the amphetamine-induced rotation were exclusively
correlated with SNc cell count and that the cylinder test was inﬂu-
enced more by the SNc than by the VTA. These results show that
the inﬂuence of the VTA on the majority of tests is small and that
behavioural performance is largely driven by SNc cell counts. On
the corridor test and the amphetamine induced rotation, perfor-
mance is driven exclusively via SNc cell counts whereas no single
test exclusively correlated with VTA cell loss. Interestingly, spon-
taneous rotation and performance on the balance beam apparatus
correlate more with cell counts in the VTA than cell counts in the
SNc, revealing that these two  tests are inﬂuenced by cell loss in
both areas.
These results demonstrate (i) the sensitivity of the behavioural
tasks to motor deﬁcits of varying magnitude and (ii) that some of
the behavioural impairments are differentially correlated with cell
loss in the SNc and VTA. It has recently been suggested that the use
of multiple tasks to assess the size of a unilateral 6-OHDA lesion
is appropriate [13], speciﬁcally the use of drug-induced rotation,
followed by simple behavioural tests such as the cylinder and/or
the corridor test. Here we  conﬁrm the usage of the corridor test,
the cylinder test and amphetamine-induced rotation in that they
correlate highly with SNc cell count. Furthermore, we would extend
this suggestion to include the balance beam test and spontaneous
rotation and, in addition, extend the behavioural ﬁndings to the
other two  mouse lesion models of nigrostriatal dysfunction.
The present results are in accordance with previous work that
characterised the role of the VTA and SNc and their primary target
sites the NAcc and the striatum. In a comprehensive study Kirik
et al. compared complete MFB  lesions to striatal lesions of sev-
eral different sites (1, 2, 3, and 4 site) on different behavioural
tests in rats. Only rats with extensive DA depletion (MFB and 4-
site striatal lesions) showed deﬁcits on the staircase test and the
stepping test. Cell loss in the VTA was less than 30% in all stri-
atal lesion groups compared to 80% depletion in the bundle lesion
group. The authors suggest that a behavioural impairment is seen
only in severely depleted rats. In rats, a critical depletion level
for behavioural impairments has been shown to occur at a lower
level for amphetamine induced rotations (30–50% SNc cell loss)
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ompared to staircase test (60–80% SNc cell loss) [41]. Smaller
epletions may  lead to spontaneous behavioural recovery [52]. The
ehavioural impairment is largely dependent on three factors, the
ite of injection, the degree of depletion and the behavioural test
sed [41]. Whereas some tests are more sensitive to dorsolateral
triatal dopamine depletion, as e.g. the drug induced rotation tests,
thers are more sensitive to ventromedial striatal dopamine deple-
ion as locomotor activity.
.4. Selection of mice based on behavioural performance
The results discussed above indicate the level of variability that
ur group experiences with each of the three lesion types respec-
ively. We  have described the histopathological and behavioural
hanges in these groups compared to untreated control mice. After
electing a subgroup of mice post hoc based on <20% remaining TH-
r cells in the SNc on the lesioned side of the brain we can see that
hese mice are impaired on a number of tests described above (see
able 6). These mice displayed a strong bias on the corridor test
23.1–16.4%) and greater difﬁculties to stay on the rotarod appa-
atus (< 77 s). Furthermore, lesioned mice rotated to challenges
ith amphetamine (78 rotations) and apomorphine (−32 rota-
ions). The balance beam apparatus was especially useful in MFB
80% bias) and SN (89% bias) lesioned mice, whereas the cylinder
est was more useful in the striatum (73% bias) and MFB  (77% bias)
esion groups. The stability of the lesion has been shown by [13]
or SN lesioned mice, when depletion exceeded 60% denervation of
he striatum. Furthermore, the behavioural impairment described
bove is comparable to the criteria proposed by [13] for a selection
f well-lesioned mice.
. Conclusion
Despite the ease and frequency of use of the unilateral 6-OHDA
esion rat, there are signiﬁcant complications involved in translat-
ng this model to the mouse. Mice are certainly more vulnerable
ollowing surgery but an intensive post-operative welfare regime
eeps survival rates high. Lesion success is dependent on the site of
njection: on the one hand, smaller targets (SNc, MFB) typically pro-
uce more variable lesion results, but on the other hand when well
argeted they can result in more complete lesions. Here, we present
everal drug-induced and voluntary simple motor behavioural
asks that are sensitive to detect damage to the dopaminergic sys-
em in mice and on several tests performance correlates well with
he extent of SNc cell loss, whereas only one test, cage lid turn-
ng, was preferentially associated with unilateral VTA cell loss. The
resent results allow for the selection of the most suitable lesion
odel and behavioural tests for pharmacological and cell replace-
ent therapies in unilateral mouse models of PD.
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Chapter 3.5 
Experiment 5: Comparison of 6-hydroxydopamine 
lesions of the substantia nigra and the medial 
forebrain bundle on a lateralised choice reaction time 
task in mice. 
 
After the assessment of the initial work of characterising the motor impairments of 
unilateral infusion of 6-OHDA along the nigro-striatal pathway in mice we aimed to (i) 
further characterise the lesion model on a more complex behavioural task, i.e. the 
lateral choice reaction time task in the 9-hole box in mice, and (ii) investigate the 
stability of the lesion over time to assess the usefulness of the model for future 
transplantation studies.  
 
Unpublished work by the author has shown that in a direct comparison of quinolinic 
acid lesioned mice, administered intrastriatally, and 6-OHDA lesioned mice, 
administered intra-nigrally, that using the lateralised choice reaction time task in mice 
is feasible for the analysis of lesion induced deficits. In this first study we assessed 
the task parameters (both hold and stimulus duration) and characterised the 
response profile of the lesion. Unfortunately the 6-OHDA SN lesions, which are 
relevant for the present thesis, did undergo spontaneous recovery on response 
accuracy within 3 weeks of post-lesion testing, whereas lesioned animals still 
displayed impairments in movement time latencies. The 6-OHDA SN lesion model 
was primarily chosen for this study because of the associated low mortality rates and 
the larger ‘completeness’ of the lesion compared to striatal lesions. However, 
because of the recovery seen, which was largely due to remaining DA innervation, 
this model was deemed not suitable for long-term behavioural studies. In the light of 
similar experiments in rats we opted for a direct comparison between SN lesioned 
mice with MFB lesioned mice on the choice reaction time task. 
 
The experiment conducted in the present paper as well as analysis of the data, 
histology and preparation of the manuscript was undertaken entirely by myself. 
Professor S.B. Dunnett was involved in planning of the experiment and gave help 
and advice throughout as well as in the writing of the manuscript. Fellow PhD student 
Gaynor Ann Smith also assisted during surgery of the large number of animals 
involved.  
  
BEHAVIORAL NEUROSCIENCE
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Abstract
Parkinson’s disease is most commonly modelled via unilateral infusion of the neurotoxin 6-hydroxydopamine (6-OHDA) in the rat,
but recent work has been aimed to translate the reproducibility and reliability of the model to the mouse. Here we present the
effects of unilateral 6-OHDA lesions to either the medial forebrain bundle or the substantia nigra (SN) in mice, which were trained
on a lateralised choice reaction time (RT) task. This task measures response accuracy as well as RT and movement time laten-
cies, and offers the opportunity for a more fine-grained analysis of the precise nature of the movement deficit, motor learning and
functional recovery than can be achieved using classical tests of simple motor asymmetry. Both lesion types caused impaired
response accuracy, which was more pronounced when responses had to be directed contralateral to the lesion. Furthermore,
movement times were increased for both lesion groups, whereas only the bundle lesion group displayed a RT deficit. The lesions
were stable over three consecutive weeks of testing, therefore lesion-type and behavioural assessment on the operant task are
suitable to investigate the dopaminergic system in parkinsonian mice. Both lesions were stable over time, and were more pro-
nounced when responses were directed in contralateral space; the mice with more complete bundle lesions displayed a greater
deficit than mice that received lesions to the SN. The translation of this choice RT task will be beneficial for the assessment of
therapeutics in mouse models of the disease.
Introduction
Parkinson’s disease (PD) is most commonly modelled in the rat via
unilateral injection of the neurotoxin 6-hydroxydopamine (6-OHDA)
at various levels of the medial forebrain bundle (MFB), which leads
to subsequent degeneration of catecholaminergic cells in the sub-
stantia nigra (SN; Ungerstedt, 1968; Ungerstedt & Arbuthnott, 1970;
Kirik et al., 1998; Deumens et al., 2002; Bove et al., 2005) and a
subsequent loss of dopamine (DA) in the striatum (Blandini et al.,
2000, 2007; Grealish et al., 2008), which in turn gives rise to the
cardinal symptoms of PD (Evarts et al., 1981; Berardelli et al.,
2001; Shahed & Jankovic, 2007). Although the unilateral 6-OHDA
rat lesion model has been used extensively to model PD and poten-
tial treatments such as pharmacological and cell replacement thera-
pies, relatively little research has been conducted in mice.
As model organisms, mice have the advantage that genetic modi-
ﬁcations are more readily achievable, allowing manipulation of
genes that have been linked to sporadic PD in man (Alvarez-Fischer
et al., 2008; Duty & Jenner, 2011; Blandini & Armentero, 2012).
To circumvent the high mortality rates in mice with MFB lesions
(Lundblad et al., 2004; Grealish et al., 2010), striatal and nigral
lesions have been utilised (Lundblad et al., 2004, 2005; Cenci &
Lundblad, 2007; Grealish et al., 2010), resulting in better survival,
but less complete lesions both of the neostriatum itself and with
sparing of ﬁbres that originate in the adjacent ventral tegmental area
(VTA; Carli et al., 1989; Kirik et al., 1998; Grealish et al., 2008).
In a recent study, the three main lesion sites (SN, MFB, intra-stria-
tal) have been compared on a series of simple motor behavioural
tests in mice, and increased survival rates were achieved by inten-
sive post-operative caring regimes (Francardo et al., 2011; Heuer
et al., 2012; Smith et al., 2012).
Unilateral 6-OHDA lesions have been shown to produce an asym-
metry on behavioural tests measuring motor output, such as turning-
behaviour, paw preference and increased movement times (Ungerstedt
& Arbuthnott, 1970; Schallert et al., 1978; Carli et al., 1985, 1989;
Torres & Dunnett, 2007; Grealish et al., 2010; Heuer et al., 2012;
Smith et al., 2012). Although tests of simple motor behaviour are rela-
tively inexpensive in terms of costs and time (Francardo et al., 2011;
Heuer et al., 2012; Smith et al., 2012), more complex functions that
can allow more precise dissection of the precise nature of the motor
impairment are rarely assessed. Operant analysis of animals’ behav-
iour provides a high level of stimulus control, objective gathering of
data, high throughput testing and the ability to collect systematically a
broader range of data parameters. Furthermore, this present task is
dependent on goal-directed behaviour, and allows for the assessment
of higher cognitive functions (including response selection and
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response initiation), as well as of motivation, working memory and
attention. In the context of the 6-OHDA model of PD, such tasks have
been used to investigate the functional nature of a deﬁcit, for example
whether the impairment is due to a sensory-input or a motor-output
deﬁcit (Carli et al., 1985; Dowd & Dunnett, 2005a,b). In the rat, the
lateralised choice reaction time (RT) task introduced by Carli et al.
(1985) proved sufﬁciently sensitive to detect small changes in behav-
iour where the simple motor assessments failed to measure improve-
ments (Carli et al., 1985, 1989; Dowd & Dunnett, 2004). Unilateral
lesioned rats display impairments in response accuracy, increased RTs
and increased movement times when the required response had to be
directed towards the side contralateral to the lesion (Carli et al., 1985;
Brasted et al., 1998; Dowd & Dunnett, 2005a,b).
Assessment of sensory-motor outputs by the lateralised choice RT
task has not hitherto been achieved in mice. Here we compare two
of the unilateral mouse lesion models (SN vs. MFB) on this operant
task to assess the lesion-induced deﬁcit as well as the stability of
the lesion over time. The stability of a repairable deﬁcit is funda-
mental to the development and assessment of therapies without the
danger of spontaneous recovery interfering with the results.
Materials and methods
Subjects
Fifty-eight male mice of the C57/Bl6 strain were used. All mice
were housed in standard laboratory cages in pairs of one-two in a
temperature- and humidity-regulated room (21 ± 2 °C) on a
10 : 14 h dark–light cycle, with lights on at 06:00 h. All animals
had access to food and water ad libitum, except during the testing
phases that required food restriction for motivation. All testing was
done in accordance with local ethical review and approval from Car-
diff University and licences according to the United Kingdom Ani-
mals (Scientiﬁc Procedures) Act, 1986.
Experimental design
One week after arrival all mice were food-restricted for 1 week
before starting training on the operant task (see below). After the
mice had learned the choice RT task to an asymptotic level of per-
formance, the animals were matched on their accuracy into three
groups. Two of the groups underwent lesion surgery (SN and
MFB), whereas one group served as unlesioned control. Four weeks
after the lesion the rotational response to 2.5 mg/kg methamphet-
amine was recorded and then the animals were again food-restricted.
After 3 weeks of operant testing (weeks 5–8 post-lesion), all mice
were perfused for histological analysis.
Drug-induced rotation
Rotational behaviour was assessed in automated rotometer bowls,
designed after the model by Ungerstedt (Ungerstedt & Arbuthnott,
1970). Mice were injected with methamphetamine (2.5 mg/kg;
Sigma) and placed in the rotometer bowl for 60 min. Data were
expressed as average net number of rotations per min.
Operant tests
Apparatus
Testing was conducted in a bank of 16 identical nine-hole boxes
(CeNeS, Cambridge, UK). In brief, each operant chamber was ﬁtted
with a curved array of nine response holes on one side of the
chamber and a magazine on the opposite side. Each of the response
holes was ﬁtted with infrared-sensors that could detect entries into
the respective hole. Through a peristaltic pump 5 lL of Strawberry
milk (Yazoo®, Campina, UK) was delivered into the magazine as a
reward. All boxes were placed in sound-attenuating cubicles and
controlled by a Camden controlled software system (BNC Control,
Campden Instruments, Loughborough, UK).
Choice RT task
For testing, all animals were food-restricted to 90% of their free feed-
ing weight 1 week before the start of operant testing by giving the ani-
mals weighed amounts of food into their home-cages approximately
1 h after the respective testing session. All mice were weighed regu-
larly and the daily allocation of food was adjusted to maintain body
weight at approximately 90% of their free feeding weight.
The choice RT task used in the present experiment has been
translated from a rat version that has been described elsewhere (Car-
li et al., 1985; Dowd et al., 2005). In the response array only three
holes were available for the mice to respond, which were holes 3, 5
and 7, whilst all the other holes were covered. In brief, each trial
started with illumination of the centre hole light (hole 5) whilst all
other lights were switched off. If the infrared beam in front of the
response hole was broken by the entry of the animals’ nose into the
hole a timer was started. Randomly chosen by the computer, the
mouse had to sustain its nose-poke by one of the following four
delays: 25, 50, 75, and 100 ms. Premature withdrawal from the
response hole resulted in abortion of the trial and ‘punishment’ of
5 s in darkness as timeout interval. Each procedural error resulted in
the random selection of a new trial. If the hold was sustained for
the required duration, one of the two lateralised response locations
(randomly chosen) located to either side of the animals head (holes
3 and 7) was illuminated brieﬂy (300 ms). The animal then had 5 s
to make a response. A poke into the previously illuminated response
hole would result in the delivery of a reward into the illuminated
magazine, whereas an incorrect response or no response resulted in
abortion of the trial and start of the 5-s timeout period. After the
timeout period or after the mouse had collected its reward from the
magazine, the houselight was switched on (and magazine light
switched off in the case of previous reward) for 2 s as inter-trial
interval. After the inter-trial interval ﬁnished a new trial was started.
Each daily session was 30 min long.
The main parameters that were recorded were the total number of
trials started (TTS); the total number of trials usable (TTU; i.e. the
number of trials in which the animals sustained their nose-poke for
the required delay period); response accuracy (Accuracy), as the per-
centage of correct responses divided by the number of usable trials,
expressed as a percentage; RT, deﬁned as the time recorded from
onset of the lateralised stimulus presentation until retraction of the
animals’ nose from the centre hole; and movement time, which was
deﬁned as the latency from retraction of the centre hole until the
execution of the lateralised response.
Pre-training operant task
All mice were trained in stages to the ﬁnal choice RT task outlined
above. All animals were food-restricted 1 week before operant train-
ing started. On the ﬁrst day of training, the mice were placed into the
operant boxes for 30 min with the houselights switched on and
1 mL of reward placed in the food magazine to habituate the animals
to the chamber and to teach them the location of the reward delivery.
On the second stage of training, all lights with the exception of the
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magazine light were switched off and 5 lL of reward was delivered
into the magazine. If the animal collected the reward, the magazine
light was extinguished and the houselight was switched on for the
duration of 10 s, upon which a new trial started. All mice learned to
collect the reward from the magazine within one session. On the
third stage of training all lights were switched off, with the exception
of the stimulus light in response hole 5. A ﬁxed ratio schedule of
reinforcement (FR1) was introduced so that every poke into the illu-
minated response hole would result in the delivery of 5 lL reward
into the illuminated magazine. For some mice the response hole was
baited with a drop of strawberry milk to facilitate learning, but all
mice displayed a high number of responses (137 ± 10) to the
response hole on day 6 of training. During the next stage of training,
a poke into hole 5 resulted in the illumination of response hole 3 or
7 (randomly determined by the computer). A response into the sec-
ond illuminated hole would then result in reward delivery. Over
4 weeks of training the duration of the lateralised stimulus was grad-
ually reduced from 5000 to 300 ms, and the duration the mouse had
to hold its nose in the centre hole before illumination of the latera-
lised response holes was increased from 5 to 200 ms. For the longest
delay of 200 ms only 20% of all trials were usable and therefore the
following shorter delays were chose for the ﬁnal task outlined below:
25, 50, 75 and 100 ms.
Surgery
Mice were anaesthetised in an induction chamber under 1.5–2% iso-
ﬂurane using O2 as carrier gas. Following shaving and cleaning of
the surgical area, the animal was placed in a stereotaxic frame
(Kopf) and anaesthesia was maintained under 1.5–2% isoﬂurane in a
2 : 1 mixture of O2/NO. Bregma was exposed via incision of the
skin, and a small burr hole was created using a dental drill to which
the lesion cannula was lowered to either of the following stereotaxic
coordinates: SN (1.5 lL): AP 3.0, ML 1.2 and DV 4.5; or
MFB (1.0 lL): AP 1.2, ML 1.2 and DV 4.75. The nose bar
was set at 0.0 mm. 6-OHDA (Sigma) was infused via a 30-gauge
steel cannula that was connected via polyethylene tubing to a 10-lL
Hamilton syringe mounted on a micro-drive pump. The toxin was
used at a concentration of 6 lg/lL (hydrobromide salt, calculated
from free-base weight) dissolved in 0.9% sterile saline with 0.2 mg/
mL ascorbic acid. Infusions were done at a rate of 0.5 lL/min, and
the needle was left in place for an additional 2 min to allow for dif-
fusion before retraction of the needle and suturing the wound. Dur-
ing surgery the mice would receive s.c. injections of 0.03 mL
Metacam® (Meloxicam, Boehringer, Ingelheim, Germany) as analge-
sia and 1 mL of 4% glucose–saline solution.
The animals’ body weight was monitored for 14 days post-lesion,
and all lesioned animals received injections of 0.5 mL glucose–sal-
ine s.c. three times daily, and wet palatable food was provided in
small containers on a daily basis.
Histology
After completion of behavioural testing all animals were deeply an-
aesthetised with 0.2 mL sodium pentobarbitone, and perfused
through the heart with approximately 25 mL phosphate-buffered sal-
ine (PBS; pH 7.3) followed by 50 mL 1.5% paraformaldehyde in
PBS. The brains were then post-ﬁxed for a further 24 h before being
transferred into a 25% sucrose solution where they were kept until
sunk. Thereafter all brains were cut into coronal sections (40 lm)
on a freezing sledge microtome into Tris-buffered saline (TBS; pH
7.3) with 2% azide and stored until further processing.
A 1 : 6 series of sections was washed in TBS before quenching
endogenous peroxidase activity in a 3% H2O2 and 10% methanol
solution in distilled water for 10 min. After 39 washing and
re-equilibrating in TBS, sections were incubated for 1 h in 3% nor-
mal horse serum block in TXTBS (TBS with 0.2% Triton-X) before
transferring them into primary antibody solution [tyrosine hydroxy-
lase (TH), raised in rabbit; Chemicon, 1 : 1000] and left at room
temperature overnight. After washing the sections they were incu-
bated for 3 h in biotinylated secondary antibody in TBS and 1%
serum. Following washing in TBS, the sections were transferred into
a Dako streptavidin ABC kit (Vectastain; Vector Laboratories, Peter-
borough, UK) in 1% serum for 2 h. After washing 39 in TBS and
twice in TNS (Tris non-saline; pH 7.4), the antibodies were visual-
ised by staining with diaminobenzidine (Sigma) at a concentration
of 0.5 mg/mL in TNS with 3% H2O2. Stained sections were washed
in TNS and TBS and mounted on gelatine-coated glass slides. After
mounting, all slides were air-dried overnight and dehydrated in an
ascending series of alcohols (70, 95, 99%; 5 min each) and xylene
before coverslipping using a DPX mounting media.
Optical density (o.d.)
o.d. of dopaminergic ﬁbres was assessed as described previously (Grea-
lish et al., 2010; Heuer et al., 2012). In brief, coronal pictures of
TH-immunoreactive (ir) sections were taken across four levels through
the striatum (approximately from bregma: +1.10, +0.62, +0.14 and
0.34 mm) using a Leica DM/RBM microscope under 19 magniﬁca-
tion. Using IMAGEJ software (Version 1.42; NIH, USA) o.d. was mea-
sured in all sections, correcting for non-speciﬁc staining by subtracting
values from measures at the corpus callosum. o.d. was expressed as per-
centage of the side contralateral to the lesion. Anatomical landmarks to
divide the striatum into dorsal and ventral parts were made by drawing
a horizontal line across the most dorsal point of the lateral ventricle or
the anterior commissure, where visible (Grealish et al., 2010).
TH-ir cell counts
TH-ir cells were counted at 910 magniﬁcation under a Leica DM/
RBE microscope. Cell counts were made for ipsilateral and contra-
lateral SN and VTA in one section. The medial terminal nucleus of
the accessory nucleus of the optic tract was used to select the sec-
tion and to deﬁne the boundary between VTA and SN cells (Dowd
& Dunnett, 2005a). All cell counts are expressed as percentage of
the contralateral side.
Statistics
Behavioural and histological data were analysed using the GENSTAT
(Version 12.1) statistical software package. Operant data were analysed
using repeated-measures analysis of variance (ANOVA), and all other
data were analysed using one-way ANOVA or Pearson correlations. Post
hoc comparisons between groups were done using Student’s–Newman
–Keuls test where appropriate. A signiﬁcance level of a = 0.05 was
used to determine if F-ratios were signiﬁcantly different from normal.
Results
Mortality and group sizes
Of the 58 mice that were used in the present experiment, six ani-
mals died during the course of testing. Four mice died shortly after
the lesion surgery (two from each group), whereas the remaining
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two deaths appeared to be unrelated to the procedure. Of the 46
mice that received lesions, 32 mice were allocated to the MFB
lesion group and 14 mice were allocated to the SN lesion group.
Survival rates were at acceptable levels and comparable to previous
reports from our group (Heuer et al., 2012; Smith et al., 2012).
After o.d. analysis and inspection of the TH-ir stained sections,
we excluded animals that were regarded as partially lesioned on the
basis of an o.d. score of > 35% and a degeneration of TH-ir cells in
the ipsilateral SN at maximum 20% remaining cells. The ﬁnal group
sizes used for the analysis were: Control, n = 12; MFB, n = 19; and
SN, n = 8 mice per group.
6-OHDA lesions cause degeneration of TH-ir cells
Injection of 6-OHDA into both, the SN or the MFB resulted in a
degeneration of TH-ir cells in the SN. As shown in Fig. 1, both
types of lesions reduced TH-ir staining in the dorsal neostriatum and
in the ipsilateral SN. Although ventral striatal areas and the VTA
showed marked loss of TH-ir staining, the MFB lesions produced
the larger overall depletion of TH-ir cells.
The lesion induced a reduction in TH-ir density on the side of the
lesion (Fig. 2A; Group, F2,36 = 113.97, P < 0.001). Post hoc com-
parisons showed that both lesion groups had density scores that
were signiﬁcantly lower than those of the controls (P < 0.001).
Although overall o.d. was 10% higher in the SN lesion group com-
pared with the MFB lesion group, this difference did not reach sta-
tistical signiﬁcance (n.s.). Dorsal striatal o.d. was signiﬁcantly
different between the three groups (Fig. 2B; Group, F2,36 = 132.05,
P < 0.001), with both lesion groups displaying reduced TH-ir den-
sity compared with those of the control group (both P < 0.001).
Ventral striatal density was signiﬁcantly different between the three
groups (Fig. 2C; Group, F2,36 = 84.25, P < 0.001), with both lesion
groups showing reduced o.d. compared with the control group (both,
P < 0.001). The MFB lesion group displayed a higher reduction in
ventral striatal TH density compared with the SN lesion group
(MFB = 21.1%; SN = 39.6%, P < 0.05).
There was no difference in the total number of TH-ir cells in the
contralateral SN (Group, F2,36 = 0.45, P = n.s.) and in the contralat-
eral VTA (Group, F2,36 = 0.16, P = n.s.) between the three groups,
therefore cell counts were expressed as a percentage of the contralat-
eral side for all groups. Counting TH-ir cells in the midbrain
revealed a signiﬁcant loss of cells induced by the 6-OHDA infusion
(Fig. 2D; Group, F2,36 = 105.21, P < 0.001), with both lesion
groups displaying a signiﬁcant reduced number of TH-ir cells com-
pared with the control group (both, P < 0.001). Both types of
lesions were effective in producing a near-complete depletion
(< 10% cells remaining) of TH-ir cells in the ipsilateral SN
(Fig. 2E; Group, F2,36 = 241.35, P < 0.001), with both lesion
groups differing signiﬁcantly from control (both, P < 0.001). TH-ir
cells in the VTA were less affected than the cells in the SN, but
compared with control there was a marked reduction in cell numbers
in both lesion groups (Fig. 2F; Group, F2,36 = 38.95, P < 0.001).
However, animals of the MFB lesion group displayed a higher loss
of cells in the VTA compared with animals of the SN lesion group
(10.5% more cells lost), but this difference failed to reach statistical
signiﬁcance.
Behavioural changes
Amphetamine-induced rotations
There was a difference between the groups in the average number
of net rotations in response to 2.5 mg/kg amphetamine (Fig. 3;
Group, F2,36 = 6.99, P < 0.01). Post hoc analysis showed that both
lesion groups rotated consistently higher to amphetamine than ani-
mals of the control group (both, P < 0.01), with no difference
between the lesion groups.
Choice RT task
TTS and TTU
During baseline assessment all animals started a high number of tri-
als by responding to the illuminated centre hole with a nose-poke
(Fig. 4A). The lesion caused a signiﬁcant reduction in the TTS in
both lesion groups (Fig. 4A; Week 9 Group, F3,108 = 34.67,
P < 0.001), with the most pronounced reduction seen with MFB
lesions. All post hoc comparisons demonstrated that during each of
the 3 weeks of post-lesion testing both lesion groups attempt signiﬁ-
cantly fewer trials compared with the control group, and during all
3 weeks of post-lesion assessment the MFB-lesioned animals
attempt fewer trials than animals of the SN lesion group (all
t > 4.37, P < 0.01).
Once a trial is started the animal has to sustain the nose-poke for
the required delay in order to be presented with the lateralised stim-
ulus, to which it has to respond. Therefore there are three types of
procedural errors the mouse can make in order to make a trial inva-
lid: (i) premature withdrawals; (ii) repeated centre hole pokes; and
(iii) not responding to the lateralised stimulus within the allocated
period of time (5 s). The number of trials that are started (see
above) is therefore rather a measure of motivation of the animal
rather than performance on the operant task. During baseline assess-
ment animals of all three groups produced a similar number of
usable trials (Fig. 4B), approximately 63% of the trials started were
usable during baseline testing. After the lesion, both lesion groups
produced fewer usable trials than mice in the control group
Fig. 1. Representative series of TH-ir stained sections for control, medial
forebrain bundle (MFB) and substantia nigra (SN) lesion groups, respec-
tively. The dotted line indicates the separation of the striatum into dorsal (D)
and ventral (V) subdivisions used for o.d. analysis. Scale bar: 1 mm.
 2012 Federation of European Neuroscience Societies and Blackwell Publishing Ltd
European Journal of Neuroscience, 37, 294–302
Choice reaction time in mice 297
(Week 9 Group, F3,108 = 32.52, P < 0.001). The number of TTU
was similar to the TTS, and signiﬁcantly different between the two
lesion groups and the control group, as well as between the two
lesion groups, with the MFB group producing the smallest number
of usable trials (all, t > 6.29, P < 0.01). Most of the usable trials
were produced when the delay between the initial centre hole poke
and the onset of the lateralised stimulus was short. All rats had a
higher efﬁciency [Efﬁciency % = (TTU/TTS)*100] of usable trials
when delays were short (Delays, F3,108 = 278.18, P < 0.001). This
effect was more pronounced in animals of the lesion groups, which
produce fewer usable trials as a proportion of trials started
(Group 9 Delay, F6,108 = 14.32, P < 0.001), and effect that was
only different from control after the lesion and not during baseline
testing (Weeks 9 Group 9 Delay, F18,324 = 8.44, P < 0.001).
Accuracy
Response accuracy was deﬁned as the number of correct trials
divided by the number of usable trials and expressed as a percent-
age. During baseline assessment all animals responded with a high
overall (i.e. ipsilateral and contralateral combined) accuracy towards
the lateralised stimulus (90% correct). After the lesion, animals of
both lesion groups showed impaired response accuracy, whereas the
control group continued to respond with > 90% accuracy during all
3 weeks of post-lesion assessment (Fig. 4C; Week 9 Group,
F6,108 = 21.61, P < 0.001). Both lesion groups performed with
lower response accuracy than the control group during all three
time-points of post-lesion assessment (all, t > 4.74, P < 0.01), with
the exception of the SN lesion group in the third week of post-
lesion assessment. Although the SN lesion group performed with
lower accuracy compared with the control group (t = 3.89,
P < 0.05), accuracy increased in this group from 63% correct trials
during week 1 post-lesion to 77% correct trials during week 3 post-
lesion. During all 3 weeks of post-lesion assessment the MFB lesion
group performed worse than animals in the SN lesion group (all,
t > 6.82, P < 0.01). Although response accuracy was lower overall
in lesioned animals (i.e. responses to both sides were impaired), the
impairment was more pronounced when the required response had
to be directed towards the hole located on the contralateral side of
the lesion (Fig. 5A; Week 9 Side 9 Group, F6,108 = 6.32,
P < 0.001). Although the most impaired lesion group, the MFB
lesion group, was still able to respond to ipsilateral presented stimuli
with 63% average response accuracy over the 3 weeks of post-
lesion assessment, accuracy dropped to 16–25% when responses had
to be directed into contralateral space. The average difference
between ipsilateral and contralateral response accuracy was 43.5%
in the MFB lesion group. Responses for the SN lesion group were
lateralised as well, with responses to the ipsilateral side being not
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Fig. 2. Optical density (o.d.) and cell counts. Average striatal o.d. for (A) the whole, (B) the dorsal, and (C) the ventral neostriatum on the lesioned side, in
each case expressed as a percentage of the contralateral side. Tyrosine hydroxylase-immunoreactive (TH-ir) cells were counted at one level in the midbrain and
expressed as a percentage of contralateral cell counts for (D) the total cell loss, (E) cell loss in the substantia nigra (SN), and (F) cell loss in the ventral tegmen-
tal area (VTA). The number of asterisks above the bar charts denote signiﬁcant differences at the < 0.05, < 0.01 and < 0.001 levels of signiﬁcance, respectively.
MFB, medial forebrain bundle.
Fig. 3. Performance on the amphetamine-induced rotation test in response
to 2.5 mg/kg amphetamine per group. Asterisks denote signiﬁcantly different
from control at the < 0.01 level of signiﬁcance. MFB, medial forebrain bun-
dle; SN, substantia nigra.
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different from control (all, t < 1.27, P = n.s.). As can be seen in
Figs 4C and 5A, the average difference in accuracy between the
two sides of responding was 28.9% for the SN lesion group, and
therefore 14.6% higher than the MFB lesion group difference.
RTs and movement times
The time to withdraw the nose upon detection of the lateralised
stimulus was deﬁned as the RT, whereas the time taken to execute
the lateralised response was deﬁned as the movement time. Whereas
there was no difference between the three groups during baseline
assessment in either of the two response latency measures (Fig. 4D),
after the lesion RTs were increased in animals that received lesions
to the MFB only (Group, F2,36 = 10.90, P < 0.001). The increase in
RT was not lateralised (Fig. 5B; Week 9 Sides 9 Group,
F6,108 = 1.39, P = n.s.) as the MFB lesion group took longer to
withdraw its nose in response to the lateralised stimulus irrespective
of the side of stimulus presentation.
The time to execute the lateralised response, i.e. the movement
time, was prolonged after the 6-OHDA lesion (Fig. 4E;
Weeks 9 Group, F6,108 = 13.48, P < 0.001). Both lesion groups
were taking longer to respond than control mice, but mice of the
MFB lesion group were more impaired than those in the SN lesion
group. Both lesion groups took longer for the execution of the latera-
lised response when responding to the side contralateral to the lesion
(Fig. 5C; Weeks 9 Sides 9 Group, F6,108 = 10.64, P < 0.001). When
responding to the ipsilateral side of the lesion, only the MFB group
was slower in responding than the control group, whereas the SN
group had similar response times to the controls.
The behavioural data correlate with the extent of TH-ir cell
loss in the SN
TH-ir cell counts in the SN correlated well with o.d. in the dorsal
striatum (Fig. 6A; r = 0.932, P < 0.01), and cell counts in the VTA
correlated highly with ventral striatal o.d. (Fig. 6B; r = 0.730,
P < 0.01). The behavioural performance of the animals and their
correlations with the extent of cell loss in the SN are shown in
Fig. 6C–F; amphetamine-induced rotations correlated with percent-
age of cells remaining in the SN (r = 0.512, P < 0.01). High cor-
relations were also found between remaining cells in the SN and
response accuracy (r = 0.671, P < 0.01) and movement time
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Fig. 4. Main effects of the choice RT task by week of testing. The data are collated over 5 consecutive days as baseline and three blocks of 5 consecutive days
post-lesion (weeks 1–3). (A) TTS. (B) TTU, i.e. trials in which the animals sustained the nose-poke for the required delay and executed the lateralised response.
(C) Response accuracy (% correct) on usable trials. (D) RT on correct trials. (E) Movement time on correct trials. The number of symbols denotes signiﬁcant
differences at the < 0.05 and < 0.01 levels of signiﬁcance. Asterisks denote signiﬁcantly different from control, whereas hashes denote signiﬁcantly different
between the two lesion groups, as shown by Student’s–Newman–Keuls post hoc analysis. MFB, medial forebrain bundle; SN, substantia nigra.
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(r = 0.512, P < 0.01). RT only correlated weakly with the SN cell
count (r = 0.297, P < 0.05).
Discussion
The present study has shown the effects of two unilateral mouse
lesion models of PD on a lateralised choice RT for the ﬁrst time,
and has deﬁned the parameters to assess unilateral lesions to the
nigro-striatal system in mice. The lesion caused a reduction in the
number of TH-ir cells in the midbrain and subsequent loss of TH-ir
staining in the striatum.
Mice with infusions of 6-OHDA into the MFB appeared to have
a greater TH-ir depletion than SN-lesioned animals. This was
conﬁrmed by a statistically signiﬁcant greater reduction of TH-ir o.
d. in the ventral striatum of the MFB lesion group compared with
the SN lesion group, although VTA cell counts were not statistically
different between the groups. The lesion was effective in inducing
impairments on multiple parameters of the operant task, with MFB-
lesioned mice being more impaired than those that received SN
lesions.
This study replicates the deﬁcits that have been shown in unilateral
6-OHDA lesion rat models of PD (Dowd & Dunnett, 2005a,b), and
demonstrates the validity of this task for mice. Near-complete unilat-
eral dopaminergic lesions as achieved via infusion of 6-OHDA into
the MFB led to an impairment in the TTS, TTU, a reduction in
response accuracy, and increase in RT and movement time latencies
(Carli et al., 1985; Brown & Robbins, 1989; Dowd & Dunnett, 2004,
2005a,b). Lesions to the SN in the mouse produced a behavioural pro-
ﬁle that was more similar to a striatal lesion in the rat (Carli et al.,
1985; Darbaky et al., 2003; Dowd & Dunnett, 2005a,b). Although
the SN-lesioned animals were impaired on all parameters, with the
exception of RT latencies, the behavioural impairment was less pro-
nounced compared with MFB-lesioned mice. In the rat the difference
in response proﬁle has been attributed to the terminal lesion being less
complete and having more sparing of cells located in the VTA than
those of the MFB lesions (Dowd & Dunnett, 2005a,b). Dowd & Dun-
nett proposed that the difference in behavioural proﬁle lies in either
the difference of lesion extent and/or in MFB lesions affecting addi-
tional structures compared with the terminal lesions (Carli et al.,
1985; Dowd & Dunnett, 2005a,b). Interestingly, combined lesions of
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Fig. 5. Main effects of the operant choice RT task separated for ipsilateral and contralateral responses per block of testing. The data are collated over 5
consecutive days as baseline and three blocks of 5 consecutive days post-lesion (weeks 1–3). (A) TTS. (B) TTU, i.e. trials in which the animals sustained the
nose-poke for the required delay and executed the lateralised response. (C) Response accuracy on correct trials. (D) RT on correct trials. (E) Movement time on
correct trials. The number of symbols denotes signiﬁcant differences at the < 0.05 and < 0.01 levels of signiﬁcance. Asterisks denote signiﬁcantly different from
control, whereas hashes denote signiﬁcantly different between the two lesion groups as shown by Student’s–Newman–Keuls post hoc analysis. MFB, medial
forebrain bundle; SN, substantia nigra.
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the striatum and subsequently the nucleus accumbens do not have
additive effects (Carli et al., 1989). However, on a simple RT task
conducted in the Skinner box, the larger the DA depletion in bilateral
MFB-lesioned rats, the greater was the manifestation of RT and
movement time impairments (Smith et al., 2002).
In the initial reports by Carli et al. (1985), using rats with striatal
6-OHDA lesions demonstrated no impairment in movement time. In
contrast, Dowd & Dunnett showed movement time deﬁcits in both
MFB- and striatal-lesioned rats, which is in line with the present
ﬁndings (Dowd & Dunnett, 2005a,b). It has been argued the differ-
ences in movement time deﬁcits are due to the conﬁguration of the
response holes, which were directly adjacent to the centre hole in
the initial studies (Carli et al., 1985), but were moved ‘one-hole to
the side’ in the subsequent experiments (Dowd & Dunnett, 2004,
2005a; Dowd et al., 2005). An alternative explanation was that the
initial Carli studies had lesions that were less complete, as only one
infusion site was used compared with four-site terminal injections
(Carli et al., 1985; Dowd & Dunnett, 2005a,b), which produce more
widespread dopaminergic depletion (Kirik et al., 1998).
As in previous reports, many of the outcome measures on the
operant task were impaired for stimuli presented to either side of the
body, but with the impairment being more pronounced when
responses had to be directed into the hole contralateral to the lesion.
Most importantly, the lesion-induced deﬁcit was stable over time in
both lesion groups. Whereas striatal lesions in the rat led to sponta-
neous recovery on some parameters of the choice RT task (Accu-
racy, Ipsilateral bias; Carli et al., 1985; Dowd & Dunnett, 2005a),
both lesions used in the present study were stable over three blocks
of testing. There was some improvement in response accuracy dur-
ing week 3 post-lesion in SN-lesioned mice, but the group was still
performing signiﬁcantly lower than mice of the control group. The
severe motor and motivational impairment that was induced in
MFB-lesioned mice can complicate interpretation of the deﬁcit in
accuracy. Nevertheless, even though the overall response rate was
greatly reduced in MFB-lesioned mice, the pattern of responding
was highly stable over the days of testing.
Interestingly, mice with lesions to the SN did not show the typical
increase in choice RT that has been described in rats after unilateral
DA depletion in the striatum after infusions of 6-OHDA (Carli
et al., 1985, 1989; Dowd & Dunnett, 2005a,b) or the MFB (Dowd
& Dunnett, 2004, 2005a,b). By contrast, the only study utilizing SN
lesions on a similar choice RT task did not report any differences in
RT or movement time latencies (Darbaky et al., 2003). In humans
the RT deﬁcit of patients with PD is also less clear, with some stud-
ies reporting increased RTs whereas others do not (Evarts et al.,
1981; Bloxham et al., 1984; Rafal et al., 1984; Brown & Marsden,
1986; Girotti et al., 1986; Jordan et al., 1992; Kutukcu et al.,
1999). Furthermore, the emergence of deﬁcits seems to be largely
dependent on the task and apparatus used (Jordan et al., 1992;
Gauntlett-Gilbert & Brown, 1998).
In conclusion, the current protocol of the lateralised choice RT task
in mice is a useful method to assess lesion-induced deﬁcit in unilateral
mouse models of PD. Furthermore, future studies can assess the
effects of therapeutic interventions, as cell replacement therapies,
pharmacological or surgical approaches, or protection strategies
(Dowd & Dunnett, 2004; Dowd et al., 2005), as has been done in
similar rat models, with the additional beneﬁt to use mouse-derived
stem cells without the need for immunosuppression or to lesion trans-
genic mice. This is the ﬁrst demonstration of choice RT performance
in mice showing that under the presented task parameters operant
assessment in mice is a powerful tool for behavioural analysis.
Furthermore, although simple motor tests have been deﬁned recently
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Fig. 6. Correlations between TH-ir cell counts and optical density measures in the dorsal (A) and ventral striatum (B) as well as correlations with behavioural
outcome measures and SN TH-ir cell counts on Amphetamine-induced rotations (C), Accuracy (D), Reaction time (E) and Movement time (F).
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by others (Lundblad et al., 2004; Iancu et al., 2005; Grealish et al.,
2010) and our own group (Heuer et al., 2012; Smith et al., 2012), this
is the ﬁrst demonstration using the MFB and the SN unilateral mouse
6-OHDA lesion model on a more complex behavioural task. The sta-
bility of the lesion over the period of testing will provide useful for
the assessment of cell-based therapies in the near future.
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Chapter 3.6 
Experiment 6: Behavioural recovery on simple and 
complex tasks by means of cell replacement therapy 
in unilateral 6-OHDA lesioned mice 
 
After the assessment of the simple and more complex behavioural analysis of the 
lesion induced deficits the aim of the present experiment was to investigate the 
restorative abilities of cell replacement therapies on the tests that have previously 
shown to be sensitive to DA depletion. Previous work conducted in rats reported that 
DA grafts derived from primary fetal tissue were able to restore some of the lesion 
induced deficits on a lateralised choice reaction time task in rats (see also Chapter 
3.3) as well as tests of drug induced rotations. In this study some of the simple motor 
tests proved to be sensitive to unilateral lesions. Therefore in the present experiment 
we chose to utilise some of the tests that were sensitive to detect lesion induced 
changes form experiments 4 and 5 (Chapter 3.4 and 3.5, respectively). Specifically, 
we directly investigated the restorative ability of motor function of mouse primary fetal 
tissue in the denervated striatum of 6-OHDA lesioned mice on simple and complex 
behavioural tests. 
 
The experiment conducted in the present paper as well as analysis of the data, 
histology and preparation of the manuscript was undertaken entirely by myself. 
Professor S.B. Dunnett was involved in planning of the experiment and gave help 
and advice throughout as well as in the writing of the manuscript. Ms. Ngoc-Nga Vinh 
helped with the dissection of the embryos as well as with the preparations of the cell 
suspensions prior to transplantation.  
DISORDERS OF THE NERVOUS SYSTEM
Behavioural recovery on simple and complex tasks
by means of cell replacement therapy in unilateral
6-hydroxydopamine-lesioned mice
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Abstract
Before cell replacement therapies can enter the clinic, it is imperative to test the therapeutic benefits in well-described animal
models. In the present study, we aimed to investigate the effects of 6-hydroxydopamine lesions to the medial forebrain bundle
and subsequent grafting of embryonic day (E)12.5 ventral mesencephalon into the denervated striatum in C57/Bl6 mice on a
battery of simple motor tests (drug-induced rotation, rotarod, and corridor) and the lateralised choice reaction time task con-
ducted in the mouse nine-hole box. Histological analysis confirmed effective lesions and good graft survival. The lesion
induced marked deficits in the choice reaction time task, the rotarod test, and corridor test, and these deficits were partially
but significantly alleviated in the grafted mice. Although the lesions induced significant rotation following injections of amphet-
amine and apomorphine, respectively, the grafts did not, suprisingly, alleviate the rotation deficit. This study shows the ability
of ventral mesencephalic tissue to ameliorate some of the lesion-induced deficits, and the power of operant testing in detecting
small but significant improvements. The behavioural tests presented are useful drug-free approaches for evaluating cell-based
therapies.
Introduction
Parkinson’s disease (PD) is a progressive, neurodegenerative disor-
der that is characterised by loss of dopaminergic cells in the ventral
mesencephalon (VM) (Parkinson, 2002; Braak et al., 2003; Bj€orkl-
und & Dunnett, 2007a,b; Lees et al., 2008). For more than four dec-
ades, the standard model for PD and for characterisation of the
effect of cell replacement therapies has been the unilateral 6-hy-
droxydopamine (6-OHDA) lesion to the medial forebrain bundle
(MFB) in the rat (Ungerstedt, 1968; Ungerstedt & Arbuthnott, 1970;
Kirik et al., 1998; Grealish et al., 2008). There has been a recent
rise in interest in developing and characterising mouse lesion models
of PD (Lundblad et al., 2004, 2005; Cenci & Lundblad, 2007; Grea-
lish et al., 2010b; Heuer et al., 2012a,b; Smith et al., 2012a). These
have the additional advantage over the rat that: (i) next to the lesion,
additional neuropathology can be investigated, i.e. via transgenic
lines (Fleming et al., 2005; Harvey et al., 2008); and (ii) genetic
manipulations of cells are more easily achieved (Jaeger et al.,
2011).
Cell replacement therapy promises to be a valuable therapeutic
tool for a subset of patients (Perlow et al., 1979; Dunnett &
Bj€orklund, 1999; Bj€orklund & Lindvall, 2000; Bj€orklund et al.,
2003). With the advent of alternative cell sources to primary fetal
tissue, it is imperative to compare the different cell types that are
already used for grafting with respect to the functions that the graft
can restore and the functions that it cannot restore. Basic tests of
motor asymmetry, such as drug-induced rotations, are useful for
screening dopamine depletion/release, but they do not resemble the
complex loss of motor function that is seen in humans (Dowd &
Dunnett, 2004). Although it has not hitherto been possible to ana-
lyse in rodents all of the features that are seen in humans, operant
behavioural analysis allows for a more complex breakdown of the
behavioural pattern that is induced by the lesion. Furthermore, it
has been shown previously that tests of simple motor function may
not be sensitive enough to detect small, but signiﬁcant, therapeutic
effects (Dowd & Dunnett, 2004). The lateralised choice reaction
time task, originally designed by Carli et al. (Carli et al., 1985,
1989), has been shown to be a powerful tool for the analysis of
the underlying deﬁcit of unilateral dopamine depletion (Brown &
Robbins, 1991; Dowd & Dunnett, 2004, 2005a,b; Heuer & Dun-
nett, 2013) and the effects of cell replacement therapies in rats
(Dowd & Dunnett, 2004; Heuer et al., 2013). We recently adapted
the lateralised choice reaction time task, ﬁrst developed for rats, for
mice, and characterised the effects of dopamine depletion in C57/
Bl6 mice (Heuer et al., 2012a). Thus far, grafting in mice has been
performed with limited success, and behavioural analysis has lar-
gely focused on drug-induced tests (Low et al., 1987; Shimizu
et al., 1988; Thompson et al., 2009; Smith et al., 2012b); from our
own experience, with all experimental factors being equal (dissec-
tor, media, grafting procedure, etc.), mouse grafts have been
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smaller and less reliable than rat grafts, with many grafts showing
‘pencil-line’ morphology.
Here, we analysed the effects of primary fetal [embryonic day
(E)12.5] VM single-cell suspension grafts on behavioural recovery
on a series of simple motor tests and the lateralised choice reaction
time task in mice that received unilateral 6-OHDA lesions to the
MFB.
Materials and methods
Subjects
Thirty-eight male mice of the C57/Bl6 strain (Charles Rivers, Mar-
gate, Kent, UK) were used in this experiment. All mice were housed
in pairs in standard laboratory cages under a 10-h:14-h dark/light
cycle (lights on at 06:00 h) at 21  2 °C. All mice had free access
to water at all times, but the amount of food was reduced during the
experimental phases, to restrict their body weight to 90% of the
free-feeding weight. Weighed amounts (2–4 g per mouse) of labora-
tory chow were placed directly into the home cages approximately
1 h after the testing session. This experiment was conducted in
accordance with the United Kingdom Animals (Scientiﬁc Proce-
dures) Act 1986 and local ethical review at Cardiff University.
Experimental plan
After pre-training, mice were allocated to three equal groups
matched for response accuracy. Two groups (lesion and graft)
received unilateral lesions via infusion of 6-OHDA into the MFB.
Three weeks post-lesion, we assessed the effect of the lesion on the
choice reaction time task and on tests of simple motor behaviour
(corridor, rotarod, and rotations). Once testing was concluded, one
lesion group was grafted with a single-cell suspension of dopamine-
rich tissue, implanted into the denervated striatum. The mice were
rested for 12 weeks to allow the grafts to mature, following which
they were re-tested on the choice reaction time task for two consec-
utive weeks and one additional week in a probe trial conﬁguration.
Once operant testing was concluded, post-graft performance was
assessed on the tests of simple motor function before the mice were
killed and their brains were processed.
Operant chambers
Testing was conducted in a bank of 16 operant nine-hole chambers
(Campden Instruments, Loughborough, UK) that were controlled by
a desktop computer running BNC software under the Windows XP
operating system. The dimensions of each chamber were
14 9 13.5 9 12.5 cm (Humby et al., 2005; Heuer et al., 2012a).
On one of the walls, a curved horizontal array was ﬁtted, with nine
response holes. Each hole had a photocell detector to detect entries
into the hole (i.e. nose-pokes) and an LED stimulus light. In the
present experiment, only three of the response holes were used
(holes 3, 5, and 7), and the remaining unused holes were blocked.
On the opposite wall, a food magazine was ﬁtted, into which 5 lL
of strawberry milk (Yazoo, Campina, UK) could be delivered via a
peristaltic pump. An infrared beam at the entrance of the magazine
detected entries by the mice when they collected the reward. The
magazine was ﬁtted with a panel light, which was used to indicate
delivery of a reward, and the chamber was ﬁtted with two additional
‘house’ lights on the side walls, which were used to signal proce-
dural errors. Each chamber was ﬁtted in a sound-attenuating cubicle
with an air extractor fan.
Behavioural tasks
Operant training
Behavioural testing was started 1 week after the introduction of the
food restriction regime. Training for the operant task outlined below
began with a series of shaping days. On the ﬁrst day, the mouse
was introduced to the test chamber with the magazine light on, and
a 25-lL reward was delivered into the magazine. When the mouse
had collected the reward, an inter-trial interval of 10 s was started,
with the house lights switched on and the magazine light extin-
guished. After the inter-trial time had elapsed, a 5-lL reward was
delivered into the magazine, and the house lights were switched off
and the magazine light illuminated. This initial shaping session
lasted for 15 min. For the next 3 days of training, the chamber was
dark, with only the centre hole (hole 5 on the array) illuminated. A
nose-poke into the illuminated hole resulted in the centre hole light
being switched off, and a 5-lL reward was simultaneously delivered
into the illuminated magazine. After reward collection, the magazine
light was switched off, and the centre hole light was illuminated
again. On the ﬁrst day of training, the centre holes were baited occa-
sionally to encourage the mice to nose-poke. After 4 days, all mice
were poking into the centre hole, and progressed to the training
phase of the lateralised choice reaction time task.
Lateralised choice reaction time task
The lateralised reaction time task has been described in detail for the
rat (Carli et al., 1985; Dowd & Dunnett, 2004), and recently for the
mouse (Heuer et al., 2012a). In brief, each trial started with the cham-
ber darkened and the centre hole (hole 5) lit. When the mouse
responded with a sustained nose-poke into the illuminated centre hole,
the light was switched off, and one of the lateralised holes (hole 3 or
hole 7) was brieﬂy lit (stimulus duration). When the mouse responded
correctly by nose-poking into that hole, it received a 5-lL reward into
the illuminated magazine. Upon reward collection, the magazine light
was extinguished and the inter-trial interval started, with the house
light being illuminated. When the mouse responded into the incorrect
hole, it was ‘punished’ by a time-out period in darkness. During the
initial training phase, the stimulus duration was reduced from 10 s to
300 ms, and the period over which the mouse was required to hold its
initial nose-poke was increased progressively from 10 ms to 100 ms.
After all mice had reached a stable level of performance, baseline data
were collected with the following parameters: holds – 25, 50, 75 or
100 ms; stimulus duration – 300 ms; inter-trial interval – 2 s; time-
out – 5 s; and session length – 30 min.
The outcome measures analysed in the present task were: the total
number of trials usable (the number of trials in which the mouse
sustained its nose-poke for the required delay); response accuracy
(the number of correct responses divided by the number of trials
usable, and expressed as a percentage); incorrect trials (the number
of incorrect responses divided by the number of usable trials,
expressed as a percentage); reaction time (the latency from presenta-
tion of the lateralised stimulus light to withdrawal from the centre
hole); and movement time (the latency from withdrawal from the
centre hole to the response in the lateralised response location).
Simple behavioural screens
As operant analysis of behaviour is not widely performed in
the lesion and graft model in mice, we chose to compare the
behavioural effects of the lesion and the graft on a number of simple
conventional motor tests that have previously been shown to be sen-
© 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd
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sitive to unilateral dopaminergic depletion. Whether these tasks are
sensitive in detecting changes of graft-induced recovery is unknown
at this time, and a direct comparison is therefore warranted. We
tested all mice on a series of tests, which are outlined below. All
tests were conducted after completion of operant testing, while the
mice were still on food restriction for the corridor test, and when
they had been free-feeding for at least 3 days for all other tests.
Drug-induced rotation
Drug-induced rotations were conducted in automated rotometer
bowls, which were modelled after the design of Ungerstedt (Unger-
stedt & Arbuthnott, 1970). All mice were challenged 3 weeks
post-lesion with 2.5 mg/kg intraperitoneal methamphetamine, and
post-graft after all behavioural data had been gathered with the same
dose of methamphetamine and with 0.01 mg/kg subcutaneous apo-
morphine 5 days after the last amphetamine challenge. Both drugs
were dissolved in 0.09% sterile saline solution as carrier vehicle,
and prepared fresh on the day of testing. Rotation scores were
expressed as the average of all net ipsilateral rotations when mice
were injected with amphetamine [∑(clockwise turns – counter-
clockwise turns)/min], and as the average of all net contralateral
rotations when mice were injected with apomorphine [∑(counter-
clockwise turns – clockwise turns)/min].
Rotarod
Overall performance in motor coordination, balance and strength was
assessed on the rotarod apparatus (Ugo Basile, Varese, Italy). Mice
were trained on a ﬁxed-speed protocol, at 4, 12 and 24 r.p.m. for
300 s on three separate occasions (on separate days) (Heuer et al.,
2012b). When mice fell off the rod during the training phase, they
were placed back on until the full time had elapsed. On the testing
day, the mice were tested three times, on the accelerating version of
the rotarod, which increased the speed of rotation from 4 to 44 r.p.m.
over a period of 300 s. Mice were given a break of at least 1 h
between runs. The average of the best two runs was taken as the out-
come measure.
Corridor
Lateralised sensorimotor proprioception and neglect were assessed
with the corridor test, which was recently adapted from the rat for
use in mice (Grealish et al., 2010b). Mice were habituated to the
apparatus for two consecutive days. They were placed into the corri-
dor for 10 min on each day, with some 10-mg sucrose pellets scat-
tered around the corridor ﬂoor. For the testing, 10 pairs of adjacent
pots were ﬁlled with ﬁve 10-mg precision sugar pellets along the
walls of the corridor [see Grealish et al. (2010b) for details]. Retri-
evals were scored as investigations into a pot, regardless of whether
the mouse actually took a pellet or not. On the test day, all mice
were habituated to the corridor for 5 min in one compartment, and
then transferred to the baited testing corridor (Grealish et al.,
2010b). They were removed after either they had made 20 explora-
tions/retrievals or 5 min had elapsed. Data were expressed as a per-
centage of contralateral retrievals.
Surgery
Lesion surgery
The mouse was prepared for surgery by induction of anaesthesia,
shaving the surgery area, and securing the head in a stereotaxic
frame. Anaesthesia was maintained with 1.5–2.0% isoﬂurane anaes-
thetic in a 2 : 1 oxygen/nitrous oxide mixture. Lesions were aimed
at the MFB at the following coordinates (from bregma): AP,
1.2 mm, ML, 1.2 mm; and DV, 4.75 mm (from dura); the
nose-bar was set at 0.00 mm. A volume of 1.5 lL of 6 lg/lL
6-OHDA (hydrobromide salt, calculated from free base weight), dis-
solved in a solution of 0.9% sterile saline and 0.2 mg/mL ascorbic
acid, was injected. Injections were made via a 30-gauge stainless
steel cannula connected via polyethylene tubing to a 10-lL Hamil-
ton syringe, which was driven by an automatic micro-drive pump.
After infusion of the toxin over a period of 3 min, the injection
needle was left in place for an additional 3 min to allow for diffu-
sion, before the needle was carefully retracted and the wound was
sutured. All mice were given 0.15 lL of Metacam (Meloxicam; Bo-
ehringer, Ingelheim, Germany) as an analgesic, and 1 mL of glu-
cose (4%) saline (0.09%) solution post-lesion. For 10 consecutive
days following lesion surgery, all mice received daily glucose/saline
injections and were provided with wet palatable food in their home
cages to prevent dehydration (Heuer et al., 2012b).
Graft surgery
Graft tissue was harvested from three pregnant C57/Bl6 dams at
E12.5. The quasi-single-cell suspension was prepared according to a
standard protocol (Mayer et al., 1992). In brief, dissected VMs were
washed in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM/F12; Life
Technologies, Paisley, UK) before being treated with 0.01% trypsin
(Trypsin; Worthington, Lakewood, NJ, USA)/DNase (DNAse;
Sigma, Dorset, UK) for 10 min at 37 °C. Tissue was then washed
with DMEM/F12, and collected by centrifugation at 180 g for
3 min. The medium was aspirated, cells were re-suspended in
200 lL of fresh DMEM/F12 at a density of 300 000 cells/lL, and
1 lL was injected into the denervated striatum at each of the fol-
lowing coordinates (mm) from Bregma: AP, +0.8; ML, 1.7; and
DV, 3.0 and 2.8; the incisor bar was set to 0 mm relative to the
interaural line (total, 600 000 cells; 2 9 1 lL of 300 000). The
grafting cannula was left in place for an additional 3 min to allow
for diffusion of the suspension before slow retraction of the grafting
cannula. Post-operative care was as described above.
Histology
Immunohistology
After behavioural testing was completed, all mice were deeply an-
aesthetised with 200 mg/kg sodium pentobarbitone and transcardial-
ly perfused with 25 mL of phosphate-buffered saline (pH 7.3) as a
prewash, followed by 50 mL of 1.5% paraformaldehyde in phos-
phate-buffered saline. After the brains had been carefully removed
from the skull, they were post-ﬁxed for an additional 24 h before
being cryoprotected via immersion in a 25% sucrose solution, where
they were kept until they had sunk. Thereafter, all brains were cut
on a freezing sledge microtome into coronal sections at a thickness
of 40 lm. Cut sections were then stored at +4 °C in Tris-buffered
saline (pH 7.4) with 2% azide. A 1 : 6 series of sections for each
brain was stained according to standard immunohistochemical proto-
cols (Torres & Dunnett, 2007; Heuer et al., 2012a,b) for tyrosine
hydroxylase (TH) with a rabbit TH primary antibody (polyclonal;
Chemicon; 1 : 1000). Stained sections were mounted on glass
slides, air-dried overnight, dehydrated in an ascending series of
alcohols and xylene, and coverslipped with a DPX mounting
medium.
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TH-immunoreactive (TH-ir) cell counts
Cells that stained positive for TH in the ipsilateral and contralateral
substantia nigra (SN) and ventral tegmental area (VTA) were
counted at the level of the medial terminal nucleus of the accessory
nucleus of the optic nerve. TH-ir cells were counted under 910
magniﬁcation with a Leica DM/RBE microscope, and the counts
were expressed as percentage of contralateral.
Analysis of graft survival
All cells staining positively for TH were counted on an Olympic
C.A.S.T. grid system in a 1 : 6 series of sections. One hundred
cells were randomly selected over 10 grafts, and their average
diameter was measured. The total number of cells within the graft
was estimated with Abercrombie’s (Abercrombie, 1946) correction
procedure:
T ¼ F  AM=ðD=MÞ
where T is the total number of cells, F is the frequency of sections,
A is the total count, M is the section thickness, and D is the average
cell diameter.
Statistics
All data were analysed with the GENSTAT v13.1 software package
(VSN International Ltd., Hemel Hempstead, UK; V12.1.0) with the
signiﬁcance level set at a = 0.05 for signiﬁcant F-ratios. Collated
data from the operant testing were analysed with repeated measures
ANOVA with the factors group (control, lesion, and graft), side (ipsi-
lateral and contralateral), and week (baseline, post-lesion, post-graft
1, and post-graft 2). Averages of reaction and movement time laten-
cies from the operant test were expressed as geometric, rather than
arithmetic, means, to reduce the inﬂuence of extreme data points.
Post hoc analysis was conducted with Student–Newman–Keuls test,
as appropriate.
Results
Histology results
After inspection of the stained sections, TH-ir cells were counted in
the SN and VTA to estimate the magnitude of the lesions, and in
the striatum to estimate cell numbers in the graft. Mice that had
> 30% cells remaining on the lesioned side (n = 6) or no surviving
cells in the graft (n = 3) were excluded, resulting in ﬁnal group
sizes for the statistical analysis of eight controls, 11 lesioned mice,
and 10 grafted mice.
Infusion of 6-OHDA into the MFB caused degeneration of TH-
ir cells in the VM. As shown in Fig. 1, mice of both lesion
groups had a reduced number of TH-ir cells in the ipsilateral SN
(group, F2,27 = 190.85, P < 0.001). Both lesion groups had an
approximately 89% reduction in ipsilateral SN cell counts, which
differed signiﬁcantly from the control group (P < 0.001). Further-
more, all lesioned mice had a signiﬁcant reduction in the number
of TH-ir cells in the ipsilateral VTA (group, F2,27 = 20.85,
P < 0.001), with both lesion groups showing a similar level
of depletion as compared with controls (P < 0.001). After the
grafting of primary fetal VM into the denervated striatum, viable
TH-ir cells (1649  342) could readily be detected at the
transplantation site.
Assessment on the lateralised choice reaction time task
Trials attempted
During baseline assessment, all mice produced a high number of
usable trials by responding to the illumination of the centre hole by
a sustained nose-poke for the required delay [Fig. 2A; group,
F2,27 = 0.84, not signiﬁcant (NS)]. After the lesion, mice of the con-
trol group continued to produce a high number of usable trials,
whereas mice of both lesion groups produced usable trials of
between 20% and 25% of their baseline performance (group,
F2,27 = 11.32, P < 0.001). At this block of testing, there was no dif-
ference between the lesion groups in the number of usable trials pro-
duced (t = 0.66, NS), with both lesion groups producing
signiﬁcantly fewer trials than the control group (both, t > 8.32,
P < 0.01). Engraftment of dopamine-rich tissue did not have an
effect on the number of usable trials, as the difference between the
groups was not different per block of testing (F2,27 = 0.61, NS).
Newman–Keuls post hoc tests revealed that there were no differ-
ences between the graft and the lesion groups at either of the post-
graft blocks of testing (both, t < 1.84, NS).
Error results
The types of procedural error recorded in the choice reaction time
task were: (i) premature withdrawal of the sustained nose-poke
before the delay period had elapsed (ii) perseverative centre hole
response; and (iii) omission of lateralised response. All errors per
week of testing are presented in Table 1. During baseline testing,
there was no difference between the three groups on any of the pro-
cedural errors (all, F1,27  1.95, NS). The number of premature
withdrawals increased with the weeks of testing (week,
F3,81 = 3.82, P < 0.05), but was not different between the three
experimental groups (week 9 group, F6,81 = 0.96, NS). The number
of repeated centre pokes increased post-lesion and post-graft, but the
difference failed to reach statistical signiﬁcance (week 9 group,
F6,81 = 2.18, P = 0.053). Overall, there was a signiﬁcant main effect
of week (week, F3,81 = 7.12, P < 0.001) and a signiﬁcant difference
between the groups (group, F2,27 = 3.92, P < 0.05). As compared
with the control group, whose repeated centre pokes accounted for
< 10% of errors, both lesion groups produced, on average, > 60%
repeated centre pokes at the post-lesion block of testing (Table 1).
The lack of a signiﬁcant interaction effect is most likely attributable
to the large variation in the data. The largest proportion of errors
made in the present task was omission of the lateralised response.
Whereas mice of all groups initiated the trials via the centre poke,
post-lesion > 75% of all trials were not completed by the mice that
received unilateral 6-OHDA lesions (week 9 group, F6,81 = 4.89,
P < 0.001). At both post-graft blocks of testing, mice that received
grafts omitted fewer responses than mice of the lesion group, and, at
the last time point of testing, they were not signiﬁcantly different
from controls.
Accuracy results
Response accuracy was calculated as the number of correct
responses divided by the number of usable trials, and expressed as a
percentage. During assessment of baseline performance, mice of all
groups responded accurately to the lateralised stimulus (> 90% cor-
rect), with no difference between the groups (Fig. 2B; group,
F2,27 = 2.17, NS). Furthermore, there was no difference between the
sides of stimulus presentation in response accuracy (side,
F1,27 = 0.75, NS).
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After this highly accurate performance during baseline training,
the lesion caused a signiﬁcant reduction in response accuracy
(group, F2,27 = 16.01, P < 0.001). Both lesion groups performed
with a signiﬁcantly reduced response accuracy as compared with the
control group (all, t > 11.49, P < 0.01), whereas there was no dif-
ference in performance between the experimental groups (t < 0.15,
NS), as they were matched according to this parameter. Although
responses to both sides were reduced as compared with baseline
testing (Fig. 3A; week 9 side 9 group, F6,81 = 3.16, P < 0.01),
responses made to contralateral stimuli were less frequent than
responses made to ipsilateral stimuli (side, F1,27 = 13.88, P < 0.01).
During the ﬁrst week of testing after the grafting, there was still a
difference in overall response accuracy between the groups (group,
F2,27 = 12.01, P < 0.001), with the control group performing signif-
icantly better than the two experimental groups (all, t > 8.41,
P < 0.01).
Although not signiﬁcantly different from controls, grafted mice
showed better overall accuracy scores and performed signiﬁcantly
better than mice of the lesion-only group (t28 = 4.59, P < 0.05).
As during post-lesion assessment, mice that were lesioned per-
formed worse on the side contralateral to the lesion (side 9 group,
F2,27 = 4.81, P < 0.05). Post hoc testing on the contralateral side
revealed that the graft group responded with a higher response accu-
racy than the lesion-only group (t28 = 7.59, P < 0.01). Analysis of
ipsilateral performance revealed that both lesion groups performed,
as previously, with a reduced response accuracy as compared with
the control group (all, t28 > 9.68, P < 0.01), but there was no differ-
ence between the graft and lesion-only groups at this time point of
testing (both, t28 < 0.67, NS).
There was no change in response accuracy between the two
blocks of post-graft testing (week 9 group, F1,27 = 3.10, NS), with
the effects for group, side and the interaction between them being
similar to those during the ﬁrst week of post-graft assessment. At
this time point, all lesion groups performed with a lower overall
response accuracy than the control group (both, t28 > 3.53,
P < 0.05). Similarly to the ﬁrst week post-graft assessment, mice
that received grafts responded with higher overall response accuracy
than their lesion-only counterparts (t28 = 5.44, P < 0.01). Whereas
there was no difference in ipsilateral accuracy between the lesion
and graft groups after transplantation (both, t28 < 1.53), contralateral
accuracy was signiﬁcantly higher for the graft group at both time
points (both, t28 > 7.59, P < 0.01).
A B C
D E F
Fig. 1. Representative series of TH-stained sections for control (A), lesioned (B) and grafted (C) mice, respectively. The dashed line in B indicates the separa-
tion of the VM into the VTA and SN, and the dotted line in C indicate the location of the graft in the respective section. Scale bar: 1000 lm. (D and E) Cell
numbers of TH-stained sections at the level of the VM for cells in the SN (D) and the VTA (E), respectively. Asterisks denote signiﬁcant difference from con-
trol at the P < 0.001 level of signiﬁcance. (F) High magniﬁcation (920) of the grafted TH-ir cells. Scale bar: 50 lm.
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In summary, the data show that the lesion causes a reduction in
overall response accuracy, with the side contralateral to the lesion
being the more impaired. After the grafting, all three groups
improved in contralateral responding, but only the group that was
grafted with primary fetal VM improved when a response had to be
made towards a contralateral stimulus, while still being impaired as
compared with mice of the control group.
Percentage incorrect trials
The percentage of incorrect responses (data not shown) was different
between the three groups (group, F2,27 = 6.30, P < 0.01), and
increased over the weeks of testing (week 9 group, F6,81 = 3.56,
P < 0.01). During baseline testing, across all three groups the per-
centage of incorrect responses (responses to the incorrect hole) was
5.22%  0.28%. After the lesion, mice of the control group contin-
ued to respond to the incorrect hole at a frequency of 6–7% at all
three time points. Mice of the lesion groups showed an increased
number of incorrect responses, and responded to the incorrect hole
on 12–20% of all usable trials. Incorrect responses were higher for
both lesion groups when the stimulus was presented on the contra-
lateral side to the lesion (week 9 side 9 group, F6,81 = 3.50,
P < 0.01). For mice of the lesion group, incorrect responses to con-
tralateral stimuli constituted 22.5, 23 and 35% of all usable trials,
and incorrect responses to ipsilateral stimuli constituted 13, 5, and
5%, when an ipsilateral stimulus was presented across the three
post-lesion time points. Mice that were grafted showed a similar
response pattern, with 16, 18 and 21% incorrect responses towards a
contralateral stimulus, and with 8, 15 and 12% incorrect responses
towards an ipsilateral stimulus, for each of the three post-lesion time
points, respectively. The data clearly show that the deﬁcit in
response accuracy can be broken down into three parts: an omission
of the lateralised response, a repeated centre poke (Table 1), or a
response into the incorrect hole. Mice of both lesion groups showed
a bias for responding to the hole ipsilateral to the lesion.
Reaction and movement time latencies
There was no difference between the groups during assessment of
baseline performance on either reaction time (Fig. 2C; group,
F2,27 = 0.44, NS) or movement time (Fig. 2D; group, F2,27 = 0.10,
NS). All mice reacted and responded to stimuli to either side with
similar latencies (both, side, F2,27 < 0.01, NS).
After the lesion, reaction times were different between the groups
(group, F2,27 = 5.31, P < 0.05), with both lesion groups reacting
more slowly to the lateralised stimulus light than the control group
(both, t > 4.56, P < 0.01). The lesion-only group reacted signiﬁ-
cantly more slowly than the graft group before grafting (t28 = 3.12,
P < 0.05). As reported previously (Heuer et al., 2012a), reaction
times were not differently affected according to the side of stimulus
presentation (Fig. 3B; side, F1,27 = 0.53, NS).
The movement time latencies to execute the lateralised response
were different between the three groups after the lesion (group,
F1,27 = 6.35, P < 0.01). Both lesion groups took longer to execute
the response than the control group (both, t > 5.07, P < 0.01),
whereas there was no signiﬁcant difference in movement time
latency between the two lesion groups (t28 = 2.22, NS). In contrast
to reaction times, the time taken to respond to the lateralised
A B
C D
Fig. 2. Main effects of the lateralised choice reaction time task by week of testing. Data were collated over 5 days per block at baseline, at post-lesion (Lx),
and at the ﬁrst (Tx1) and second (Tx2) weeks of post-graft testing. (A) Total number of usable trials in which the mouse sustained the nose-poke for the
required delay and executed a lateralised response. (B) Percentage accurate responses on the total number of usable trials. (C) Reaction time latencies on correct
trials. (D) Movement time latencies on correct trials. The number of symbols above the bars denotes signiﬁcant differences at the P < 0.05 (for one symbol)
and P < 0.01 (for two symbols) levels of signiﬁcance. Asterisks denote signiﬁcant differences from the control group, and hashes denote signiﬁcant differences
from the lesion group, as determined by Student–Neuman–Keuls post hoc analysis.
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response location was differently affected according to the side on
which the response had to be executed (Fig. 3C; side 9 group,
F2,27 = 4.10, P < 0.05). Overall responses towards the ipsilateral
side of stimulus presentation were faster than responses towards the
contralateral side (side, F1,27 = 7.49, P < 0.05; side 9 group,
F1,27 = 4.10, P < 0.05).
Both lesion groups responded with increased movement time
latencies towards the ipsilateral response location, as compared with
the control group (both, t28 > 2.93, P < 0.05), whereas there was no
difference in movement time between the two lesion groups
(t28 = 0.85, NS) on this side of testing. On the contralateral side to
the lesion, response times were also signiﬁcantly longer for both
lesion groups than for the control group (both, t28 > 7.15,
P < 0.01). Furthermore, the lesion-only group was slower to execute
the contralateral response than the graft group (t28 = 4.29,
P < 0.01). The graft had no effect on reaction time performance, as
there was a difference in reaction time latencies at the ﬁrst block of
post-lesion testing (group, F2,27 = 4.40, P < 0.05), with both lesion
groups responding more slowly than the control group (both,
t > 3.86, P < 0.01). During the last week of post-graft testing, the
difference in reaction time latency between the groups failed to
reach statistical signiﬁcance (group, F2,27 = 2.00, NS).
Movement time latencies were differently affected between the
groups post-graft (group, F2,27 = 5.96, P < 0.01) and were different
between the sides of testing (side, F1,27 = 8.22, P < 0.01). The
interaction effect between sides and groups failed to reach statistical
signiﬁcance (side 9 group, F2,27 = 2.77, P = 0.083). However,
overall movement time latencies were slower for both lesion groups
than for the control group (both, t28 > 5.34, P < 0.01). There was
no difference between the lesion and the graft groups post-graft
(t28 = 0.58, NS). Also, at the second week of post-graft testing, the
effects of movement time were similar to those in the ﬁrst week,
with a difference in response times between groups (group,
F2,27 = 13.36, P < 0.001), and both lesion groups taking longer to
respond (both, t > 3.50, P < 0.05). Although grafted mice
responded marginally faster than mice of the lesion group, this dif-
ference did not return signiﬁcant from the post hoc analysis
(t28 = 1.43, NS). Movement times during the second week post-graft
were still slower when responses had to be made on the side contra-
lateral to the lesion (side 9 group, F2,27 = 6.17, P < 0.01). Ipsilat-
eral responses were slower for both lesion groups than for the
control group (all, t28 > 3.74, P < 0.05), and the lesion group
responded signiﬁcantly more slowly than the graft group
(t28 = 3.00, P < 0.05). For contralateral movements, the lesion
groups responded signiﬁcantly more slowly than the control group
(both, t28 > 8.08, P < 0.01), with the lesion group responding more
slowly than the graft group (t28 = 3.34, P < 0.05).
Probe trials
During the last week of testing, we increased the duration of the lat-
eralised stimulus light to 5 s (the length of the limited response
time), which was longer than the animals’ movement time during
the standard conﬁguration. We assumed that this would decrease
task demand, as the mice could use the light as a beacon to guide
their responses to the correct location.
Although all mice produced more usable trials than during testing
with the standard conﬁguration, there was still a difference in the
number of usable trials produced (Fig. 4A; group, F2,27 = 16.16,
P < 0.001). Both lesion groups produced signiﬁcantly fewer trials
than the control group (all, t28 > 5.63, P < 0.01). Although, as dur-
ing standard testing, grafted mice produced a higher number of
usable trials than the lesion groups, this difference did not reach sta-
tistical signiﬁcance during post hoc testing (t28 = 2.78, NS).
Response accuracy was also different during probe testing (Fig. 4B;
group, F2,27 = 5.80, P < 0.01), with, interestingly, both the control
group and the graft group performing with similar accuracy (t = 0.62,
NS), and both groups differing signiﬁcantly from the lesion group
(both, t > 3.95, P < 0.01). Response accuracy was, as previously,
affected differently, depending on the side of stimulus presentation
(Fig. 5A; side 9 group, F2,27 = 6.34, P < 0.01). Whereas there were
no signiﬁcant differences on the ipsilateral side of testing between any
of the three groups (all, t28 < 1.92), response accuracy on the contra-
lateral location was signiﬁcantly impaired for the lesion group as com-
pared with the control group and the graft group (both, t28 > 5.31,
P < 0.01). Interestingly, the graft group did not differ signiﬁcantly in
Table 1. Procedural errors on the choice reaction time task
Control Lesion Graft F2,27 P
Premature withdrawal (%)
Baseline 8.91  0.48 7.51  0.47 10.16  0.79 1.95 NS
Lx 9.80  0.60 10.47  1.01 13.00  1.18 1.74 NS
Tx1 9.82  0.56 10.44  0.96 10.88  1.01 0.12 NS
Tx2 9.98  0.70 13.73  0.96 12.52  1.01 0.16 NS
Perseverative centre poke (%)
Baseline 7.13  0.54 7.20  1.40 6.18  0.56 0.21 NS
Lx 9.78  1.80 61.31  18.00** 61.06  9.03** 4.19 < 0.05
Tx1 8.00  0.62 47.15  10.69* 39.48  7.72* 4.21 < 0.05
Tx2 6.87  1.41 80.18  22.21 38.26  6.97 2.48 NS
Omission (%)
Baseline 0.78  0.10 0.76  0.30 0.82  0.19 0.01 NS
Lx 4.93  3.70 77.15  9.91** 79.41  12.30** 5.72 < 0.01
Tx1 0.82  0.24 77.55  10.24** 35.94  5.73**/†† 7.12 < 0.01
Tx2 0.38  0.27 47.20  8.74** 17.46  4.00† 5.84 < 0.01
Lx, post-lesion; Tx1, ﬁrst week of post-graft testing; Tx2, second week of post-graft testing; NS, not signiﬁcant. Statistical analysis has been restricted to the
individual weeks, as the interaction effect (week 9 group) had only borderline signiﬁcance (P = 0.053). Signiﬁcant group effects are presented per week of test-
ing. Bold numbers denote signiﬁcantly different groups, with the number of symbols denoting differences at the P < 0.05 (for one symbol) and P < 0.01 (for
two symbols) levels, respectively. *Signiﬁcantly different from control. †Signiﬁcantly different from lesion.
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contralateral response accuracy from the control group (t28 = 1.87,
NS). As previously, reaction time performance was not signiﬁcantly
different between any of the three groups (Figs 4C and 5B; group,
F2,27 = 2.37, NS). In contrast to reaction time, the time taken to exe-
cute the lateralised response was differently affected between the
groups (Fig. 4D; group, F2,27 = 13.52, P < 0.001). Whereas the graft
group did not respond signiﬁcantly more slowly than the control
group (t28 =2.68, NS), the lesion group showed overall increased
movement times as compared with the control group (t > 5.43,
P < 0.01), but not as compared with the graft group (t28 = 2.75, NS).
The deﬁcit in movement time was lateralised, with responding to the
side contralateral to the lesion being more impaired (Fig. 5C;
side 9 group, F2,27 = 11.16, P < 0.001). When the response had to
be directed towards the side ipsilateral to the lesion, there was no sig-
niﬁcant difference in movement time latencies between the groups
(all, t28 < 1.47, NS). When a contralateral response was required, both
lesion groups responded more slowly than the control group (both,
t28 > 3.47, P < 0.05), and the graft group was less impaired than the
lesion group (t28 = 7.43, P < 0.01).
Simple behavioural screen results
Rotations
Amphetamine-induced rotations. Amphetamine-induced rotations were
different after the lesion (Fig. 6A; group, F2,27 = 5.53, P < 0.01),
A
B
C
Fig. 3. Main effects on the lateralised choice reaction time task by side of response for contralateral and ipsilateral responses, respectively. Data were collated
over 5 days per block at baseline, at post-lesion (Lx), and at the ﬁrst (Tx1) and second (Tx2) weeks of post-graft testing. Note that simple effects are only anal-
ysed when signiﬁcant interactions have been found in the ANOVA; that is, although differences in reaction time seem to be lateralised in the graph, the overall
ANOVA did not show a signiﬁcant week 9 group 9 side interaction. The number of symbols denotes signiﬁcant differences at the P < 0.05 (for one symbol)
and P < 0.01 (for two symbols) levels of signiﬁcance for post hoc tests conducted after signiﬁcant main effects were reported. Asterisks denote signiﬁcant dif-
ferences from the control group, and hashes denote signiﬁcant differences from the lesion group. The task parameters analysed were: (A) response accuracy on
correct trials (B) reaction time on correct trials; and (C) movement time latencies on correct trials.
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with both lesion groups rotating signiﬁcantly more towards the side of
the lesion than the control group (both, t > 4.68, P < 0.01). After
grafting of one group with dopamine-rich tissue, the difference
between the three groups failed to reach statistical signiﬁcance (group,
F2,27 = 2.73, P < 0.1).
Apomorphine-induced rotations. Apomorphine-induced rotation assess-
ment was only conducted post-graft. There was a difference between
the three groups in the number of rotations per minute (Fig. 6B;
group, F2,27 = 6.65, P < 0.01). The lesion-only group rotated signiﬁ-
cantly more when challenged with apomorphine than untreated mice
of the control group (t28 = 5.62, P < 0.01). Mice of the graft group
rotated signiﬁcantly more than mice of the control group (t28 = 3.20,
P < 0.05), and although they rotated less than mice of the lesion
group, this difference did not reach statistical signiﬁcance (t28 = 2.42,
NS).
Rotarod
As in previous reports (Heuer et al., 2012b), unilateral lesions to the
MFB impaired rotarod performance (Fig. 6C; group, F2,27 = 9.96,
P < 0.001), with both lesion groups having a shorter latency to fall
than the control group (both, t > 5.38, P < 0.01). There was a signiﬁ-
cant interaction between group and week of testing (week 9 group,
F2,27 = 3.66, P < 0.05); after grafting, the graft group performed sig-
niﬁcantly better than the lesion-only group (t28 > 4.35, P < 0.01).
Corridor
After the lesion, there was a signiﬁcant difference in the percentage
of pellets retrieved (Fig. 6D; group, F2,27 = 8.94, P < 0.001). Mice
of the lesion group were signiﬁcantly more biased to retrieve pellets
from the ipsilateral side than mice of the control and graft groups
(both, t28 > 3.88, P < 0.05). Mice that received grafts were less
impaired than mice of the lesion group, and the difference from the
control group did not reach statistical signiﬁcance (t28 = 2.37, NS).
Discussion
In the present study, we aimed to assess the effects of primary fetal
tissue grafts rich in dopamine on a series of simple and complex
behavioural tasks in the unilateral 6-OHDA mouse lesion model of
PD. We found that the lesion-induced deﬁcits were similar to those
reported previously, in that the unilateral lesion caused contralateral
deﬁcits and impaired task performance on all tests evaluated. Fur-
thermore, VM grafts provided partial amelioration of a subset of the
deﬁcits. The effects of the graft were larger when task demands
were reduced on the operant task.
Lesion-induced deficit
Injections of the neurotoxin 6-OHDA into the MFB led to a deple-
tion of TH-ir cells in the SN and the VTA on the side of injection,
as in previous reports (Grealish et al., 2010b; Francardo et al.,
2011; Heuer et al., 2012a,b; Smith et al., 2012a,b). The lesion
caused a subsequent depletion of dopamine as determined via the
TH marker in the striatum, the nucleus accumbens, the olfactory
tubercle, and the prefrontal cortex.
Post-lesion assessment of behavioural performance on the oper-
ant task showed a reduction in the number of usable trials, an
increase in movement time latencies, more errors in the form of
omission of the lateralised response, and a deﬁcit in response accu-
racy, which was more pronounced when responses had to be made
to the side contralateral to the lesion. All deﬁcits on the operant
A B
C D
Fig. 4. Main effects of the probe trial. Stimulus duration was increased to 5 s to reduce demand on working memory. All mice produced more usable trials
(A) and response accuracy (B). Note that the graft group did not perform signiﬁcantly different from the control group. As during testing with the standard con-
ﬁguration, the lesion did not signiﬁcantly affect reaction time performance (C) and, furthermore, grafted mice were not slower in executing the lateralised
response than mice of the control group (D). Asterisks denote signiﬁcant differences from the control group, and hashes denote signiﬁcant differences from the
lesion group, both at P < 0.01.
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task were stable on sub-acute and chronic testing. The lesion-
induced deﬁcits were similar in all parameters to those in previous
studies using the same experimental setup in mice (Heuer et al.,
2012a) and rats (Dowd & Dunnett, 2004, 2005a,b). The largest
difference between the lesion-induced deﬁcits between the two spe-
cies is the lack of reaction time deﬁcits in the mouse, although
these have been reported in the rat, irrespective of whether testing
was conducted in the Skinner box apparatus or the nine-hole box
(Dowd & Dunnett, 2004; Heuer & Dunnett, 2012; Heuer et al.,
2012a). In the present study, an overall increase (not lateralised) in
reaction time latencies was reported in the ﬁrst week post-lesion
and the ﬁrst week post-graft. Although lesioned mice in this and
previous studies showed increased reaction times, the difference
was often not signiﬁcant. The main reason is the large variability
in the reaction time data, relative to other parameters. Furthermore,
longer delay periods may tease out reaction time difference, but
with the cost of having a smaller number of usable trials. The
large reduction in the number of usable trials is an additional fac-
tor that needs to be considered when interpreting the data of the
operant task, as the substantial depletion does certainly cause wide
impairment in a number of parameters involving motivation and
attention. However, the response proﬁle of the lesion is stable over
the weeks of testing, and although lesioned animals make fewer
responses, their pattern of responding is highly stable. Previous
studies have reported a similar decline in the number of trials
started and number of trials usable in rats and mice that were
tested on operant tasks (Dowd & Dunnett, 2004; Heuer & Dun-
nett, 2012; Heuer et al., 2012a).
Previous studies with the nine-hole box, using similar lesions in
rats, reported an interesting phenomenon when lesioned animals
were ﬁrst re-introduced into the operant chambers. In the ﬁrst ses-
sions of post-lesion assessment, the contralateral deﬁcit in response
accuracy was not present from the start, but, rather, gradually devel-
oped over the ﬁrst few days (Dowd & Dunnett, 2004, 2007). Even
when testing was interrupted and animals were re-introduced to the
boxes 12 weeks post-lesion, the deﬁcit, which had been established
at sub-acute testing, re-emerged and, as previously, gradually devel-
oped over the course of testing (Dowd & Dunnett, 2004, 2007). It
was argued that such an ‘extinction-like’ response proﬁle suggests a
reward-signalling function of the nigro-striatal pathway (Schultz
et al., 1997; Schultz, 2000; Dowd & Dunnett, 2007). Whereas stria-
tal dopamine is not necessary for the execution of the lateralised
A
B
C
Fig. 5. Main effects of probe trial testing presented per side of response. Whereas there was no difference in response accuracy on the ipsilateral side (A), on
the contralateral side grafted mice performed with similar response accuracy to mice of the control group. Reaction time performance was not affected by the
lesion on either side of testing (B). Movement time latencies were only increased when mice responded on the side contralateral to the lesion, with both lesion
groups showing increased response latencies as compared with the control group, but the graft group responding faster than the lesion-only group (C). The num-
ber of symbols denotes signiﬁcant differences at the P < 0.05 (for one symbol) and P < 0.01 (for two symbols) levels of signiﬁcance, respectively. Asterisks
denote signiﬁcant differences from the control group, and hashes denote signiﬁcant differences from the lesion group.
© 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd
European Journal of Neuroscience, 37, 1691–1704
1700 A. Heuer et al.
response, but for the maintenance of the stimulus–response associa-
tion governing the lateralised response, the ‘extinction-like’ effect
seen after unilateral dopamine depletion resembled the extinction
curve seen after one side was not rewarded (Dowd & Dunnett,
2007). As in our previous study (Heuer et al., 2012a), we did not
ﬁnd this ‘extinction-like’ effect in our current study. The reasons for
this are not clear, but might be dependent on task parameters and
conﬁguration, because, with a different response conﬁguration in the
same apparatus, a smaller effect of day was present during acute
post-lesion assessment (Heuer et al., 2013), whereas no effect of
day was observed with similar lesions when rats were tested in the
Skinner box apparatus (Heuer & Dunnett, 2012).
In addition to the operant assessment of the lesion-induced deﬁ-
cits, we investigated the behavioural performance on a number of
simple tests of spontaneous motor function. When challenged with
the dopaminergic stimulant methamphetamine, mice showed the typ-
ical rotational response towards the side of the lesion, conﬁrming
the imbalance in striatal dopamine (Ungerstedt & Arbuthnott, 1970;
Torres & Dunnett, 2007). The average rotational response (6 r.p.m.)
was in between those in previous studies using similar lesions
[> 3 r.p.m. (Heuer et al., 2012b) and > 8 r.p.m. (Brundin et al.,
1986; Heuer et al., 2012a)], but lower than with lesions to the cell
bodies in the SN or the terminals in the striatum (Grealish et al.,
2010b; Heuer et al., 2012b). The reason for the reduction in
amphetamine-induced rotations after bundle lesions is thought to lie
in the substantial degeneration of cells in the VTA and the subse-
quent depletion of dopamine in the nucleus accumbens. Rats with
striatal lesions that received additional, bilateral, lesions to the
nucleus accumbens rotated less than those with striatal lesions alone
(Kelly & Moore, 1976, 1977), a phenomenon that is well known in
the rat (Kirik et al., 1998; Torres & Dunnett, 2007; Grealish et al.,
2008). Dopamine in the nucleus accumbens is thought to drive/acti-
vate general activity, as lesions to this area resulted in a reduction in
the number of trials initiated in rats and mice (Cousins & Salamone,
1996; Dowd & Dunnett, 2004; Heuer et al., 2012a; Heuer & Dun-
nett, 2013), as well as in reduced locomotor activity. In addition to
the drug-induced rotational testing, we investigated the effects of the
lesion on the rotarod test, one of the simple motor tests that is most
frequently used in mice, and on the corridor test, which has recently
been translated and characterised for unilateral mouse lesion models
of PD (Dowd et al., 2005; Grealish et al., 2010b; Heuer et al.,
2012b). Both tests have previously been shown to be sensitive for
detecting clear behavioural deﬁcits in mice with unilateral 6-OHDA
MFB lesions (Heuer et al., 2012b). Indeed, both tests reveal stable
deﬁcits, with shorter latencies to stay on the rotating rod and a pro-
found ipsilateral bias on the corridor test.
Graft-induced recovery
Some of the profound deﬁcits that were induced by the lesions
could be ameliorated by grafts of dopamine-rich tissue harvested
from the developing VM. The grafts had similar numbers of surviv-
ing TH-ir cells as in a previous study in mice (Smith et al., 2012b),
whereas other studies have not quantiﬁed surviving cell numbers of
intra-striatal grafted cells derived from primary mouse fetal tissue
(Brundin et al., 1986; Low et al., 1987; Shimizu et al., 1988).
Recent reports of good graft survival and re-innervation when grafts
were aimed at the SN are difﬁcult to compare with the present para-
digm, as here the cells were not grafted into their original environ-
ment (Thompson et al., 2009). The ﬁnal cell number (1649  342
TH-ir cells) was higher than in a recent report (800 TH-ir cells),
where the graft was effective in compensating for the amphetamine-
A B
C D
Fig. 6. Tests of simple motor behaviour. Mice of both lesion groups showed turning behaviour towards the side of the lesion (A) when challenged with
amphetamine after the lesion. After grafting of one of the lesion groups, the difference in rotational response between any of the three groups was no longer sig-
niﬁcant. Apomorphine-induced rotations conducted post-graft were higher for both lesion groups than for the control group, but were somewhat reduced for
mice that were grafted (B). Whereas both lesion groups were impaired on the rotarod (C) and corridor test (D) after the lesion, mice that were grafted improved
in their performance after the grafting. The number of symbols denotes signiﬁcant differences at the P < 0.05 and P < 0.01 levels of signiﬁcance, respectively.
Asterisks denote signiﬁcant differences from the control group, and hashes denote signiﬁcant differences from the lesion group.
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induced rotational behaviour and graft induced dyskinesias in
response to an amphetamine challenge (Smith et al., 2012b).
When discussing the effects of grafts, three factors are important:
(i) the model used (ii) the placement of the graft; and (iii) the donor
tissue. Here, we used a bundle lesion model which, as discussed
above, depletes dopamine not only from the striatum, but also,
among other structures, from the nucleus accumbens, the olfactory
tubercle, and the prefrontal cortex. These structures are important
for optimal performance on the task, as mice use their olfactory
sense to explore the world, the nucleus accumbens has classically
been implicated in motivation and reward (Fink & Smith, 1980;
Cousins & Salamone, 1994, 1996; Salamone et al., 1994; Cousins
et al., 1996, 1999; Nicola, 2007), and mice use the prefrontal cortex
in planning and decision-making (Joel & Weiner, 1994; Joel et al.,
1997; Birrell & Brown, 2000; Robbins, 2002; Chudasama et al.,
2003; Dunnett et al., 2005). Restoring dopamine levels via cell
grafting into the striatum will not alleviate all deﬁcits. Furthermore,
in the present paradigm, cells were not grafted into their original
environment, but rather ectopically. The current model provided re-
innervation of TH-ir ﬁbres and re-introduction of cells that release
dopamine into the depleted areas, but grafting with these parameters
does not allow for a full reconstruction of the original circuitry that
is lost as a result of the lesion. Recent reports have shown that the
A9 type of dopaminergic cells constitutes the important component
of a graft for behavioural recovery (Thompson et al., 2005, 2009;
Grealish et al., 2010a). In the current model, we grafted cells from
the whole developing VM, and therefore a mixture of cells, not all
of which will even be dopaminergic.
Despite this, primary fetal tissue grafts were able to ameliorate
the lesion-induced deﬁcit on multiple parameters in the simple and
more complex tests of motor function that were employed in the
present study. On the operant task, mice that received grafts
improved in their contralateral response accuracy and showed mar-
ginally faster movement times than their lesioned counterparts. Fur-
thermore, they also made fewer omission errors than mice of the
lesion group. When the task demand was reduced by increasing the
stimulus duration, response accuracy was not signiﬁcantly different
from that in controls. This effect of the graft was therefore stable
and different from the effect of lesion only for at least 15 consecu-
tive days of testing (2 9 5 standard and 1 9 5 probe conﬁguration).
In a previous investigation of primary fetal tissue in the rat, using a
similar task, the effect of the graft on response accuracy was differ-
ent from lesioned rats for only 10 days. After longer testing,
lesioned rats improved so much that the difference from the grafted
group was no longer signiﬁcant (both groups at 50% contralateral
accuracy), whereas the graft led to sustained improvement on other
parameters (trials attempted, premature withdrawals, and movement
time) (Dowd & Dunnett, 2004). Furthermore, in the present study,
contralateral response accuracy was increased to > 70% at the sec-
ond week under the standard conﬁguration and to > 89% under the
probe conﬁguration. One of the major advantages of operant testing
is that task demand and difﬁculty can easily be adapted to tease out
differences between respective groups of animals and interventions.
The signiﬁcant difference in movement time has to be taken care-
fully, as both lesion groups already differed signiﬁcantly on this
parameter during post-lesion assessment. This was because of the
removal of mice owing to incomplete lesions and/or grafts. Grafted
mice did rotate less than lesioned mice on both the amphetamine-
induced and the apomorphine-induced rotation tests, although the
difference failed to reach statistical signiﬁcance. Moreover, the fail-
ure to detect signiﬁcant graft effects on drug-induced rotation, a test
that is particularly sensitive to graft-mediated recovery in rats,
suggests species differences that may reﬂect practical/physical difﬁ-
culties in the automated monitoring of rotation in mice, rather than
fundamental differences in the underlying pathways of motor con-
trol. Rotation analysis in mice is more variable than in rats, and dif-
ferent methods are used. Some studies used video-tracking in an
open ﬁeld (Francardo et al., 2011), or video-recording and post hoc
scoring (Smith & Heuer, 2011; Smith et al., 2012a), whereas others
used automated rotometer bowls (Grealish et al., 2010b; Heuer
et al., 2012a). Furthermore, other factors that are not uniformly
applied are the method of restriction (harness vs. elastic band), the
shape of the environment (glass cylinder vs. bowls), the size of the
mouse, and the volume and concentration of injection (Smith &
Heuer, 2011). Mice that are restrained too much might not move or
freeze, whereas those that are not restrained enough might escape
from the harness/elastic band. Many of these problems are not pres-
ent in the rat, and, if not obtained in a free-moving animal, rota-
tional data might be under-estimated.
In addition to the drug-induced tests, we analysed the effects of the
graft on the corridor test and the rotarod test. Grafted mice improved
in their performance as compared with lesioned mice and their own
post-lesion scores. The corridor test has been shown to be sensitive for
detecting dopamine depletion and graft-induced recovery in the unilat-
eral rat model (Dowd et al., 2005; Torres et al., 2008). After a recent
characterisation of the corridor task in SN-lesioned mice (Grealish
et al., 2010b) and subsequent assessment in MFB-lesioned mice
(Heuer et al., 2012b), we report here that, as in the rat, the ipsilateral
deﬁcit can be reduced by the graft. The rotarod is one of the standard
tests used to assess general motor function, strength and balance in
mice, and was shown to be sensitive to the effects of dopamine cell
replacement in rat models of PD (Rozas & Labandeira Garcia, 1997).
Here, we report similar results, in that grafted mice stayed longer on
the rotating drum than their lesioned counterparts.
Conclusion
In the present study, we have presented a characterisation of lesion-
induced deﬁcits on a series of simple and more complex tests of
motor function. Lesions produced impairments on all tasks, which
were largely lateralised, revealing an impairment in the ipsilateral
striatum. Grafts of dopamine-rich tissue were able to ameliorate
some, but not all, of the deﬁcits; most notable were the improve-
ments in contralateral response accuracy and rotarod and corridor
performance. Both the operant task and the rotarod and corridor
tests can be used as drug-free alternatives to assess the effects of
cell replacement therapies. Whether novel cell sources can provide
improvement of function on more complex behavioural tasks, such
as the one presented here, will have to be investigated in the future.
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4.1 Summary 
 
The main goal of the series of experiments presented in this thesis was to 
characterise the effects of unilateral 6-OHDA lesions in rodent models of PD on 
complex behavioural tasks for cell replacement therapies. I have shown that it is 
feasible to use the classical choice reaction time task in the Skinner box apparatus, 
rather than the 9-Hole box (Chapter 3.1) and that the deficit induced by 6-OHDA 
lesions causes an impairment in directing responses into far contralateral space, 
regardless of the exact spatial position of the two response options (Chapter 3.2 and 
3.3). The lateralised choice reaction time task, and novel versions thereof, are 
suitable in combination with the bundle lesion model to reveal lasting deficits that are 
not prone to spontaneous recovery in the rat. Engraftment of DA rich fetal tissue was 
able to ameliorate some, but not all of the deficits induced by the lesion.  In a second 
strand of experiments three different unilateral mouse lesion models were 
characterised using a bank of simple behavioural tests (Chapter 3.4). Two of the 
models (SN and MFB) produced larger lesions than the terminal lesion model and 
were subsequently used for a first translation of the lateralised choice reaction time 
task to a mouse model (Chapter 3.5). Again, the bundle lesion model produced a 
lasting impairment. Subsequently it was shown that engraftment of DA rich fetal 
tissue was able to ameliorate some of the lesion-induced deficits in the mouse as 
well (Chapter 3.6). Further improvements in grafting technique, cell survival, and re-
innervation might lead to improved recovery of function. We have shown that 
complex behavioural testing is feasible and necessary for the assessment of cell 
replacement therapies. In the following discussion the main findings of the presented 
experiments will be discussed. 
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General discussion 
This general discussion will be split into two parts. In the first few pages, I summarise 
the research presented in this thesis. In the latter part, I discuss a few thoughts on 
cell replacement therapy, methods of grafting and the choice of behavioural models.  
 
The thesis findings  
More work has been conducted on the rat model of dopamine depletion, compared to 
the mouse, and typically, tests of simple motor function, not higher cognitive function, 
are employed to investigate the effects of cell replacement therapies. With new 
transplantation trials quickly approaching and the development of novel cell sources 
being a primary research focus, it is only a matter of time before stem cell-derived 
sources will become available to replace the current ‘gold standard’ of primary fetal 
tissue.  
 
Whereas the expression of specific biomarkers is certainly important in determining 
optimal cell lines for therapy, it is also important to index simple motor behaviours, 
such as overcompensation of the rotational response to amphetamine, as a proof of 
a surviving and connecting graft. Moreover, investigations of the impact of cell 
replacement therapies on non-motor and higher cognitive function is critical. Thus, it 
is imperative to characterise fully the lesion models they are tested on and, 
furthermore, to investigate the deficits that these cell replacement therapies 
can/cannot ameliorate. The ultimate question will then be of how these novel cell 
sources compare to the ‘gold standard’ primary fetal tissue.  
 
The experiments presented in this thesis were aimed at the characterisation of 
lesion-induced deficits on more complex behavioural tasks of motor and cognitive 
function for the purpose of the assessment of cell replacement therapies. In the 
unilateral 6-OHDA lesion model of PD so far operant assessment of primary fetal rat 
tissue grafts has utilised choice reaction time tasks. Therefore I aimed to utilise 
versions of the lateralised choice reaction time task to investigate the lesion-induced 
deficits and the potential of cell replacement therapies to alleviate the deficit. As 
interest in mouse models has increased over recent years, and these have not been 
sufficiently characterised, I aimed to assess basic and more complex lesion-induced 
deficits. After comparing three types of lesions along the nigro-striatal pathway on a 
histological and behavioural level, I investigated two of the models that produced the 
largest depletion on the mouse version of the lateralised choice reaction time task. 
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Once the basic task parameters and the lesion-induced deficit were assessed on the 
task I conducted a primary grafting experiment to show that primary fetal tissue grafts 
are able to ameliorate the lesion induced deficit in a similar way to the rat.  
 
The first manuscript ‘unilateral 6-OHDA lesions induce lateralised deficits in a 
‘Skinner box’ operant choice reaction time task in rats’ translated choice reaction time 
task from the most commonly used rat lesion model of PD from the 9-hole box to the 
Skinner box. Whilst even in behavioural laboratories the 9-hole is a rather esoteric 
piece of equipment, the retractable lever Skinner box is more widely available. The 
lateralised choice reaction time task has been used in the Skinner box previously 
utilising intra-striatal excitotoxin infusion as a model for HD, but DA depletion via 
unilateral 6-OHDA infusion to the MFB has, to our knowledge, never been attempted.  
 
Whereas an earlier study had shown that lesioned animals do display spontaneous 
recovery on the Skinner box version of the lateralised choice reaction time task 
(Heuer & Dunnett, unpublished observation), in the present manuscript surgical and 
task parameters have been adapted to produce lesions that resulted in a stable and 
chronic deficit in dopamine-depleted rats. The failure of previous experiments was 
mainly due to incomplete lesions and differences in task design/parameters. Firstly, 
during an initial experiment using exactly the protocol described by Döbrössy and 
Dunnett (1997), rats that were lesioned via unilateral 6-OHDA infusion into the MFB 
did recover on their accuracy within three weeks of post-lesion testing, despite all 
lesioned rats displaying initial impairments during the first week of testing after the 
lesion. Although the data provided some insights into the neuronal function of DA, as 
the main aim of the present work was to assess the viability of complex behavioural 
tests for assessing cell replacement therapy, the recovery seen made this 
impossible. In our laboratory and other groups the success of the unilateral 6-OHDA 
MFB lesion using this protocol dropped substantially and the recovery seen above 
could be ascribed to incomplete lesion (Torres et al., 2011). With the readjustment of 
the lesion co-ordinates, keeping all other parameters the same (concentration, flow-
rate, volume, cannula size), we achieved a > 90% lesion success rate in the 
subsequent experiments presented in this thesis. The second parameter that was 
changed in respect to the previously mentioned study was the duration of the 
lateralised stimulus light. Whereas in the previous studies the light was signalling the 
correct response until a response had been made (5 sec) (Dobrossy & Dunnett, 
1997; 1998), in the current experiment the stimulus duration was limited to 1 sec. 
This reduction is thought to increase demands on working memory as the rat has to 
 134 
keep the location of the stimulus in mind, rather than being able to rely on the 
stimulus light being used as a beacon. We have shown that under these parameters, 
the lateralised choice reaction time task conducted in the Skinner box apparatus is a 
powerful tool for the analysis of lesion-induced deficits. The results obtained are 
comparable to the deficits reported when experiments had been conducted in the 9-
hole box.  
 
A previous comparison between the two boxes had shown that the task can be used 
in principle, but was less sensitive in measuring deficits in reaction time, when 
assessing the effects of intra-striatal quinolinic acid lesions as a model of HD 
(Brasted et al., 1998). In the present experiment (Chapter 3.1) we reported a deficit in 
all parameters, including reaction time performance (Heuer & Dunnett, 2012) giving 
further support to the sensitivity of the Skinner box apparatus with the current 
configuration. All deficits were stable sub-acute and long-term, making the 
task/apparatus useful as a tool for the assessment of cell replacement therapies. 
  
In the second manuscript ‘Dopamine-rich grafts alleviate deficits in contralateral 
response space induced by extensive dopamine depletion in rats’ we characterised 
further the lesion-induced deficit on a version of the lateralised choice reaction time 
task. Previous studies have shown the effect of contralateral impairments in 
response accuracy in the 9-hole box that we reported in the Skinner box in chapter 
3.1 (Carli et al., 1985; Carli et al., 1989; Dowd & Dunnett, 2004; 2005a; b). 
Furthermore, when rats were presented with a near and a far response location, 
rather than responses being presented to either side of the animals’ head, intra-
striatal administration of 6-OHDA led to a neglect of the far contralateral response 
whilst responding to the near contralateral side was intact (Brown & Robbins, 1989b). 
Lesions made ipsilateral to the side of testing did not have any statistical significant 
effect on main task parameters intact (Brown & Robbins, 1989b). This version of the 
task provided a more in-depth analysis of the lesion-induced deficit as it measures an 
additional dimension to the standard bilateral two choice condition. In order to employ 
this task for the assessment of cell replacement therapies, we needed to characterise 
it for the bundle lesion model and to show that the lesion induced deficit is stable 
over long-term testing, since terminal lesions were employed in the Brown and 
Robbins (1989) study. Terminal lesions are in general less complete than infusions to 
the MFB as they largely spare most cells in the VTA as well as some nigral cells, 
whereas MFB lesions will produce a near complete loss of nigral neuons as well as 
substantial VTA loss when targeted correctly. Terminal lesioned rats have been 
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shown to be prone to spontaneous recovery on the standard configuration of the 
choice reaction time task, as discussed above (Dowd & Dunnett, 2005a). In the 
submitted manuscript we showed that (i) the lesion produces a deficit that is similar 
to that reported after terminal lesions (Brown & Robbins, 1989b), although we 
reported an impairment on the ipsilateral side of the lesion as well (Heuer et al., 
2013a); (ii) the lesion-induced deficit was stable during both acute post-lesion and 
long-term assessment. Even after 50 consecutive days of testing there was no sign 
of recovery on any of the parameters assessed. As discussed above, the lack of 
spontaneous recovery is imperative to assess the effects of cell replacement 
therapies so that the beneficial effects of the graft are not obscured. Although the 
effects of the graft do encompass more parameters than response accuracy, this 
parameter is one of the most interesting as it represents recovery of a deficit that is 
not primarily motor or sensory in nature. In one study published on the effects of 
nigral grafts in standard configuration of the lateralised choice reaction time task, the 
effect of response accuracy seems to be different from lesioned rats only for 10 days 
of long term testing (see Dowd and Dunnett, 2004). However, rats of the lesion group 
did exhibit some recovery over the last two days of testing, so that the difference to 
the graft group was not significant, despite the near-complete lesion (Dowd & 
Dunnett, 2004). We have shown here that the current adaptation of the lateralised 
choice reaction time task, including a near and far response location, is sufficiently 
sensitive to reveal a stable effect of the lesion as well as to separate lesioned and 
grafted rats on multiple parameters. Rats that were grafted with DA-rich fetal cells 
attempted more trials, produced a higher number of correct responses to the 
previously neglected, contralateral far response location and displayed movement 
time latencies not significantly different from the control group. The grafts also had an 
effect on ipsilateral accuracy. The contralateral near hole bias displayed by lesioned 
rats was not affected by variations of the stimulus duration or by shifting the response 
location. Although grafted animals do not recover to the level of controls, the 
improvement by the grafts is remarkable, as lesioned rats do produce very few 
responses to the contralateral far hole. This is, to our knowledge, the first study 
assessing the sensitivity of this type of choice reaction time task in MFB lesioned rats 
and grafted rats and will therefore serve as a guide for future studies.  
 
In the third manuscript ‘Characterisation of spatial neglect induced by unilateral 6-
OHDA lesions on a choice reaction time task in rats’ we investigated an interesting 
phenomenon that emerged from the previous experiments. Although rats were tested 
over more than 50 consecutive days, lesioned rats did not recover on their far 
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contralateral response accuracy. Although we did not expect full recovery, some 
improvements with repeated testing were anticipated. Furthermore, lesioned rats in 
experiment 1 not only displayed a contralateral accuracy deficit, but when they 
responded towards the contralateral lever, they did so with a full body turn, rather 
than a direct (and shorter) movement. These two observations led us to speculate 
that lesioned rats adapt their response strategy as a result of the dopamine 
depletion. If rats in experiment 1 biased all their responses towards the contralateral 
near hole they would still get rewarded on 50% of the trials. In experiment number 3 
we implemented an error correction procedure that would present the same trial to 
the rat again, when an incorrect response had been made. Consequently, if the rat 
biases all responses towards the contralateral near hole it will receive no further 
rewards after the first correct response. The results suggest that rats do not display a 
shift in response strategy but rather, as previously suggested, a failure to direct 
responses accurately in far contralateral space (Brown & Robbins, 1989b; Brasted et 
al., 1997; Heuer & Dunnett, 2013), i.e. all lesioned rats continued to display a near-
hole bias when tested on the contralateral configuration. We manipulated the 
configuration further in a series of probe trials which showed that the response deficit 
was irrespective of the absolute position in space, i.e. shifting of the absolute 
response location shifted the deficit and the lesioned rats directed almost all their 
contralateral responses towards the more proximal response location. Furthermore 
there seems to be some overlap between the two striata as no contralateral deficit 
could be detected when the response location was immediately adjacent to the 
centre hole in a simple reaction time setting, but only when the response location 
was further away. However, even when the contralateral response location was most 
distal, the deficit was smaller in a simple reaction time setting when compared to 
when making a less distal choice response. This study gave further insight into the 
lesion-induced deficit and the power of the choice reaction time task (and its 
variations) to investigate DA depletion models in rats.  
 
Thus, the first three experimental chapters presented in this thesis have provided 
further insight into the unilateral 6-OHDA near complete lesion model of PD in the rat. 
The deficits caused by the extensive, near-complete DA depletion (>95%) on the task 
are manifold and encompass motivational, attentional, motor and cognitive processes 
due to the DA depletion in multiple areas of the brain.  
 
The second strand of research in my thesis was concerned with the development of 
the 6-OHDA lesion model of PD in the mouse. Whereas some early studies did use 
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the mouse to model PD (Von Voigtlander & Moore, 1973; Mandel & Randall, 1985; 
1990; Mandel et al., 1992), the majority of studies in the last 40 years have focused 
almost entirely on utilising rat. The major reasons are that rats are relatively easy to 
handle and house and they are more robust to insults than mice. There is also a long 
and rich psychological literature developing a very wide range of tests and tools for 
behavioural analysis in the rat. As a tool for transplantation and to model the DA loss 
of PD the rat lesion model has been the gold standard since the 1960s. On the other 
hand, mice have the advantage that genetic manipulations are more readily 
inducible, e.g. GFP mice can be used as donor tissue to trace grafted fibre 
outgrowth, and mice with specific gene mutations – whether using transgenic, 
knockin, knockout or conditional gene expression technologies – can be combined 
with lesions to mimic different aspects of the disease. In recent years a number of 
studies have revitalised the mouse lesion model of PD (Lundblad et al., 2004; 
Lundblad et al., 2005; Grealish et al., 2010b). With the introduction of intensive post-
operative caring regime mortality rates have been at acceptable levels and mouse 
testing has become more feasible (Francardo et al., 2011; Smith & Heuer, 2011; 
Heuer et al., 2012; Smith et al., 2012a). Whereas previous work has characterised 
one or two aspects of the unilateral 6-OHDA lesion model, no comparison has been 
done with injections to any of the three main sites of the nigro-striatal pathway.  
 
In the fourth manuscript, entitled ‘Unilateral nigrostriatal 6-hydroxydopamine lesions 
in mice I: Motor impairments identify extent of dopamine depletion at three different 
lesion sites’, I have therefore compared the three most widely used nigro-striatal 
lesion models on a series of simple-motor tests. We showed that mice with a loss of 
>80% of TH-ir cells in the SN displayed impairments on the corridor test and rotarod 
apparatus, in addition to amphetamine- and apomorphine-induced rotation tests. The 
results obtained are in line with work that was published shortly after the current 
experiment had been completed (Grealish et al., 2010b). Grealish et al (2010) 
showed that a combination of tests is useful to assess the size of the lesion. Both in 
studies of drug-induced rotation as well as using the cylinder test they were able to 
detect lesion-induced deficits. One recent report by Francardo et al. (2012) does 
provide a comparison of the three lesion models in the development of l-DOPA 
induced dyskinesias, but behavioural assessment was limited to a few simple 
behavioural tests (Francardo et al., 2011). Thus, whereas the former paper (Grealish 
et al., 2010b) only employed one type of lesion (SN) and the latter provides a 
comparison of all three lesion models (Francardo et al., 2011), we here presented the 
behavioural performance of all three lesion types on a wider array of behavioural 
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tests. The results presented can help to guide future studies to choose the best 
lesion mode, depending on investigation, the degree of DA depletion wanted and 
which behavioural test to use to select successfully lesioned mice. The present 
manuscript has shown that mouse models of PD are feasible to use as long as some 
aspects are considered, which will be discussed below.  
  
Firstly, apart from the obvious differences, mice are not just small rats. Thus, mice 
are easier to startle; are more anxious; are less robust to insult; typically exhibit a 
higher mortality after lesion; and they can utilise different strategies on behavioural 
tests such as the Morris water maze (Frick et al., 2000). When conducting 
behavioural testing in mice, greater attention is required to testing procedures to 
achieve optimal performance. Furthermore, whereas unilateral near-complete lesion 
via 6-OHDA infusion into the MFB in the rat virtually never causes mortality, the 
same procedure in the mouse has been reported to cause mortality in some studies 
greater than 80% (Lundblad et al., 2004; Grealish et al., 2010b). In the context of 
animal welfare, ethics and regulation, this is not acceptable as a routine strategy. 
Moreover, whereas rats can be considered more exploratory and display diverse 
foraging and predator-like behaviour, mice certainly exhibit more similarities to a prey 
species, and the resulting differences in species-specific behaviour have to be taken 
into account in the design of appropriate assessments. As shown in manuscript 
number 4, the cylinder test, which is frequently used in the rat, was less sensitive to 
detect lesion-induced deficits, whereas the corridor test, which is not as frequently 
used, does distinguish well lesioned from unlesioned mice.  
 
In the fifth manuscript, entitled ‘Comparison of 6-hydroxydopamine lesions of the 
substantia nigra and the medial forebrain bundle on a lateralised choice reaction time 
task in mice’, we aimed to establish and characterise the classical choice reaction 
time task from the rat to the mouse (Carli et al., 1985; Heuer et al., 2013b; Heuer et 
al., 2013c). We showed that mice, similar to rats, were impaired on a range of 
parameters of performance, including trials usable, response accuracy and 
movement time. As shown previously, bundle lesions produced the more complete 
DA degeneration and subsequent behavioural impairment, compared to the other two 
infusion sites (Dowd & Dunnett, 2005a; b; Heuer et al., 2013b). Although the overall 
impairment was similar between the two species, there were some differences as 
well. Firstly, the deficit in the rat was more lateralised, with no significant impairment 
on ipsilateral response accuracy, whereas in the mouse we reported a bilateral 
impairment that was more pronounced on the side contralateral to the lesion on this 
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task parameter (Dowd & Dunnett, 2005b). Secondly, reaction time was significantly 
increased in the rat whereas in the mice the difference between the bundle lesion 
and the control group failed to reach statistical significance in the post hoc analysis. 
For other task parameters, such as movement time, mice performed with a similar 
pattern as reported for the rat (Dowd & Dunnett, 2005b). Interesting, whereas 
terminal lesioned rats with a 70% reduction in the number of TH-ir cells on the 
lesioned side were not impaired in movement time and only marginally impaired 
during acute post-lesion testing on task accuracy (Dowd & Dunnett, 2005a), SN 
lesioned mice were impaired in the present studies on these task parameters. The 
main difference can be attributed to the larger sparing of remaining TH-ir cells in the 
ipsilateral SN in the rat terminal lesion group, compared to the mouse SN lesioned 
group (<25% TH-ir cells left). Similar to the rat, a deficit that at least encompasses a 
80% reduction will produce stable lesions.  
 
Because of the successful adaptation of the choice reaction time task, in the final 
study presented in the manuscript entitled ‘Behavioural recovery on simple and 
complex tasks by means of cell replacement therapy in unilateral 6-OHDA lesioned 
mice’ I tested whether DA rich fetal grafts can ameliorate lesion-induced deficits in 
mouse PD models similar to the recovery seen in rats. Only few studies have been 
published using primary fetal VM as donor tissue in mice as hosts, and almost all 
focused on drug-induced rotations, rather than drug-free and/or more complex tests 
of motor behaviour. Despite this significant improvement, not all parameters were 
recovered and even though response accuracy increased, the grafted mice still 
performed at a level below that of the control animals. The failure of full recovery by 
primary fetal VM tissue grafted into the denervated striatum will be discussed in 
further detail below. Despite the fact that ‘full’ recovery was not achieved (similar to 
Experiment 3.2), the effects of the graft were remarkable. Although both, the lesion 
and the graft groups, had similar levels of depletion, with a near complete absence of 
TH-ir cells in the SN, the latter group did improve the lesion-induced deficits on a 
number of parameters. These improvements could be detected on simple and 
complex behavioural tests. Specifically, DA-rich grafts led to amelioration on 
contralateral response accuracy on the choice reaction time task as well as improved 
motor function on the rotarod test and the sensori-motor neglect on the corridor test. 
Although grafted animals did not display a rotational bias, unlike lesioned mice, at the 
post-graft time-point, this difference failed to reach statistical significance. This is 
most likely due to the large variation seen in these data. Whereas all other 
parameters measured are analysed of averages of multiple sessions, thereby 
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reducing variability, rotation tests were conducted only the once. In our hands, the 
use of automated rotometer bowls can lead to an underestimation of the actual 
rotation score. Although the use of this automated system makes testing easy and 
quick, it is hampered by the restriction of the animal to the elastic band. Whereas a 
similar procedure in the rat does not seem to affect (or bother) the animal, mice do 
try to escape from the restriction. Therefore the restriction has to be balanced, 
between too loose so the mouse does not escape and too tight so the mouse is not 
restricted in its movement. Videotaping or another restraining method might 
circumvent this problem. From our experience and even the data provided in Chapter 
3.4 and 3.6 mice do rotate, similar to rats, in response to DAergic drugs such as 
amphetamine and apomorphine. Correlations between rotation scores and TH-ir cell 
loss in the ipsilateral SN were not possible due to the small variation in the remaining 
cells as all animals displayed a large loss of the cells. However, on the other tests, 
grafted mice certainly benefitted from the graft for the three weeks of operant testing 
and the week of simple motor behavioural testing. Especially during the probe trial on 
the operant task grafted mice were not significantly different to mice of the control 
group in their movement times and response accuracy, despite lesioned mice 
displaying an impairment on these parameters even under the condition where task 
demand was lower than during the standard configuration. Furthermore grafted mice 
had fewer procedural errors in terms of omissions at both post-graft time points, 
compared to mice of the lesion group. The data presented will provide a baseline of 
simple and complex behavioural test that can be alleviated by a DA-rich graft. 
Alternative cell sources that are currently developed will have to hold up the 
performance of the ‘gold standard’ that has been presented in experimental chapter 
3.6. 
 
Mortality in the unilateral 6-OHDA mouse lesion model of PD 
Whereas the unilateral 6-OHDA lesion is relatively easy to achieve in the rat, similar 
lesions in mice have been hampered for several reasons, but mainly due to the high 
mortality rate that is associated with near complete lesion when the toxin-infusion is 
aimed at the MFB (Lundblad et al., 2004; Grealish et al., 2010b). For the purpose of 
the work presented in this thesis a stable lesion is needed as the aim of the work is to 
characterise tests that are sensitive to detect lesion-induced deficits and subsequent-
induced recovery. Only a lesion that is stable over long term testing will provide the 
baseline against which to measure the intervention. Whereas mortality in unilateral 
lesioned rats is very rare, similar lesions produce a high level of mortality in mice. 
With the introduction of an intensive post-operative caring regime mortality rates 
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could be reduced to an acceptable level (<10%) in our and other studies (Cenci & 
Lundblad, 2007; Francardo et al., 2011; Smith & Heuer, 2011; Heuer et al., 2012; 
Smith et al., 2012a; Smith et al., 2012b; Heuer et al., 2013b). After the lesion, mice 
are prone to dehydration and excessive weight loss can follow, especially in animals 
with a good lesion. Observing the mice in their home cage clearly shows that they 
rotate spontaneously and this rotation is much higher than that of seen in rats 
receiving similar lesions. Mice that attempt to drink and eat from the snout of the 
water bottle or food-pellet hopper rotate away, rather than standing still to feed. 
Furthermore unlesioned/less depleted mice do bully weaker animals away from 
food/water. Three measures have been implemented in the current work which 
allowed us to use the unilateral 6-OHDA MFB lesion model in an acceptable fashion 
in mice; (i) mice were montiored every day for a minimum of 14 days post-lesion to 
detect weight loss early. The researcher then is able to intervene before the critical 
weight has been reached; (ii) mice are closely monitored in their home cages and 
bullied mice are promptly separated from the aggressor; (iii) dehydration and weight 
loss is tackled by daily injections of 0.5ml of glucose-saline solution s.c. three times 
daily and providing the animals with palatable wet mash in multiple containers in their 
home cages 2-3 times daily. This procedure is laborious, especially if large cohorts 
are tested, but after 10-14 days of intensive post-operative care mortality rates can 
be reduced to acceptable levels. However, once these measures are taken, the 
unilateral near-complete mouse lesion provides a powerful model to investigate 
grafting of mouse-derived DAergic stem cells without the need for 
immunosuppression, and can be used as readily in genetically-modified as in 
wildtype animals. A great deal of data has now been accumulated by other groups as 
well as ours to select the appropriate lesion model and to identify behavioural tests 
that are sensitive to detect different degrees of DAergic cell loss in the SN (Lundblad 
et al., 2004; Iancu et al., 2005; Lundblad et al., 2005; Cenci & Lundblad, 2007; 
Grealish et al., 2010b; Smith & Heuer, 2011; Heuer et al., 2012; Smith et al., 2012a; 
Smith et al., 2012b; Heuer et al., 2013b). 
 
Graft placement 
In the present model we grafted tissue into the denervated striatum ectopically rather 
than homotopically into the SN from where the host nigral cells are lost. Although this 
ectopic graft placement does lead to recovery on numerous parameters and tasks, 
as stated above, it only allows for a limited recovery.  
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The lesion used in the present model was chosen mainly because of the stability of 
the lesion and the large depletion of DA that is produced by the current procedure. 
Lesion-induced deficits are stable over long-term testing and therefore behavioural 
recovery by the transplants can confidently be ascribed to the intervention (the graft) 
rather than spontaneous recovery. The downside of the present model is that the 
toxin infusion into the MFB leads to a destruction of cells not only in the ipsilateral SN 
but also to a large degeneration of cells located in the adjacent VTA. The result is a 
depletion of DA from not only the striatum but also from the nucleus accumbens, the 
olfactory tubercle, the thalamus and the prefrontal cortex (Kirik et al., 1998; Dowd & 
Dunnett, 2004; Grealish et al., 2008; Walsh et al., 2011). Grafting into the striatum 
leaves remaining structures without DA and therefore it is unlikely that the graft has a 
(direct) effect on these. Although grafted fetal DAergic cells do re-innervate the 
immediate surrounding host area, usually seen via the TH-ir ‘halo’ that surrounds the 
graft core, the re-innervation is less extensive than is seen in the intact SN, where 
one cell in the SN sends out projections to the striatum where the axon terminals 
undergo massive ramification and form up to 250,000 connections (Yurek & Sladek, 
1990). Primary fetal tissue transplants do form connections with the host tissue 
(Doucet et al., 1989; Doucet et al., 1990). However as allograft re-innervation is 
confined to a relatively small location, Winkler et al. (1999) and others have grafted 
multiple smaller deposits (‘microtranplants’) throughout the striatum in order to 
achieve greater re-innervation (Nikkhah et al., 1993; Nikkhah et al., 1994b; Winkler et 
al., 1999; Nikkhah et al., 2009). Interestingly, intra-nigral transplants alone had some 
effect on postural-balance and skilled forelimb use but the benefits offered by the 
intra-SN graft have never matched the efficacy of grafts placed into the striatum 
(Winkler et al., 1999). Intra-SN grafts of GABAergic cells on the other hand did 
improve behaviour on paw reaching, and this effect was larger than by intra-striatal 
placed grafts of DAergic tissue. By combining the two approaches, GABAergic grafts 
into the SN and DAergic grafts into the striatum led to the best – although still 
incomplete – behavioural recovery (Winkler et al., 1999). Striatal fibre density was 
actually increased to 50% of normal in the caudal striatum, 60% in the nucleus 
accumbens and central striatum and 75% in the rostral striatum. The authors state 
that the re-innervation of TH-ir was between 45% and 80% to that of controls. 
Despite this large re-innervation by microtransplantation and the additional effects of 
intra-SN grafts of GABAergic cells, behavioural recovery was only complete on the 
drug-induced rotation test, with the tests that require a more complex behavioural 
response not recovering to normal, despite large improvements when compared to 
rats of the lesion only group (Winkler et al., 1999). The authors concluded that a 
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minimal re-innervation of 30% of control is necessary to detect functional effects by 
the graft, but that any additional innervation does not lead to greater recovery 
(Winkler et al., 1999). By using the micro-transplantation approach, rather than 
grafting the cells in one large deposit, re-innervation is greater by a factor 2.5 and 
survival by a factor 2.8, compared to the latter approach (Nikkhah et al., 1994b). 
Other double-grafting paradigms, by placing cells simultaneously into the SN and the 
striatum, have been shown to produce greater innervation and faster behavioural 
recovery, although this has only been assessed using drug-induced rotations (Baker 
et al., 2000; Mendez et al., 2000). When assessing lesion-induced deficits and graft-
induced recovery, the majority of studies utilize the drug-induced rotation model. It is 
important to note that, although the rotational response to amphetamine gives a good 
indication of the size of the lesion/nigro-striatal degeneration, graft size does not 
influence the rotational response once a certain number of surviving cells is reached. 
This ceiling effect has been estimated to be about 100-200 DAergic cells necessary 
to reduce the rotational response to amphetamine by 50%. Larger grafts (300-500 
cells) did not produce more alleviation (Brundin et al., 1988). 
 
Interestingly, even though there is a large re-innervation throughout the striatum (up 
to 80% of control in some animals), behavioural deficits were still detectable. This 
further shows that replacing the DA lost is by itself insufficient to induce full 
behavioural recovery. Indeed, a 20% depletion would be difficult to detect and most 
likely be prone to spontaneous recovery (Kirik et al., 1998). In another interesting 
study, the effects of intrastriatal nigral grafts were compared on the extent of the 
lesion (Kirik et al., 2001b). Graft survival and outgrowth was lower in rats with partial 
lesions and graft-induced recovery could actually only be detected in rats that had a 
depletion level of larger than 70% (Doucet et al., 1990; Kirik et al., 2001b). However, 
in rats in which the lesion was confined to the striatum greater recovery could be 
detected (Kirik et al., 2001b). This can be taken as further evidence that the near-
complete lesions produce deficits that cannot be recovered by intra-striatal nigral 
grafts, mainly due to the extra-striatal pathology. Interestingly, these two findings 
pose opposite challenges/opportunities for translation to the clinic. On the one hand 
grafts exert their largest effect when grafted into a partial lesion, in particular when 
DA depletion in the patient is restricted to the striatum. On the other hand, at that 
early stage, due to the remaining DA-innervation, graft survival and fibre outgrowth is 
restricted due to the non-permissive environment (Kirik et al., 2001b). In line with the 
ideas about circuit reconstruction it can be assumed that the tonic DA release by 
ectopically place grafts is necessary, but not sufficient to induce behavioural recovery 
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on more complex tests. Similar to the pharmacological action of l-DOPA, tonically 
released DA does alleviate deficits on simple motor behaviour. Placing the graft 
homotopically into the SN would theoretically circumvent this problem if the graft 
would make the appropriate connections and re-innervations.  
 
Homotopically placed grafts into the SN of rats and mice do survive, although there 
were mixed reports about their axonal outgrowth (Bjorklund et al., 1983b; Dunnett et 
al., 1983a; Nikkhah et al., 1994a; Nikkhah et al., 1995; Winkler et al., 1999; Winkler 
et al., 2000; Thompson et al., 2009; Kauhausen et al., 2013). In most reports fibre 
outgrowth remains in the proximate areas surrounding the graft and does not reach 
the striatum (Nikkhah et al., 1994b; Dunnett, 1999a; Winkler et al., 1999) It has been 
suggested that inhibitory factors prevent grafted tissue to grow the distance to the 
denervated target area (Fawcett, 1997). Interestingly, xenogenic tissue is able to 
grow further suggesting that the inhibitory effect is tissue specific, for example, 
transplanted human dopaminergic fibroblasts were able to grow a distance up to 10 
mm and innervate the striatum, amygdale, frontal cortex and the olfactory bulb. 
(Wictorin et al., 1990a; Wictorin et al., 1990b; Wictorin et al., 1992; Barker et al., 
1999; Barker et al., 2000). Furthermore, the inhibition seems to be specific for adult 
host tissue as transplants that were grafted into neonatal rats did show remarkable 
fibre outgrowth (Nikkhah et al., 1995). This approach led to one of the largest 
behavioural effects reported to date using DAergic cell replacement in 6-OHDA 
lesioned rats. Despite the large recovery on rotation tests and skilled forelimb use, as 
previously, not all deficits were recovered. Bridge-grafts have been used to grow 
axons from the SN along a bridge of Schwann cells into the striatum where their 
terminals were re-innervating the striatum. These type of grafting technique allowed 
for a reduction in amphetamine-induced rotations and increased graft survival 
compared to rats that received grafts but no ‘bridge’ between them (Brecknell et al., 
1996a; Brecknell et al., 1996b). Other studies have shown with similar techniques 
that bridges between the SN and the striatum produce greater graft survival, in terms 
of cell numbers, and allow for TH-ir axons to grow along the bridges and reach the 
striatum. Not each type of tissue is usable for providing viable ‘bridges’; better results 
have been achieved using sciatic nerve (Aguayo et al., 1984), Schwann cells 
(Brecknell et al., 1996a), and striatal or olfactory neuron bridges (Dunnett et al., 
1989), but not laminin-coated beads or astrocytes (Dunnett et al., 1989). 
Furthermore, of the four types of cell-bridges used by Dunnett et al. (striatal, 
olfactory, astrocyte, laminin), only rats that received striatal bridges and displayed 
TH-ir fibre innervation of the striatum displayed a reduction in methamphetamine-
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induced rotation scores (Dunnett et al., 1989). Using bridge grafts to provide the 
homotopicially grafted DAergic cells with a ‘scaffold’ or ‘trajectory’ to grow along, has 
shown to provide greater innervation of the striatum than without, although overall 
innervation pattern were still low (Aguayo et al., 1984; Brecknell et al., 1996a; 
Brecknell et al., 1996b; Dunnett, 1999a). However, although graft placement is 
important for the recovery of certain functions (Dunnett et al., 1981c; Dunnett et al., 
1983a; Dunnett et al., 1984; Dunnett et al., 1988a), it is not the only important factor 
to consider (Barker & Dunnett, 1999). When comparing wGE grafts in the QA lesion 
model and VM grafts in the 6-OHDA lesion model, behavioural recovery does not 
only depend on lateral graft placement but also on the type of tissue used. Whereas 
in the former model recovery on skilled paw use in a reaching test is improved, the 
graft in the PD model does not show any beneficial effects, despite being placed in 
the same location within the striatum (Dunnett et al., 1988b; Montoya et al., 1990; 
Barker & Dunnett, 1999). 
 
The tissue used for primary fetal grafts consists not only of DAergic neurons, but 
rather of a mixture of different cell types. Recently it has been shown that the nigral 
A9-type of cells in particular are needed for greater innervation and functional 
behavioural improvements (Grealish et al., 2010a). With the development of new 
techniques such as cell sorting, cell labelling, and stem cell technologies (e.g., 
reporter cell lines) it will be possible to provide a more pure cell suspension, which 
can help to resolve the theoretical issue and in turn may provide a better functional 
outcome. Additionally, these new techniques will allow for a better visualisation of the 
graft and which cell populations are important for what aspect of recovery, e.g., A9 
grafts for general motor improvement and astrocytes for better graft survival. 
 
Recent studies in rats and mice have shown that the use of younger donor tissue 
provides larger grafts, which is mainly due to improved survival and a larger 
proportion of the A9-type cells (Thompson et al., 2005; Torres et al., 2007; Torres et 
al., 2008a; Thompson et al., 2009; Bye et al., 2012). Advances in stem cell 
technologies will eventually provide pure populations of certain cell types, although at 
present, there are a lack of markers and transcription factors. Although A9 and A10 
type of cells can be distinguished on their relative co-expression of GIRK-2 or 
Calbindin with TH, this distinction is not absolute as there are cells that display 
considerable overlap of the respective markers (Thompson et al., 2005; Bye et al., 
2012). Furthermore developmental factors as LMX1A or FOXA2 are currently used to 
confirm that cells are developing into a DAergic lineage (Nelander et al., 2009; 
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Pfisterer et al., 2011a; Kirkeby et al., 2012), but there is as yet no conclusive marker 
that can be expressed to confirm full developmentof the A9 phenotype. New 
technologies in the form of induced pluripotent stem cells (iPS) (Takahashi & 
Yamanaka, 2006), direct induced neurons (iN) (Pfisterer et al., 2011a; Pfisterer et al., 
2011b), embryonic stem cells (ES) (Kriks et al., 2011) or cells from expanded primary 
fetal VMs will help to generate ‘pure’ A9-type cell populations eventually, although at 
the moment the race is still open with primary fetal tissue remaining the currently 
availble ‘gold standard’. 
 
Grafting parameters 
Greater re-innervation can mainly be achieved by combining findings from multiple 
lines of research. Usually laboratories change one parameter at a time to investigate 
the effects of specific manipulations of cell numbers transplanted or the effect of 
trophic factors, but when translating the findings to the clinic a combined approach 
has to be considered first. In the paradigm used by Winkler et al. (1999), combined 
grafts of intrastriatal transplanted DAergic grafts and intra-SN transplanted 
GABAergic grafts had additive effects (Winkler et al., 1999). 
 
Larger grafts and more extensive re-innervation can be achieved via several 
methods. First, it is important to note that the transplanted cell suspension, derived 
from an entire VM dissection consists of, only 5-11% (about 35,000 cells in the rat) of 
cells that are actually DAergic (Sauer & Brundin, 1991; Nakao et al., 1995; Schierle 
et al., 1999). Moreover, the majority of the grafted cells die within the first 6 days after 
transplantation (Brundin & Bjorklund, 1987). The mechanisms responsible for cell 
death have been identified as apoptosis, injury, oxidative stress and energy 
deprivation, to which the DAergic subpopulation is particularly susceptible (Brundin & 
Bjorklund, 1987; Castilho et al., 2000). Improvements in dissection technique, cell 
preparation, and transplantation are directly under the control of the investigator. 
Dissections should be narrow to exclude the non-DA cells away from the midline and 
relatively rostral to exclude the large caudal population of serotonergic cells; 
handeling of the preparation should be done with utmost care to prevent damage to 
the cells; transplantation should occur producing a minimum of trauma to the host 
brain; the use of the right donor age (Torres et al., 2007; Torres et al., 2008a; 
Kauhausen et al., 2013), preparation of the host environment by trophic factors 
(Sinclair et al., 1996; Ahn et al., 2005; Torres et al., 2005a), the use of smaller tissue 
pieces, rather than single cell suspensions (Watts et al., 2000a; b), grafting cells with 
a syringe with a small outer diameter or a fine glass-capillary (Nikkhah et al., 1994b; 
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Nikkhah et al., 1994c; Nikkhah et al., 2009) are all important parameters in optimising 
cell yields. Furthermore, pre-treatment of the grafting site (e.g., GDNF, FGF) might 
be a strategy to help the grafted cells to better survive and to direct them down an A9 
phenotype (Ahn et al., 2005; Torres et al., 2005a; Kauhausen et al., 2013). Cell 
survival can further be increased via pre-treatment by anti-apoptotic or antioxidant 
factors (e.g., caspase inhibitors, lazaroids) (Brundin et al., 2000a; Brundin et al., 
2000b). Given the heterotopic innervation of the striatum, graft placement should be 
focussed on key functional targets (Mandel et al., 1990). The general idea behind 
most of the improvements is to be gentle to the tissue, avoiding trauma, e.g. gentle 
mechanical dissociation, rather than producing a single cell suspension, and to 
transplant the cells into a non-immune-reactive environment such that the grafted 
cells become re-vascularized quickly. 
 
Circuit reconstruction 
Despite evidence of partial recovery and amelioration of the lesion-induced deficits, 
cell replacement therapy based on fetal DAergic cells has never achieved complete 
recovery of all the impairments resulting from loss of striatal DA. This is also true for 
experiments presented in this thesis (Chapters 3.3 and 3.6) as well as those 
published over the last 40 years. With the exception of drug-induced rotation, none of 
the other tests bring behavioural performance back to the level of unoperated 
controls. Despite remarkable improvements by fetal nigral grafts, previous studies 
have failed to show full recovery on a series of behavioural tests such as operant 
assessment on the choice reaction time tasks (Dowd & Dunnett, 2004; Heuer et al., 
2013a; Heuer et al., 2013c), staircase (Abrous et al., 1993a; Abrous et al., 1993b; 
Nikkhah et al., 1993), sensory neglect (Dunnett et al., 1987; Nikkhah et al., 1993; 
Dowd et al., 2005a), and disengage-behaviour (Nikkhah et al., 1993). This is not to 
denigrate fetal nigral cell grafts, as they indeed show a remarkable effect on 
behaviour compared to lesion performance, but there is room for improvement. 
Especially considering that alleviation of deficits is seen with striatal grafts 
(transplanting developing whole ganglionic eminence (wGE) for HD models) on tests 
such as the staircase test, where nigral grafts do not prove to be effective (Montoya 
et al., 1990; Montoya et al., 1991). 
 
Striatal grafts are able to alleviate many of the deficits that cannot be reinstated by 
nigral grafts. Although both graft-types reverse the pattern of drug-induced rotations, 
on other tests only striatal grafts offer recovery. Skilled paw use for example is 
recovered by lateral grafts of striatal tissue but not by nigral tissue when assessed in 
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reaching cages (Dunnett et al., 1988b) or the staircase apparatus (Montoya et al., 
1990; Montoya et al., 1991; Klein et al., 2007; Rath et al., 2012). Also on the 
lateralised choice reaction time task a similar pattern is seen with striatal grafts 
allowing for greater recovery than nigral grafts (Mayer et al., 1992; Dobrossy & 
Dunnett, 1998; Brasted et al., 1999b; Dowd & Dunnett, 2004; Heuer et al., 2013a). 
Interestingly, in the striatal wGE-graft model described above, the improvement seen 
was not evident from the first day of testing, but rather, grafted rats improved over the 
consecutive weeks of post-graft testing (Mayer et al., 1992; Brasted et al., 1999c; 
2000b). This effect has been termed ‘learning to use the transplant’ (Mayer et al., 
1992). Extensive retraining is required for the graft-effect to emerge; in the original 
description grafted rats performed at control level with six weeks of testing (Mayer et 
al., 1992; Brasted et al., 2000b). Most fascinating, this training effect is very specific. 
In an elegant designed study, rats were trained either on the ipsilateral side to the 
graft first and then on the contralateral side or in the opposite pattern (Brasted et al., 
1999b). Training on the side opposite to the transplant led to recovery over the 
course of testing (re-learning) whereas lesioned rats that did not receive grafts 
stayed impaired. Rats that were trained on the ipsilateral side to the lesion/graft first 
only displayed a marginal deficit. When the sides of testing was then altered for both 
groups, the data showed that there was no transfer of training effect, grafted rats that 
were trained on the ipsilateral side first were impaired during the first days of 
contralateral testing, although they had received 30 days of ipsilateral training. 
Furthermore, also this group did then improve over the weeks of testing to a similar 
degree to the rats that were trained on the contralateral side first (Brasted et al., 
1999b). Although the training to use the transplant effect has been repeatedly 
reported, the level of recovery seen is dependent on the task as well. More complex 
behavioural tests allow for a great deal of relearning but grafted animals still do not 
perform at the same level as untreated controls (Brasted et al., 1999b; Dunnett & 
White, 2006). The learning to use the transplant effect is thought to be dependent on 
(partial) reconstruction of the fronto-striatal circuitry (Dunnett, 1995; 1999b; 2000). 
Circuit reconstruction and the learning to use the transplant effect has been shown in 
other models as well as retina transplantation (Coffey et al., 1989; 1990). Here rats 
received retianae transplants neonatally and were tested once the animals were 
mature. Although initially rats did not make use of information that was provided to 
the transplant, after training on a foot-shock paradigm (high motivation), rats learned 
to use information conveyed to the transplant (Coffey et al., 1989; 1990). It can be 
speculated that once transplantation techniques are developed to provide the 
anatomical foundation of circuit reconstruction, behavioural recovery will be 
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improved. Furthermore, similar to the striatal transplantation model, it can be 
assumed that extensive post-operative training will be necessary to re-establish 
functional circuits and for re-learning of S-R relationship to take place. 
 
Comparing the graft effect of the present and previous studies clearly shows the 
limitations of DA rich grafts that are transplanted ectopically into the denervated 
striatum. Here, although a great deal of recovery is achieved, grafts to not increase 
functional recovery with extensive testing as in experiment 3.2 rats were trained over 
70 consecutive days. Although experimental evidence is still lacking, it can be 
speculated that (full) circuit reconstruction via grafting primary fetal VM donor tissue 
into the SN will allow for greater recovery if the graft makes not only the appropriate 
connections in the host midbrain, but also grows axons, re-innervating the lesioned 
striatum where appropriate connections are made. Furthermore, even if such an 
anatomical reconstruction of the nigro-striatal circuitry would be achieved it can be 
assumed that extensive post-operative training will be needed to re-establish the 
teaching signal conveyed by the DAergic cells for recovery to occur. In the following 
sections grafting parameters will be discussed further with respect to the biological 
foundations of greater behavioural recovery by nigral grafts.  
 
Behavioural assessment 
Any therapeutic approach will have to undergo rigorous testing and a systematic 
comparison to the ‘gold standard’ that is currently primary fetal tissue and will have to 
prove beneficial in order to progress. Alternative cell sources will have to be proven 
to (out-)perform primary fetal tissue not only on a histological level, but also on a 
functional level in long term behavioural tests. However, even if ‘performance’ of 
those new cell lines is less than that of primary fetal tissue, they might still be used 
because, once perfected, they are advantageous in terms of less ethical challenges 
on tissue acquisition, standardisation of tissue production, sterility and quality control, 
and logistical constraints, all factors that are important for a standardised widespread 
application. 
 
The type of tests used has to be carefully considered and a stable lesion is of utmost 
importance. It is extremely difficult to to distinguish the effect of the therapeutic 
intervention from unrelated factors against a moving baseline, such as can result in 
the presence of spontaneous behavioural recovery. In the respective chapters we 
have shown that bundle lesions produce not only the most severe, but importantly 
the most stable, impairment, both in rats and mice, and there are several tests of 
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drug-induced and spontaneous motor behaviour that are suitable for behavioural 
assessment of the bundle lesion type, both in mice (Lundblad et al., 2004; Iancu et 
al., 2005; Lundblad et al., 2005; Grealish et al., 2008; Francardo et al., 2011; Smith & 
Heuer, 2011; Heuer et al., 2012; Smith et al., 2012a; Smith et al., 2012b; Heuer et 
al., 2013c) and in rats (Dunnett et al., 1981b; Dunnett et al., 1983b; a; Nikkhah et al., 
1994a; Dowd & Dunnett, 2004; Dowd et al., 2005a; Torres & Dunnett, 2007; Torres 
et al., 2008a).  
 
In the second strand of this thesis (Chapters 3.4 to 3.6) we have shown that the 
unilateral mouse lesion model is a viable research tool when several factors are kept 
in mind. As discussed above, mice are not small rats, and require more attention to 
detail. In addition to the necessity of the testing conditions to be quiet and odour 
neutral, the intensive post-operative care demands a lot of attention from the 
researcher. Keeping this in mind, we and others have successfully utilised the mouse 
as a research tool and we have shown here that the unilateral lesion produces similar 
effects to those reported in the rat (Dowd & Dunnett, 2004; Lundblad et al., 2004; 
Dowd & Dunnett, 2005a; Iancu et al., 2005; Lundblad et al., 2005; Grealish et al., 
2010b; Smith & Heuer, 2011; Smith et al., 2012a; Smith et al., 2012b). Whereas, 
some tests (e.g., the cylinder test) are more sensitive and useful in rats than in mice, 
others, such as the corridor test, seem to be more useful in the latter species 
(Chapter 3.4). Although knowledge about one species’ behaviour is useful as a 
starting point in designing new behavioural tasts for a second species, systematic 
characterisation and validation of those tests is required before they can be 
confidently adopted as an assessment tool or therapeutic screen.  
 
Behavioural testing can require large groups of animals, especially when there is 
large variation in the data, as is often in the case with mice. Moreover, testing can be 
time-consuming and labour intensive. Furthermore ethical regulations (i.e. 3Rs) make 
it imperative to reduce the number of animals used to the minimum numbers 
necessary to achieve reliable results. Initial studies, especially those using stem cells 
in the (near) future, should conduct their initial assessments in simple tests of motor 
asymmetry, including drug-induced tests of rotation for a first screening of the cells. If 
the cells compensate the rotational response, there is sufficient face validity to 
commence more complex behavioural testing. Long-term testing using stem cells 
derived from other species, including human cells will cause an immune response. 
Using immunosuppresants will make long-term operant testing almost impossible as 
(i) there is associated weight loss with long-term immunosuppression, (ii) cells need 
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to mature a long time before exerting beneficial effects, and (iii) additional food-
restriction for motivation may be too tough on the animals’ health. Fortunately, the 
recently described concept of tolerisation/desensitisation may help to conduct long-
term behavioural studies, although still more data needs to be generated to address 
long term (>12 month) survival (Kelly et al., 2009).  
 
The lesion model described and used throughout the present thesis is most useful 
where the therapy is acting on the DA system, with other effects being speculative. 
As recently shown, GDNF overexpression was protective against 6-OHDA insult but 
not against cell loss caused by !-synuclein overexpression (Decressac et al., 2011). 
Caution must therefore be taken when it comes to selection of the animal model. 
However, the tests used and described in this thesis have a high face and construct 
validity when used for cell replacement therapies based on DA. Furthermore, 
predictive validity is high as the model is highly responsive to DAergic drugs as l-
DOPA. Whereas operant testing is highly reliable, given that the lesion is stable, 
simple tests of motor behaviour, that are not dependent on activation by a drug or 
motivation via food restriction, are often easy to implement but can be less reliable. 
The cylinder test is one such example where repeated testing, if not interrupted by 
some time, will cause the animal to cease exploring. Operant analysis of behaviour 
has the advantage of being fully automated and controlled by the computer, and as 
such is objective and less subject to experimenter bias than tests dependent upon 
hand testing, observation or rating measures. Furthermore, because of the large 
number of trials that can be gathered in a single session, standard errors of 
measurement can be reduced dramatically, increasing the power to detect 
statistically small differences in the dependent variables. Indeed, systematic 
multivariate designs using multifactorial analyses of variance are often only possible 
with this sort of data acquisition. As a consequence, operant testing has previously 
been shown to be more sensitive to small, but highly significant therapeutic effects, 
where simple tests of motor asymmetry have failed (Dowd & Dunnett, 2004). 
 
When using animal models like the one in the present thesis it is important to keep in 
mind that they are models of certain aspects of the disease pathology and not 
models of the actual disease. No animal model does present all the clinical and 
neuropathological features of PD. PD does neither occur naturally in mice nor rats, 
most likely due to their short lifespan. Despite this, the DA depletion model used in 
the present work has high construct validity in the sense that DA depletion is thought 
to be the underlying cause of most motor deficits and most logically this model lends 
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itself to investigate DA replacement via the transplantation of cells. Caution must be 
taken when choosing the model as other disease models may be more useful 
depending on the question asked. Whereas GDNF has been shown to have 
neuroprotective effects against 6-OHDA insult to the rat brain (Rosenblad et al., 
1999; Kirik et al., 2000a; Rosenblad et al., 2000; Kirik et al., 2001a; Kirik et al., 2004; 
Dowd et al., 2005b), it failed to protect DAergic neurons from !-synuclein insult and a 
recent clinical trial was aborted (Gill et al., 2003; Lo Bianco et al., 2004; Hutchinson 
et al., 2007; Decressac et al., 2011).  
 
Furthermore, rodents differ genetically and behaviourally from humans in many 
aspects (primary sense used, dexterity, language, cognition). The tremor at rest that 
is one of the hallmark symptoms for PD has not successfully been modelled in rats or 
mice and the pathology seen in man is progressive spanning decades. Despite 
obvious advantages of the unilateral lesion model, the degeneration in man occurs 
bilaterally. The development of bilateral models and tests is therefore an imperative 
requirement to more truly assess the lesion-induced deficits and the ability of 
subsequent DA cell replacement to ameliorate these. Using excitotoxins or 
transgenic animals, studies have shown the feasibility of using cognitive and 
psychiatric tests as well as other sensory modalities than sight and smell, to model 
the human condition in the rodent (Birrell & Brown, 2000; Trueman et al., 2005; 
Brooks et al., 2006; Tait et al., 2007; Tait & Brown, 2008; Dunnett et al., 2012). Tests 
of set-shifting, olfactory discrimination, maze running, etc. will have to be developed 
for the bilateral rat-lesion model of PD. First studies assessing cognitive 
manipulations in bilateral 6-OHDA lesioned rats are emerging (Smith et al., 2002), 
although, unfortunately, studies with partial and focal lesions do not report long-term 
data, therefore it cannot be assumed that the lesion produced is stable, rendering the 
model useless for cell replacement therapy unless such a long-term characterisation 
has been conducted. Here we use a model with clear advantages and limitations, 
and, whilst acknowledging the limitations, for the assessment of cell replacement 
therapies it is the best model available at the current stand of research. 
 
In summary, behavioural testing depends on many parameters from selection of the 
right model to selection of the right test. For cell replacement therapy a stable lesion 
is imperative to disentangle the effects of the lesion from those of the therapeutic 
intervention. A range of tests are available covering many motor, cognitive and 
psychiatric domains, and it would be wise to select tests from a range of these as no 
single test will capture all aspects of the condition.  
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Future work 
There are a number of improvements that could be addressed in future experiments 
to further alleviate the deficit. A more widespread innervation of the striatum can be 
achieved via transplanting cells throughout the striatum via multiple small deposits 
(Nikkhah et al., 1994b), larger grafts by using younger donor tissue (Torres et al., 
2007; Torres et al., 2008a), preparation of the graft site via injection of a GDNF 
vector previous to transplantation (Dowd et al., 2005b; Kauhausen et al., 2013), and 
the use of additional treatments, e.g., STN lesions, DBS in the STN, or additional 
grafts into the SN (Baker et al., 2000; Mendez et al., 2000). However, despite all 
these promising approaches to improve graft function, the ultimate goal of circuit 
reconstruction is not achieved by ectopic graft placement. Homotopic graft placement 
would circumvent this problem and might alleviate more deficits than ectopic 
transplantation. Recent use of a GFP mouse has shown that fibres can reach the 
striatum and even the prefrontal cortex when transplanted into lesioned mice 
(Thompson et al., 2005; Thompson et al., 2009). Furthermore, using the same GFP-
positive tissue, it was shown that it is the A9 component of the graft that is mainly 
responsible for the improvement in motor function in the unilateral rat lesion model of 
PD (Grealish et al., 2010a). The proportion of A9 type cells within the graft was 
increased by the use of younger donor tissue (Bye et al., 2012; Kauhausen et al., 
2013). With these new research tools available it will be interesting to attempt circuit 
reconstruction in the unilateral mouse lesion model and compare the effects of the 
two graft placements.  
 
As full behavioural recovery via reconstruction of the nigro-striatal circuit has not 
been experimentally shown in the PD rodent model this should be the ultimate aim. 
In an elegantly designed disconnection experiment Dunnett and White trained rats on 
the classical delayed alternation task conducted in the Skinner box and showed that 
at least one fronto-striatal circuit is necessary for optimal task performance (Dunnett 
& White, 2006; White & Dunnett, 2006). In their latest study they showed functional 
recovery achieved with a unilateral graft in bilateral quinolinic acid lesioned rats 
(Dunnett & White, 2006). To display true circuit reconstruction Dunnett proposed a 
disconnection study which should reinstate the deficit if the recovery was due to 
circuit reconstruction (Dunnett & White, 2006). This is an interesting proposal that 
should be taken up and combined with future studies in the DA cell replacement field. 
A recent study by Graybiel has shown that optogenetic manipulation can be used to 
temporarily inhibit cells in certain (here infralimbic cortex; = rat mPFC) brain regions 
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(Smith et al., 2012c). If cells could be transfected with the EYFP coding AAV-5 viral 
vector prior to grafting, and then be transplanted into the striatum/nigra, the effects of 
the graft could be manipulated from the outside, whereas up to date only the 
removal/disconnection of the graft could be done. This form of manipulation, 
especially once a widespread re-innervation is achieved by nigral grafts in homotopic 
placement, has the potential to provide compelling evidence for circuit reconstruction.  
 
Conclusion  
 
Although many questions remain in terms of what cells to use and where to place the 
transplant, cell replacement therapies offer a viable therapeutic alternative in a 
subgroup of patients. Here we further characterised rodent models of PD for the 
assessment of what is actually impaired in the lesion and what can be repaired by 
our standard method of grafting. The presented data will be useful for studies to 
come as they provide a baseline for alternative cells/therapies to be measured 
against.  
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Chapter 6 
Appendix 
Solutions used 
 
TRIS buffered saline (stock solution) 
48g TRIS base (Sigma) 
36g Sodium Chloride (Sigma) 
1l distilled water 
pH = 7.4 
 
Phosphate buffered saline 
90g di-sodium hydrogen orthophosphate (Bhd) 
45 g Sodium Chloride (Sigma) 
5l distilled water 
pH = 7.4 
 
Paraform aldehyde solution (1.5%) 
90g di-sodium hydrogen phosphate (Bhd) 
45g Sodium chloride (Sigma) 
Paraformaldehyde (1.5%) 
3300ml distilled water 
pH = 7.3 
 
Succrose solution (25%) 
25g succrose (Fisher) 
100ml phosphate buffered saline 
 
ABC solution 
5"l A (DAKO) 
5 "l B (DAKO) 
1ml 1% serum in TBS 
 
Quench 
10ml Methanol (Fisher) 
10ml Hydrogen peroxide (VWR Prolabo BHD) 
80ml distilled water 
 
Tris non saline (TNS) 
6g Trisma base (Sigma) 
1l distilled water 
pH = 7.4 
 
